data_2khi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2khi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.9 -31.28 84.74 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.367 3.378 . . . . 0.0 115.999 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 93.27 119.21 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.665 3.586 . . . . 0.0 109.316 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.13 54.47 Favored Glycine 0 C--N 1.372 2.575 0 CA-C-O 124.74 2.3 . . . . 0.0 112.581 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.84 134.61 44.75 Favored 'General case' 0 CA--C 1.507 -0.684 1 C-N-CA 133.235 4.614 . . . . 0.0 102.479 172.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 12.5 ptmt -103.1 152.56 21.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 10.9 mt -126.05 174.05 8.74 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 124.406 2.051 . . . . 0.0 107.64 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.94 137.15 53.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 168.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -146.98 175.06 26.56 Favored Glycine 0 CA--C 1.482 -1.995 0 CA-C-O 123.783 1.769 . . . . 0.0 111.04 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -117.99 134.82 54.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.87 133.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.302 1.4 t -121.23 -44.19 2.39 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.337 0.3 OUTLIER -136.29 174.83 10.19 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.69 -1.881 . . . . 0.0 111.068 175.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 1.1 mp -121.08 142.01 50.24 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . 0.332 1.1 t -112.49 179.16 4.06 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.564 1.173 . . . . 0.0 110.815 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.44 -28.88 60.77 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 130.129 3.372 . . . . 0.0 115.409 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.251 19.2 p90 -156.92 46.76 0.42 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 123.921 1.819 . . . . 0.0 110.025 175.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 174.76 -163.48 33.88 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . 0.461 ' HG ' ' HE3' ' A' ' 347' ' ' LYS . 0.7 OUTLIER -135.23 151.44 50.6 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.582 1.553 . . . . 0.0 107.535 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.284 57.2 m-85 -105.65 136.18 45.71 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.94 134.83 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.942 0 CA-C-N 112.316 -2.22 . . . . 0.0 106.285 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -100.12 128.55 46.18 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.856 -1.153 . . . . 0.0 113.302 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.326 29.5 mm -81.53 -103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 123.046 1.403 . . . . 0.0 113.89 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -107.82 169.67 8.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 129.313 3.045 . . . . 0.0 106.813 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.73 119.5 9.42 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 120.114 -1.616 . . . . 0.0 114.591 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 89.26 -5.98 83.78 Favored Glycine 0 C--N 1.369 2.368 0 C-N-CA 127.065 2.269 . . . . 0.0 115.638 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.67 113.49 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.34 2.256 . . . . 0.0 110.802 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.1 157.62 46.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 118.388 -2.695 . . . . 0.0 106.801 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -126.47 174.0 18.03 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 124.307 2.06 . . . . 0.0 115.901 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 7.9 tp -124.51 125.0 43.49 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.769 1.627 . . . . 0.0 107.888 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.2 110.85 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 C-N-CA 125.997 1.719 . . . . 0.0 107.74 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -79.04 115.14 18.53 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.373 1.599 0 C-N-CA 130.861 3.664 . . . . 0.0 119.111 -175.376 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -114.0 162.88 15.87 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 128.357 2.663 . . . . 0.0 105.678 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.05 120.47 12.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 126.145 1.778 . . . . 0.0 109.493 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.32 13.74 58.21 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 126.081 1.801 . . . . 0.0 116.532 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.84 149.22 21.42 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 126.04 1.736 . . . . 0.0 111.308 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.5 p -100.03 134.21 40.33 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-O 123.415 1.579 . . . . 0.0 110.502 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.75 -178.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 1 C-N-CA 134.3 5.04 . . . . 0.0 110.594 -173.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -127.34 147.02 50.26 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 129.014 2.925 . . . . 0.0 103.813 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.5 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 1.6 m -146.46 163.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 57.0 ttp -126.53 136.05 52.08 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.54 132.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -136.65 0.3 Allowed 'General case' 0 N--CA 1.417 -2.097 1 N-CA-C 97.92 -4.845 . . . . 0.0 97.92 172.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.32 2.6 t70 -63.2 112.41 2.66 Favored 'General case' 0 C--N 1.316 -0.88 1 N-CA-C 123.205 4.52 . . . . 0.0 123.205 -156.767 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . 0.334 0.0 OUTLIER -101.71 136.77 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 126.065 1.746 . . . . 0.0 111.36 -177.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -139.83 102.86 4.52 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 167.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.14 -18.3 63.3 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 129.124 2.97 . . . . 0.0 113.805 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.33 -32.71 58.85 Favored 'General case' 0 N--CA 1.433 -1.288 1 C-N-CA 133.042 4.537 . . . . 0.0 112.621 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -108.94 -31.64 7.58 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-O 123.188 1.47 . . . . 0.0 112.477 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.342 68.9 mtp180 74.91 50.46 0.09 Allowed 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 130.932 3.693 . . . . 0.0 113.112 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 125.53 44.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 111.683 -2.508 . . . . 0.0 104.763 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.88 130.01 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.216 1 N-CA-C 98.694 -4.558 . . . . 0.0 98.694 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 5.1 t -102.26 92.47 4.74 Favored 'General case' 0 C--N 1.377 1.804 1 C-N-CA 110.298 -4.561 . . . . 0.0 104.336 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.467 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -103.78 136.34 43.65 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 117.244 -1.783 . . . . 0.0 111.306 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.66 123.06 1.65 Allowed Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.357 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.5 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.664 1.5 tt -138.89 -90.07 0.21 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 131.176 3.79 . . . . 0.0 108.589 174.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . 0.461 ' HE3' ' HG ' ' A' ' 292' ' ' CYS 0.342 19.4 tttt 101.35 23.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 167.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.43 -47.67 63.36 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.473 11.8 p 95.28 164.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.374 1 C-N-CA 133.75 4.82 . . . . 0.0 113.916 -177.857 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -92.83 164.15 13.45 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.855 2.062 . . . . 0.0 111.582 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.5 99.31 11.49 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 119.235 -2.165 . . . . 0.0 107.849 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 91.45 64.44 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.831 0 C-N-CA 131.027 3.731 . . . . 0.0 105.968 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--N 1.368 1.59 0 C-N-CA 123.063 2.509 . . . . 0.0 113.728 -170.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -67.58 177.06 4.32 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.95 3.767 . . . . 0.0 116.011 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.49 135.6 21.41 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.12 5.11 44.11 Favored Glycine 0 C--N 1.369 2.386 0 CA-C-O 123.856 1.809 . . . . 0.0 112.546 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 70.5 p -95.93 121.87 38.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 130.923 3.689 . . . . 0.0 103.775 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -90.03 146.96 23.96 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.72 1.248 . . . . 0.0 113.362 -176.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -129.21 174.2 9.8 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-N 112.786 -2.006 . . . . 0.0 106.655 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.29 143.78 51.17 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.64 173.73 38.06 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -119.04 138.36 52.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 132.98 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.158 -1.589 . . . . 0.0 115.153 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.267 2.3 t -136.13 -25.57 1.2 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -133.4 174.37 10.48 Favored 'General case' 0 C--N 1.372 1.551 0 CA-C-N 123.484 2.856 . . . . 0.0 108.053 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.9 OUTLIER -121.01 151.41 39.79 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 167.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 178.18 4.38 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -65.59 -29.35 69.93 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.835 2.054 . . . . 0.0 115.663 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.11 44.44 0.72 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 125.126 2.394 . . . . 0.0 107.915 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.27 -165.21 29.82 Favored Glycine 0 CA--C 1.468 -2.869 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.7 t -143.3 153.83 43.17 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 126.266 1.826 . . . . 0.0 106.694 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.291 65.3 m-85 -114.81 142.22 46.84 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-O 124.885 2.279 . . . . 0.0 111.85 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.56 139.18 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.965 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -100.79 119.28 38.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.601 -1.312 . . . . 0.0 110.391 164.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.277 28.8 mt -60.15 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 124.433 2.063 . . . . 0.0 116.19 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.26 147.34 50.23 Favored 'General case' 0 CA--C 1.495 -1.153 1 N-CA-C 98.963 -4.458 . . . . 0.0 98.963 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -57.41 119.97 7.4 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.17 -10.55 47.49 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.731 1.634 . . . . 0.0 114.649 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.3 t -116.24 143.93 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 C-N-CA 127.966 2.506 . . . . 0.0 105.067 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -152.42 149.75 28.92 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 119.282 -2.136 . . . . 0.0 105.841 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.424 ' HA3' ' CD1' ' A' ' 344' ' ' LEU . . . -130.51 173.87 19.92 Favored Glycine 0 CA--C 1.485 -1.84 0 CA-C-O 124.368 2.093 . . . . 0.0 113.924 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 62.2 tp -97.81 163.49 12.78 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 120.378 -1.66 . . . . 0.0 110.157 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.263 11.8 t -116.76 118.89 60.28 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -79.87 113.27 17.91 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.386 7.6 p . . . . . 0 C--N 1.377 1.786 1 N-CA-C 122.003 4.075 . . . . 0.0 122.003 -166.565 . . . . . . . . 2 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.297 4.1 t . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 125.009 2.338 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -109.47 168.17 9.59 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.364 3.065 . . . . 0.0 107.66 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.33 121.2 23.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.38 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.43 14.95 56.42 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 125.676 1.608 . . . . 0.0 114.225 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.65 143.71 26.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.998 1.319 . . . . 0.0 110.912 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.405 HG23 ' HZ3' ' A' ' 350' ' ' LYS . 1.0 OUTLIER -99.83 136.25 31.92 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.773 1.273 . . . . 0.0 108.519 176.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.77 177.89 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 129.664 3.186 . . . . 0.0 107.074 -171.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -123.91 138.32 54.5 Favored 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 98.819 -4.512 . . . . 0.0 98.819 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 7.7 m -143.47 139.97 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 100.667 -3.827 . . . . 0.0 100.667 -167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.7 ttm -102.57 141.64 35.07 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 120.363 -1.46 . . . . 0.0 108.781 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.5 133.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 119.936 -1.727 . . . . 0.0 115.463 -170.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -135.35 0.29 Allowed 'General case' 0 N--CA 1.426 -1.643 1 N-CA-C 99.618 -4.215 . . . . 0.0 99.618 172.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.402 0.8 OUTLIER -59.69 112.72 1.92 Allowed 'General case' 0 N--CA 1.481 1.122 1 N-CA-C 124.196 4.887 . . . . 0.0 124.196 -158.976 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -101.48 112.83 35.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 C-N-CA 125.65 1.58 . . . . 0.0 114.176 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.55 107.48 6.67 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.87 7.32 37.81 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 126.535 1.934 . . . . 0.0 112.302 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . 0.25 24.1 mm-40 -82.71 -41.91 18.71 Favored 'General case' 0 N--CA 1.432 -1.351 1 C-N-CA 134.021 4.928 . . . . 0.0 108.831 170.955 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -101.51 -27.08 13.32 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.655 1.982 . . . . 0.0 111.349 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 63.1 mtm-85 75.32 53.21 0.07 Allowed 'General case' 0 C--N 1.35 0.604 1 C-N-CA 131.968 4.107 . . . . 0.0 112.702 -179.933 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -124.53 134.0 53.13 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 111.092 -2.776 . . . . 0.0 109.621 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.83 122.0 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 1 N-CA-C 94.44 -6.133 . . . . 0.0 94.44 172.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 94.96 5.76 Favored 'General case' 0 CA--C 1.463 -2.366 1 C-N-CA 110.845 -4.342 . . . . 0.0 104.35 -162.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.424 ' CD1' ' HA3' ' A' ' 302' ' ' GLY . 1.0 OUTLIER -96.34 171.24 8.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 118.925 -2.359 . . . . 0.0 109.547 -164.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -154.81 136.91 5.39 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 116.688 -2.672 . . . . 0.0 112.857 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.06 152.79 3.9 Favored 'General case' 0 C--N 1.35 0.592 1 N-CA-C 125.029 5.196 . . . . 0.0 125.029 -163.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -108.32 -102.25 0.37 Allowed 'General case' 0 C--N 1.386 2.159 0 O-C-N 121.208 -0.933 . . . . 0.0 111.909 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -139.33 24.25 2.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 120.196 -1.565 . . . . 0.0 114.85 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.485 0.9 OUTLIER 70.84 173.67 0.31 Allowed 'General case' 0 C--N 1.373 1.625 0 C-N-CA 126.334 1.853 . . . . 0.0 115.31 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -80.46 159.67 25.52 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.47 -1.394 . . . . 0.0 111.739 174.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.415 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -85.33 54.59 3.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 110.758 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.294 3.3 p30 123.01 94.32 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.801 1 C-N-CA 136.196 5.798 . . . . 0.0 104.977 -171.834 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 CA--C 1.556 1.584 0 C-N-CA 123.404 2.736 . . . . 0.0 110.511 -178.334 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -81.83 -37.37 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.394 3.396 . . . . 0.0 111.776 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 84.03 123.5 0.04 OUTLIER 'General case' 0 C--N 1.372 1.584 0 C-N-CA 129.637 3.175 . . . . 0.0 112.733 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.75 10.23 44.06 Favored Glycine 0 C--N 1.375 2.744 0 CA-C-O 124.255 2.031 . . . . 0.0 113.356 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.17 166.36 13.42 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 131.431 3.893 . . . . 0.0 103.31 167.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HZ2' ' HB2' ' A' ' 331' ' ' MET . 29.2 mmmt -112.14 146.98 37.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 120.244 -1.535 . . . . 0.0 111.906 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.8 mp -120.95 174.13 6.82 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 123.926 1.822 . . . . 0.0 107.094 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 89.1 m -141.09 138.28 33.44 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.381 -1.449 . . . . 0.0 108.228 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.91 179.06 36.62 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-O 124.183 1.991 . . . . 0.0 115.638 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -125.4 135.38 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.12 133.5 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 119.134 3.013 . . . . 0.0 119.134 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.255 12.4 t -115.59 -40.6 3.36 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 112.968 -1.923 . . . . 0.0 115.083 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -135.9 172.63 12.73 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.103 1.774 . . . . 0.0 109.138 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.18 142.36 50.5 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.652 1.581 . . . . 0.0 107.86 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 173.67 6.26 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 121.006 -1.059 . . . . 0.0 109.284 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -28.87 69.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.62 2.368 . . . . 0.0 115.537 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -153.3 48.46 0.69 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 123.494 1.616 . . . . 0.0 107.744 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 177.66 -161.55 28.83 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 167.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.36 0.8 OUTLIER -145.9 164.58 31.52 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 125.017 1.327 . . . . 0.0 109.523 168.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -102.92 122.44 44.57 Favored 'General case' 0 C--N 1.357 0.892 0 O-C-N 121.202 -0.936 . . . . 0.0 108.894 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.4 125.94 67.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.27 123.73 35.81 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.7 mm -91.25 48.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.932 -1.105 . . . . 0.0 111.231 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.268 38.0 mt-10 79.95 173.56 0.14 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.116 2.566 . . . . 0.0 110.481 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.56 119.4 12.29 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.92 -33.91 4.7 Favored Glycine 0 C--N 1.367 2.305 0 C-N-CA 127.65 2.548 . . . . 0.0 114.337 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . 0.298 1.8 p -117.35 123.54 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.0 112.03 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.38 154.65 45.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 119.066 -2.272 . . . . 0.0 107.276 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -116.27 172.15 14.09 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-O 124.083 1.935 . . . . 0.0 112.045 163.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 5.1 tp -126.75 126.48 43.51 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.638 ' CG2' ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -92.14 120.22 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 171.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -94.92 132.5 39.68 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 123.647 0.592 . . . . 0.0 111.801 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 176.733 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.234 0.271 0 CA-C-O 122.697 1.236 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -106.09 171.09 7.53 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 123.568 1.651 . . . . 0.0 108.863 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.49 120.66 2.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 128.261 2.624 . . . . 0.0 113.703 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.74 14.72 72.29 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 114.193 -1.367 . . . . 0.0 115.588 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.1 133.94 34.56 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 126.791 2.037 . . . . 0.0 106.494 172.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.04 135.59 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.433 ' HA ' ' N ' ' A' ' 349' ' ' CYS . 30.5 m -139.99 175.49 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 124.988 2.327 . . . . 0.0 111.462 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -108.51 150.93 26.76 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -138.55 167.05 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 -177.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.541 ' HB2' ' HZ2' ' A' ' 279' ' ' LYS . 31.9 ttm -115.52 138.81 50.66 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.431 ' HB ' HD12 ' A' ' 344' ' ' LEU . 1.2 p -85.7 131.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.91 -137.33 0.3 Allowed 'General case' 0 N--CA 1.414 -2.231 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.29 28.0 m-20 -65.01 112.45 3.33 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.816 4.376 . . . . 0.0 122.816 -155.084 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.431 0.1 OUTLIER -109.66 124.8 66.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 C-N-CA 125.409 1.484 . . . . 0.0 110.14 -179.202 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.26 112.68 13.57 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -78.97 -4.82 51.88 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 123.729 1.728 . . . . 0.0 112.866 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -86.52 -41.19 14.55 Favored 'General case' 0 N--CA 1.425 -1.689 1 C-N-CA 135.378 5.471 . . . . 0.0 111.269 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -103.11 -28.99 11.62 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 113.572 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.271 16.4 mmm180 75.02 48.88 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 128.118 2.567 . . . . 0.0 113.665 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.56 134.28 52.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 128.278 2.631 . . . . 0.0 106.337 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.3 mm -116.54 129.59 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 1 N-CA-C 95.052 -5.907 . . . . 0.0 95.052 168.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.68 94.36 5.25 Favored 'General case' 0 C--N 1.385 2.123 1 C-N-CA 111.037 -4.265 . . . . 0.0 106.425 -167.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 332' ' ' VAL . 0.2 OUTLIER -101.14 135.36 42.72 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 116.611 -2.035 . . . . 0.0 108.895 -171.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -124.28 134.68 9.25 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 121.652 -0.655 . . . . 0.0 112.943 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.638 ' H ' ' CG2' ' A' ' 304' ' ' VAL 0.353 0.1 OUTLIER -73.49 163.08 28.53 Favored 'General case' 0 C--N 1.368 1.381 1 N-CA-C 128.779 6.585 . . . . 0.0 128.779 -154.586 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -121.52 -105.77 0.37 Allowed 'General case' 0 C--N 1.384 2.108 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -163.6 152.0 13.59 Favored 'General case' 0 C--N 1.349 0.566 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 173.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.433 ' N ' ' HA ' ' A' ' 328' ' ' VAL . 13.0 t -86.35 -39.2 16.67 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.781 3.658 . . . . 0.0 108.922 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -129.35 165.14 22.09 Favored 'General case' 0 N--CA 1.449 -0.524 1 CA-C-N 104.258 -5.883 . . . . 0.0 108.759 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.22 46.18 1.01 Allowed 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.008 -1.683 . . . . 0.0 109.675 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.286 1.0 OUTLIER 154.94 69.31 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.629 1 C-N-CA 132.808 4.443 . . . . 0.0 106.56 -176.493 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.368 1.58 0 C-N-CA 124.74 3.627 . . . . 0.0 110.971 177.482 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.29 91.12 1.03 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.224 2.616 . . . . 0.0 107.247 168.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.28 151.58 46.75 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 128.714 2.805 . . . . 0.0 118.117 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.26 8.35 55.14 Favored Glycine 0 C--N 1.384 3.214 0 CA-C-O 124.753 2.307 . . . . 0.0 112.336 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 2.9 p -96.46 147.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.75 1 C-N-CA 135.136 5.374 . . . . 0.0 101.929 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 7.7 ptmt -112.35 156.07 23.08 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 119.007 -2.308 . . . . 0.0 113.399 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.12 151.61 40.91 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.8 m -109.03 139.24 44.17 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.666 -1.271 . . . . 0.0 109.679 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -140.51 -179.18 17.84 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 123.215 1.453 . . . . 0.0 112.083 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -119.07 137.64 53.42 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.82 125.93 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.3 t -106.68 -36.58 6.68 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 111.758 -2.474 . . . . 0.0 112.772 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.27 0.9 OUTLIER -136.64 170.26 16.36 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.819 1.645 . . . . 0.0 109.299 177.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.72 148.05 45.11 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.7 m -112.02 172.56 6.83 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -68.05 -28.09 67.09 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.174 -2.204 . . . . 0.0 113.298 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.68 44.07 1.37 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.949 1.7 . . . . 0.0 107.757 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -179.05 -168.31 37.94 Favored Glycine 0 CA--C 1.471 -2.71 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 145.86 26.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -101.14 118.69 37.49 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.67 125.04 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.19 119.47 33.06 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.246 -1.534 . . . . 0.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 37.5 mm -60.19 -65.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -138.08 166.52 23.91 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -65.52 118.87 10.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.835 -1.166 . . . . 0.0 114.046 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.02 -16.94 53.61 Favored Glycine 0 C--N 1.368 2.329 0 C-N-CA 127.128 2.299 . . . . 0.0 115.851 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.91 117.83 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.941 1.697 . . . . 0.0 109.94 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.76 160.31 37.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 119.346 -2.097 . . . . 0.0 110.299 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.35 173.54 15.35 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 125.946 1.736 . . . . 0.0 114.181 169.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.2 tp -126.22 115.53 19.88 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 126.442 1.897 . . . . 0.0 107.088 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.256 4.3 p -87.34 112.77 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -79.16 123.46 27.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.165 -176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.508 2.439 0 CA-C-N 122.942 2.61 . . . . 0.0 115.911 176.106 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 123.805 1.764 . . . . 0.0 114.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -120.16 169.06 10.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.09 121.27 26.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 C-N-CA 126.56 1.944 . . . . 0.0 107.834 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.42 53.79 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -98.89 164.46 12.19 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 130.009 3.324 . . . . 0.0 104.13 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.29 0.2 OUTLIER -121.41 138.17 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.302 -1.499 . . . . 0.0 109.925 -175.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . 0.259 0.9 OUTLIER -139.23 163.47 26.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 CA-C-O 122.879 1.323 . . . . 0.0 108.086 179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.24 155.38 18.06 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.491 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 3.1 m -141.1 163.71 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 51.6 ttp -120.71 141.43 50.44 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.9 p -80.72 131.37 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.411 ' HB2' ' H ' ' A' ' 334' ' ' ASP . 0.6 OUTLIER -123.36 -136.66 0.29 Allowed 'General case' 0 N--CA 1.42 -1.968 1 N-CA-C 99.953 -4.092 . . . . 0.0 99.953 176.571 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . 0.461 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.254 24.7 m-20 -69.45 112.32 5.9 Favored 'General case' 0 C--N 1.31 -1.152 1 N-CA-C 122.702 4.334 . . . . 0.0 122.702 -154.766 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.335 0.1 OUTLIER -102.87 125.39 57.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 C-N-CA 127.266 2.226 . . . . 0.0 109.28 179.607 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.72 110.62 14.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -74.94 -3.43 32.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.025 2.13 . . . . 0.0 113.539 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -88.17 -35.55 17.32 Favored 'General case' 0 N--CA 1.432 -1.358 1 C-N-CA 132.49 4.316 . . . . 0.0 110.766 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -103.71 -39.93 6.48 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.507 1.523 . . . . 0.0 111.806 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.361 92.5 mtt180 74.48 52.49 0.09 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 132.423 4.289 . . . . 0.0 112.606 -179.272 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -124.87 132.85 53.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 127.802 2.441 . . . . 0.0 104.638 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 131.15 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' SER . . . . . 0.461 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 3.9 m -107.32 92.19 3.97 Favored 'General case' 0 C--N 1.381 1.94 1 C-N-CA 111.061 -4.256 . . . . 0.0 105.105 -166.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.6 138.28 38.8 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 119.961 1.255 . . . . 0.0 111.45 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -149.12 123.81 1.7 Allowed Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.309 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.491 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.741 4.0 tt -139.58 -86.93 0.22 Allowed 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.493 3.517 . . . . 0.0 112.348 174.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.263 29.7 ttmt 93.78 44.2 0.0 OUTLIER 'General case' 0 C--N 1.371 1.506 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -79.8 -46.83 16.21 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 118.822 -2.424 . . . . 0.0 113.324 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.259 63.0 m 90.02 160.1 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 130.425 3.49 . . . . 0.0 111.492 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 4.9 mmtp -72.16 166.81 21.59 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.413 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -92.24 4.04 54.11 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.801 2.04 . . . . 0.0 114.469 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -168.64 75.58 0.8 Allowed Pre-proline 0 CA--C 1.541 0.626 1 C-N-CA 131.84 4.056 . . . . 0.0 105.183 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo . . . . . 0 C--N 1.372 1.769 1 C-N-CA 125.478 4.119 . . . . 0.0 116.045 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . 0.291 4.5 m-85 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.89 114.82 4.01 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.666 2.911 . . . . 0.0 109.727 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.3 125.19 27.25 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.809 1.644 . . . . 0.0 111.822 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.04 2.24 31.73 Favored Glycine 0 C--N 1.363 2.074 0 CA-C-O 122.929 1.294 . . . . 0.0 113.551 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 46.8 p -93.23 142.58 27.15 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 28.5 mmtp -97.65 146.03 25.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.559 1.171 . . . . 0.0 112.933 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.87 175.46 6.54 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 124.319 2.009 . . . . 0.0 110.238 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 48.3 m -116.92 129.87 56.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -132.4 173.44 20.79 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 124.42 2.122 . . . . 0.0 111.877 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -129.51 126.33 38.39 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.36 136.63 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 119.575 -1.953 . . . . 0.0 115.988 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.323 4.1 t -145.41 -20.35 0.48 Allowed 'General case' 0 C--N 1.361 1.083 0 N-CA-C 121.253 3.798 . . . . 0.0 121.253 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.347 2.6 t-20 -134.19 175.92 9.06 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 123.734 2.97 . . . . 0.0 110.672 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 142.44 49.85 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 119.134 -2.229 . . . . 0.0 108.512 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.0 m -112.51 178.38 4.32 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.85 -29.62 65.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.86 46.39 0.14 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 123.742 1.735 . . . . 0.0 110.278 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.0 -167.58 36.23 Favored Glycine 0 CA--C 1.48 -2.1 1 N-CA-C 101.17 -4.772 . . . . 0.0 101.17 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.258 0.1 OUTLIER -134.6 161.41 35.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -98.95 128.33 45.09 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.79 -1.819 . . . . 0.0 107.972 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.58 133.19 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.446 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.3 126.42 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 118.61 -2.556 . . . . 0.0 111.879 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.64 173.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 119.859 -1.776 . . . . 0.0 111.225 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -78.04 -17.72 56.72 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-O 127.315 3.436 . . . . 0.0 117.126 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.98 154.11 39.45 Favored 'General case' 0 C--N 1.303 -1.439 2 C-N-CA 143.072 8.549 . . . . 0.0 112.797 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.77 2.77 72.39 Favored Glycine 0 C--N 1.371 2.49 0 O-C-N 119.296 -2.128 . . . . 0.0 115.7 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.08 144.93 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 129.679 3.192 . . . . 0.0 108.605 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -115.17 158.24 22.51 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.984 -1.697 . . . . 0.0 107.925 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -110.25 172.92 15.99 Favored Glycine 0 C--N 1.359 1.841 0 CA-C-O 125.058 2.477 . . . . 0.0 112.973 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.3 tp -118.48 114.62 23.14 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.296 1.5 p -79.43 100.02 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 122.858 1.313 . . . . 0.0 107.54 174.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -87.92 114.7 24.79 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.937 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 177.755 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.269 10.0 t . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.728 0.775 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.79 172.3 8.73 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 124.406 2.05 . . . . 0.0 111.09 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.64 120.64 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 112.328 -2.215 . . . . 0.0 109.758 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.61 62.25 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 125.88 1.705 . . . . 0.0 115.827 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -93.4 151.67 19.6 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.766 2.427 . . . . 0.0 110.474 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.58 138.55 26.42 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 126.16 1.784 . . . . 0.0 107.727 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.639 HG23 ' H ' ' A' ' 349' ' ' CYS 0.253 7.5 p -147.92 170.16 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 124.354 2.025 . . . . 0.0 108.707 -173.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.37 140.6 38.24 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.5 167.67 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.682 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -173.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 23.6 ttm -118.4 138.8 52.2 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 171.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 92.5 t -81.6 124.74 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.531 -1.356 . . . . 0.0 111.14 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . 0.253 1.8 mp -125.03 -141.41 0.29 Allowed 'General case' 0 N--CA 1.409 -2.501 0 CA-C-O 126.847 3.213 . . . . 0.0 102.453 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . 0.426 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.35 4.9 t70 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 -152.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.8 tp -109.99 132.46 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.303 -172.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.44 104.05 5.96 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 101.58 -3.489 . . . . 0.0 101.58 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.57 -9.16 59.25 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.186 2.195 . . . . 0.0 114.026 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.13 -37.29 14.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.181 3.792 . . . . 0.0 111.074 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -100.62 -23.3 14.7 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 124.731 1.212 . . . . 0.0 112.365 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.276 1.5 mmp_? 74.45 46.7 0.15 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 129.491 3.116 . . . . 0.0 113.883 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.67 111.92 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 111.119 -2.764 . . . . 0.0 105.214 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.65 130.23 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 2 C-N-CA 133.579 4.752 . . . . 0.0 99.597 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' SER . . . . . 0.426 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 2.5 m -115.12 93.72 4.43 Favored 'General case' 0 CA--C 1.471 -2.063 1 C-N-CA 109.217 -4.993 . . . . 0.0 105.48 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 136.29 40.47 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -150.44 124.46 1.74 Allowed Glycine 0 N--CA 1.47 0.948 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.897 -164.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -32.93 154.15 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 2 C-N-CA 135.37 5.468 . . . . 0.0 124.72 -168.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -101.94 -79.75 0.51 Allowed 'General case' 0 C--N 1.384 2.089 0 C-N-CA 124.188 0.995 . . . . 0.0 109.531 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.31 0.4 OUTLIER -176.44 46.75 0.01 OUTLIER 'General case' 0 C--N 1.372 1.585 0 N-CA-C 118.278 2.696 . . . . 0.0 118.278 176.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.639 ' H ' HG23 ' A' ' 328' ' ' VAL 0.421 13.4 p 68.18 161.74 0.19 Allowed 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.205 4.15 . . . . 0.0 122.205 169.845 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -77.53 168.76 19.46 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 128.646 2.778 . . . . 0.0 113.33 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -101.81 18.29 20.88 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 118.895 -2.378 . . . . 0.0 113.257 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -174.89 52.21 0.11 Allowed Pre-proline 0 N--CA 1.438 -1.032 0 C-N-CA 129.673 3.189 . . . . 0.0 109.12 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo . . . . . 0 C--N 1.377 2.066 0 C-N-CA 125.005 3.803 . . . . 0.0 114.968 -171.125 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.76 -176.19 3.11 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.829 3.019 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.31 126.92 49.14 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.512 1.125 . . . . 0.0 108.791 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.36 36.49 Favored Glycine 0 C--N 1.367 2.296 0 CA-C-O 123.804 1.78 . . . . 0.0 114.645 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 4.1 p -96.62 134.22 40.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 131.152 3.781 . . . . 0.0 102.923 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 21.2 pttp -100.13 149.63 23.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.327 1.537 . . . . 0.0 114.687 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.95 175.28 6.14 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 123.447 1.594 . . . . 0.0 110.445 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 94.8 m -118.04 132.82 56.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.82 179.15 26.83 Favored Glycine 0 CA--C 1.481 -2.093 0 CA-C-O 123.875 1.819 . . . . 0.0 111.337 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -124.45 146.57 48.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 5.0 t -92.27 133.66 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.374 -1.453 . . . . 0.0 112.051 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -125.49 -38.88 2.22 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.87 174.69 10.19 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 121.334 1.879 . . . . 0.0 107.281 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.9 mp -119.53 151.08 39.2 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 119.98 -1.7 . . . . 0.0 110.583 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 178.94 4.12 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -30.05 69.0 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 119.066 -2.271 . . . . 0.0 115.711 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -145.72 39.28 1.14 Allowed 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 123.18 1.467 . . . . 0.0 110.504 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.38 -170.97 37.54 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 5.3 m -135.82 157.12 47.62 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.2 125.74 44.85 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.29 133.58 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 125.586 1.554 . . . . 0.0 107.344 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.43 126.47 46.83 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.811 2.096 . . . . 0.0 114.478 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 8.6 mm -104.56 56.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.626 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 75.22 171.6 0.27 Allowed 'General case' 0 C--N 1.364 1.236 0 C-N-CA 127.477 2.311 . . . . 0.0 111.877 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.96 119.04 12.66 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.75 -2.469 . . . . 0.0 115.593 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 118.82 -32.71 5.06 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 127.193 2.33 . . . . 0.0 114.987 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 342' ' ' ILE . 40.3 t -116.9 130.64 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 127.543 2.337 . . . . 0.0 107.739 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.98 157.02 28.06 Favored 'General case' 0 CA--C 1.478 -1.798 0 O-C-N 118.307 -2.746 . . . . 0.0 104.916 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -125.87 174.07 17.7 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.61 122.26 37.69 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 125.932 1.693 . . . . 0.0 106.866 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.61 118.79 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -96.48 133.24 41.18 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 117.359 -1.736 . . . . 0.0 112.454 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.269 52.4 t . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.399 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 118.566 2.802 . . . . 0.0 118.566 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -109.66 148.96 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.4 p -78.67 120.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.696 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 88.24 25.63 30.64 Favored Glycine 0 C--N 1.361 1.924 0 C-N-CA 124.31 0.957 . . . . 0.0 113.457 -170.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.83 158.0 15.87 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.674 1.99 . . . . 0.0 108.88 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -117.02 136.56 53.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.264 10.7 p -147.49 175.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 130.764 3.626 . . . . 0.0 108.225 -166.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -114.69 141.71 47.45 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 1.4 m -124.37 166.5 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 35.2 ttm -121.12 141.09 51.13 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.8 t -81.66 131.86 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.593 -1.317 . . . . 0.0 113.522 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.48 -136.35 0.29 Allowed 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.252 10.5 t70 -63.84 112.05 2.73 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.585 4.291 . . . . 0.0 122.585 -153.651 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.267 2.8 tp -101.13 112.38 33.9 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 CA-C-O 122.7 1.238 . . . . 0.0 108.882 176.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.07 117.15 23.33 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.481 1.112 . . . . 0.0 108.166 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -80.96 -2.79 49.19 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.331 1.853 . . . . 0.0 115.128 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -89.56 -37.64 14.55 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.622 2.769 . . . . 0.0 111.463 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -103.13 -30.8 10.49 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.259 1.424 . . . . 0.0 112.454 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 16.9 mmm180 72.49 52.83 0.17 Allowed 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 129.925 3.29 . . . . 0.0 111.928 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.0 ptp180 -124.58 135.19 52.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 129.16 2.984 . . . . 0.0 107.768 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.443 HG13 HG11 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -108.88 130.04 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 167.373 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -102.57 94.74 5.81 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 111.781 -3.968 . . . . 0.0 107.246 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . 0.306 2.1 mm? -96.12 136.87 36.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 120.129 -1.607 . . . . 0.0 108.464 -172.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -135.15 127.69 4.47 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.454 ' HG ' ' CG2' ' A' ' 328' ' ' VAL . 6.9 mp -45.43 155.85 0.13 Allowed 'General case' 0 C--N 1.359 1.016 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -167.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -131.42 -62.74 0.86 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.64 124.31 1.92 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 173.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 7.4 p -47.63 151.88 0.77 Allowed 'General case' 0 C--N 1.361 1.084 1 C-N-CA 139.628 7.171 . . . . 0.0 117.48 169.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.13 162.73 27.75 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 127.403 2.281 . . . . 0.0 115.49 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -104.63 24.52 11.62 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.305 1.842 . . . . 0.0 112.548 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -175.64 51.69 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 129.702 3.201 . . . . 0.0 109.204 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.379 2.172 1 C-N-CA 126.388 4.725 . . . . 0.0 116.615 -167.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.68 -48.92 8.02 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.697 3.598 . . . . 0.0 114.116 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 82.39 118.77 0.05 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 128.994 2.917 . . . . 0.0 113.919 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.42 58.1 Favored Glycine 0 C--N 1.375 2.696 0 CA-C-O 124.556 2.198 . . . . 0.0 112.231 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 19.6 p -97.45 126.21 42.57 Favored 'General case' 0 CA--C 1.509 -0.629 1 C-N-CA 133.267 4.627 . . . . 0.0 103.475 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -95.85 144.57 26.09 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.666 1.698 . . . . 0.0 112.859 -178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.77 174.09 7.34 Favored 'General case' 0 CA--C 1.487 -1.446 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.566 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.5 m -110.83 139.85 45.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -153.9 173.28 32.57 Favored Glycine 0 CA--C 1.482 -1.989 0 CA-C-O 123.543 1.635 . . . . 0.0 111.69 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.4 ' HG2' ' CG2' ' A' ' 327' ' ' VAL . 30.6 mtp-105 -127.54 135.37 50.24 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.53 132.08 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 113.869 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -130.19 -31.04 1.91 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.271 1.2 t-20 -133.75 176.09 8.87 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-N 121.751 2.069 . . . . 0.0 108.379 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.0 OUTLIER -120.47 156.37 31.62 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.255 -1.528 . . . . 0.0 113.174 176.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 178.57 4.25 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -68.33 -25.49 65.13 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.533 2.333 . . . . 0.0 115.037 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -162.55 54.05 0.21 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.225 2.61 . . . . 0.0 107.039 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.97 -170.48 41.66 Favored Glycine 0 CA--C 1.468 -2.865 1 N-CA-C 100.573 -5.011 . . . . 0.0 100.573 171.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.8 m -139.91 169.82 17.01 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.493 1.117 . . . . 0.0 108.852 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.83 128.71 56.2 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-O 123.128 1.442 . . . . 0.0 109.182 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.93 138.27 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 C-N-CA 125.862 1.665 . . . . 0.0 107.006 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -99.89 123.84 44.57 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 119.703 -1.873 . . . . 0.0 112.157 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.61 52.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 122.878 1.323 . . . . 0.0 111.616 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 79.07 174.97 0.15 Allowed 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.932 2.493 . . . . 0.0 109.716 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -68.22 119.72 13.23 Favored 'General case' 0 CA--C 1.558 1.285 0 O-C-N 119.871 -1.768 . . . . 0.0 114.181 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.0 32.4 Favored Glycine 0 C--N 1.367 2.262 0 C-N-CA 127.44 2.448 . . . . 0.0 115.196 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.18 143.99 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.125 1.77 . . . . 0.0 109.865 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -153.51 149.81 28.08 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 118.851 -2.405 . . . . 0.0 105.435 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -131.38 174.36 20.06 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-O 124.824 2.347 . . . . 0.0 112.44 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 51.7 tp -98.38 162.63 13.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.703 2.001 . . . . 0.0 107.484 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 346' ' ' LEU . 2.4 p -128.82 117.15 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 161.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -95.21 134.89 37.45 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 119.09 -1.044 . . . . 0.0 113.792 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.272 1.0 OUTLIER . . . . . 0 C--N 1.38 1.93 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.507 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 123.372 1.558 . . . . 0.0 114.37 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -104.7 151.07 24.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 123.935 1.826 . . . . 0.0 112.527 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.15 120.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 C-N-CA 127.052 2.141 . . . . 0.0 108.633 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 97.03 8.37 56.84 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 125.723 1.63 . . . . 0.0 115.626 -172.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.73 160.5 14.94 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.885 -1.362 . . . . 0.0 109.091 171.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.4 ' CG2' ' HG2' ' A' ' 283' ' ' ARG . 35.0 t -117.82 137.41 51.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.01 178.99 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 CA-C-O 126.043 2.83 . . . . 0.0 108.979 -173.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.5 133.55 55.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.2 m -135.48 139.2 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.0 ttp -101.79 143.82 31.24 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 120.63 -1.294 . . . . 0.0 108.181 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.88 131.67 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.9 -133.13 0.3 Allowed 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 100.293 -3.966 . . . . 0.0 100.293 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.436 11.7 m-20 -53.21 112.65 0.91 Allowed 'General case' 0 CA--C 1.503 -0.831 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -154.991 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 5.8 tp -111.3 122.2 65.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -171.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.55 116.16 7.16 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -106.05 22.8 15.07 Favored 'General case' 0 C--N 1.365 1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 112.707 -172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -110.96 -43.7 3.73 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.526 1.93 . . . . 0.0 107.732 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . 0.305 34.3 mmt180 -68.69 -38.53 80.38 Favored 'General case' 0 C--N 1.349 0.571 1 C-N-CA 132.956 4.503 . . . . 0.0 113.345 171.262 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.338 33.0 mmt180 74.98 51.38 0.08 Allowed 'General case' 0 C--N 1.347 0.487 1 C-N-CA 132.595 4.358 . . . . 0.0 113.481 173.334 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.46 133.73 52.33 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 111.622 -2.535 . . . . 0.0 112.389 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.61 127.22 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 1 N-CA-C 96.922 -5.214 . . . . 0.0 96.922 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.8 103.05 10.27 Favored 'General case' 0 CA--C 1.457 -2.627 1 C-N-CA 110.787 -4.365 . . . . 0.0 106.892 -170.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.5 170.75 9.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 122.921 2.601 . . . . 0.0 112.077 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -156.24 141.69 8.19 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.788 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.412 1.4 pt? -51.13 159.0 0.67 Allowed 'General case' 0 C--N 1.374 1.65 1 N-CA-C 124.761 5.097 . . . . 0.0 124.761 -165.464 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -125.44 -55.86 1.53 Allowed 'General case' 0 C--N 1.38 1.93 0 O-C-N 120.948 -1.095 . . . . 0.0 109.962 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.34 2.1 pt20 -121.02 -105.26 0.38 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 18.7 p 159.71 171.1 0.01 OUTLIER 'General case' 0 C--N 1.349 0.561 1 C-N-CA 131.954 4.101 . . . . 0.0 101.677 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -91.1 161.47 15.09 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.936 1.294 . . . . 0.0 111.989 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -96.79 77.0 2.8 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 118.912 -2.367 . . . . 0.0 109.737 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 40.4 t30 104.67 66.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 130.417 3.487 . . . . 0.0 107.675 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.382 2.31 1 C-N-CA 126.293 4.662 . . . . 0.0 112.313 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.06 122.17 9.86 Favored 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 125.382 4.055 . . . . 0.0 114.204 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.63 114.84 6.59 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 129.077 2.951 . . . . 0.0 113.16 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.92 7.79 40.71 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 123.633 1.685 . . . . 0.0 114.766 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 72.9 p -96.9 144.19 27.06 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 129.044 2.938 . . . . 0.0 103.543 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 92.5 mttt -105.87 155.3 19.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 119.867 -1.771 . . . . 0.0 115.203 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.33 173.42 10.18 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.809 2.243 . . . . 0.0 107.802 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.5 m -114.34 135.68 53.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.27 170.52 29.55 Favored Glycine 0 CA--C 1.48 -2.118 0 CA-C-O 124.097 1.943 . . . . 0.0 110.045 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -129.61 133.81 47.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 113.576 -1.312 . . . . 0.0 108.041 -171.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.88 127.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.3 t -109.15 -41.96 4.54 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 112.763 -2.017 . . . . 0.0 113.632 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER -135.28 174.56 10.48 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 119.962 -1.711 . . . . 0.0 110.248 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 147.13 45.8 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.328 -1.483 . . . . 0.0 108.136 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.05 177.69 4.56 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 124.242 1.017 . . . . 0.0 108.885 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -71.25 -12.26 61.36 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.231 2.612 . . . . 0.0 114.572 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.44 ' CD2' ' HE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -164.34 47.42 0.11 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 123.842 1.782 . . . . 0.0 109.83 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 169.38 -160.28 33.48 Favored Glycine 0 CA--C 1.47 -2.759 0 N-CA-C 106.295 -2.722 . . . . 0.0 106.295 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.58 164.05 32.88 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -102.35 120.38 40.39 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.3 125.27 65.04 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.13 131.79 35.79 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.38 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 120.743 -1.223 . . . . 0.0 110.752 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.258 57.6 mm-40 84.65 167.31 0.09 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 127.577 2.351 . . . . 0.0 107.514 -167.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.01 118.89 9.13 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 112.81 -20.06 20.46 Favored Glycine 0 C--N 1.371 2.506 0 C-N-CA 126.867 2.175 . . . . 0.0 116.748 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.4 122.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.3 144.86 24.93 Favored 'General case' 0 CA--C 1.483 -1.601 0 O-C-N 119.489 -2.007 . . . . 0.0 111.275 -165.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -106.84 175.1 20.54 Favored Glycine 0 CA--C 1.491 -1.454 0 C-N-CA 128.099 2.762 . . . . 0.0 117.186 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 11.5 tp -126.0 120.0 29.15 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 126.776 2.03 . . . . 0.0 106.916 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -92.32 118.46 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . 0.44 ' HE1' ' CD2' ' A' ' 290' ' ' TYR . 8.1 t60 -80.98 124.09 28.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.162 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.368 1.4 0 N-CA-C 121.227 3.788 . . . . 0.0 121.227 -172.43 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.412 33.1 t . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 124.622 2.153 . . . . 0.0 115.646 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.42 150.39 40.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 128.452 2.701 . . . . 0.0 105.459 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.43 121.37 29.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.912 1.339 . . . . 0.0 108.979 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 86.46 29.35 24.76 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.23 1.395 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -92.34 150.47 20.82 Favored 'General case' 0 C--N 1.364 1.218 0 O-C-N 120.636 -1.508 . . . . 0.0 109.311 172.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.282 0.7 OUTLIER -117.08 130.52 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 120.065 -1.647 . . . . 0.0 107.385 175.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -133.85 179.57 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 1 C-N-CA 133.186 4.594 . . . . 0.0 106.933 -171.768 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 346' ' ' LEU . 40.7 tt0 -112.03 150.14 31.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 100.558 -3.867 . . . . 0.0 100.558 172.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.506 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -146.51 144.19 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.518 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 42.7 ttm -105.84 141.66 36.88 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 120.125 -1.609 . . . . 0.0 107.45 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.59 128.92 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.05 -136.16 0.28 Allowed 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 171.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.307 19.3 m-20 -61.15 111.86 1.88 Allowed 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -154.363 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.2 tp -101.94 118.36 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 124.023 1.868 . . . . 0.0 108.886 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -117.62 103.29 9.9 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.84 -11.11 59.78 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.614 1.966 . . . . 0.0 115.42 -168.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.04 -33.55 15.47 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 128.201 2.601 . . . . 0.0 111.183 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -100.8 -29.48 12.23 Favored 'General case' 0 C--N 1.368 1.406 0 C-N-CA 125.052 1.341 . . . . 0.0 113.156 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.297 65.2 mtp85 72.96 51.96 0.14 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 128.858 2.863 . . . . 0.0 112.618 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.62 132.79 53.41 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 110.79 -2.914 . . . . 0.0 106.631 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . 0.258 2.1 mt -114.09 129.7 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.2 t -102.52 94.23 5.55 Favored 'General case' 0 C--N 1.384 2.096 0 C-N-CA 111.854 -3.938 . . . . 0.0 105.801 -168.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 344' ' ' LEU . 0.0 OUTLIER -97.23 136.29 37.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 119.495 -2.003 . . . . 0.0 107.637 -169.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -152.67 123.42 1.45 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.498 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.506 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.59 0.2 OUTLIER -140.46 -93.0 0.16 Allowed 'General case' 0 C--N 1.363 1.186 0 C-N-CA 129.691 3.196 . . . . 0.0 109.137 172.383 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.356 35.6 mtmm 111.84 18.09 0.0 OUTLIER 'General case' 0 C--N 1.378 1.815 0 C-N-CA 126.781 2.033 . . . . 0.0 113.265 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.58 82.27 2.27 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 120.285 -1.509 . . . . 0.0 112.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 27.6 p -31.57 157.3 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 2 C-N-CA 135.519 5.527 . . . . 0.0 121.902 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -75.23 166.85 22.99 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 129.588 3.155 . . . . 0.0 114.551 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.76 88.22 3.98 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.708 1.603 . . . . 0.0 108.071 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 87.24 70.83 0.05 OUTLIER Pre-proline 0 C--N 1.357 0.927 0 C-N-CA 130.14 3.376 . . . . 0.0 108.777 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 C--N 1.37 1.672 1 C-N-CA 126.391 4.728 . . . . 0.0 117.662 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.25 -48.28 10.23 Favored 'Trans proline' 0 CA--C 1.546 1.101 1 C-N-CA 125.506 4.137 . . . . 0.0 113.617 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 81.38 126.81 0.04 OUTLIER 'General case' 0 C--N 1.373 1.615 0 C-N-CA 128.884 2.874 . . . . 0.0 113.187 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.97 11.13 56.89 Favored Glycine 0 C--N 1.381 3.058 0 CA-C-O 124.979 2.433 . . . . 0.0 112.41 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 20.6 p -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.45 -0.442 1 C-N-CA 133.252 4.621 . . . . 0.0 102.887 172.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -105.09 153.95 20.81 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 123.0 1.381 . . . . 0.0 113.509 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . 0.335 0.0 OUTLIER -136.1 173.88 11.23 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-O 123.485 1.612 . . . . 0.0 109.229 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.7 m -106.51 138.65 42.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -143.54 176.89 22.69 Favored Glycine 0 CA--C 1.483 -1.953 0 CA-C-O 123.387 1.549 . . . . 0.0 111.629 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -128.31 132.09 48.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.69 127.48 39.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.41 1.484 . . . . 0.0 114.147 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -107.94 -53.11 2.67 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.357 1.863 . . . . 0.0 112.853 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.27 174.83 9.97 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 120.695 -1.253 . . . . 0.0 111.071 -170.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 150.75 39.84 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 166.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 177.88 4.48 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.64 -24.18 62.67 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.902 2.081 . . . . 0.0 113.606 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -151.56 45.35 0.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 124.579 2.133 . . . . 0.0 109.046 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.46 -164.91 33.28 Favored Glycine 0 CA--C 1.47 -2.765 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 15.3 p -143.5 151.13 39.91 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 123.783 0.833 . . . . 0.0 109.356 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.59 124.44 44.8 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.769 -0.582 . . . . 0.0 109.645 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.59 131.69 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.516 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.02 122.18 42.5 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.215 -1.553 . . . . 0.0 113.68 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.17 56.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 111.379 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 77.8 170.0 0.22 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.608 2.363 . . . . 0.0 109.92 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.88 119.46 12.6 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 119.594 -1.941 . . . . 0.0 115.192 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.11 -31.84 5.69 Favored Glycine 0 C--N 1.367 2.294 0 C-N-CA 127.1 2.286 . . . . 0.0 115.069 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.27 128.27 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.89 1.676 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -141.83 158.66 43.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 118.675 -2.515 . . . . 0.0 106.868 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -130.69 173.1 20.27 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 123.849 1.805 . . . . 0.0 113.743 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.52 121.41 37.42 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 126.468 1.907 . . . . 0.0 107.514 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.39 113.18 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.494 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.12 115.78 11.75 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.368 1.376 0 N-CA-C 120.383 3.475 . . . . 0.0 120.383 -174.722 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 123.246 1.498 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -104.72 165.98 10.7 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 126.684 1.993 . . . . 0.0 110.773 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.1 121.23 30.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 C-N-CA 126.866 2.066 . . . . 0.0 107.661 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.53 16.06 53.5 Favored Glycine 0 C--N 1.357 1.725 0 C-N-CA 125.426 1.489 . . . . 0.0 113.957 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -90.51 164.05 14.39 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.042 2.137 . . . . 0.0 111.187 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.44 125.07 72.19 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 51.6 t -134.42 165.49 31.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 C-N-CA 127.11 2.164 . . . . 0.0 106.653 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -114.92 135.58 54.05 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 100.931 -3.729 . . . . 0.0 100.931 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 2.8 m -129.81 163.28 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.362 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -169.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 33.1 ttm -127.9 138.03 52.52 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.07 132.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.01 -134.54 0.28 Allowed 'General case' 0 N--CA 1.408 -2.554 1 N-CA-C 98.951 -4.462 . . . . 0.0 98.951 174.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.98 111.81 6.65 Favored 'General case' 0 C--N 1.313 -1.018 1 N-CA-C 122.028 4.084 . . . . 0.0 122.028 -155.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.365 0.1 OUTLIER -96.83 112.52 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 126.615 1.966 . . . . 0.0 107.336 177.352 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.41 102.36 15.09 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 128.845 2.858 . . . . 0.0 105.092 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.19 -3.12 41.02 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -166.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.88 -43.15 14.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 130.001 3.32 . . . . 0.0 110.902 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -99.52 -38.05 8.93 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.167 2.187 . . . . 0.0 113.348 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.389 47.2 mtm105 75.22 51.73 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 1 C-N-CA 134.857 5.263 . . . . 0.0 114.215 179.802 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.5 OUTLIER -116.23 125.54 52.37 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 126.229 1.812 . . . . 0.0 107.348 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.8 mm -91.62 131.12 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 1 C-N-CA 132.876 4.471 . . . . 0.0 108.964 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.1 t -102.87 92.57 4.64 Favored 'General case' 0 C--N 1.385 2.144 1 C-N-CA 110.602 -4.439 . . . . 0.0 106.048 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.438 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -102.86 136.98 41.68 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 119.415 -2.053 . . . . 0.0 109.305 -174.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -130.81 138.51 10.23 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -172.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.492 0.1 OUTLIER -54.19 162.26 1.08 Allowed 'General case' 0 C--N 1.369 1.44 1 N-CA-C 127.146 5.98 . . . . 0.0 127.146 -161.32 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -125.4 -48.63 1.69 Allowed 'General case' 0 C--N 1.382 1.996 0 O-C-N 121.732 -0.605 . . . . 0.0 111.989 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.25 48.3 tp60 -124.51 -86.3 0.63 Allowed 'General case' 0 C--N 1.37 1.473 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.307 20.8 p 111.89 146.32 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 1 C-N-CA 131.965 4.106 . . . . 0.0 106.321 -172.438 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -94.89 130.24 41.58 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.279 -1.513 . . . . 0.0 111.143 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.08 75.45 4.08 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.094 2.158 . . . . 0.0 111.216 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 1.1 t30 125.29 66.94 0.0 OUTLIER Pre-proline 0 C--N 1.344 0.366 1 C-N-CA 133.955 4.902 . . . . 0.0 102.748 -175.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 C--N 1.359 1.083 0 C-N-CA 124.194 3.263 . . . . 0.0 113.119 -175.345 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.25 -40.87 1.45 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 124.23 3.287 . . . . 0.0 112.236 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . 0.263 44.4 mt-10 79.84 111.0 0.07 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.984 2.514 . . . . 0.0 113.001 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 8.69 38.12 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 123.894 1.83 . . . . 0.0 113.436 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 68.5 p -98.56 139.21 34.63 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 169.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 93.8 mttt -97.98 146.1 25.83 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.059 -2.275 . . . . 0.0 111.577 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.44 143.03 39.5 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.579 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.8 m -82.35 142.65 31.84 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.842 -1.162 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.47 173.57 33.62 Favored Glycine 0 CA--C 1.486 -1.721 0 CA-C-O 123.174 1.43 . . . . 0.0 112.719 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 60.2 mtm-85 -117.8 131.08 56.62 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 125.925 1.69 . . . . 0.0 108.655 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 17.6 t -77.38 133.24 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.281 10.1 t -122.62 -39.85 2.51 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -133.82 165.98 23.71 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 3.8 mp -121.16 153.17 37.88 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 122.131 2.241 . . . . 0.0 116.871 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 178.41 4.29 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -29.33 66.31 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.255 18.1 m-85 -156.8 52.72 0.51 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.96 3.704 . . . . 0.0 103.481 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.11 37.22 Favored Glycine 0 N--CA 1.432 -1.62 1 N-CA-C 100.469 -5.053 . . . . 0.0 100.469 172.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 31.5 p -165.32 172.09 12.74 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.653 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -103.14 120.2 40.27 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 135.89 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -100.19 121.03 40.8 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.603 -1.936 . . . . 0.0 111.254 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.28 40.1 mm -66.65 -87.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -140.04 166.63 24.13 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 131.402 3.881 . . . . 0.0 101.329 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.16 120.28 7.28 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.4 -15.72 59.79 Favored Glycine 0 C--N 1.367 2.302 0 C-N-CA 127.18 2.324 . . . . 0.0 115.441 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.73 121.41 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.538 1.935 . . . . 0.0 111.246 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.87 151.24 50.66 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -119.8 173.48 15.18 Favored Glycine 0 CA--C 1.493 -1.284 0 CA-C-O 124.954 2.419 . . . . 0.0 115.303 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.8 tp -125.7 121.59 33.89 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.311 1.5 p -87.15 121.1 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-O 122.422 1.106 . . . . 0.0 109.838 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -86.51 108.9 18.75 Favored 'General case' 0 N--CA 1.397 -3.118 0 C-N-CA 128.48 2.712 . . . . 0.0 109.087 155.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.379 1.883 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 164.659 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.494 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 122.496 1.141 . . . . 0.0 112.854 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.75 145.56 24.5 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.134 1.445 . . . . 0.0 109.792 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.51 121.0 30.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.02 23.27 55.83 Favored Glycine 0 C--N 1.357 1.703 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.67 31.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 118.749 1.275 . . . . 0.0 108.166 171.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.252 2.0 p -96.29 129.36 46.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 CA-C-O 123.416 1.579 . . . . 0.0 108.554 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -130.48 -179.57 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 1 C-N-CA 132.312 4.245 . . . . 0.0 110.834 -173.396 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -124.27 142.29 51.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.512 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 2.9 m -146.71 139.37 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 46.5 ttp -96.32 131.38 42.9 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 118.525 -2.61 . . . . 0.0 111.109 -173.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.11 124.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -166.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.51 -130.32 0.25 Allowed 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.338 7.4 t70 -57.8 112.46 1.48 Allowed 'General case' 0 N--CA 1.475 0.811 1 N-CA-C 122.586 4.291 . . . . 0.0 122.586 -158.36 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . 0.266 3.4 tp -107.81 114.41 46.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 96.1 m-20 -124.7 119.74 29.83 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.518 1.927 . . . . 0.0 107.849 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -88.14 -5.36 58.47 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 125.461 1.504 . . . . 0.0 114.635 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.64 -35.3 14.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.296 2.238 . . . . 0.0 110.285 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 336' ' ' ASP . 0.0 OUTLIER -89.88 -46.93 8.21 Favored 'General case' 0 CA--C 1.508 -0.647 1 C-N-CA 132.08 4.152 . . . . 0.0 112.379 -177.512 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.322 64.5 mtm-85 75.07 52.53 0.08 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 131.135 3.774 . . . . 0.0 112.532 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 133.14 52.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 111.451 -2.613 . . . . 0.0 107.943 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.73 129.5 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.828 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 170.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.92 4.8 Favored 'General case' 0 CA--C 1.474 -1.981 1 C-N-CA 111.082 -4.247 . . . . 0.0 107.715 -164.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.96 135.57 39.48 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.748 -172.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.18 122.76 1.63 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.815 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.512 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.663 0.7 OUTLIER -144.55 -99.04 0.1 Allowed 'General case' 0 C--N 1.37 1.46 0 C-N-CA 128.979 2.911 . . . . 0.0 113.105 178.512 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.454 48.2 mtmt 85.01 68.3 0.01 OUTLIER 'General case' 0 C--N 1.374 1.651 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -118.11 -10.86 10.24 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 120.632 -1.292 . . . . 0.0 111.547 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . 0.432 ' H ' HG12 ' A' ' 328' ' ' VAL 0.277 37.2 m 78.81 170.34 0.19 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 130.293 3.437 . . . . 0.0 116.19 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -91.39 170.9 9.59 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 127.774 2.43 . . . . 0.0 111.989 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.66 78.74 3.33 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.817 2.047 . . . . 0.0 109.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 14.3 t30 101.2 74.18 0.0 OUTLIER Pre-proline 0 C--N 1.361 1.105 0 C-N-CA 131.203 3.801 . . . . 0.0 108.541 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.363 1.327 1 C-N-CA 125.648 4.232 . . . . 0.0 119.392 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 276' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -86.14 96.85 0.55 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.968 3.112 . . . . 0.0 108.107 160.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 274' ' ' TYR . 5.7 tm-20 -68.92 138.7 54.85 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 128.867 2.867 . . . . 0.0 114.813 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.76 14.96 47.88 Favored Glycine 0 C--N 1.387 3.401 0 CA-C-O 124.514 2.174 . . . . 0.0 112.799 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 6.0 p -92.78 146.05 23.94 Favored 'General case' 0 CA--C 1.509 -0.602 1 C-N-CA 133.16 4.584 . . . . 0.0 100.799 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.6 OUTLIER -108.03 153.37 23.21 Favored 'General case' 0 CA--C 1.49 -1.348 0 O-C-N 119.847 -1.783 . . . . 0.0 110.411 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.64 174.34 8.35 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 112.073 -2.33 . . . . 0.0 107.476 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 88.9 m -118.29 137.98 52.69 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -157.16 170.0 34.32 Favored Glycine 0 CA--C 1.478 -2.259 0 CA-C-O 123.241 1.467 . . . . 0.0 110.384 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 327' ' ' VAL . 44.3 ttm-85 -117.15 135.14 53.99 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 124.787 1.235 . . . . 0.0 108.465 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.92 132.29 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 120.265 -1.522 . . . . 0.0 113.63 -172.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -128.32 -33.43 2.14 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -171.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -133.74 173.06 11.94 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 122.004 2.184 . . . . 0.0 107.332 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 2.3 mp -120.54 150.83 40.25 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 118.908 -2.37 . . . . 0.0 112.761 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.62 178.14 4.4 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -29.02 68.53 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.346 2.258 . . . . 0.0 115.195 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.262 1.7 p90 -149.84 43.1 0.89 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 124.194 1.949 . . . . 0.0 109.634 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.09 -170.81 40.75 Favored Glycine 0 CA--C 1.468 -2.872 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 165.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 2.8 m -134.71 147.1 50.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.31 126.46 36.4 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.231 -1.543 . . . . 0.0 108.982 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.34 138.28 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 125.939 1.696 . . . . 0.0 106.546 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -100.12 124.05 45.07 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.573 -1.33 . . . . 0.0 108.028 168.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -67.87 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 124.905 2.288 . . . . 0.0 116.1 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.38 161.41 35.06 Favored 'General case' 0 CA--C 1.485 -1.551 2 N-CA-C 98.716 -4.55 . . . . 0.0 98.716 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.81 119.5 10.1 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 104.34 -11.58 51.21 Favored Glycine 0 C--N 1.364 2.107 0 C-N-CA 125.526 1.536 . . . . 0.0 116.379 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.63 144.3 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.62 1.968 . . . . 0.0 106.942 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.01 155.11 48.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.182 -1.574 . . . . 0.0 112.082 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.9 174.88 15.93 Favored Glycine 0 C--N 1.36 1.886 0 C-N-CA 130.439 3.876 . . . . 0.0 117.526 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 42.6 tp -127.28 116.08 20.01 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 111.965 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.296 6.4 p -92.25 104.38 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 O-C-N 120.495 -1.378 . . . . 0.0 108.268 175.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -70.44 129.05 38.24 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 124.749 1.22 . . . . 0.0 113.011 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.157 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -120.43 155.64 33.07 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.8 121.58 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.531 1.532 . . . . 0.0 109.974 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 87.95 23.56 38.0 Favored Glycine 0 C--N 1.362 1.998 0 C-N-CA 125.999 1.761 . . . . 0.0 114.056 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.96 146.04 48.75 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.922 -1.34 . . . . 0.0 110.753 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 283' ' ' ARG 0.306 2.7 p -92.59 138.72 19.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 125.434 1.494 . . . . 0.0 112.18 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.94 179.39 2.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 C-N-CA 129.195 2.998 . . . . 0.0 108.828 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -110.89 140.39 45.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.507 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 3.4 m -144.93 139.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 58.8 ttp -104.71 138.59 40.78 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-N 121.12 1.782 . . . . 0.0 108.337 -173.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 1.9 m -77.08 128.38 37.94 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 -165.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.64 -131.77 0.27 Allowed 'General case' 0 N--CA 1.421 -1.913 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.386 11.6 m-20 -54.64 113.07 1.16 Allowed 'General case' 0 N--CA 1.478 0.953 1 N-CA-C 124.452 4.982 . . . . 0.0 124.452 -156.748 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.68 129.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -145.07 118.5 9.04 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 170.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -16.0 52.43 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 125.179 1.392 . . . . 0.0 113.845 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.35 -35.45 19.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 130.013 3.325 . . . . 0.0 111.374 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -94.87 -26.74 16.05 Favored 'General case' 0 C--N 1.367 1.359 0 C-N-CA 125.103 1.361 . . . . 0.0 111.389 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.304 47.0 mtm180 73.37 48.1 0.17 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 131.115 3.766 . . . . 0.0 113.761 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 129.16 48.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 110.278 -3.146 . . . . 0.0 108.091 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.92 123.3 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.433 1 N-CA-C 95.976 -5.565 . . . . 0.0 95.976 174.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.05 94.51 5.21 Favored 'General case' 0 CA--C 1.468 -2.21 1 C-N-CA 110.975 -4.29 . . . . 0.0 106.503 -166.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.98 139.02 34.43 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 121.165 1.802 . . . . 0.0 107.68 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -145.35 122.41 1.7 Allowed Glycine 0 CA--C 1.471 -2.703 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.815 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . 0.507 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.759 0.2 OUTLIER -141.57 -107.07 0.14 Allowed 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 127.499 2.32 . . . . 0.0 112.531 171.019 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.355 13.3 pttp 121.95 29.5 0.0 OUTLIER 'General case' 0 C--N 1.382 2.003 0 C-N-CA 129.954 3.302 . . . . 0.0 115.587 -173.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -86.59 16.84 4.29 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 118.438 -2.664 . . . . 0.0 117.181 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.279 11.9 p 62.51 147.87 0.02 OUTLIER 'General case' 0 C--N 1.366 1.314 0 N-CA-C 120.804 3.631 . . . . 0.0 120.804 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -103.28 169.3 8.63 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 125.645 1.578 . . . . 0.0 110.518 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.3 81.36 3.61 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.039 -2.288 . . . . 0.0 111.742 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 94.49 75.2 0.03 OUTLIER Pre-proline 0 C--N 1.354 0.795 1 C-N-CA 132.812 4.445 . . . . 0.0 106.161 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 C--N 1.366 1.494 1 C-N-CA 125.574 4.183 . . . . 0.0 117.277 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.84 -34.88 1.13 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.519 3.48 . . . . 0.0 112.181 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 73.68 124.72 0.04 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 128.657 2.783 . . . . 0.0 114.23 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.08 11.1 43.79 Favored Glycine 0 C--N 1.372 2.545 0 CA-C-O 124.373 2.096 . . . . 0.0 113.114 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 22.6 p -101.43 136.46 41.23 Favored 'General case' 0 CA--C 1.508 -0.663 1 C-N-CA 131.992 4.117 . . . . 0.0 101.354 171.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -109.37 157.13 19.2 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-O 123.852 1.786 . . . . 0.0 113.039 -176.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -133.93 173.75 11.22 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.126 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.6 m -108.57 144.73 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.59 176.94 30.59 Favored Glycine 0 CA--C 1.486 -1.747 0 CA-C-O 123.822 1.79 . . . . 0.0 111.348 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -130.94 130.43 43.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.867 1.267 . . . . 0.0 108.477 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 27.7 t -74.95 131.76 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -114.73 -34.87 5.02 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 112.135 -2.302 . . . . 0.0 112.026 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 293' ' ' PHE . 1.3 t-20 -135.13 155.8 50.08 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.63 136.51 54.94 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 164.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.45 176.84 4.85 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -30.11 71.28 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 118.769 -2.457 . . . . 0.0 116.544 -177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -145.7 40.94 1.2 Allowed 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 125.758 1.623 . . . . 0.0 110.524 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 178.55 -162.19 29.27 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 105.363 -3.095 . . . . 0.0 105.363 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 28.2 p -143.31 165.16 28.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 286' ' ' ASN . 9.7 m-85 -115.28 126.59 54.67 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.2 t -118.9 132.2 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -167.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.93 127.36 41.88 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.255 -1.528 . . . . 0.0 112.734 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.288 26.7 mm -73.98 -86.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 123.822 1.772 . . . . 0.0 113.941 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.26 171.35 14.57 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 130.037 3.335 . . . . 0.0 103.514 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.09 119.77 10.15 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.44 -17.2 58.08 Favored Glycine 0 C--N 1.37 2.436 0 C-N-CA 127.222 2.344 . . . . 0.0 115.524 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.21 113.31 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.549 1.939 . . . . 0.0 110.527 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -135.5 157.82 45.92 Favored 'General case' 0 CA--C 1.481 -1.71 0 O-C-N 118.307 -2.746 . . . . 0.0 108.215 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -124.6 172.53 16.89 Favored Glycine 0 CA--C 1.482 -1.973 0 CA-C-O 127.1 3.611 . . . . 0.0 114.424 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.59 161.11 16.56 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 110.307 -2.947 . . . . 0.0 103.269 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.13 130.33 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 O-C-N 124.479 1.112 . . . . 0.0 108.76 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -91.8 114.76 27.38 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 166.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.373 1.595 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 -177.283 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.504 -0.821 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.71 158.08 16.37 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 123.641 1.686 . . . . 0.0 107.576 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.38 120.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 C-N-CA 125.199 1.4 . . . . 0.0 109.565 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.49 18.03 53.44 Favored Glycine 0 C--N 1.364 2.098 0 C-N-CA 124.658 1.123 . . . . 0.0 114.235 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.5 144.03 32.83 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 125.501 1.521 . . . . 0.0 109.659 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.85 139.86 16.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 124.006 1.86 . . . . 0.0 111.345 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.59 174.72 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 130.111 3.364 . . . . 0.0 107.32 -170.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.91 144.07 46.64 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.09 139.82 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -175.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 52.7 ttp -104.0 136.88 42.83 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 119.916 -1.74 . . . . 0.0 109.299 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . 0.267 0.2 OUTLIER -83.83 135.41 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -169.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.411 ' HB2' ' H ' ' A' ' 334' ' ' ASP . 0.3 OUTLIER -122.46 -126.86 0.26 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 175.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ASP . . . . . 0.499 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.437 12.2 m-20 -59.49 113.55 2.26 Favored 'General case' 0 N--CA 1.483 1.181 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -160.014 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.9 tp -112.89 120.82 63.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 -165.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -140.44 118.57 11.96 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.23 -1.73 57.62 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 126.576 1.95 . . . . 0.0 113.858 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.2 -40.12 9.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 129.245 3.018 . . . . 0.0 109.73 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -88.22 -32.74 18.41 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 131.275 3.83 . . . . 0.0 112.765 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.329 1.3 mmp_? 75.27 50.9 0.08 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 129.426 3.09 . . . . 0.0 114.89 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 132.22 52.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 110.848 -2.887 . . . . 0.0 108.945 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.99 126.84 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 1 N-CA-C 94.177 -6.231 . . . . 0.0 94.177 171.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' SER . . . . . 0.499 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 39.6 m -111.0 102.45 10.93 Favored 'General case' 0 CA--C 1.446 -3.053 1 C-N-CA 111.291 -4.164 . . . . 0.0 107.063 -165.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 173.58 7.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 125.06 2.362 . . . . 0.0 110.913 -165.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.36 136.32 6.23 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.841 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.8 149.17 40.85 Favored 'General case' 0 C--N 1.369 1.435 1 N-CA-C 123.584 4.661 . . . . 0.0 123.584 -164.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -94.92 -98.33 0.16 Allowed 'General case' 0 C--N 1.39 2.363 0 O-C-N 120.916 -1.115 . . . . 0.0 112.8 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -141.24 -1.18 1.37 Allowed 'General case' 0 C--N 1.373 1.601 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.316 3.6 m 79.81 163.36 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.257 1.823 . . . . 0.0 115.445 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 353' ' ' PRO . 0.0 OUTLIER -56.69 -145.24 0.0 OUTLIER 'General case' 0 C--N 1.354 0.766 1 C-N-CA 134.535 5.134 . . . . 0.0 118.88 174.114 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 164.9 89.04 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 129.935 3.294 . . . . 0.0 102.969 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 93.11 74.47 0.03 OUTLIER Pre-proline 0 C--N 1.358 0.963 0 C-N-CA 130.087 3.355 . . . . 0.0 105.795 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' PRO . . . . . 0.455 ' HB3' ' HG3' ' A' ' 350' ' ' LYS . 57.9 Cg_endo . . . . . 0 CA--C 1.564 2.019 0 C-N-CA 124.509 3.473 . . . . 0.0 112.29 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.5 m95 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.8 t -106.82 129.64 60.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 124.96 1.304 . . . . 0.0 107.947 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.3 61.36 4.07 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 126.319 1.848 . . . . 0.0 113.554 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . 0.512 10.6 pt 65.07 -34.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 1 C-N-CA 132.056 4.143 . . . . 0.0 119.491 -179.57 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -164.77 93.97 0.66 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.892 2.477 . . . . 0.0 107.498 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -144.95 142.91 30.24 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.746 -1.221 . . . . 0.0 109.938 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.521 ' HE ' HD13 ' A' ' 335' ' ' ILE . 10.8 mtt180 -115.65 -54.77 2.49 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.626 -175.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -89.12 152.92 48.71 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 130.113 3.365 . . . . 0.0 108.942 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.9 -31.28 84.74 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.367 3.378 . . . . 0.0 115.999 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 93.27 119.21 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.665 3.586 . . . . 0.0 109.316 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.13 54.47 Favored Glycine 0 C--N 1.372 2.575 0 CA-C-O 124.74 2.3 . . . . 0.0 112.581 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.84 134.61 44.75 Favored 'General case' 0 CA--C 1.507 -0.684 1 C-N-CA 133.235 4.614 . . . . 0.0 102.479 172.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 12.5 ptmt -103.1 152.56 21.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 10.9 mt -126.05 174.05 8.74 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 124.406 2.051 . . . . 0.0 107.64 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.94 137.15 53.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 168.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -146.98 175.06 26.56 Favored Glycine 0 CA--C 1.482 -1.995 0 CA-C-O 123.783 1.769 . . . . 0.0 111.04 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -117.99 134.82 54.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 70.0 t -78.87 133.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.302 1.4 t -121.23 -44.19 2.39 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.337 0.3 OUTLIER -136.29 174.83 10.19 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.69 -1.881 . . . . 0.0 111.068 175.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 1.1 mp -121.08 142.01 50.24 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . 0.332 1.1 t -112.49 179.16 4.06 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.564 1.173 . . . . 0.0 110.815 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.44 -28.88 60.77 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 130.129 3.372 . . . . 0.0 115.409 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.251 19.2 p90 -156.92 46.76 0.42 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 123.921 1.819 . . . . 0.0 110.025 175.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 174.76 -163.48 33.88 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . 0.461 ' HG ' ' HE3' ' A' ' 347' ' ' LYS . 0.7 OUTLIER -135.23 151.44 50.6 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.582 1.553 . . . . 0.0 107.535 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.284 57.2 m-85 -105.65 136.18 45.71 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.94 134.83 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.942 0 CA-C-N 112.316 -2.22 . . . . 0.0 106.285 -176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -100.12 128.55 46.18 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.856 -1.153 . . . . 0.0 113.302 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.326 29.5 mm -81.53 -103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 123.046 1.403 . . . . 0.0 113.89 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -107.82 169.67 8.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 129.313 3.045 . . . . 0.0 106.813 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.73 119.5 9.42 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 120.114 -1.616 . . . . 0.0 114.591 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 89.26 -5.98 83.78 Favored Glycine 0 C--N 1.369 2.368 0 C-N-CA 127.065 2.269 . . . . 0.0 115.638 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.67 113.49 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.34 2.256 . . . . 0.0 110.802 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.1 157.62 46.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 118.388 -2.695 . . . . 0.0 106.801 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.467 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -126.47 174.0 18.03 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 124.307 2.06 . . . . 0.0 115.901 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 7.9 tp -124.51 125.0 43.49 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.769 1.627 . . . . 0.0 107.888 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.2 110.85 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 C-N-CA 125.997 1.719 . . . . 0.0 107.74 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -79.04 115.14 18.53 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -36.49 -37.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.599 0 C-N-CA 130.861 3.664 . . . . 0.0 119.111 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.4 t -87.68 -5.19 58.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.397 1.479 . . . . 0.0 114.883 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.62 54.84 0.63 Allowed 'General case' 0 C--N 1.373 1.595 0 C-N-CA 126.395 1.878 . . . . 0.0 114.372 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 42.0 ttm -176.18 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.812 -1.18 . . . . 0.0 109.056 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 28.7 t70 90.81 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.624 0 C-N-CA 128.346 2.658 . . . . 0.0 109.497 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -67.3 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.207 3.403 . . . . 0.0 116.395 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.8 m -149.42 133.29 17.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.496 2.318 . . . . 0.0 105.248 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.26 50.3 m-80 116.05 -57.02 0.0 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 131.434 3.894 . . . . 0.0 106.486 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -95.22 16.69 15.92 Favored 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.432 1.893 . . . . 0.0 111.469 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.429 HD22 ' HE2' ' A' ' 320' ' ' LYS . 25.0 t-20 -92.79 -5.76 50.43 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 127.909 2.484 . . . . 0.0 112.919 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 5.6 mt 72.99 -45.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.324 0 C-N-CA 131.32 3.848 . . . . 0.0 113.164 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . 0.449 ' C ' ' H ' ' A' ' 319' ' ' SER . 50.9 m-70 -56.1 137.7 73.54 Favored Pre-proline 0 C--N 1.356 0.864 1 C-N-CA 131.939 4.095 . . . . 0.0 118.625 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.5 38.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.61 1 C-N-CA 127.11 5.207 . . . . 0.0 114.32 166.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 317' ' ' HIS 0.42 3.0 t 87.43 24.84 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 130.185 3.394 . . . . 0.0 114.336 177.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.429 ' HE2' HD22 ' A' ' 315' ' ' ASN 0.489 0.0 OUTLIER 72.23 22.84 3.46 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 133.388 4.675 . . . . 0.0 110.23 -170.169 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.428 3.7 t 82.28 64.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.61 1 C-N-CA 132.045 4.138 . . . . 0.0 109.715 177.319 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 9.8 t -94.64 100.39 11.03 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -114.0 162.88 15.87 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 128.357 2.663 . . . . 0.0 105.678 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.05 120.47 12.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 126.145 1.778 . . . . 0.0 109.493 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.32 13.74 58.21 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 126.081 1.801 . . . . 0.0 116.532 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.84 149.22 21.42 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 126.04 1.736 . . . . 0.0 111.308 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.5 p -100.03 134.21 40.33 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-O 123.415 1.579 . . . . 0.0 110.502 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.75 -178.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 1 C-N-CA 134.3 5.04 . . . . 0.0 110.594 -173.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -127.34 147.02 50.26 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 129.014 2.925 . . . . 0.0 103.813 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.5 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 1.6 m -146.46 163.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.555 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 57.0 ttp -126.53 136.05 52.08 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.54 132.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -136.65 0.3 Allowed 'General case' 0 N--CA 1.417 -2.097 1 N-CA-C 97.92 -4.845 . . . . 0.0 97.92 172.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.32 2.6 t70 -63.2 112.41 2.66 Favored 'General case' 0 C--N 1.316 -0.88 1 N-CA-C 123.205 4.52 . . . . 0.0 123.205 -156.767 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.521 HD13 ' HE ' ' A' ' 273' ' ' ARG 0.334 0.0 OUTLIER -101.71 136.77 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 126.065 1.746 . . . . 0.0 111.36 -177.406 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -139.83 102.86 4.52 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 167.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -63.14 -18.3 63.3 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 129.124 2.97 . . . . 0.0 113.805 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.33 -32.71 58.85 Favored 'General case' 0 N--CA 1.433 -1.288 1 C-N-CA 133.042 4.537 . . . . 0.0 112.621 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -108.94 -31.64 7.58 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-O 123.188 1.47 . . . . 0.0 112.477 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.342 68.9 mtp180 74.91 50.46 0.09 Allowed 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 130.932 3.693 . . . . 0.0 113.112 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 125.53 44.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 111.683 -2.508 . . . . 0.0 104.763 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.88 130.01 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.216 1 N-CA-C 98.694 -4.558 . . . . 0.0 98.694 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 5.1 t -102.26 92.47 4.74 Favored 'General case' 0 C--N 1.377 1.804 1 C-N-CA 110.298 -4.561 . . . . 0.0 104.336 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.467 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -103.78 136.34 43.65 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 117.244 -1.783 . . . . 0.0 111.306 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.66 123.06 1.65 Allowed Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.357 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.5 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.664 1.5 tt -138.89 -90.07 0.21 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 131.176 3.79 . . . . 0.0 108.589 174.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . 0.461 ' HE3' ' HG ' ' A' ' 292' ' ' CYS 0.342 19.4 tttt 101.35 23.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 167.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.43 -47.67 63.36 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.473 11.8 p 95.28 164.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.374 1 C-N-CA 133.75 4.82 . . . . 0.0 113.916 -177.857 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -92.83 164.15 13.45 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.855 2.062 . . . . 0.0 111.582 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.5 99.31 11.49 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 119.235 -2.165 . . . . 0.0 107.849 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 91.45 64.44 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.831 0 C-N-CA 131.027 3.731 . . . . 0.0 105.968 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.69 -16.41 13.08 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.063 2.509 . . . . 0.0 113.728 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -110.72 136.52 49.67 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 128.551 2.74 . . . . 0.0 108.103 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -141.11 176.65 8.65 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.447 1.899 . . . . 0.0 107.008 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -79.25 68.34 5.21 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -64.13 71.8 0.03 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.042 2.937 . . . . 0.0 117.161 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -133.41 143.74 49.09 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.28 115.76 4.77 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.74 0.781 . . . . 0.0 108.911 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 45.5 m 169.51 62.72 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.613 1 N-CA-C 98.935 -4.469 . . . . 0.0 98.935 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 . . . . . 0 C--O 1.26 1.634 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.008 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 86.2 m95 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.78 151.17 31.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 125.705 1.602 . . . . 0.0 108.32 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -107.81 -68.93 0.87 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.337 1.855 . . . . 0.0 108.984 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.3 tt -153.04 145.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 127.262 2.225 . . . . 0.0 106.547 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.255 . . 89.16 -108.25 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 128.96 2.904 . . . . 0.0 111.203 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . 0.312 8.0 ptpt -147.33 -78.64 0.16 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.203 1.477 . . . . 0.0 108.006 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -113.1 -61.22 1.77 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 127.017 2.127 . . . . 0.0 111.759 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -113.17 149.32 41.23 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.936 2.095 . . . . 0.0 108.318 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -67.58 177.06 4.32 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.95 3.767 . . . . 0.0 116.011 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.49 135.6 21.41 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.12 5.11 44.11 Favored Glycine 0 C--N 1.369 2.386 0 CA-C-O 123.856 1.809 . . . . 0.0 112.546 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 70.5 p -95.93 121.87 38.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 130.923 3.689 . . . . 0.0 103.775 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -90.03 146.96 23.96 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.72 1.248 . . . . 0.0 113.362 -176.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -129.21 174.2 9.8 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-N 112.786 -2.006 . . . . 0.0 106.655 -170.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.29 143.78 51.17 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.64 173.73 38.06 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -119.04 138.36 52.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.47 132.98 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.158 -1.589 . . . . 0.0 115.153 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.267 2.3 t -136.13 -25.57 1.2 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -133.4 174.37 10.48 Favored 'General case' 0 C--N 1.372 1.551 0 CA-C-N 123.484 2.856 . . . . 0.0 108.053 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.9 OUTLIER -121.01 151.41 39.79 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 167.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 178.18 4.38 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -65.59 -29.35 69.93 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.835 2.054 . . . . 0.0 115.663 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.11 44.44 0.72 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 125.126 2.394 . . . . 0.0 107.915 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.27 -165.21 29.82 Favored Glycine 0 CA--C 1.468 -2.869 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.7 t -143.3 153.83 43.17 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 126.266 1.826 . . . . 0.0 106.694 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.291 65.3 m-85 -114.81 142.22 46.84 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-O 124.885 2.279 . . . . 0.0 111.85 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.56 139.18 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.965 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -100.79 119.28 38.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.601 -1.312 . . . . 0.0 110.391 164.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.277 28.8 mt -60.15 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 124.433 2.063 . . . . 0.0 116.19 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.26 147.34 50.23 Favored 'General case' 0 CA--C 1.495 -1.153 1 N-CA-C 98.963 -4.458 . . . . 0.0 98.963 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -57.41 119.97 7.4 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.17 -10.55 47.49 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.731 1.634 . . . . 0.0 114.649 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.3 t -116.24 143.93 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 C-N-CA 127.966 2.506 . . . . 0.0 105.067 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -152.42 149.75 28.92 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 119.282 -2.136 . . . . 0.0 105.841 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.424 ' HA3' ' CD1' ' A' ' 344' ' ' LEU . . . -130.51 173.87 19.92 Favored Glycine 0 CA--C 1.485 -1.84 0 CA-C-O 124.368 2.093 . . . . 0.0 113.924 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 62.2 tp -97.81 163.49 12.78 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 120.378 -1.66 . . . . 0.0 110.157 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.263 11.8 t -116.76 118.89 60.28 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -79.87 113.27 17.91 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.386 7.6 p -27.25 -51.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.786 1 N-CA-C 122.003 4.075 . . . . 0.0 122.003 -166.565 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 25.0 p -91.06 -3.45 57.16 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.23 61.39 4.73 Favored 'General case' 0 C--N 1.366 1.311 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 17.2 ttt -99.79 -62.17 1.27 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.678 1.591 . . . . 0.0 107.363 170.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -168.57 -57.98 0.02 OUTLIER 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -154.1 172.64 17.2 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.9 t -164.08 130.8 3.17 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 57.8 t30 150.6 -80.68 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -110.05 43.92 1.29 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.827 1.251 . . . . 0.0 109.561 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -86.42 -19.83 29.08 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.092 1.757 . . . . 0.0 112.175 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 5.6 mt 71.78 -33.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 130.604 3.562 . . . . 0.0 114.928 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -90.32 113.9 59.11 Favored Pre-proline 0 C--N 1.351 0.632 0 C-N-CA 131.073 3.749 . . . . 0.0 117.478 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -64.17 44.39 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.431 1 C-N-CA 127.795 5.664 . . . . 0.0 113.794 165.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' SER . . . . . 0.449 ' HB3' ' HB ' ' A' ' 322' ' ' VAL 0.481 1.2 t 87.67 13.5 0.1 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 125.333 2.492 . . . . 0.0 113.204 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.323 18.0 mttp 77.03 28.39 0.64 Allowed 'General case' 0 C--N 1.365 1.239 1 C-N-CA 132.964 4.506 . . . . 0.0 110.037 -170.025 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.467 1.5 t 74.53 62.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 1 C-N-CA 132.034 4.134 . . . . 0.0 111.513 -179.103 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 319' ' ' SER 0.297 4.1 t -77.44 102.8 4.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.605 0 CA-C-O 125.009 2.338 . . . . 0.0 111.007 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -109.47 168.17 9.59 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.364 3.065 . . . . 0.0 107.66 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.33 121.2 23.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.38 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.43 14.95 56.42 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 125.676 1.608 . . . . 0.0 114.225 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.65 143.71 26.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.998 1.319 . . . . 0.0 110.912 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.405 HG23 ' HZ3' ' A' ' 350' ' ' LYS . 1.0 OUTLIER -99.83 136.25 31.92 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.773 1.273 . . . . 0.0 108.519 176.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.77 177.89 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 129.664 3.186 . . . . 0.0 107.074 -171.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -123.91 138.32 54.5 Favored 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 98.819 -4.512 . . . . 0.0 98.819 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 7.7 m -143.47 139.97 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 100.667 -3.827 . . . . 0.0 100.667 -167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.7 ttm -102.57 141.64 35.07 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 120.363 -1.46 . . . . 0.0 108.781 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.5 133.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 119.936 -1.727 . . . . 0.0 115.463 -170.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -135.35 0.29 Allowed 'General case' 0 N--CA 1.426 -1.643 1 N-CA-C 99.618 -4.215 . . . . 0.0 99.618 172.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.402 0.8 OUTLIER -59.69 112.72 1.92 Allowed 'General case' 0 N--CA 1.481 1.122 1 N-CA-C 124.196 4.887 . . . . 0.0 124.196 -158.976 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -101.48 112.83 35.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 C-N-CA 125.65 1.58 . . . . 0.0 114.176 -176.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.55 107.48 6.67 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.87 7.32 37.81 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 126.535 1.934 . . . . 0.0 112.302 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . 0.25 24.1 mm-40 -82.71 -41.91 18.71 Favored 'General case' 0 N--CA 1.432 -1.351 1 C-N-CA 134.021 4.928 . . . . 0.0 108.831 170.955 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -101.51 -27.08 13.32 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.655 1.982 . . . . 0.0 111.349 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 63.1 mtm-85 75.32 53.21 0.07 Allowed 'General case' 0 C--N 1.35 0.604 1 C-N-CA 131.968 4.107 . . . . 0.0 112.702 -179.933 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -124.53 134.0 53.13 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 111.092 -2.776 . . . . 0.0 109.621 -177.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.83 122.0 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 1 N-CA-C 94.44 -6.133 . . . . 0.0 94.44 172.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 94.96 5.76 Favored 'General case' 0 CA--C 1.463 -2.366 1 C-N-CA 110.845 -4.342 . . . . 0.0 104.35 -162.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.424 ' CD1' ' HA3' ' A' ' 302' ' ' GLY . 1.0 OUTLIER -96.34 171.24 8.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 118.925 -2.359 . . . . 0.0 109.547 -164.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -154.81 136.91 5.39 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 116.688 -2.672 . . . . 0.0 112.857 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.06 152.79 3.9 Favored 'General case' 0 C--N 1.35 0.592 1 N-CA-C 125.029 5.196 . . . . 0.0 125.029 -163.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -108.32 -102.25 0.37 Allowed 'General case' 0 C--N 1.386 2.159 0 O-C-N 121.208 -0.933 . . . . 0.0 111.909 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -139.33 24.25 2.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 120.196 -1.565 . . . . 0.0 114.85 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.485 0.9 OUTLIER 70.84 173.67 0.31 Allowed 'General case' 0 C--N 1.373 1.625 0 C-N-CA 126.334 1.853 . . . . 0.0 115.31 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -80.46 159.67 25.52 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.47 -1.394 . . . . 0.0 111.739 174.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.415 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -85.33 54.59 3.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 110.758 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.294 3.3 p30 123.01 94.32 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.801 1 C-N-CA 136.196 5.798 . . . . 0.0 104.977 -171.834 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 -99.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.404 2.736 . . . . 0.0 110.511 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -88.43 75.42 8.43 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.667 1.987 . . . . 0.0 111.338 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.88 173.41 10.57 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.513 1.125 . . . . 0.0 108.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -128.4 175.36 8.56 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 127.246 2.218 . . . . 0.0 106.054 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 66.41 -167.78 0.21 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 127.043 2.137 . . . . 0.0 115.775 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -130.52 58.37 1.69 Allowed 'General case' 0 C--N 1.359 0.985 0 O-C-N 120.608 -1.308 . . . . 0.0 109.826 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.79 149.81 41.44 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.795 1.238 . . . . 0.0 110.683 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.2 m 178.16 147.9 0.17 Allowed 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 C--O 1.267 2.016 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -179.76 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 120.921 0.391 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.28 152.59 8.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.37 42.43 1.04 Allowed 'General case' 0 C--N 1.363 1.163 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.2 tt -169.12 157.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 124.361 1.064 . . . . 0.0 109.622 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 54.71 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.361 1.084 2 C-N-CA 132.925 4.49 . . . . 0.0 122.741 170.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -48.11 124.22 7.38 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 120.286 3.439 . . . . 0.0 120.286 -168.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.536 ' H ' ' HE ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -107.01 17.43 23.06 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.964 1.706 . . . . 0.0 112.733 -172.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.9 151.81 19.7 Favored Pre-proline 0 N--CA 1.445 -0.706 0 C-N-CA 124.92 1.288 . . . . 0.0 109.75 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -81.83 -37.37 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.394 3.396 . . . . 0.0 111.776 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 84.03 123.5 0.04 OUTLIER 'General case' 0 C--N 1.372 1.584 0 C-N-CA 129.637 3.175 . . . . 0.0 112.733 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.75 10.23 44.06 Favored Glycine 0 C--N 1.375 2.744 0 CA-C-O 124.255 2.031 . . . . 0.0 113.356 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.17 166.36 13.42 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 131.431 3.893 . . . . 0.0 103.31 167.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HZ2' ' HB2' ' A' ' 331' ' ' MET . 29.2 mmmt -112.14 146.98 37.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 120.244 -1.535 . . . . 0.0 111.906 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.8 mp -120.95 174.13 6.82 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 123.926 1.822 . . . . 0.0 107.094 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 89.1 m -141.09 138.28 33.44 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.381 -1.449 . . . . 0.0 108.228 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.91 179.06 36.62 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-O 124.183 1.991 . . . . 0.0 115.638 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -125.4 135.38 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.12 133.5 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 119.134 3.013 . . . . 0.0 119.134 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.255 12.4 t -115.59 -40.6 3.36 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 112.968 -1.923 . . . . 0.0 115.083 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -135.9 172.63 12.73 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.103 1.774 . . . . 0.0 109.138 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 tt -122.18 142.36 50.5 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.652 1.581 . . . . 0.0 107.86 166.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 173.67 6.26 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 121.006 -1.059 . . . . 0.0 109.284 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -28.87 69.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.62 2.368 . . . . 0.0 115.537 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -153.3 48.46 0.69 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 123.494 1.616 . . . . 0.0 107.744 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 177.66 -161.55 28.83 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 167.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.36 0.8 OUTLIER -145.9 164.58 31.52 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 125.017 1.327 . . . . 0.0 109.523 168.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -102.92 122.44 44.57 Favored 'General case' 0 C--N 1.357 0.892 0 O-C-N 121.202 -0.936 . . . . 0.0 108.894 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.4 125.94 67.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.27 123.73 35.81 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.7 mm -91.25 48.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.932 -1.105 . . . . 0.0 111.231 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.268 38.0 mt-10 79.95 173.56 0.14 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.116 2.566 . . . . 0.0 110.481 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.56 119.4 12.29 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.92 -33.91 4.7 Favored Glycine 0 C--N 1.367 2.305 0 C-N-CA 127.65 2.548 . . . . 0.0 114.337 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . 0.298 1.8 p -117.35 123.54 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.0 112.03 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.38 154.65 45.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 119.066 -2.272 . . . . 0.0 107.276 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -116.27 172.15 14.09 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-O 124.083 1.935 . . . . 0.0 112.045 163.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 5.1 tp -126.75 126.48 43.51 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.638 ' CG2' ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -92.14 120.22 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 171.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -94.92 132.5 39.68 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 123.647 0.592 . . . . 0.0 111.801 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 t -47.79 -23.01 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 12.2 t -69.33 -25.65 64.31 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.442 2.697 . . . . 0.0 114.496 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -104.09 66.5 0.83 Allowed 'General case' 0 C--N 1.363 1.178 0 C-N-CA 127.291 2.236 . . . . 0.0 107.796 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 67.3 ttp -141.63 -97.07 0.13 Allowed 'General case' 0 C--N 1.357 0.912 0 O-C-N 121.059 -1.026 . . . . 0.0 110.399 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -175.41 -116.3 0.0 OUTLIER 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -169.03 -178.21 3.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 126.322 1.849 . . . . 0.0 106.977 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.9 t -127.27 135.68 50.93 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 120.235 -1.54 . . . . 0.0 111.277 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.7 44.43 1.83 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 57.1 tttm 91.54 38.01 0.01 OUTLIER 'General case' 0 C--N 1.366 1.308 0 C-N-CA 130.641 3.576 . . . . 0.0 108.442 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -116.75 2.65 12.92 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.276 1.9 mp 67.65 -60.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.684 1 C-N-CA 132.413 4.285 . . . . 0.0 114.625 178.38 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 147.05 105.44 0.0 OUTLIER Pre-proline 0 C--N 1.348 0.518 0 C-N-CA 131.598 3.959 . . . . 0.0 106.419 -172.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -56.5 -26.02 61.45 Favored 'Trans proline' 0 C--N 1.37 1.686 1 C-N-CA 126.241 4.628 . . . . 0.0 116.355 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 20.0 t -83.43 -2.74 56.55 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.404 2.282 . . . . 0.0 114.894 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -120.28 -4.7 9.94 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 121.341 1.882 . . . . 0.0 113.056 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.2 m -93.97 5.49 7.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 C-N-CA 125.678 1.591 . . . . 0.0 112.438 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.69 126.18 53.15 Favored 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 126.455 1.902 . . . . 0.0 109.364 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -106.09 171.09 7.53 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 123.568 1.651 . . . . 0.0 108.863 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.49 120.66 2.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 128.261 2.624 . . . . 0.0 113.703 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.74 14.72 72.29 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 114.193 -1.367 . . . . 0.0 115.588 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.1 133.94 34.56 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 126.791 2.037 . . . . 0.0 106.494 172.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.04 135.59 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.433 ' HA ' ' N ' ' A' ' 349' ' ' CYS . 30.5 m -139.99 175.49 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 124.988 2.327 . . . . 0.0 111.462 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -108.51 150.93 26.76 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -138.55 167.05 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 -177.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.541 ' HB2' ' HZ2' ' A' ' 279' ' ' LYS . 31.9 ttm -115.52 138.81 50.66 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.431 ' HB ' HD12 ' A' ' 344' ' ' LEU . 1.2 p -85.7 131.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.91 -137.33 0.3 Allowed 'General case' 0 N--CA 1.414 -2.231 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.29 28.0 m-20 -65.01 112.45 3.33 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.816 4.376 . . . . 0.0 122.816 -155.084 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.431 0.1 OUTLIER -109.66 124.8 66.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 C-N-CA 125.409 1.484 . . . . 0.0 110.14 -179.202 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.26 112.68 13.57 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -78.97 -4.82 51.88 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 123.729 1.728 . . . . 0.0 112.866 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -86.52 -41.19 14.55 Favored 'General case' 0 N--CA 1.425 -1.689 1 C-N-CA 135.378 5.471 . . . . 0.0 111.269 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -103.11 -28.99 11.62 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 113.572 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.271 16.4 mmm180 75.02 48.88 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 128.118 2.567 . . . . 0.0 113.665 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.56 134.28 52.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 128.278 2.631 . . . . 0.0 106.337 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.3 mm -116.54 129.59 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 1 N-CA-C 95.052 -5.907 . . . . 0.0 95.052 168.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.68 94.36 5.25 Favored 'General case' 0 C--N 1.385 2.123 1 C-N-CA 111.037 -4.265 . . . . 0.0 106.425 -167.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.431 HD12 ' HB ' ' A' ' 332' ' ' VAL . 0.2 OUTLIER -101.14 135.36 42.72 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 116.611 -2.035 . . . . 0.0 108.895 -171.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -124.28 134.68 9.25 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 121.652 -0.655 . . . . 0.0 112.943 -176.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.638 ' H ' ' CG2' ' A' ' 304' ' ' VAL 0.353 0.1 OUTLIER -73.49 163.08 28.53 Favored 'General case' 0 C--N 1.368 1.381 1 N-CA-C 128.779 6.585 . . . . 0.0 128.779 -154.586 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -121.52 -105.77 0.37 Allowed 'General case' 0 C--N 1.384 2.108 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -163.6 152.0 13.59 Favored 'General case' 0 C--N 1.349 0.566 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 173.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.433 ' N ' ' HA ' ' A' ' 328' ' ' VAL . 13.0 t -86.35 -39.2 16.67 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.781 3.658 . . . . 0.0 108.922 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -129.35 165.14 22.09 Favored 'General case' 0 N--CA 1.449 -0.524 1 CA-C-N 104.258 -5.883 . . . . 0.0 108.759 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.22 46.18 1.01 Allowed 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.008 -1.683 . . . . 0.0 109.675 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.286 1.0 OUTLIER 154.94 69.31 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.629 1 C-N-CA 132.808 4.443 . . . . 0.0 106.56 -176.493 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.35 128.88 18.07 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 124.74 3.627 . . . . 0.0 110.971 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -62.42 127.41 31.19 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.31 2.244 . . . . 0.0 116.854 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.84 -15.18 20.34 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.51 114.83 3.89 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 119.936 -1.727 . . . . 0.0 108.911 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.313 97.0 m-85 77.53 47.62 0.06 Allowed 'General case' 0 C--N 1.362 1.126 0 C-N-CA 129.242 3.017 . . . . 0.0 117.39 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -85.27 95.11 9.09 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 120.639 -1.288 . . . . 0.0 111.088 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -111.18 -98.41 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.401 1.08 . . . . 0.0 109.256 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.6 p -112.0 -81.07 0.59 Allowed 'General case' 0 C--N 1.348 0.534 0 C-N-CA 126.609 1.964 . . . . 0.0 110.705 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 . . . . . 0 C--O 1.261 1.663 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.722 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 14.4 t90 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 75.0 t -99.62 117.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 128.144 2.578 . . . . 0.0 109.138 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.93 -8.67 51.25 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.81 133.85 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 86.16 45.31 0.01 OUTLIER 'General case' 0 C--N 1.355 0.822 0 C-N-CA 128.377 2.671 . . . . 0.0 112.27 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -87.61 131.8 34.3 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 127.0 2.12 . . . . 0.0 110.727 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -116.88 -32.0 5.24 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.993 0.917 . . . . 0.0 111.799 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 79.11 142.29 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 128.041 2.537 . . . . 0.0 116.589 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.29 91.12 1.03 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.224 2.616 . . . . 0.0 107.247 168.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.28 151.58 46.75 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 128.714 2.805 . . . . 0.0 118.117 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.26 8.35 55.14 Favored Glycine 0 C--N 1.384 3.214 0 CA-C-O 124.753 2.307 . . . . 0.0 112.336 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 2.9 p -96.46 147.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.75 1 C-N-CA 135.136 5.374 . . . . 0.0 101.929 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 7.7 ptmt -112.35 156.07 23.08 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 119.007 -2.308 . . . . 0.0 113.399 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.12 151.61 40.91 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.8 m -109.03 139.24 44.17 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.666 -1.271 . . . . 0.0 109.679 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -140.51 -179.18 17.84 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 123.215 1.453 . . . . 0.0 112.083 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -119.07 137.64 53.42 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.82 125.93 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.3 t -106.68 -36.58 6.68 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 111.758 -2.474 . . . . 0.0 112.772 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.27 0.9 OUTLIER -136.64 170.26 16.36 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.819 1.645 . . . . 0.0 109.299 177.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.72 148.05 45.11 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.7 m -112.02 172.56 6.83 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -68.05 -28.09 67.09 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.174 -2.204 . . . . 0.0 113.298 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.68 44.07 1.37 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.949 1.7 . . . . 0.0 107.757 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -179.05 -168.31 37.94 Favored Glycine 0 CA--C 1.471 -2.71 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 145.86 26.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -101.14 118.69 37.49 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.67 125.04 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.19 119.47 33.06 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.246 -1.534 . . . . 0.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 37.5 mm -60.19 -65.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -138.08 166.52 23.91 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -65.52 118.87 10.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.835 -1.166 . . . . 0.0 114.046 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.02 -16.94 53.61 Favored Glycine 0 C--N 1.368 2.329 0 C-N-CA 127.128 2.299 . . . . 0.0 115.851 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.91 117.83 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.941 1.697 . . . . 0.0 109.94 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.76 160.31 37.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 119.346 -2.097 . . . . 0.0 110.299 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.35 173.54 15.35 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 125.946 1.736 . . . . 0.0 114.181 169.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.2 tp -126.22 115.53 19.88 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 126.442 1.897 . . . . 0.0 107.088 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.256 4.3 p -87.34 112.77 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -79.16 123.46 27.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.165 -176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.63 -23.8 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 122.942 2.61 . . . . 0.0 115.911 176.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.8 p -87.07 11.29 14.15 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 131.48 3.912 . . . . 0.0 114.308 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 50.13 0.04 OUTLIER 'General case' 0 C--N 1.378 1.83 0 C-N-CA 128.415 2.686 . . . . 0.0 114.923 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 32.9 ttm -164.44 -61.8 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -163.2 -83.67 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -132.22 11.09 4.57 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.392 -0.818 . . . . 0.0 113.068 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . 0.41 0.6 OUTLIER 83.46 -150.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.056 3.342 . . . . 0.0 111.854 -177.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 74.45 -60.55 0.52 Allowed 'General case' 0 C--N 1.365 1.264 0 C-N-CA 129.993 3.317 . . . . 0.0 111.626 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -66.08 -14.13 61.21 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 131.515 3.926 . . . . 0.0 112.306 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -73.93 -27.85 61.23 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 127.093 2.157 . . . . 0.0 111.219 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.5 mt 68.56 -33.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 130.48 3.512 . . . . 0.0 117.722 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -78.29 110.73 14.62 Favored Pre-proline 0 C--N 1.352 0.707 1 C-N-CA 131.886 4.074 . . . . 0.0 119.204 -176.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -67.47 54.21 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 126.637 4.891 . . . . 0.0 115.46 168.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 92.78 6.96 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 128.957 2.903 . . . . 0.0 110.481 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.26 5.7 tmtp? 72.32 19.04 4.47 Favored 'General case' 0 C--N 1.371 1.532 1 C-N-CA 132.026 4.13 . . . . 0.0 109.54 -169.588 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.426 0.9 OUTLIER 57.16 57.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.467 1 C-N-CA 133.415 4.686 . . . . 0.0 112.381 -171.089 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.84 145.1 8.73 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 C-N-CA 130.184 3.394 . . . . 0.0 114.189 -172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -120.16 169.06 10.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.09 121.27 26.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 C-N-CA 126.56 1.944 . . . . 0.0 107.834 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.42 53.79 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -98.89 164.46 12.19 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 130.009 3.324 . . . . 0.0 104.13 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.29 0.2 OUTLIER -121.41 138.17 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.302 -1.499 . . . . 0.0 109.925 -175.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . 0.259 0.9 OUTLIER -139.23 163.47 26.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 CA-C-O 122.879 1.323 . . . . 0.0 108.086 179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.24 155.38 18.06 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.491 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 3.1 m -141.1 163.71 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 51.6 ttp -120.71 141.43 50.44 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 11.9 p -80.72 131.37 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -168.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.411 ' HB2' ' H ' ' A' ' 334' ' ' ASP . 0.6 OUTLIER -123.36 -136.66 0.29 Allowed 'General case' 0 N--CA 1.42 -1.968 1 N-CA-C 99.953 -4.092 . . . . 0.0 99.953 176.571 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . 0.461 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.254 24.7 m-20 -69.45 112.32 5.9 Favored 'General case' 0 C--N 1.31 -1.152 1 N-CA-C 122.702 4.334 . . . . 0.0 122.702 -154.766 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.335 0.1 OUTLIER -102.87 125.39 57.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 C-N-CA 127.266 2.226 . . . . 0.0 109.28 179.607 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.72 110.62 14.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -74.94 -3.43 32.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.025 2.13 . . . . 0.0 113.539 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -88.17 -35.55 17.32 Favored 'General case' 0 N--CA 1.432 -1.358 1 C-N-CA 132.49 4.316 . . . . 0.0 110.766 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -103.71 -39.93 6.48 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.507 1.523 . . . . 0.0 111.806 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.361 92.5 mtt180 74.48 52.49 0.09 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 132.423 4.289 . . . . 0.0 112.606 -179.272 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -124.87 132.85 53.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 127.802 2.441 . . . . 0.0 104.638 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 131.15 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' SER . . . . . 0.461 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 3.9 m -107.32 92.19 3.97 Favored 'General case' 0 C--N 1.381 1.94 1 C-N-CA 111.061 -4.256 . . . . 0.0 105.105 -166.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.7 mp -101.6 138.28 38.8 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 119.961 1.255 . . . . 0.0 111.45 -175.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -149.12 123.81 1.7 Allowed Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.309 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.491 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.741 4.0 tt -139.58 -86.93 0.22 Allowed 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.493 3.517 . . . . 0.0 112.348 174.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.263 29.7 ttmt 93.78 44.2 0.0 OUTLIER 'General case' 0 C--N 1.371 1.506 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 174.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -79.8 -46.83 16.21 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 118.822 -2.424 . . . . 0.0 113.324 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.259 63.0 m 90.02 160.1 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 130.425 3.49 . . . . 0.0 111.492 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.413 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 4.9 mmtp -72.16 166.81 21.59 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.413 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -92.24 4.04 54.11 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.801 2.04 . . . . 0.0 114.469 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -168.64 75.58 0.8 Allowed Pre-proline 0 CA--C 1.541 0.626 1 C-N-CA 131.84 4.056 . . . . 0.0 105.183 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -61.66 -27.36 81.22 Favored 'Trans proline' 0 C--N 1.372 1.769 1 C-N-CA 125.478 4.119 . . . . 0.0 116.045 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -129.53 144.55 51.31 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 129.208 3.003 . . . . 0.0 104.124 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -134.34 125.44 27.62 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -167.47 152.21 6.95 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.23 -31.8 20.1 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 115.132 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -149.95 132.49 15.75 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 136.91 -46.62 0.01 OUTLIER 'General case' 0 C--N 1.362 1.152 0 C-N-CA 128.811 2.844 . . . . 0.0 107.106 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 66.7 m -76.16 -23.03 54.75 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 127.295 2.238 . . . . 0.0 112.219 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 C--O 1.259 1.581 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 175.645 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.6 m95 . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.48 145.4 12.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 C-N-CA 125.53 1.532 . . . . 0.0 108.424 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -141.95 166.67 24.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.217 -2.882 . . . . 0.0 103.217 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . 0.408 7.2 pt 68.8 -2.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 129.597 3.159 . . . . 0.0 119.043 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 75.12 -78.07 0.05 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 129.618 3.167 . . . . 0.0 114.074 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -160.99 134.65 6.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.555 ' HA ' HG12 ' A' ' 335' ' ' ILE . 7.1 mmm180 -129.02 -83.28 0.57 Allowed 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . 0.291 4.5 m-85 82.44 154.6 0.12 Allowed Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 170.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.89 114.82 4.01 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.666 2.911 . . . . 0.0 109.727 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.3 125.19 27.25 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.809 1.644 . . . . 0.0 111.822 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.04 2.24 31.73 Favored Glycine 0 C--N 1.363 2.074 0 CA-C-O 122.929 1.294 . . . . 0.0 113.551 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 46.8 p -93.23 142.58 27.15 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 28.5 mmtp -97.65 146.03 25.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.559 1.171 . . . . 0.0 112.933 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.87 175.46 6.54 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 124.319 2.009 . . . . 0.0 110.238 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 48.3 m -116.92 129.87 56.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -132.4 173.44 20.79 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 124.42 2.122 . . . . 0.0 111.877 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -129.51 126.33 38.39 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.36 136.63 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 119.575 -1.953 . . . . 0.0 115.988 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.323 4.1 t -145.41 -20.35 0.48 Allowed 'General case' 0 C--N 1.361 1.083 0 N-CA-C 121.253 3.798 . . . . 0.0 121.253 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.347 2.6 t-20 -134.19 175.92 9.06 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 123.734 2.97 . . . . 0.0 110.672 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 142.44 49.85 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 119.134 -2.229 . . . . 0.0 108.512 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.0 m -112.51 178.38 4.32 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.85 -29.62 65.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.86 46.39 0.14 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 123.742 1.735 . . . . 0.0 110.278 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.0 -167.58 36.23 Favored Glycine 0 CA--C 1.48 -2.1 1 N-CA-C 101.17 -4.772 . . . . 0.0 101.17 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.258 0.1 OUTLIER -134.6 161.41 35.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -98.95 128.33 45.09 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.79 -1.819 . . . . 0.0 107.972 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.58 133.19 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.446 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.3 126.42 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 118.61 -2.556 . . . . 0.0 111.879 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.64 173.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 119.859 -1.776 . . . . 0.0 111.225 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -78.04 -17.72 56.72 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-O 127.315 3.436 . . . . 0.0 117.126 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.98 154.11 39.45 Favored 'General case' 0 C--N 1.303 -1.439 2 C-N-CA 143.072 8.549 . . . . 0.0 112.797 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.77 2.77 72.39 Favored Glycine 0 C--N 1.371 2.49 0 O-C-N 119.296 -2.128 . . . . 0.0 115.7 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.08 144.93 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 129.679 3.192 . . . . 0.0 108.605 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -115.17 158.24 22.51 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.984 -1.697 . . . . 0.0 107.925 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -110.25 172.92 15.99 Favored Glycine 0 C--N 1.359 1.841 0 CA-C-O 125.058 2.477 . . . . 0.0 112.973 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.3 tp -118.48 114.62 23.14 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.296 1.5 p -79.43 100.02 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 122.858 1.313 . . . . 0.0 107.54 174.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -87.92 114.7 24.79 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.937 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 27.6 m -28.48 -20.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.1 p -64.83 -28.92 69.89 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 131.167 3.787 . . . . 0.0 114.85 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.87 24.27 0.0 OUTLIER 'General case' 0 C--N 1.371 1.512 0 C-N-CA 131.145 3.778 . . . . 0.0 120.701 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 55.7 ttp -58.37 -59.91 4.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.373 3.469 . . . . 0.0 118.893 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 29.8 t70 97.24 -67.5 0.0 OUTLIER 'General case' 0 C--N 1.363 1.169 0 C-N-CA 128.972 2.909 . . . . 0.0 109.885 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -157.76 173.91 16.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.4 t -105.92 161.56 14.35 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.621 1.568 . . . . 0.0 113.807 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.256 66.2 m-80 106.47 -22.84 0.01 OUTLIER 'General case' 0 C--N 1.365 1.266 1 C-N-CA 132.614 4.366 . . . . 0.0 111.035 -178.68 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -111.86 -1.63 15.47 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.442 1.897 . . . . 0.0 112.242 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -88.6 -70.02 0.67 Allowed 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.277 -1.514 . . . . 0.0 114.892 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.7 mp 67.62 -52.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 C-N-CA 131.131 3.772 . . . . 0.0 115.636 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -167.89 105.8 0.57 Allowed Pre-proline 0 C--N 1.345 0.382 0 C-N-CA 126.71 2.004 . . . . 0.0 111.684 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -60.66 13.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.091 1 C-N-CA 127.473 5.449 . . . . 0.0 119.52 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.1 t -140.08 -1.01 1.6 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.73 0.812 . . . . 0.0 111.481 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -99.56 9.82 42.49 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 120.5 1.5 . . . . 0.0 111.015 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.41 139.47 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 1 N-CA-C 98.764 -4.532 . . . . 0.0 98.764 176.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.269 10.0 t 72.73 106.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.797 0 CA-C-N 121.686 2.039 . . . . 0.0 111.946 -173.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.79 172.3 8.73 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 124.406 2.05 . . . . 0.0 111.09 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.64 120.64 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 112.328 -2.215 . . . . 0.0 109.758 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.61 62.25 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 125.88 1.705 . . . . 0.0 115.827 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -93.4 151.67 19.6 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.766 2.427 . . . . 0.0 110.474 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.58 138.55 26.42 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 126.16 1.784 . . . . 0.0 107.727 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.639 HG23 ' H ' ' A' ' 349' ' ' CYS 0.253 7.5 p -147.92 170.16 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 124.354 2.025 . . . . 0.0 108.707 -173.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.37 140.6 38.24 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.5 167.67 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.682 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -173.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 23.6 ttm -118.4 138.8 52.2 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 171.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 92.5 t -81.6 124.74 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.531 -1.356 . . . . 0.0 111.14 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . 0.253 1.8 mp -125.03 -141.41 0.29 Allowed 'General case' 0 N--CA 1.409 -2.501 0 CA-C-O 126.847 3.213 . . . . 0.0 102.453 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . 0.426 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.35 4.9 t70 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 -152.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.555 HG12 ' HA ' ' A' ' 273' ' ' ARG . 4.8 tp -109.99 132.46 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.303 -172.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.44 104.05 5.96 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 101.58 -3.489 . . . . 0.0 101.58 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.57 -9.16 59.25 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.186 2.195 . . . . 0.0 114.026 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.13 -37.29 14.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.181 3.792 . . . . 0.0 111.074 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -100.62 -23.3 14.7 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 124.731 1.212 . . . . 0.0 112.365 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.276 1.5 mmp_? 74.45 46.7 0.15 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 129.491 3.116 . . . . 0.0 113.883 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.67 111.92 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 111.119 -2.764 . . . . 0.0 105.214 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.65 130.23 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 2 C-N-CA 133.579 4.752 . . . . 0.0 99.597 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' SER . . . . . 0.426 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 2.5 m -115.12 93.72 4.43 Favored 'General case' 0 CA--C 1.471 -2.063 1 C-N-CA 109.217 -4.993 . . . . 0.0 105.48 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 136.29 40.47 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -150.44 124.46 1.74 Allowed Glycine 0 N--CA 1.47 0.948 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.897 -164.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -32.93 154.15 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 2 C-N-CA 135.37 5.468 . . . . 0.0 124.72 -168.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -101.94 -79.75 0.51 Allowed 'General case' 0 C--N 1.384 2.089 0 C-N-CA 124.188 0.995 . . . . 0.0 109.531 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.31 0.4 OUTLIER -176.44 46.75 0.01 OUTLIER 'General case' 0 C--N 1.372 1.585 0 N-CA-C 118.278 2.696 . . . . 0.0 118.278 176.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.639 ' H ' HG23 ' A' ' 328' ' ' VAL 0.421 13.4 p 68.18 161.74 0.19 Allowed 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.205 4.15 . . . . 0.0 122.205 169.845 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -77.53 168.76 19.46 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 128.646 2.778 . . . . 0.0 113.33 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -101.81 18.29 20.88 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 118.895 -2.378 . . . . 0.0 113.257 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -174.89 52.21 0.11 Allowed Pre-proline 0 N--CA 1.438 -1.032 0 C-N-CA 129.673 3.189 . . . . 0.0 109.12 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.62 -43.96 6.8 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 125.005 3.803 . . . . 0.0 114.968 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -153.68 -159.81 1.03 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -80.94 62.28 4.87 Favored 'General case' 0 C--N 1.362 1.134 0 C-N-CA 127.896 2.478 . . . . 0.0 111.513 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -80.41 54.65 2.07 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.278 2.231 . . . . 0.0 115.838 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.17 49.34 5.6 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.442 3.097 . . . . 0.0 118.442 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -94.98 87.9 5.09 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 119.967 -1.708 . . . . 0.0 109.898 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . 0.294 36.4 mt-10 83.93 -174.52 0.03 OUTLIER 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.291 3.036 . . . . 0.0 112.829 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 14.4 t -137.2 -4.56 1.89 Allowed 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.661 -1.275 . . . . 0.0 111.823 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.27 2.18 2 C-N-CA 132.936 4.494 . . . . 0.0 99.407 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.5 65.65 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 126.292 1.837 . . . . 0.0 111.106 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -142.85 29.38 1.52 Allowed 'General case' 0 C--N 1.349 0.587 0 C-N-CA 126.399 1.88 . . . . 0.0 106.626 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 21.3 tt -168.35 159.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.255 . . 80.65 -73.51 0.05 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 129.023 2.929 . . . . 0.0 116.708 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.539 ' CG ' ' H ' ' A' ' 273' ' ' ARG . 36.4 ttpt -173.98 -127.71 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.539 ' H ' ' CG ' ' A' ' 272' ' ' LYS 0.274 13.4 mmp_? 94.4 119.08 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.777 1 C-N-CA 134.403 5.081 . . . . 0.0 110.074 -178.572 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -102.91 156.34 35.43 Favored Pre-proline 0 C--N 1.351 0.668 0 C-N-CA 127.994 2.518 . . . . 0.0 109.194 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.76 -176.19 3.11 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.829 3.019 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.31 126.92 49.14 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.512 1.125 . . . . 0.0 108.791 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.36 36.49 Favored Glycine 0 C--N 1.367 2.296 0 CA-C-O 123.804 1.78 . . . . 0.0 114.645 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 4.1 p -96.62 134.22 40.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 131.152 3.781 . . . . 0.0 102.923 171.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 21.2 pttp -100.13 149.63 23.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.327 1.537 . . . . 0.0 114.687 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.0 mp -120.95 175.28 6.14 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 123.447 1.594 . . . . 0.0 110.445 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 94.8 m -118.04 132.82 56.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.82 179.15 26.83 Favored Glycine 0 CA--C 1.481 -2.093 0 CA-C-O 123.875 1.819 . . . . 0.0 111.337 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -124.45 146.57 48.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 5.0 t -92.27 133.66 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.374 -1.453 . . . . 0.0 112.051 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -125.49 -38.88 2.22 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.87 174.69 10.19 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 121.334 1.879 . . . . 0.0 107.281 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.9 mp -119.53 151.08 39.2 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 119.98 -1.7 . . . . 0.0 110.583 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 178.94 4.12 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -30.05 69.0 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 119.066 -2.271 . . . . 0.0 115.711 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -145.72 39.28 1.14 Allowed 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 123.18 1.467 . . . . 0.0 110.504 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.38 -170.97 37.54 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 5.3 m -135.82 157.12 47.62 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.2 125.74 44.85 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.29 133.58 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 125.586 1.554 . . . . 0.0 107.344 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.43 126.47 46.83 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.811 2.096 . . . . 0.0 114.478 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 8.6 mm -104.56 56.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.626 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 75.22 171.6 0.27 Allowed 'General case' 0 C--N 1.364 1.236 0 C-N-CA 127.477 2.311 . . . . 0.0 111.877 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.96 119.04 12.66 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.75 -2.469 . . . . 0.0 115.593 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 118.82 -32.71 5.06 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 127.193 2.33 . . . . 0.0 114.987 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.443 HG11 HG13 ' A' ' 342' ' ' ILE . 40.3 t -116.9 130.64 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 127.543 2.337 . . . . 0.0 107.739 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.98 157.02 28.06 Favored 'General case' 0 CA--C 1.478 -1.798 0 O-C-N 118.307 -2.746 . . . . 0.0 104.916 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -125.87 174.07 17.7 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.61 122.26 37.69 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 125.932 1.693 . . . . 0.0 106.866 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 2.4 p -93.61 118.79 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -96.48 133.24 41.18 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 117.359 -1.736 . . . . 0.0 112.454 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.269 52.4 t -51.47 -39.09 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.1 p -88.22 23.12 2.23 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.502 1.521 . . . . 0.0 114.785 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -119.03 77.27 1.17 Allowed 'General case' 0 C--N 1.365 1.277 0 C-N-CA 126.063 1.745 . . . . 0.0 110.213 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 49.5 ttp -148.51 -122.79 0.05 Allowed 'General case' 0 C--N 1.362 1.126 0 O-C-N 119.504 -1.997 . . . . 0.0 108.281 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -158.03 -94.06 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.07 -1.644 . . . . 0.0 109.097 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -121.48 132.82 54.93 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 122.544 1.164 . . . . 0.0 110.48 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 15.0 t -113.66 46.9 1.23 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-O 125.674 2.654 . . . . 0.0 105.449 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -99.11 64.77 1.41 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 128.514 2.726 . . . . 0.0 109.564 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . 0.251 47.5 mmtm 82.93 19.8 0.23 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 128.063 2.545 . . . . 0.0 111.565 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.34 -38.66 7.12 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 128.2 2.6 . . . . 0.0 111.094 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 1.8 mp 67.84 -59.13 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.096 1 C-N-CA 133.957 4.903 . . . . 0.0 112.576 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 77.26 102.47 0.03 OUTLIER Pre-proline 0 C--N 1.349 0.547 0 C-N-CA 130.664 3.586 . . . . 0.0 115.776 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.52 -24.86 78.79 Favored 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 125.636 4.224 . . . . 0.0 112.679 167.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.5 m -54.19 -31.44 52.86 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.015 4.926 . . . . 0.0 115.131 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -97.19 -0.05 47.49 Favored 'General case' 0 C--N 1.365 1.266 0 O-C-N 120.199 -1.563 . . . . 0.0 114.063 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.4 t -111.95 -57.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 125.706 1.602 . . . . 0.0 106.76 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.399 0.7 OUTLIER 55.44 159.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.346 0 C-N-CA 129.182 2.993 . . . . 0.0 118.566 177.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -109.66 148.96 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.4 p -78.67 120.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.696 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 88.24 25.63 30.64 Favored Glycine 0 C--N 1.361 1.924 0 C-N-CA 124.31 0.957 . . . . 0.0 113.457 -170.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.83 158.0 15.87 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.674 1.99 . . . . 0.0 108.88 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -117.02 136.56 53.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.264 10.7 p -147.49 175.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 130.764 3.626 . . . . 0.0 108.225 -166.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -114.69 141.71 47.45 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 1.4 m -124.37 166.5 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.498 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 35.2 ttm -121.12 141.09 51.13 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.8 t -81.66 131.86 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.593 -1.317 . . . . 0.0 113.522 -173.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.48 -136.35 0.29 Allowed 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.252 10.5 t70 -63.84 112.05 2.73 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.585 4.291 . . . . 0.0 122.585 -153.651 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.267 2.8 tp -101.13 112.38 33.9 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 CA-C-O 122.7 1.238 . . . . 0.0 108.882 176.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.07 117.15 23.33 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.481 1.112 . . . . 0.0 108.166 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -80.96 -2.79 49.19 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.331 1.853 . . . . 0.0 115.128 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -89.56 -37.64 14.55 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.622 2.769 . . . . 0.0 111.463 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -103.13 -30.8 10.49 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.259 1.424 . . . . 0.0 112.454 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 16.9 mmm180 72.49 52.83 0.17 Allowed 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 129.925 3.29 . . . . 0.0 111.928 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.0 ptp180 -124.58 135.19 52.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 129.16 2.984 . . . . 0.0 107.768 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.443 HG13 HG11 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -108.88 130.04 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 167.373 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -102.57 94.74 5.81 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 111.781 -3.968 . . . . 0.0 107.246 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . 0.306 2.1 mm? -96.12 136.87 36.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 120.129 -1.607 . . . . 0.0 108.464 -172.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -135.15 127.69 4.47 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.454 ' HG ' ' CG2' ' A' ' 328' ' ' VAL . 6.9 mp -45.43 155.85 0.13 Allowed 'General case' 0 C--N 1.359 1.016 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -167.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -131.42 -62.74 0.86 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.64 124.31 1.92 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 173.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 7.4 p -47.63 151.88 0.77 Allowed 'General case' 0 C--N 1.361 1.084 1 C-N-CA 139.628 7.171 . . . . 0.0 117.48 169.259 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.13 162.73 27.75 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 127.403 2.281 . . . . 0.0 115.49 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -104.63 24.52 11.62 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.305 1.842 . . . . 0.0 112.548 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -175.64 51.69 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 129.702 3.201 . . . . 0.0 109.204 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -58.77 -41.83 59.28 Favored 'Trans proline' 0 C--N 1.379 2.172 1 C-N-CA 126.388 4.725 . . . . 0.0 116.615 -167.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -132.1 -95.64 0.34 Allowed 'General case' 0 C--N 1.361 1.09 0 CA-C-N 120.308 1.413 . . . . 0.0 107.668 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . 0.319 24.4 mp0 59.27 -37.26 0.07 Allowed 'General case' 0 C--N 1.368 1.403 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 173.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.363 12.6 tt0 102.37 -62.39 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.025 2.93 . . . . 0.0 115.66 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -66.28 43.85 0.02 OUTLIER 'General case' 0 C--N 1.358 0.971 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -167.81 -55.7 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.71 1.204 . . . . 0.0 108.575 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -82.82 -83.26 0.13 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.134 2.174 . . . . 0.0 115.987 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 86.5 m 175.39 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.359 0.984 0 N-CA-C 100.879 -3.748 . . . . 0.0 100.879 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.435 0 O-C-N 119.363 -2.085 . . . . 0.0 105.597 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 9.4 t90 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.49 164.57 13.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -101.57 50.42 0.85 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.779 1.632 . . . . 0.0 111.429 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 8.8 tt -168.14 -175.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 102.361 -3.199 . . . . 0.0 102.361 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -139.37 -174.28 3.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.838 1.199 . . . . 0.0 108.253 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -83.8 -41.78 17.18 Favored 'General case' 0 C--N 1.363 1.187 0 CA-C-O 123.752 1.739 . . . . 0.0 110.796 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -156.71 -71.25 0.1 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 131.505 3.922 . . . . 0.0 104.447 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -116.88 152.23 48.34 Favored Pre-proline 0 CA--C 1.517 -0.302 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.68 -48.92 8.02 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.697 3.598 . . . . 0.0 114.116 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 82.39 118.77 0.05 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 128.994 2.917 . . . . 0.0 113.919 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.42 58.1 Favored Glycine 0 C--N 1.375 2.696 0 CA-C-O 124.556 2.198 . . . . 0.0 112.231 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 19.6 p -97.45 126.21 42.57 Favored 'General case' 0 CA--C 1.509 -0.629 1 C-N-CA 133.267 4.627 . . . . 0.0 103.475 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -95.85 144.57 26.09 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.666 1.698 . . . . 0.0 112.859 -178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.77 174.09 7.34 Favored 'General case' 0 CA--C 1.487 -1.446 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.566 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.5 m -110.83 139.85 45.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -153.9 173.28 32.57 Favored Glycine 0 CA--C 1.482 -1.989 0 CA-C-O 123.543 1.635 . . . . 0.0 111.69 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.4 ' HG2' ' CG2' ' A' ' 327' ' ' VAL . 30.6 mtp-105 -127.54 135.37 50.24 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.53 132.08 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 113.869 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -130.19 -31.04 1.91 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -169.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.271 1.2 t-20 -133.75 176.09 8.87 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-N 121.751 2.069 . . . . 0.0 108.379 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.0 OUTLIER -120.47 156.37 31.62 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.255 -1.528 . . . . 0.0 113.174 176.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 178.57 4.25 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -68.33 -25.49 65.13 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.533 2.333 . . . . 0.0 115.037 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -162.55 54.05 0.21 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.225 2.61 . . . . 0.0 107.039 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.97 -170.48 41.66 Favored Glycine 0 CA--C 1.468 -2.865 1 N-CA-C 100.573 -5.011 . . . . 0.0 100.573 171.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.8 m -139.91 169.82 17.01 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.493 1.117 . . . . 0.0 108.852 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.83 128.71 56.2 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-O 123.128 1.442 . . . . 0.0 109.182 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.93 138.27 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 C-N-CA 125.862 1.665 . . . . 0.0 107.006 -174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -99.89 123.84 44.57 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 119.703 -1.873 . . . . 0.0 112.157 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.61 52.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 122.878 1.323 . . . . 0.0 111.616 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 79.07 174.97 0.15 Allowed 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.932 2.493 . . . . 0.0 109.716 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -68.22 119.72 13.23 Favored 'General case' 0 CA--C 1.558 1.285 0 O-C-N 119.871 -1.768 . . . . 0.0 114.181 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.0 32.4 Favored Glycine 0 C--N 1.367 2.262 0 C-N-CA 127.44 2.448 . . . . 0.0 115.196 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.18 143.99 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.125 1.77 . . . . 0.0 109.865 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -153.51 149.81 28.08 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 118.851 -2.405 . . . . 0.0 105.435 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -131.38 174.36 20.06 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-O 124.824 2.347 . . . . 0.0 112.44 176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 51.7 tp -98.38 162.63 13.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.703 2.001 . . . . 0.0 107.484 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 346' ' ' LEU . 2.4 p -128.82 117.15 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 161.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -95.21 134.89 37.45 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 119.09 -1.044 . . . . 0.0 113.792 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.272 1.0 OUTLIER -37.82 -41.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.93 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 86.2 p -92.26 -2.15 56.65 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.233 -1.542 . . . . 0.0 114.042 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -79.03 55.92 1.88 Allowed 'General case' 0 C--N 1.369 1.44 0 O-C-N 119.737 -1.852 . . . . 0.0 114.245 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 9.4 ttm -162.15 -80.41 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -145.5 -100.83 0.1 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -127.01 123.6 37.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.9 m -141.18 161.79 37.03 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.904 1.681 . . . . 0.0 106.649 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.264 29.5 m-80 134.47 -61.51 0.0 OUTLIER 'General case' 0 C--N 1.369 1.437 0 C-N-CA 131.105 3.762 . . . . 0.0 107.215 175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.7 17.66 13.52 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.309 1.844 . . . . 0.0 110.156 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.34 -13.44 37.89 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.313 1.845 . . . . 0.0 111.416 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.299 2.7 mp 61.57 -44.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.225 1 C-N-CA 132.187 4.195 . . . . 0.0 117.214 177.294 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -26.07 115.37 0.23 Allowed Pre-proline 0 C--N 1.363 1.185 1 C-N-CA 132.116 4.166 . . . . 0.0 118.059 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -58.01 -23.81 62.3 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.105 4.537 . . . . 0.0 115.146 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 p -82.18 -20.72 37.28 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.814 2.046 . . . . 0.0 113.996 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -83.98 -30.58 26.1 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 124.897 1.279 . . . . 0.0 112.109 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 t -95.16 -54.0 7.64 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 C-N-CA 125.915 1.686 . . . . 0.0 111.31 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.507 0.4 OUTLIER 85.61 134.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 129.654 3.182 . . . . 0.0 114.37 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -104.7 151.07 24.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 123.935 1.826 . . . . 0.0 112.527 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.4 p -69.15 120.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 C-N-CA 127.052 2.141 . . . . 0.0 108.633 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 97.03 8.37 56.84 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 125.723 1.63 . . . . 0.0 115.626 -172.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.73 160.5 14.94 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.885 -1.362 . . . . 0.0 109.091 171.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.4 ' CG2' ' HG2' ' A' ' 283' ' ' ARG . 35.0 t -117.82 137.41 51.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.01 178.99 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 CA-C-O 126.043 2.83 . . . . 0.0 108.979 -173.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.5 133.55 55.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.2 m -135.48 139.2 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.0 ttp -101.79 143.82 31.24 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 120.63 -1.294 . . . . 0.0 108.181 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 84.1 t -84.88 131.67 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.9 -133.13 0.3 Allowed 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 100.293 -3.966 . . . . 0.0 100.293 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.436 11.7 m-20 -53.21 112.65 0.91 Allowed 'General case' 0 CA--C 1.503 -0.831 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -154.991 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 5.8 tp -111.3 122.2 65.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -171.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.55 116.16 7.16 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -106.05 22.8 15.07 Favored 'General case' 0 C--N 1.365 1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 112.707 -172.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -110.96 -43.7 3.73 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.526 1.93 . . . . 0.0 107.732 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . 0.305 34.3 mmt180 -68.69 -38.53 80.38 Favored 'General case' 0 C--N 1.349 0.571 1 C-N-CA 132.956 4.503 . . . . 0.0 113.345 171.262 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.338 33.0 mmt180 74.98 51.38 0.08 Allowed 'General case' 0 C--N 1.347 0.487 1 C-N-CA 132.595 4.358 . . . . 0.0 113.481 173.334 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.46 133.73 52.33 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 111.622 -2.535 . . . . 0.0 112.389 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.61 127.22 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 1 N-CA-C 96.922 -5.214 . . . . 0.0 96.922 172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.8 103.05 10.27 Favored 'General case' 0 CA--C 1.457 -2.627 1 C-N-CA 110.787 -4.365 . . . . 0.0 106.892 -170.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.5 170.75 9.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 122.921 2.601 . . . . 0.0 112.077 -170.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -156.24 141.69 8.19 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.788 167.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.412 1.4 pt? -51.13 159.0 0.67 Allowed 'General case' 0 C--N 1.374 1.65 1 N-CA-C 124.761 5.097 . . . . 0.0 124.761 -165.464 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -125.44 -55.86 1.53 Allowed 'General case' 0 C--N 1.38 1.93 0 O-C-N 120.948 -1.095 . . . . 0.0 109.962 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.34 2.1 pt20 -121.02 -105.26 0.38 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . . 18.7 p 159.71 171.1 0.01 OUTLIER 'General case' 0 C--N 1.349 0.561 1 C-N-CA 131.954 4.101 . . . . 0.0 101.677 -169.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -91.1 161.47 15.09 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.936 1.294 . . . . 0.0 111.989 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -96.79 77.0 2.8 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 118.912 -2.367 . . . . 0.0 109.737 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 40.4 t30 104.67 66.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 130.417 3.487 . . . . 0.0 107.675 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.03 146.98 91.76 Favored 'Trans proline' 0 C--N 1.382 2.31 1 C-N-CA 126.293 4.662 . . . . 0.0 112.313 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . 0.304 4.0 t90 -8.67 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.255 2 N-CA-C 124.832 5.123 . . . . 0.0 124.832 -173.8 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -108.73 -4.49 16.94 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.412 -2.055 . . . . 0.0 112.768 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.303 28.3 mt-30 81.67 87.14 0.04 OUTLIER 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.97 2.508 . . . . 0.0 115.064 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -78.76 -92.56 0.04 OUTLIER 'General case' 0 C--N 1.37 1.485 0 O-C-N 120.653 -1.279 . . . . 0.0 113.242 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 65.18 -41.78 0.31 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 129.117 2.967 . . . . 0.0 118.933 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 97.42 -62.44 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 130.439 3.496 . . . . 0.0 107.396 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 13.1 t 162.0 -35.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 129.14 2.976 . . . . 0.0 106.875 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 C--O 1.266 1.962 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 -176.02 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 84.2 m95 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 51.6 t -103.14 140.08 22.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 125.69 1.596 . . . . 0.0 107.896 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -131.56 15.57 4.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.156 1.383 . . . . 0.0 111.239 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.8 pt -139.49 -153.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 127.1 2.16 . . . . 0.0 106.718 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -137.76 -171.19 2.94 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 7.3 pttm -107.88 1.79 22.97 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . 0.279 7.0 mtp180 72.77 -73.49 0.1 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.697 3.599 . . . . 0.0 116.04 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.86 63.11 Favored Pre-proline 0 N--CA 1.448 -0.571 0 C-N-CA 128.007 2.523 . . . . 0.0 112.995 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.06 122.17 9.86 Favored 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 125.382 4.055 . . . . 0.0 114.204 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.63 114.84 6.59 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 129.077 2.951 . . . . 0.0 113.16 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.92 7.79 40.71 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 123.633 1.685 . . . . 0.0 114.766 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 72.9 p -96.9 144.19 27.06 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 129.044 2.938 . . . . 0.0 103.543 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 92.5 mttt -105.87 155.3 19.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 119.867 -1.771 . . . . 0.0 115.203 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.33 173.42 10.18 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.809 2.243 . . . . 0.0 107.802 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.5 m -114.34 135.68 53.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.27 170.52 29.55 Favored Glycine 0 CA--C 1.48 -2.118 0 CA-C-O 124.097 1.943 . . . . 0.0 110.045 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -129.61 133.81 47.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 113.576 -1.312 . . . . 0.0 108.041 -171.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.88 127.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.3 t -109.15 -41.96 4.54 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 112.763 -2.017 . . . . 0.0 113.632 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER -135.28 174.56 10.48 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 119.962 -1.711 . . . . 0.0 110.248 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 147.13 45.8 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.328 -1.483 . . . . 0.0 108.136 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.05 177.69 4.56 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 124.242 1.017 . . . . 0.0 108.885 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -71.25 -12.26 61.36 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.231 2.612 . . . . 0.0 114.572 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.44 ' CD2' ' HE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -164.34 47.42 0.11 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 123.842 1.782 . . . . 0.0 109.83 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 169.38 -160.28 33.48 Favored Glycine 0 CA--C 1.47 -2.759 0 N-CA-C 106.295 -2.722 . . . . 0.0 106.295 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.58 164.05 32.88 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -102.35 120.38 40.39 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.3 125.27 65.04 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.13 131.79 35.79 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 3.9 mt -85.38 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 120.743 -1.223 . . . . 0.0 110.752 168.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.258 57.6 mm-40 84.65 167.31 0.09 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 127.577 2.351 . . . . 0.0 107.514 -167.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.01 118.89 9.13 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 112.81 -20.06 20.46 Favored Glycine 0 C--N 1.371 2.506 0 C-N-CA 126.867 2.175 . . . . 0.0 116.748 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.4 122.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.3 144.86 24.93 Favored 'General case' 0 CA--C 1.483 -1.601 0 O-C-N 119.489 -2.007 . . . . 0.0 111.275 -165.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -106.84 175.1 20.54 Favored Glycine 0 CA--C 1.491 -1.454 0 C-N-CA 128.099 2.762 . . . . 0.0 117.186 175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 11.5 tp -126.0 120.0 29.15 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 126.776 2.03 . . . . 0.0 106.916 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.284 8.3 p -92.32 118.46 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.44 ' HE1' ' CD2' ' A' ' 290' ' ' TYR . 8.1 t60 -80.98 124.09 28.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.162 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -49.43 -10.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.4 0 N-CA-C 121.227 3.788 . . . . 0.0 121.227 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 11.1 t -106.44 -0.85 23.77 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.787 1.635 . . . . 0.0 112.103 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -67.24 55.8 0.05 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 118.61 2.818 . . . . 0.0 118.61 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 46.3 ttm 144.71 -76.16 0.0 OUTLIER 'General case' 0 C--N 1.371 1.505 0 C-N-CA 129.789 3.236 . . . . 0.0 110.788 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.6 t70 83.25 -98.35 0.01 OUTLIER 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.088 2.955 . . . . 0.0 110.437 -172.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . 0.272 4.1 t90 61.65 -158.75 0.33 Allowed 'General case' 0 C--N 1.369 1.425 0 C-N-CA 130.443 3.497 . . . . 0.0 116.366 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 t -145.26 145.95 31.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 100.326 -3.953 . . . . 0.0 100.326 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.255 0.1 OUTLIER 95.41 -11.08 0.1 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 126.562 1.945 . . . . 0.0 110.202 -175.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.57 0.57 8.8 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 128.359 2.664 . . . . 0.0 110.261 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.77 -10.22 58.99 Favored 'General case' 0 C--N 1.37 1.497 0 O-C-N 119.671 -1.893 . . . . 0.0 113.561 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.55 -7.92 11.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 1 C-N-CA 132.985 4.514 . . . . 0.0 110.385 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -81.44 119.35 75.39 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 129.075 2.95 . . . . 0.0 112.912 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.22 -23.12 75.14 Favored 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.09 4.526 . . . . 0.0 113.11 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.7 m -81.04 9.47 6.56 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 128.527 2.731 . . . . 0.0 113.681 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -87.58 -20.48 26.35 Favored 'General case' 0 C--N 1.369 1.452 0 C-N-CA 123.801 0.84 . . . . 0.0 109.474 164.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 32.6 t -105.43 -48.87 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 127.567 2.347 . . . . 0.0 107.274 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.412 33.1 t 93.56 137.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 129.757 3.223 . . . . 0.0 115.646 173.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.42 150.39 40.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 128.452 2.701 . . . . 0.0 105.459 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.43 121.37 29.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.912 1.339 . . . . 0.0 108.979 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 86.46 29.35 24.76 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.23 1.395 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -92.34 150.47 20.82 Favored 'General case' 0 C--N 1.364 1.218 0 O-C-N 120.636 -1.508 . . . . 0.0 109.311 172.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.282 0.7 OUTLIER -117.08 130.52 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 120.065 -1.647 . . . . 0.0 107.385 175.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -133.85 179.57 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 1 C-N-CA 133.186 4.594 . . . . 0.0 106.933 -171.768 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 346' ' ' LEU . 40.7 tt0 -112.03 150.14 31.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 100.558 -3.867 . . . . 0.0 100.558 172.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.506 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -146.51 144.19 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.518 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 42.7 ttm -105.84 141.66 36.88 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 120.125 -1.609 . . . . 0.0 107.45 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 68.4 t -69.59 128.92 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.05 -136.16 0.28 Allowed 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 171.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.307 19.3 m-20 -61.15 111.86 1.88 Allowed 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -154.363 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.2 tp -101.94 118.36 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 124.023 1.868 . . . . 0.0 108.886 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -117.62 103.29 9.9 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.84 -11.11 59.78 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.614 1.966 . . . . 0.0 115.42 -168.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.04 -33.55 15.47 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 128.201 2.601 . . . . 0.0 111.183 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -100.8 -29.48 12.23 Favored 'General case' 0 C--N 1.368 1.406 0 C-N-CA 125.052 1.341 . . . . 0.0 113.156 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.297 65.2 mtp85 72.96 51.96 0.14 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 128.858 2.863 . . . . 0.0 112.618 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.62 132.79 53.41 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 110.79 -2.914 . . . . 0.0 106.631 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . 0.258 2.1 mt -114.09 129.7 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 4.2 t -102.52 94.23 5.55 Favored 'General case' 0 C--N 1.384 2.096 0 C-N-CA 111.854 -3.938 . . . . 0.0 105.801 -168.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' A' ' 344' ' ' LEU . 0.0 OUTLIER -97.23 136.29 37.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 119.495 -2.003 . . . . 0.0 107.637 -169.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -152.67 123.42 1.45 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.498 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.506 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.59 0.2 OUTLIER -140.46 -93.0 0.16 Allowed 'General case' 0 C--N 1.363 1.186 0 C-N-CA 129.691 3.196 . . . . 0.0 109.137 172.383 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.356 35.6 mtmm 111.84 18.09 0.0 OUTLIER 'General case' 0 C--N 1.378 1.815 0 C-N-CA 126.781 2.033 . . . . 0.0 113.265 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.58 82.27 2.27 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 120.285 -1.509 . . . . 0.0 112.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 27.6 p -31.57 157.3 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 2 C-N-CA 135.519 5.527 . . . . 0.0 121.902 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -75.23 166.85 22.99 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 129.588 3.155 . . . . 0.0 114.551 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.76 88.22 3.98 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.708 1.603 . . . . 0.0 108.071 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 87.24 70.83 0.05 OUTLIER Pre-proline 0 C--N 1.357 0.927 0 C-N-CA 130.14 3.376 . . . . 0.0 108.777 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.44 -14.38 25.0 Favored 'Trans proline' 0 C--N 1.37 1.672 1 C-N-CA 126.391 4.728 . . . . 0.0 117.662 -173.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -122.31 28.2 7.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 126.303 1.841 . . . . 0.0 110.045 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.15 59.98 0.77 Allowed 'General case' 0 C--N 1.361 1.075 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.3 72.32 7.14 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.312 3.045 . . . . 0.0 116.057 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.258 16.7 m-85 72.02 99.86 0.07 Allowed 'General case' 0 C--N 1.365 1.241 0 N-CA-C 118.202 2.667 . . . . 0.0 118.202 171.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 102.6 -131.23 0.0 OUTLIER 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.136 2.974 . . . . 0.0 108.054 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -94.13 -52.25 4.47 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.225 -0.922 . . . . 0.0 111.928 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . 0.387 32.2 p 113.48 131.23 0.0 OUTLIER 'General case' 0 C--N 1.358 0.939 1 C-N-CA 132.257 4.223 . . . . 0.0 109.061 -176.696 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 13.1 p80 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 -176.785 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 12.7 t90 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.76 122.68 38.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 127.1 2.16 . . . . 0.0 112.508 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -101.34 2.77 39.97 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 125.426 1.49 . . . . 0.0 113.92 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 3.6 pt -126.63 29.37 2.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 127.302 2.241 . . . . 0.0 107.934 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.87 114.22 4.36 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 128.465 2.706 . . . . 0.0 115.017 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -98.19 149.74 22.23 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 124.536 1.134 . . . . 0.0 113.922 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -151.05 -45.27 0.12 Allowed 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 125.902 1.681 . . . . 0.0 108.467 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 75.42 171.05 0.11 Allowed Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 169.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.25 -48.28 10.23 Favored 'Trans proline' 0 CA--C 1.546 1.101 1 C-N-CA 125.506 4.137 . . . . 0.0 113.617 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 81.38 126.81 0.04 OUTLIER 'General case' 0 C--N 1.373 1.615 0 C-N-CA 128.884 2.874 . . . . 0.0 113.187 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.97 11.13 56.89 Favored Glycine 0 C--N 1.381 3.058 0 CA-C-O 124.979 2.433 . . . . 0.0 112.41 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 20.6 p -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.45 -0.442 1 C-N-CA 133.252 4.621 . . . . 0.0 102.887 172.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -105.09 153.95 20.81 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 123.0 1.381 . . . . 0.0 113.509 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . 0.335 0.0 OUTLIER -136.1 173.88 11.23 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-O 123.485 1.612 . . . . 0.0 109.229 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.7 m -106.51 138.65 42.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -143.54 176.89 22.69 Favored Glycine 0 CA--C 1.483 -1.953 0 CA-C-O 123.387 1.549 . . . . 0.0 111.629 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -128.31 132.09 48.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 3.1 t -82.69 127.48 39.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.41 1.484 . . . . 0.0 114.147 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -107.94 -53.11 2.67 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.357 1.863 . . . . 0.0 112.853 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.27 174.83 9.97 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 120.695 -1.253 . . . . 0.0 111.071 -170.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 150.75 39.84 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 166.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 177.88 4.48 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.64 -24.18 62.67 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.902 2.081 . . . . 0.0 113.606 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -151.56 45.35 0.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 124.579 2.133 . . . . 0.0 109.046 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.46 -164.91 33.28 Favored Glycine 0 CA--C 1.47 -2.765 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 15.3 p -143.5 151.13 39.91 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 123.783 0.833 . . . . 0.0 109.356 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.59 124.44 44.8 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.769 -0.582 . . . . 0.0 109.645 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.59 131.69 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.516 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.02 122.18 42.5 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.215 -1.553 . . . . 0.0 113.68 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.17 56.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 111.379 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 77.8 170.0 0.22 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.608 2.363 . . . . 0.0 109.92 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.88 119.46 12.6 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 119.594 -1.941 . . . . 0.0 115.192 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.11 -31.84 5.69 Favored Glycine 0 C--N 1.367 2.294 0 C-N-CA 127.1 2.286 . . . . 0.0 115.069 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.27 128.27 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.89 1.676 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -141.83 158.66 43.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 118.675 -2.515 . . . . 0.0 106.868 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -130.69 173.1 20.27 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 123.849 1.805 . . . . 0.0 113.743 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.52 121.41 37.42 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 126.468 1.907 . . . . 0.0 107.514 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 95.8 t -86.39 113.18 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.494 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.12 115.78 11.75 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -30.72 -44.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 120.383 3.475 . . . . 0.0 120.383 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 6.9 m -91.31 -0.58 57.68 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 124.994 1.318 . . . . 0.0 113.939 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -100.91 65.46 1.11 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.82 1.648 . . . . 0.0 109.769 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 11.8 ttt -115.53 -10.35 11.92 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.016 -1.678 . . . . 0.0 112.567 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.6 t70 97.05 -85.33 0.0 OUTLIER 'General case' 0 C--N 1.368 1.375 0 C-N-CA 128.557 2.743 . . . . 0.0 106.948 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -91.28 86.6 6.19 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-O 122.575 1.179 . . . . 0.0 110.164 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 12.1 t -143.73 -166.17 2.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.475 -1.39 . . . . 0.0 108.418 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 78.58 -51.87 0.47 Allowed 'General case' 0 C--N 1.356 0.853 0 C-N-CA 130.242 3.417 . . . . 0.0 110.834 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -9.98 59.66 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.415 2.286 . . . . 0.0 112.987 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -88.34 -17.21 31.09 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 129.747 3.219 . . . . 0.0 111.539 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.6 mp 59.52 -37.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.352 1 C-N-CA 132.837 4.455 . . . . 0.0 117.321 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -130.42 100.82 17.89 Favored Pre-proline 0 N--CA 1.444 -0.738 0 C-N-CA 125.738 1.615 . . . . 0.0 110.724 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.71 -17.51 37.74 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.313 3.342 . . . . 0.0 111.854 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 11.1 p -82.84 3.13 30.88 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 129.592 3.157 . . . . 0.0 115.673 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -6.73 15.72 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.687 -1.258 . . . . 0.0 110.194 170.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 17.3 t -102.73 -48.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 C-N-CA 127.067 2.147 . . . . 0.0 109.275 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.9 t -96.7 116.31 38.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 126.295 1.838 . . . . 0.0 109.749 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -104.72 165.98 10.7 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 126.684 1.993 . . . . 0.0 110.773 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.1 121.23 30.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 C-N-CA 126.866 2.066 . . . . 0.0 107.661 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.53 16.06 53.5 Favored Glycine 0 C--N 1.357 1.725 0 C-N-CA 125.426 1.489 . . . . 0.0 113.957 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -90.51 164.05 14.39 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.042 2.137 . . . . 0.0 111.187 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.44 125.07 72.19 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 51.6 t -134.42 165.49 31.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 C-N-CA 127.11 2.164 . . . . 0.0 106.653 -174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -114.92 135.58 54.05 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 100.931 -3.729 . . . . 0.0 100.931 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 2.8 m -129.81 163.28 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.362 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -169.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 33.1 ttm -127.9 138.03 52.52 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.07 132.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.01 -134.54 0.28 Allowed 'General case' 0 N--CA 1.408 -2.554 1 N-CA-C 98.951 -4.462 . . . . 0.0 98.951 174.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.98 111.81 6.65 Favored 'General case' 0 C--N 1.313 -1.018 1 N-CA-C 122.028 4.084 . . . . 0.0 122.028 -155.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.365 0.1 OUTLIER -96.83 112.52 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 126.615 1.966 . . . . 0.0 107.336 177.352 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.41 102.36 15.09 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 128.845 2.858 . . . . 0.0 105.092 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.19 -3.12 41.02 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -166.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.88 -43.15 14.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 130.001 3.32 . . . . 0.0 110.902 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -99.52 -38.05 8.93 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.167 2.187 . . . . 0.0 113.348 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.389 47.2 mtm105 75.22 51.73 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 1 C-N-CA 134.857 5.263 . . . . 0.0 114.215 179.802 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.5 OUTLIER -116.23 125.54 52.37 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 126.229 1.812 . . . . 0.0 107.348 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.8 mm -91.62 131.12 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 1 C-N-CA 132.876 4.471 . . . . 0.0 108.964 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.1 t -102.87 92.57 4.64 Favored 'General case' 0 C--N 1.385 2.144 1 C-N-CA 110.602 -4.439 . . . . 0.0 106.048 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.438 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -102.86 136.98 41.68 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 119.415 -2.053 . . . . 0.0 109.305 -174.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -130.81 138.51 10.23 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -172.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.492 0.1 OUTLIER -54.19 162.26 1.08 Allowed 'General case' 0 C--N 1.369 1.44 1 N-CA-C 127.146 5.98 . . . . 0.0 127.146 -161.32 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -125.4 -48.63 1.69 Allowed 'General case' 0 C--N 1.382 1.996 0 O-C-N 121.732 -0.605 . . . . 0.0 111.989 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.25 48.3 tp60 -124.51 -86.3 0.63 Allowed 'General case' 0 C--N 1.37 1.473 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.307 20.8 p 111.89 146.32 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 1 C-N-CA 131.965 4.106 . . . . 0.0 106.321 -172.438 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -94.89 130.24 41.58 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.279 -1.513 . . . . 0.0 111.143 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.08 75.45 4.08 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.094 2.158 . . . . 0.0 111.216 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 1.1 t30 125.29 66.94 0.0 OUTLIER Pre-proline 0 C--N 1.344 0.366 1 C-N-CA 133.955 4.902 . . . . 0.0 102.748 -175.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.93 -27.42 10.16 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 124.194 3.263 . . . . 0.0 113.119 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -114.11 -126.83 0.29 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.261 1.824 . . . . 0.0 108.753 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -121.16 138.27 54.29 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.515 2.326 . . . . 0.0 109.367 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -159.53 55.31 0.39 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 122.638 1.209 . . . . 0.0 107.881 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.33 46.38 0.26 Allowed 'General case' 0 C--N 1.365 1.256 0 C-N-CA 127.978 2.511 . . . . 0.0 116.973 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -147.22 75.54 1.38 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.536 1.534 . . . . 0.0 106.871 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -127.87 -124.15 0.23 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.721 1.209 . . . . 0.0 111.098 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.8 t -140.21 35.65 1.9 Allowed 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.973 -1.704 . . . . 0.0 108.89 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 . . . . . 0 C--O 1.261 1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.422 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.419 HG11 ' H ' ' A' ' 270' ' ' ILE . 40.7 t -97.52 161.3 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 130.962 3.705 . . . . 0.0 107.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.41 11.01 32.13 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.204 -2.185 . . . . 0.0 116.088 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . 0.419 ' H ' HG11 ' A' ' 268' ' ' VAL . 20.5 tt -163.19 151.82 3.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 O-C-N 120.556 -1.34 . . . . 0.0 107.404 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.294 . . 85.84 -109.08 0.01 OUTLIER 'General case' 0 C--N 1.355 0.809 0 C-N-CA 128.065 2.546 . . . . 0.0 115.126 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . 0.306 9.6 pttp -149.94 -75.08 0.16 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 124.216 1.96 . . . . 0.0 113.379 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -69.88 0.83 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 127.876 2.47 . . . . 0.0 109.323 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -93.53 152.11 40.66 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.25 -40.87 1.45 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 124.23 3.287 . . . . 0.0 112.236 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . 0.263 44.4 mt-10 79.84 111.0 0.07 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.984 2.514 . . . . 0.0 113.001 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 8.69 38.12 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 123.894 1.83 . . . . 0.0 113.436 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 68.5 p -98.56 139.21 34.63 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 169.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 93.8 mttt -97.98 146.1 25.83 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.059 -2.275 . . . . 0.0 111.577 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.44 143.03 39.5 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.579 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.8 m -82.35 142.65 31.84 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.842 -1.162 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.47 173.57 33.62 Favored Glycine 0 CA--C 1.486 -1.721 0 CA-C-O 123.174 1.43 . . . . 0.0 112.719 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 60.2 mtm-85 -117.8 131.08 56.62 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 125.925 1.69 . . . . 0.0 108.655 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 17.6 t -77.38 133.24 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.281 10.1 t -122.62 -39.85 2.51 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -133.82 165.98 23.71 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 3.8 mp -121.16 153.17 37.88 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 122.131 2.241 . . . . 0.0 116.871 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 178.41 4.29 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -29.33 66.31 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.255 18.1 m-85 -156.8 52.72 0.51 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.96 3.704 . . . . 0.0 103.481 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.11 37.22 Favored Glycine 0 N--CA 1.432 -1.62 1 N-CA-C 100.469 -5.053 . . . . 0.0 100.469 172.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 31.5 p -165.32 172.09 12.74 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.653 173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -103.14 120.2 40.27 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.88 135.89 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -100.19 121.03 40.8 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.603 -1.936 . . . . 0.0 111.254 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.28 40.1 mm -66.65 -87.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -140.04 166.63 24.13 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 131.402 3.881 . . . . 0.0 101.329 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.16 120.28 7.28 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.4 -15.72 59.79 Favored Glycine 0 C--N 1.367 2.302 0 C-N-CA 127.18 2.324 . . . . 0.0 115.441 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 92.9 t -116.73 121.41 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.538 1.935 . . . . 0.0 111.246 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.87 151.24 50.66 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -119.8 173.48 15.18 Favored Glycine 0 CA--C 1.493 -1.284 0 CA-C-O 124.954 2.419 . . . . 0.0 115.303 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.8 tp -125.7 121.59 33.89 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.311 1.5 p -87.15 121.1 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-O 122.422 1.106 . . . . 0.0 109.838 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 308' ' ' GLU . 54.4 m-70 -86.51 108.9 18.75 Favored 'General case' 0 N--CA 1.397 -3.118 0 C-N-CA 128.48 2.712 . . . . 0.0 109.087 155.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.51 -62.47 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.883 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 164.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 1.2 t -144.45 41.88 1.36 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.577 ' CB ' ' HA ' ' A' ' 305' ' ' HIS . 5.8 tm-20 -62.19 70.16 0.01 OUTLIER 'General case' 0 C--N 1.403 2.908 0 C-N-CA 128.263 2.625 . . . . 0.0 113.148 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 11.9 ttt -122.2 -128.0 0.26 Allowed 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 128.419 2.688 . . . . 0.0 109.7 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.71 22.65 5.43 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 126.623 1.969 . . . . 0.0 110.604 -169.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -98.92 154.67 17.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.6 t -149.3 156.26 41.82 Favored 'General case' 0 C--N 1.367 1.358 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 170.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 156.73 -51.17 0.0 OUTLIER 'General case' 0 C--N 1.357 0.914 0 N-CA-C 102.186 -3.264 . . . . 0.0 102.186 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -111.34 27.29 9.82 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.609 1.564 . . . . 0.0 111.91 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.26 -10.62 52.52 Favored 'General case' 0 C--N 1.378 1.846 0 O-C-N 118.65 -2.531 . . . . 0.0 114.491 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.1 -15.5 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 1 C-N-CA 133.022 4.529 . . . . 0.0 111.106 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -84.38 115.97 62.87 Favored Pre-proline 0 C--N 1.368 1.372 0 C-N-CA 125.663 1.585 . . . . 0.0 110.247 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.5 -20.87 51.38 Favored 'Trans proline' 0 C--N 1.373 1.851 1 C-N-CA 126.347 4.698 . . . . 0.0 116.024 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.1 p -80.01 -20.44 45.39 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 128.671 2.789 . . . . 0.0 113.521 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -88.89 -16.67 31.34 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 111.527 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.0 -71.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.617 1.567 . . . . 0.0 109.142 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.494 0.4 OUTLIER 87.73 160.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 128.118 2.567 . . . . 0.0 112.854 -178.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.75 145.56 24.5 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.134 1.445 . . . . 0.0 109.792 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.51 121.0 30.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.02 23.27 55.83 Favored Glycine 0 C--N 1.357 1.703 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.67 31.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 118.749 1.275 . . . . 0.0 108.166 171.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.252 2.0 p -96.29 129.36 46.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 CA-C-O 123.416 1.579 . . . . 0.0 108.554 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -130.48 -179.57 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 1 C-N-CA 132.312 4.245 . . . . 0.0 110.834 -173.396 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -124.27 142.29 51.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.512 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 2.9 m -146.71 139.37 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 46.5 ttp -96.32 131.38 42.9 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 118.525 -2.61 . . . . 0.0 111.109 -173.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 7.9 p -74.11 124.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -166.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.51 -130.32 0.25 Allowed 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.338 7.4 t70 -57.8 112.46 1.48 Allowed 'General case' 0 N--CA 1.475 0.811 1 N-CA-C 122.586 4.291 . . . . 0.0 122.586 -158.36 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . 0.266 3.4 tp -107.81 114.41 46.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 96.1 m-20 -124.7 119.74 29.83 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.518 1.927 . . . . 0.0 107.849 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -88.14 -5.36 58.47 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 125.461 1.504 . . . . 0.0 114.635 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.64 -35.3 14.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.296 2.238 . . . . 0.0 110.285 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 336' ' ' ASP . 0.0 OUTLIER -89.88 -46.93 8.21 Favored 'General case' 0 CA--C 1.508 -0.647 1 C-N-CA 132.08 4.152 . . . . 0.0 112.379 -177.512 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.322 64.5 mtm-85 75.07 52.53 0.08 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 131.135 3.774 . . . . 0.0 112.532 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 133.14 52.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 111.451 -2.613 . . . . 0.0 107.943 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.73 129.5 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.828 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 170.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.92 4.8 Favored 'General case' 0 CA--C 1.474 -1.981 1 C-N-CA 111.082 -4.247 . . . . 0.0 107.715 -164.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.6 mp -97.96 135.57 39.48 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.748 -172.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.18 122.76 1.63 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.815 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.512 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.663 0.7 OUTLIER -144.55 -99.04 0.1 Allowed 'General case' 0 C--N 1.37 1.46 0 C-N-CA 128.979 2.911 . . . . 0.0 113.105 178.512 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.454 48.2 mtmt 85.01 68.3 0.01 OUTLIER 'General case' 0 C--N 1.374 1.651 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -118.11 -10.86 10.24 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 120.632 -1.292 . . . . 0.0 111.547 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . 0.432 ' H ' HG12 ' A' ' 328' ' ' VAL 0.277 37.2 m 78.81 170.34 0.19 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 130.293 3.437 . . . . 0.0 116.19 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -91.39 170.9 9.59 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 127.774 2.43 . . . . 0.0 111.989 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.66 78.74 3.33 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.817 2.047 . . . . 0.0 109.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 14.3 t30 101.2 74.18 0.0 OUTLIER Pre-proline 0 C--N 1.361 1.105 0 C-N-CA 131.203 3.801 . . . . 0.0 108.541 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.24 14.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.363 1.327 1 C-N-CA 125.648 4.232 . . . . 0.0 119.392 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -89.62 -160.57 0.69 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-N 121.858 2.117 . . . . 0.0 115.371 -171.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -138.12 21.66 2.81 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 120.301 -1.499 . . . . 0.0 109.879 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.53 75.32 3.25 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.067 1.747 . . . . 0.0 115.036 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.256 14.2 m-85 64.55 -63.68 0.16 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 130.922 3.689 . . . . 0.0 118.321 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -120.83 105.06 10.35 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -109.72 156.2 20.58 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 125.729 1.612 . . . . 0.0 113.78 -175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 41.83 0.01 OUTLIER 'General case' 0 C--N 1.364 1.226 1 C-N-CA 132.645 4.378 . . . . 0.0 117.897 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 C--O 1.261 1.677 1 C-N-CA 132.291 4.237 . . . . 0.0 108.608 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 47.0 m95 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 26.3 t -106.33 141.58 21.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 C-N-CA 127.004 2.122 . . . . 0.0 105.995 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.2 -21.67 64.86 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.44 -155.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 129.424 3.09 . . . . 0.0 108.363 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 75.14 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.357 0.921 0 C-N-CA 129.753 3.221 . . . . 0.0 114.988 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -178.45 137.03 0.16 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 128.713 2.805 . . . . 0.0 105.586 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.1 21.39 12.35 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 113.043 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.4 ' CE1' ' HB2' ' A' ' 276' ' ' GLU . 0.0 OUTLIER -167.41 162.06 10.29 Favored Pre-proline 0 C--N 1.348 0.504 0 O-C-N 119.657 -1.902 . . . . 0.0 112.992 -173.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -86.14 96.85 0.55 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.968 3.112 . . . . 0.0 108.107 160.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 274' ' ' TYR . 5.7 tm-20 -68.92 138.7 54.85 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 128.867 2.867 . . . . 0.0 114.813 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.76 14.96 47.88 Favored Glycine 0 C--N 1.387 3.401 0 CA-C-O 124.514 2.174 . . . . 0.0 112.799 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 6.0 p -92.78 146.05 23.94 Favored 'General case' 0 CA--C 1.509 -0.602 1 C-N-CA 133.16 4.584 . . . . 0.0 100.799 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.6 OUTLIER -108.03 153.37 23.21 Favored 'General case' 0 CA--C 1.49 -1.348 0 O-C-N 119.847 -1.783 . . . . 0.0 110.411 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -125.64 174.34 8.35 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 112.073 -2.33 . . . . 0.0 107.476 -174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 88.9 m -118.29 137.98 52.69 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -157.16 170.0 34.32 Favored Glycine 0 CA--C 1.478 -2.259 0 CA-C-O 123.241 1.467 . . . . 0.0 110.384 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 327' ' ' VAL . 44.3 ttm-85 -117.15 135.14 53.99 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 124.787 1.235 . . . . 0.0 108.465 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.92 132.29 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 120.265 -1.522 . . . . 0.0 113.63 -172.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -128.32 -33.43 2.14 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -171.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -133.74 173.06 11.94 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 122.004 2.184 . . . . 0.0 107.332 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 2.3 mp -120.54 150.83 40.25 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 118.908 -2.37 . . . . 0.0 112.761 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.62 178.14 4.4 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -29.02 68.53 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.346 2.258 . . . . 0.0 115.195 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.262 1.7 p90 -149.84 43.1 0.89 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 124.194 1.949 . . . . 0.0 109.634 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.09 -170.81 40.75 Favored Glycine 0 CA--C 1.468 -2.872 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 165.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 2.8 m -134.71 147.1 50.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.31 126.46 36.4 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.231 -1.543 . . . . 0.0 108.982 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.34 138.28 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 125.939 1.696 . . . . 0.0 106.546 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -100.12 124.05 45.07 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.573 -1.33 . . . . 0.0 108.028 168.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.67 -67.87 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 124.905 2.288 . . . . 0.0 116.1 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.38 161.41 35.06 Favored 'General case' 0 CA--C 1.485 -1.551 2 N-CA-C 98.716 -4.55 . . . . 0.0 98.716 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.81 119.5 10.1 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 104.34 -11.58 51.21 Favored Glycine 0 C--N 1.364 2.107 0 C-N-CA 125.526 1.536 . . . . 0.0 116.379 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.63 144.3 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.62 1.968 . . . . 0.0 106.942 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.01 155.11 48.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.182 -1.574 . . . . 0.0 112.082 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.9 174.88 15.93 Favored Glycine 0 C--N 1.36 1.886 0 C-N-CA 130.439 3.876 . . . . 0.0 117.526 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 42.6 tp -127.28 116.08 20.01 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 111.965 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.296 6.4 p -92.25 104.38 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 O-C-N 120.495 -1.378 . . . . 0.0 108.268 175.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -70.44 129.05 38.24 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 124.749 1.22 . . . . 0.0 113.011 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -52.75 -21.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 p -83.1 -13.39 55.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.276 3.03 . . . . 0.0 115.277 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -74.75 42.48 0.17 Allowed 'General case' 0 C--N 1.372 1.553 0 O-C-N 118.994 -2.316 . . . . 0.0 115.751 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' MET . . . . . 0.464 ' HA ' ' HZ1' ' A' ' 347' ' ' LYS . 17.2 ttt -84.59 -42.24 15.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.863 3.265 . . . . 0.0 115.533 -177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 30.4 t70 84.72 -72.1 0.03 OUTLIER 'General case' 0 C--N 1.367 1.335 0 C-N-CA 127.431 2.293 . . . . 0.0 111.268 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -162.91 179.44 7.59 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 128.152 2.581 . . . . 0.0 104.4 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 4.7 t -82.23 59.48 4.51 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 127.599 2.36 . . . . 0.0 111.19 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -93.34 58.36 2.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 128.267 2.627 . . . . 0.0 111.106 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 77.18 32.63 0.46 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 129.294 3.037 . . . . 0.0 110.381 -175.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.37 -52.21 2.8 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.137 1.775 . . . . 0.0 112.619 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.269 2.4 mp 73.56 -50.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 C-N-CA 130.271 3.428 . . . . 0.0 112.701 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -143.4 126.13 8.82 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 127.772 2.429 . . . . 0.0 108.083 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -77.48 29.36 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 125.12 3.88 . . . . 0.0 113.459 176.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 10.4 p -124.55 -6.31 7.55 Favored 'General case' 0 N--CA 1.436 -1.134 1 C-N-CA 131.937 4.095 . . . . 0.0 109.421 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -90.3 -46.12 8.61 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.262 3.7 m -85.07 14.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.331 0 O-C-N 119.418 -2.051 . . . . 0.0 115.682 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.75 116.43 38.05 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 C-N-CA 127.246 2.219 . . . . 0.0 107.362 172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -120.43 155.64 33.07 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.8 121.58 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.531 1.532 . . . . 0.0 109.974 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 87.95 23.56 38.0 Favored Glycine 0 C--N 1.362 1.998 0 C-N-CA 125.999 1.761 . . . . 0.0 114.056 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.96 146.04 48.75 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.922 -1.34 . . . . 0.0 110.753 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 283' ' ' ARG 0.306 2.7 p -92.59 138.72 19.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 125.434 1.494 . . . . 0.0 112.18 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.94 179.39 2.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 C-N-CA 129.195 2.998 . . . . 0.0 108.828 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -110.89 140.39 45.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.507 ' HA ' ' CB ' ' A' ' 346' ' ' LEU . 3.4 m -144.93 139.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 58.8 ttp -104.71 138.59 40.78 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-N 121.12 1.782 . . . . 0.0 108.337 -173.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 1.9 m -77.08 128.38 37.94 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 -165.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.64 -131.77 0.27 Allowed 'General case' 0 N--CA 1.421 -1.913 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.386 11.6 m-20 -54.64 113.07 1.16 Allowed 'General case' 0 N--CA 1.478 0.953 1 N-CA-C 124.452 4.982 . . . . 0.0 124.452 -156.748 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.68 129.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -145.07 118.5 9.04 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 170.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -16.0 52.43 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 125.179 1.392 . . . . 0.0 113.845 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.35 -35.45 19.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 130.013 3.325 . . . . 0.0 111.374 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -94.87 -26.74 16.05 Favored 'General case' 0 C--N 1.367 1.359 0 C-N-CA 125.103 1.361 . . . . 0.0 111.389 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.304 47.0 mtm180 73.37 48.1 0.17 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 131.115 3.766 . . . . 0.0 113.761 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 129.16 48.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 110.278 -3.146 . . . . 0.0 108.091 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.92 123.3 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.433 1 N-CA-C 95.976 -5.565 . . . . 0.0 95.976 174.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.05 94.51 5.21 Favored 'General case' 0 CA--C 1.468 -2.21 1 C-N-CA 110.975 -4.29 . . . . 0.0 106.503 -166.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.98 139.02 34.43 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 121.165 1.802 . . . . 0.0 107.68 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -145.35 122.41 1.7 Allowed Glycine 0 CA--C 1.471 -2.703 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.815 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . 0.507 ' CB ' ' HA ' ' A' ' 330' ' ' VAL 0.759 0.2 OUTLIER -141.57 -107.07 0.14 Allowed 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 127.499 2.32 . . . . 0.0 112.531 171.019 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . 0.464 ' HZ1' ' HA ' ' A' ' 309' ' ' MET 0.355 13.3 pttp 121.95 29.5 0.0 OUTLIER 'General case' 0 C--N 1.382 2.003 0 C-N-CA 129.954 3.302 . . . . 0.0 115.587 -173.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -86.59 16.84 4.29 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 118.438 -2.664 . . . . 0.0 117.181 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.279 11.9 p 62.51 147.87 0.02 OUTLIER 'General case' 0 C--N 1.366 1.314 0 N-CA-C 120.804 3.631 . . . . 0.0 120.804 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -103.28 169.3 8.63 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 125.645 1.578 . . . . 0.0 110.518 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.3 81.36 3.61 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.039 -2.288 . . . . 0.0 111.742 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 94.49 75.2 0.03 OUTLIER Pre-proline 0 C--N 1.354 0.795 1 C-N-CA 132.812 4.445 . . . . 0.0 106.161 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.23 -2.29 4.69 Favored 'Trans proline' 0 C--N 1.366 1.494 1 C-N-CA 125.574 4.183 . . . . 0.0 117.277 -172.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -94.38 -15.96 23.88 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.011 2.124 . . . . 0.0 109.554 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . 0.256 9.3 tt0 85.64 90.01 0.03 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.783 3.233 . . . . 0.0 116.783 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -85.27 161.15 19.66 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.248 1.419 . . . . 0.0 108.777 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -64.05 97.97 0.2 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 128.246 2.618 . . . . 0.0 114.6 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 56.32 -109.1 0.47 Allowed 'General case' 0 C--N 1.365 1.272 0 C-N-CA 129.052 2.941 . . . . 0.0 116.534 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -108.81 63.51 0.61 Allowed 'General case' 0 C--N 1.355 0.835 0 C-N-CA 126.659 1.984 . . . . 0.0 109.602 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.1 p -116.11 29.35 8.03 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.558 1.543 . . . . 0.0 109.298 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.43 0 C-N-CA 129.465 3.106 . . . . 0.0 103.86 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.5 m95 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 2.1 t -7.05 103.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.332 1 C-N-CA 134.513 5.125 . . . . 0.0 121.166 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.41 47.96 1.14 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.301 1.44 . . . . 0.0 112.875 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.9 tt -170.41 175.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 74.89 -39.02 0.4 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 128.555 2.742 . . . . 0.0 117.926 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -73.43 138.4 45.18 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.178 2.991 . . . . 0.0 112.904 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -95.72 -13.5 24.14 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -167.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -138.57 163.44 46.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.84 -34.88 1.13 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.519 3.48 . . . . 0.0 112.181 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 73.68 124.72 0.04 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 128.657 2.783 . . . . 0.0 114.23 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.08 11.1 43.79 Favored Glycine 0 C--N 1.372 2.545 0 CA-C-O 124.373 2.096 . . . . 0.0 113.114 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 22.6 p -101.43 136.46 41.23 Favored 'General case' 0 CA--C 1.508 -0.663 1 C-N-CA 131.992 4.117 . . . . 0.0 101.354 171.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -109.37 157.13 19.2 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-O 123.852 1.786 . . . . 0.0 113.039 -176.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -133.93 173.75 11.22 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.126 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.6 m -108.57 144.73 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.59 176.94 30.59 Favored Glycine 0 CA--C 1.486 -1.747 0 CA-C-O 123.822 1.79 . . . . 0.0 111.348 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -130.94 130.43 43.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.867 1.267 . . . . 0.0 108.477 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 27.7 t -74.95 131.76 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -114.73 -34.87 5.02 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 112.135 -2.302 . . . . 0.0 112.026 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 293' ' ' PHE . 1.3 t-20 -135.13 155.8 50.08 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.63 136.51 54.94 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 164.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.45 176.84 4.85 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -30.11 71.28 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 118.769 -2.457 . . . . 0.0 116.544 -177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -145.7 40.94 1.2 Allowed 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 125.758 1.623 . . . . 0.0 110.524 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 178.55 -162.19 29.27 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 105.363 -3.095 . . . . 0.0 105.363 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 28.2 p -143.31 165.16 28.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 286' ' ' ASN . 9.7 m-85 -115.28 126.59 54.67 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 93.2 t -118.9 132.2 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -167.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.93 127.36 41.88 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.255 -1.528 . . . . 0.0 112.734 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.288 26.7 mm -73.98 -86.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 123.822 1.772 . . . . 0.0 113.941 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.26 171.35 14.57 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 130.037 3.335 . . . . 0.0 103.514 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.09 119.77 10.15 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.44 -17.2 58.08 Favored Glycine 0 C--N 1.37 2.436 0 C-N-CA 127.222 2.344 . . . . 0.0 115.524 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.21 113.31 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.549 1.939 . . . . 0.0 110.527 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -135.5 157.82 45.92 Favored 'General case' 0 CA--C 1.481 -1.71 0 O-C-N 118.307 -2.746 . . . . 0.0 108.215 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -124.6 172.53 16.89 Favored Glycine 0 CA--C 1.482 -1.973 0 CA-C-O 127.1 3.611 . . . . 0.0 114.424 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.59 161.11 16.56 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 110.307 -2.947 . . . . 0.0 103.269 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.2 t -116.13 130.33 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 O-C-N 124.479 1.112 . . . . 0.0 108.76 163.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -91.8 114.76 27.38 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 166.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.92 -23.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.595 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.0 m -80.74 -13.23 59.17 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.351 2.661 . . . . 0.0 111.658 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -101.97 68.26 1.12 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 127.06 2.144 . . . . 0.0 106.685 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 25.3 ttt -168.61 -96.95 0.01 OUTLIER 'General case' 0 C--N 1.35 0.617 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -153.58 -114.64 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -144.1 114.67 7.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 12.2 t -164.76 173.62 11.61 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 79.44 -50.74 0.41 Allowed 'General case' 0 C--N 1.364 1.212 0 C-N-CA 128.171 2.588 . . . . 0.0 110.382 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -77.37 2.46 15.87 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 130.692 3.597 . . . . 0.0 112.292 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -104.99 -112.57 0.25 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 127.169 2.188 . . . . 0.0 108.164 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.85 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.036 0 O-C-N 119.546 -1.972 . . . . 0.0 108.808 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -108.23 120.47 46.62 Favored Pre-proline 0 C--N 1.356 0.87 0 O-C-N 119.421 -2.049 . . . . 0.0 112.879 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.17 -28.33 7.42 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 123.98 3.12 . . . . 0.0 110.877 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 8.2 m -61.64 -16.9 52.65 Favored 'General case' 0 C--N 1.368 1.402 1 C-N-CA 133.1 4.56 . . . . 0.0 115.421 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.254 22.4 pttp -91.72 -36.35 13.64 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 125.269 1.428 . . . . 0.0 114.142 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 26.2 m -90.98 -23.61 5.88 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-N 121.265 1.848 . . . . 0.0 112.468 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.32 107.78 17.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.71 158.08 16.37 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 123.641 1.686 . . . . 0.0 107.576 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.38 120.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 C-N-CA 125.199 1.4 . . . . 0.0 109.565 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.49 18.03 53.44 Favored Glycine 0 C--N 1.364 2.098 0 C-N-CA 124.658 1.123 . . . . 0.0 114.235 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.5 144.03 32.83 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 125.501 1.521 . . . . 0.0 109.659 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.85 139.86 16.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 124.006 1.86 . . . . 0.0 111.345 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.59 174.72 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 130.111 3.364 . . . . 0.0 107.32 -170.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.91 144.07 46.64 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.09 139.82 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -175.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 52.7 ttp -104.0 136.88 42.83 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 119.916 -1.74 . . . . 0.0 109.299 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . 0.267 0.2 OUTLIER -83.83 135.41 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -169.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.411 ' HB2' ' H ' ' A' ' 334' ' ' ASP . 0.3 OUTLIER -122.46 -126.86 0.26 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 175.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ASP . . . . . 0.499 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.437 12.2 m-20 -59.49 113.55 2.26 Favored 'General case' 0 N--CA 1.483 1.181 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -160.014 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.9 tp -112.89 120.82 63.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 -165.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -140.44 118.57 11.96 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.23 -1.73 57.62 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 126.576 1.95 . . . . 0.0 113.858 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.2 -40.12 9.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 129.245 3.018 . . . . 0.0 109.73 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -88.22 -32.74 18.41 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 131.275 3.83 . . . . 0.0 112.765 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.329 1.3 mmp_? 75.27 50.9 0.08 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 129.426 3.09 . . . . 0.0 114.89 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.25 132.22 52.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 110.848 -2.887 . . . . 0.0 108.945 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.99 126.84 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 1 N-CA-C 94.177 -6.231 . . . . 0.0 94.177 171.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' SER . . . . . 0.499 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 39.6 m -111.0 102.45 10.93 Favored 'General case' 0 CA--C 1.446 -3.053 1 C-N-CA 111.291 -4.164 . . . . 0.0 107.063 -165.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 173.58 7.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 125.06 2.362 . . . . 0.0 110.913 -165.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.36 136.32 6.23 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.841 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.8 149.17 40.85 Favored 'General case' 0 C--N 1.369 1.435 1 N-CA-C 123.584 4.661 . . . . 0.0 123.584 -164.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -94.92 -98.33 0.16 Allowed 'General case' 0 C--N 1.39 2.363 0 O-C-N 120.916 -1.115 . . . . 0.0 112.8 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -141.24 -1.18 1.37 Allowed 'General case' 0 C--N 1.373 1.601 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.316 3.6 m 79.81 163.36 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.257 1.823 . . . . 0.0 115.445 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 353' ' ' PRO . 0.0 OUTLIER -56.69 -145.24 0.0 OUTLIER 'General case' 0 C--N 1.354 0.766 1 C-N-CA 134.535 5.134 . . . . 0.0 118.88 174.114 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 164.9 89.04 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 129.935 3.294 . . . . 0.0 102.969 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 93.11 74.47 0.03 OUTLIER Pre-proline 0 C--N 1.358 0.963 0 C-N-CA 130.087 3.355 . . . . 0.0 105.795 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' PRO . . . . . 0.455 ' HB3' ' HG3' ' A' ' 350' ' ' LYS . 57.9 Cg_endo -68.01 148.04 75.03 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.509 3.473 . . . . 0.0 112.29 -174.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 46.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 130.983 3.713 . . . . 0.0 120.643 -175.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -133.92 -61.3 0.8 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.561 1.544 . . . . 0.0 110.639 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER 88.86 126.08 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.245 2.618 . . . . 0.0 112.626 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -93.95 166.31 12.23 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 125.892 1.677 . . . . 0.0 112.014 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -94.76 66.06 3.11 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.764 1.626 . . . . 0.0 111.786 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -150.88 147.71 27.55 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 73.2 p -106.85 55.15 0.66 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 126.302 1.841 . . . . 0.0 110.738 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.267 2.008 2 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.9 -31.28 84.74 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.367 3.378 . . . . 0.0 115.999 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 93.27 119.21 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.665 3.586 . . . . 0.0 109.316 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.13 54.47 Favored Glycine 0 C--N 1.372 2.575 0 CA-C-O 124.74 2.3 . . . . 0.0 112.581 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.84 134.61 44.75 Favored 'General case' 0 CA--C 1.507 -0.684 1 C-N-CA 133.235 4.614 . . . . 0.0 102.479 172.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 12.5 ptmt -103.1 152.56 21.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 10.9 mt -126.05 174.05 8.74 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 124.406 2.051 . . . . 0.0 107.64 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.94 137.15 53.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 168.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -146.98 175.06 26.56 Favored Glycine 0 CA--C 1.482 -1.995 0 CA-C-O 123.783 1.769 . . . . 0.0 111.04 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -117.99 134.82 54.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.455 HG21 HG13 ' A' ' 322' ' ' VAL . 70.0 t -78.87 133.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.302 1.4 t -121.23 -44.19 2.39 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.337 0.3 OUTLIER -136.29 174.83 10.19 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.69 -1.881 . . . . 0.0 111.068 175.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 1.1 mp -121.08 142.01 50.24 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 290' ' ' TYR 0.332 1.1 t -112.49 179.16 4.06 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.564 1.173 . . . . 0.0 110.815 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.44 -28.88 60.77 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 130.129 3.372 . . . . 0.0 115.409 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.413 ' H ' HG23 ' A' ' 288' ' ' THR 0.251 19.2 p90 -156.92 46.76 0.42 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 123.921 1.819 . . . . 0.0 110.025 175.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 174.76 -163.48 33.88 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 0.7 OUTLIER -135.23 151.44 50.6 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.582 1.553 . . . . 0.0 107.535 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.284 57.2 m-85 -105.65 136.18 45.71 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 284' ' ' VAL . 3.7 t -119.94 134.83 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.942 0 CA-C-N 112.316 -2.22 . . . . 0.0 106.285 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -100.12 128.55 46.18 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.856 -1.153 . . . . 0.0 113.302 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.326 29.5 mm -81.53 -103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 123.046 1.403 . . . . 0.0 113.89 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -107.82 169.67 8.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 129.313 3.045 . . . . 0.0 106.813 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.73 119.5 9.42 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 120.114 -1.616 . . . . 0.0 114.591 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 89.26 -5.98 83.78 Favored Glycine 0 C--N 1.369 2.368 0 C-N-CA 127.065 2.269 . . . . 0.0 115.638 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.67 113.49 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.34 2.256 . . . . 0.0 110.802 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.1 157.62 46.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 118.388 -2.695 . . . . 0.0 106.801 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.539 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -126.47 174.0 18.03 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 124.307 2.06 . . . . 0.0 115.901 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 7.9 tp -124.51 125.0 43.49 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.769 1.627 . . . . 0.0 107.888 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.2 110.85 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 C-N-CA 125.997 1.719 . . . . 0.0 107.74 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -79.04 115.14 18.53 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.373 1.599 0 C-N-CA 130.861 3.664 . . . . 0.0 119.111 -175.376 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 284' ' ' VAL . 9.8 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -114.0 162.88 15.87 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 128.357 2.663 . . . . 0.0 105.678 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.05 120.47 12.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 126.145 1.778 . . . . 0.0 109.493 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.32 13.74 58.21 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 126.081 1.801 . . . . 0.0 116.532 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.84 149.22 21.42 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 126.04 1.736 . . . . 0.0 111.308 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.5 p -100.03 134.21 40.33 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-O 123.415 1.579 . . . . 0.0 110.502 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -134.75 -178.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 1 C-N-CA 134.3 5.04 . . . . 0.0 110.594 -173.171 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -127.34 147.02 50.26 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 129.014 2.925 . . . . 0.0 103.813 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.404 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 1.6 m -146.46 163.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 57.0 ttp -126.53 136.05 52.08 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.54 132.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -136.65 0.3 Allowed 'General case' 0 N--CA 1.417 -2.097 1 N-CA-C 97.92 -4.845 . . . . 0.0 97.92 172.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.32 2.6 t70 -63.2 112.41 2.66 Favored 'General case' 0 C--N 1.316 -0.88 1 N-CA-C 123.205 4.52 . . . . 0.0 123.205 -156.767 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.454 HD11 ' HG2' ' A' ' 337' ' ' GLU 0.334 0.0 OUTLIER -101.71 136.77 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 126.065 1.746 . . . . 0.0 111.36 -177.406 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -139.83 102.86 4.52 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 167.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLU . . . . . 0.454 ' HG2' HD11 ' A' ' 335' ' ' ILE . 24.8 mt-10 -63.14 -18.3 63.3 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 129.124 2.97 . . . . 0.0 113.805 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.33 -32.71 58.85 Favored 'General case' 0 N--CA 1.433 -1.288 1 C-N-CA 133.042 4.537 . . . . 0.0 112.621 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -108.94 -31.64 7.58 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-O 123.188 1.47 . . . . 0.0 112.477 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.342 68.9 mtp180 74.91 50.46 0.09 Allowed 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 130.932 3.693 . . . . 0.0 113.112 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -124.83 125.53 44.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 111.683 -2.508 . . . . 0.0 104.763 178.271 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.88 130.01 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.216 1 N-CA-C 98.694 -4.558 . . . . 0.0 98.694 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 5.1 t -102.26 92.47 4.74 Favored 'General case' 0 C--N 1.377 1.804 1 C-N-CA 110.298 -4.561 . . . . 0.0 104.336 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -103.78 136.34 43.65 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 117.244 -1.783 . . . . 0.0 111.306 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.66 123.06 1.65 Allowed Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.357 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.404 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.664 1.5 tt -138.89 -90.07 0.21 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 131.176 3.79 . . . . 0.0 108.589 174.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.342 19.4 tttt 101.35 23.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 167.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.43 -47.67 63.36 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.524 ' HA ' HG13 ' A' ' 328' ' ' VAL 0.473 11.8 p 95.28 164.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.374 1 C-N-CA 133.75 4.82 . . . . 0.0 113.916 -177.857 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -92.83 164.15 13.45 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.855 2.062 . . . . 0.0 111.582 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.5 99.31 11.49 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 119.235 -2.165 . . . . 0.0 107.849 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 61.2 t30 91.45 64.44 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.831 0 C-N-CA 131.027 3.731 . . . . 0.0 105.968 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--N 1.368 1.59 0 C-N-CA 123.063 2.509 . . . . 0.0 113.728 -170.809 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 275' ' ' PRO . 94.5 m-85 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 274' ' ' TYR . 40.4 Cg_exo -67.58 177.06 4.32 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.95 3.767 . . . . 0.0 116.011 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.49 135.6 21.41 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.12 5.11 44.11 Favored Glycine 0 C--N 1.369 2.386 0 CA-C-O 123.856 1.809 . . . . 0.0 112.546 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 70.5 p -95.93 121.87 38.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 130.923 3.689 . . . . 0.0 103.775 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -90.03 146.96 23.96 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.72 1.248 . . . . 0.0 113.362 -176.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 332' ' ' VAL . 2.6 mm? -129.21 174.2 9.8 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-N 112.786 -2.006 . . . . 0.0 106.655 -170.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.29 143.78 51.17 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.64 173.73 38.06 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -119.04 138.36 52.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 322' ' ' VAL . 21.8 t -83.47 132.98 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.158 -1.589 . . . . 0.0 115.153 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.267 2.3 t -136.13 -25.57 1.2 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -133.4 174.37 10.48 Favored 'General case' 0 C--N 1.372 1.551 0 CA-C-N 123.484 2.856 . . . . 0.0 108.053 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.9 OUTLIER -121.01 151.41 39.79 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 167.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 178.18 4.38 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -65.59 -29.35 69.93 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.835 2.054 . . . . 0.0 115.663 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.11 44.44 0.72 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 125.126 2.394 . . . . 0.0 107.915 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 306' ' ' VAL . . . -173.27 -165.21 29.82 Favored Glycine 0 CA--C 1.468 -2.869 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.7 t -143.3 153.83 43.17 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 126.266 1.826 . . . . 0.0 106.694 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.291 65.3 m-85 -114.81 142.22 46.84 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-O 124.885 2.279 . . . . 0.0 111.85 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.56 139.18 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.965 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -100.79 119.28 38.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.601 -1.312 . . . . 0.0 110.391 164.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.277 28.8 mt -60.15 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 124.433 2.063 . . . . 0.0 116.19 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.26 147.34 50.23 Favored 'General case' 0 CA--C 1.495 -1.153 1 N-CA-C 98.963 -4.458 . . . . 0.0 98.963 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -57.41 119.97 7.4 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.17 -10.55 47.49 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.731 1.634 . . . . 0.0 114.649 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.3 t -116.24 143.93 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 C-N-CA 127.966 2.506 . . . . 0.0 105.067 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -152.42 149.75 28.92 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 119.282 -2.136 . . . . 0.0 105.841 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 344' ' ' LEU . . . -130.51 173.87 19.92 Favored Glycine 0 CA--C 1.485 -1.84 0 CA-C-O 124.368 2.093 . . . . 0.0 113.924 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 292' ' ' CYS . 62.2 tp -97.81 163.49 12.78 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 120.378 -1.66 . . . . 0.0 110.157 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.263 11.8 t -116.76 118.89 60.28 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -79.87 113.27 17.91 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.43 ' HB ' ' HA2' ' A' ' 291' ' ' GLY 0.386 7.6 p . . . . . 0 C--N 1.377 1.786 1 N-CA-C 122.003 4.075 . . . . 0.0 122.003 -166.565 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 284' ' ' VAL 0.297 4.1 t . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 125.009 2.338 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -109.47 168.17 9.59 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.364 3.065 . . . . 0.0 107.66 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.33 121.2 23.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.38 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.43 14.95 56.42 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 125.676 1.608 . . . . 0.0 114.225 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.65 143.71 26.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.998 1.319 . . . . 0.0 110.912 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.83 136.25 31.92 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.773 1.273 . . . . 0.0 108.519 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -139.77 177.89 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 129.664 3.186 . . . . 0.0 107.074 -171.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -123.91 138.32 54.5 Favored 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 98.819 -4.512 . . . . 0.0 98.819 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 7.7 m -143.47 139.97 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 100.667 -3.827 . . . . 0.0 100.667 -167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.7 ttm -102.57 141.64 35.07 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 120.363 -1.46 . . . . 0.0 108.781 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 342' ' ' ILE . 74.9 t -81.5 133.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 119.936 -1.727 . . . . 0.0 115.463 -170.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -135.35 0.29 Allowed 'General case' 0 N--CA 1.426 -1.643 1 N-CA-C 99.618 -4.215 . . . . 0.0 99.618 172.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.402 0.8 OUTLIER -59.69 112.72 1.92 Allowed 'General case' 0 N--CA 1.481 1.122 1 N-CA-C 124.196 4.887 . . . . 0.0 124.196 -158.976 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 0.3 OUTLIER -101.48 112.83 35.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 C-N-CA 125.65 1.58 . . . . 0.0 114.176 -176.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.55 107.48 6.67 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.87 7.32 37.81 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 126.535 1.934 . . . . 0.0 112.302 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . 0.25 24.1 mm-40 -82.71 -41.91 18.71 Favored 'General case' 0 N--CA 1.432 -1.351 1 C-N-CA 134.021 4.928 . . . . 0.0 108.831 170.955 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -101.51 -27.08 13.32 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.655 1.982 . . . . 0.0 111.349 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 63.1 mtm-85 75.32 53.21 0.07 Allowed 'General case' 0 C--N 1.35 0.604 1 C-N-CA 131.968 4.107 . . . . 0.0 112.702 -179.933 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.9 ptt180 -124.53 134.0 53.13 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 111.092 -2.776 . . . . 0.0 109.621 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 332' ' ' VAL . 0.7 OUTLIER -118.83 122.0 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 1 N-CA-C 94.44 -6.133 . . . . 0.0 94.44 172.561 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 94.96 5.76 Favored 'General case' 0 CA--C 1.463 -2.366 1 C-N-CA 110.845 -4.342 . . . . 0.0 104.35 -162.043 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.415 ' CD1' ' HA3' ' A' ' 302' ' ' GLY . 1.0 OUTLIER -96.34 171.24 8.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 118.925 -2.359 . . . . 0.0 109.547 -164.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -154.81 136.91 5.39 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 116.688 -2.672 . . . . 0.0 112.857 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 328' ' ' VAL . 0.2 OUTLIER -53.06 152.79 3.9 Favored 'General case' 0 C--N 1.35 0.592 1 N-CA-C 125.029 5.196 . . . . 0.0 125.029 -163.618 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -108.32 -102.25 0.37 Allowed 'General case' 0 C--N 1.386 2.159 0 O-C-N 121.208 -0.933 . . . . 0.0 111.909 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -139.33 24.25 2.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 120.196 -1.565 . . . . 0.0 114.85 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.485 0.9 OUTLIER 70.84 173.67 0.31 Allowed 'General case' 0 C--N 1.373 1.625 0 C-N-CA 126.334 1.853 . . . . 0.0 115.31 -179.218 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -80.46 159.67 25.52 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.47 -1.394 . . . . 0.0 111.739 174.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.437 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -85.33 54.59 3.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 110.758 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.294 3.3 p30 123.01 94.32 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.801 1 C-N-CA 136.196 5.798 . . . . 0.0 104.977 -171.834 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 CA--C 1.556 1.584 0 C-N-CA 123.404 2.736 . . . . 0.0 110.511 -178.334 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -81.83 -37.37 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.394 3.396 . . . . 0.0 111.776 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 84.03 123.5 0.04 OUTLIER 'General case' 0 C--N 1.372 1.584 0 C-N-CA 129.637 3.175 . . . . 0.0 112.733 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.75 10.23 44.06 Favored Glycine 0 C--N 1.375 2.744 0 CA-C-O 124.255 2.031 . . . . 0.0 113.356 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.17 166.36 13.42 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 131.431 3.893 . . . . 0.0 103.31 167.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 29.2 mmmt -112.14 146.98 37.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 120.244 -1.535 . . . . 0.0 111.906 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 280' ' ' LEU . 1.8 mp -120.95 174.13 6.82 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 123.926 1.822 . . . . 0.0 107.094 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 89.1 m -141.09 138.28 33.44 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.381 -1.449 . . . . 0.0 108.228 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.91 179.06 36.62 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-O 124.183 1.991 . . . . 0.0 115.638 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -125.4 135.38 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.12 133.5 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 119.134 3.013 . . . . 0.0 119.134 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.255 12.4 t -115.59 -40.6 3.36 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 112.968 -1.923 . . . . 0.0 115.083 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -135.9 172.63 12.73 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.103 1.774 . . . . 0.0 109.138 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 292' ' ' CYS . 1.3 tt -122.18 142.36 50.5 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.652 1.581 . . . . 0.0 107.86 166.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 173.67 6.26 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 121.006 -1.059 . . . . 0.0 109.284 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -28.87 69.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.62 2.368 . . . . 0.0 115.537 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -153.3 48.46 0.69 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 123.494 1.616 . . . . 0.0 107.744 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 177.66 -161.55 28.83 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 167.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 287' ' ' LEU 0.36 0.8 OUTLIER -145.9 164.58 31.52 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 125.017 1.327 . . . . 0.0 109.523 168.538 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -102.92 122.44 44.57 Favored 'General case' 0 C--N 1.357 0.892 0 O-C-N 121.202 -0.936 . . . . 0.0 108.894 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.4 125.94 67.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.27 123.73 35.81 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.7 mm -91.25 48.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.932 -1.105 . . . . 0.0 111.231 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.268 38.0 mt-10 79.95 173.56 0.14 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.116 2.566 . . . . 0.0 110.481 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.56 119.4 12.29 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.92 -33.91 4.7 Favored Glycine 0 C--N 1.367 2.305 0 C-N-CA 127.65 2.548 . . . . 0.0 114.337 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . 0.298 1.8 p -117.35 123.54 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.0 112.03 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.38 154.65 45.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 119.066 -2.272 . . . . 0.0 107.276 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -116.27 172.15 14.09 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-O 124.083 1.935 . . . . 0.0 112.045 163.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 5.1 tp -126.75 126.48 43.51 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.667 ' CG2' ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -92.14 120.22 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 171.254 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -94.92 132.5 39.68 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 123.647 0.592 . . . . 0.0 111.801 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 176.733 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.234 0.271 0 CA-C-O 122.697 1.236 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -106.09 171.09 7.53 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 123.568 1.651 . . . . 0.0 108.863 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.49 120.66 2.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 128.261 2.624 . . . . 0.0 113.703 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.74 14.72 72.29 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 114.193 -1.367 . . . . 0.0 115.588 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.1 133.94 34.56 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 126.791 2.037 . . . . 0.0 106.494 172.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.04 135.59 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.405 ' HA ' ' N ' ' A' ' 349' ' ' CYS . 30.5 m -139.99 175.49 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 124.988 2.327 . . . . 0.0 111.462 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -108.51 150.93 26.76 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -138.55 167.05 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 -177.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 31.9 ttm -115.52 138.81 50.66 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.623 ' HB ' HD12 ' A' ' 344' ' ' LEU . 1.2 p -85.7 131.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.91 -137.33 0.3 Allowed 'General case' 0 N--CA 1.414 -2.231 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.29 28.0 m-20 -65.01 112.45 3.33 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.816 4.376 . . . . 0.0 122.816 -155.084 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.431 0.1 OUTLIER -109.66 124.8 66.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 C-N-CA 125.409 1.484 . . . . 0.0 110.14 -179.202 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.26 112.68 13.57 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -78.97 -4.82 51.88 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 123.729 1.728 . . . . 0.0 112.866 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -86.52 -41.19 14.55 Favored 'General case' 0 N--CA 1.425 -1.689 1 C-N-CA 135.378 5.471 . . . . 0.0 111.269 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -103.11 -28.99 11.62 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 113.572 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.271 16.4 mmm180 75.02 48.88 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 128.118 2.567 . . . . 0.0 113.665 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.56 134.28 52.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 128.278 2.631 . . . . 0.0 106.337 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.3 mm -116.54 129.59 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 1 N-CA-C 95.052 -5.907 . . . . 0.0 95.052 168.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.68 94.36 5.25 Favored 'General case' 0 C--N 1.385 2.123 1 C-N-CA 111.037 -4.265 . . . . 0.0 106.425 -167.048 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' A' ' 332' ' ' VAL . 0.2 OUTLIER -101.14 135.36 42.72 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 116.611 -2.035 . . . . 0.0 108.895 -171.176 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -124.28 134.68 9.25 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 121.652 -0.655 . . . . 0.0 112.943 -176.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.667 ' H ' ' CG2' ' A' ' 304' ' ' VAL 0.353 0.1 OUTLIER -73.49 163.08 28.53 Favored 'General case' 0 C--N 1.368 1.381 1 N-CA-C 128.779 6.585 . . . . 0.0 128.779 -154.586 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -121.52 -105.77 0.37 Allowed 'General case' 0 C--N 1.384 2.108 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -163.6 152.0 13.59 Favored 'General case' 0 C--N 1.349 0.566 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 173.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 328' ' ' VAL . 13.0 t -86.35 -39.2 16.67 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.781 3.658 . . . . 0.0 108.922 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -129.35 165.14 22.09 Favored 'General case' 0 N--CA 1.449 -0.524 1 CA-C-N 104.258 -5.883 . . . . 0.0 108.759 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.22 46.18 1.01 Allowed 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.008 -1.683 . . . . 0.0 109.675 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.286 1.0 OUTLIER 154.94 69.31 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.629 1 C-N-CA 132.808 4.443 . . . . 0.0 106.56 -176.493 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.368 1.58 0 C-N-CA 124.74 3.627 . . . . 0.0 110.971 177.482 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.29 91.12 1.03 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.224 2.616 . . . . 0.0 107.247 168.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.28 151.58 46.75 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 128.714 2.805 . . . . 0.0 118.117 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.26 8.35 55.14 Favored Glycine 0 C--N 1.384 3.214 0 CA-C-O 124.753 2.307 . . . . 0.0 112.336 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 332' ' ' VAL . 2.9 p -96.46 147.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.75 1 C-N-CA 135.136 5.374 . . . . 0.0 101.929 173.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 7.7 ptmt -112.35 156.07 23.08 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 119.007 -2.308 . . . . 0.0 113.399 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.12 151.61 40.91 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.8 m -109.03 139.24 44.17 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.666 -1.271 . . . . 0.0 109.679 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -140.51 -179.18 17.84 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 123.215 1.453 . . . . 0.0 112.083 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -119.07 137.64 53.42 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.82 125.93 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.3 t -106.68 -36.58 6.68 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 111.758 -2.474 . . . . 0.0 112.772 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.27 0.9 OUTLIER -136.64 170.26 16.36 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.819 1.645 . . . . 0.0 109.299 177.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.72 148.05 45.11 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.7 m -112.02 172.56 6.83 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -68.05 -28.09 67.09 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.174 -2.204 . . . . 0.0 113.298 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.68 44.07 1.37 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.949 1.7 . . . . 0.0 107.757 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -179.05 -168.31 37.94 Favored Glycine 0 CA--C 1.471 -2.71 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 145.86 26.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -101.14 118.69 37.49 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.67 125.04 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.19 119.47 33.06 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.246 -1.534 . . . . 0.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 37.5 mm -60.19 -65.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -138.08 166.52 23.91 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -65.52 118.87 10.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.835 -1.166 . . . . 0.0 114.046 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.02 -16.94 53.61 Favored Glycine 0 C--N 1.368 2.329 0 C-N-CA 127.128 2.299 . . . . 0.0 115.851 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.91 117.83 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.941 1.697 . . . . 0.0 109.94 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.76 160.31 37.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 119.346 -2.097 . . . . 0.0 110.299 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.35 173.54 15.35 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 125.946 1.736 . . . . 0.0 114.181 169.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.2 tp -126.22 115.53 19.88 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 126.442 1.897 . . . . 0.0 107.088 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 347' ' ' LYS 0.256 4.3 p -87.34 112.77 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -79.16 123.46 27.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.165 -176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.508 2.439 0 CA-C-N 122.942 2.61 . . . . 0.0 115.911 176.106 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 123.805 1.764 . . . . 0.0 114.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -120.16 169.06 10.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.09 121.27 26.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 C-N-CA 126.56 1.944 . . . . 0.0 107.834 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.42 53.79 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -98.89 164.46 12.19 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 130.009 3.324 . . . . 0.0 104.13 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.29 0.2 OUTLIER -121.41 138.17 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.302 -1.499 . . . . 0.0 109.925 -175.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.259 0.9 OUTLIER -139.23 163.47 26.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 CA-C-O 122.879 1.323 . . . . 0.0 108.086 179.001 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.24 155.38 18.06 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.443 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 3.1 m -141.1 163.71 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 51.6 ttp -120.71 141.43 50.44 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 278' ' ' THR . 11.9 p -80.72 131.37 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -168.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.36 -136.66 0.29 Allowed 'General case' 0 N--CA 1.42 -1.968 1 N-CA-C 99.953 -4.092 . . . . 0.0 99.953 176.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ASP . . . . . 0.501 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.254 24.7 m-20 -69.45 112.32 5.9 Favored 'General case' 0 C--N 1.31 -1.152 1 N-CA-C 122.702 4.334 . . . . 0.0 122.702 -154.766 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.335 0.1 OUTLIER -102.87 125.39 57.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 C-N-CA 127.266 2.226 . . . . 0.0 109.28 179.607 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.72 110.62 14.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -74.94 -3.43 32.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.025 2.13 . . . . 0.0 113.539 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -88.17 -35.55 17.32 Favored 'General case' 0 N--CA 1.432 -1.358 1 C-N-CA 132.49 4.316 . . . . 0.0 110.766 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -103.71 -39.93 6.48 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.507 1.523 . . . . 0.0 111.806 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.361 92.5 mtt180 74.48 52.49 0.09 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 132.423 4.289 . . . . 0.0 112.606 -179.272 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -124.87 132.85 53.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 127.802 2.441 . . . . 0.0 104.638 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 131.15 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' SER . . . . . 0.501 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 3.9 m -107.32 92.19 3.97 Favored 'General case' 0 C--N 1.381 1.94 1 C-N-CA 111.061 -4.256 . . . . 0.0 105.105 -166.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 332' ' ' VAL . 1.7 mp -101.6 138.28 38.8 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 119.961 1.255 . . . . 0.0 111.45 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -149.12 123.81 1.7 Allowed Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.443 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.741 4.0 tt -139.58 -86.93 0.22 Allowed 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.493 3.517 . . . . 0.0 112.348 174.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 347' ' ' LYS . . . . . 0.639 ' HB2' HG21 ' A' ' 304' ' ' VAL 0.263 29.7 ttmt 93.78 44.2 0.0 OUTLIER 'General case' 0 C--N 1.371 1.506 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 174.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -79.8 -46.83 16.21 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 118.822 -2.424 . . . . 0.0 113.324 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.259 63.0 m 90.02 160.1 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 130.425 3.49 . . . . 0.0 111.492 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 4.9 mmtp -72.16 166.81 21.59 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.466 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -92.24 4.04 54.11 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.801 2.04 . . . . 0.0 114.469 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -168.64 75.58 0.8 Allowed Pre-proline 0 CA--C 1.541 0.626 1 C-N-CA 131.84 4.056 . . . . 0.0 105.183 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo . . . . . 0 C--N 1.372 1.769 1 C-N-CA 125.478 4.119 . . . . 0.0 116.045 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . 0.291 4.5 m-85 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.89 114.82 4.01 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.666 2.911 . . . . 0.0 109.727 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.3 125.19 27.25 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.809 1.644 . . . . 0.0 111.822 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.04 2.24 31.73 Favored Glycine 0 C--N 1.363 2.074 0 CA-C-O 122.929 1.294 . . . . 0.0 113.551 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 46.8 p -93.23 142.58 27.15 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 28.5 mmtp -97.65 146.03 25.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.559 1.171 . . . . 0.0 112.933 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.87 175.46 6.54 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 124.319 2.009 . . . . 0.0 110.238 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 48.3 m -116.92 129.87 56.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -132.4 173.44 20.79 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 124.42 2.122 . . . . 0.0 111.877 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -129.51 126.33 38.39 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.448 HG21 ' CG1' ' A' ' 322' ' ' VAL . 5.0 t -87.36 136.63 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 119.575 -1.953 . . . . 0.0 115.988 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.323 4.1 t -145.41 -20.35 0.48 Allowed 'General case' 0 C--N 1.361 1.083 0 N-CA-C 121.253 3.798 . . . . 0.0 121.253 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.347 2.6 t-20 -134.19 175.92 9.06 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 123.734 2.97 . . . . 0.0 110.672 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 142.44 49.85 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 119.134 -2.229 . . . . 0.0 108.512 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 289' ' ' ASP . 2.0 m -112.51 178.38 4.32 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 288' ' ' THR . 0.4 OUTLIER -57.85 -29.62 65.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.86 46.39 0.14 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 123.742 1.735 . . . . 0.0 110.278 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.0 -167.58 36.23 Favored Glycine 0 CA--C 1.48 -2.1 1 N-CA-C 101.17 -4.772 . . . . 0.0 101.17 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.258 0.1 OUTLIER -134.6 161.41 35.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -98.95 128.33 45.09 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.79 -1.819 . . . . 0.0 107.972 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.58 133.19 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.446 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.3 126.42 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 118.61 -2.556 . . . . 0.0 111.879 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 297' ' ' GLU . 7.8 mm -83.64 173.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 119.859 -1.776 . . . . 0.0 111.225 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 296' ' ' ILE . 37.8 mm-40 -78.04 -17.72 56.72 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-O 127.315 3.436 . . . . 0.0 117.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.98 154.11 39.45 Favored 'General case' 0 C--N 1.303 -1.439 2 C-N-CA 143.072 8.549 . . . . 0.0 112.797 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.77 2.77 72.39 Favored Glycine 0 C--N 1.371 2.49 0 O-C-N 119.296 -2.128 . . . . 0.0 115.7 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.08 144.93 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 129.679 3.192 . . . . 0.0 108.605 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -115.17 158.24 22.51 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.984 -1.697 . . . . 0.0 107.925 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -110.25 172.92 15.99 Favored Glycine 0 C--N 1.359 1.841 0 CA-C-O 125.058 2.477 . . . . 0.0 112.973 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.3 tp -118.48 114.62 23.14 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 346' ' ' LEU 0.296 1.5 p -79.43 100.02 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 122.858 1.313 . . . . 0.0 107.54 174.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -87.92 114.7 24.79 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.937 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 177.755 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.448 ' CG1' HG21 ' A' ' 284' ' ' VAL 0.269 10.0 t . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.728 0.775 . . . . 0.0 111.946 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.79 172.3 8.73 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 124.406 2.05 . . . . 0.0 111.09 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.64 120.64 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 112.328 -2.215 . . . . 0.0 109.758 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.61 62.25 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 125.88 1.705 . . . . 0.0 115.827 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -93.4 151.67 19.6 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.766 2.427 . . . . 0.0 110.474 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.58 138.55 26.42 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 126.16 1.784 . . . . 0.0 107.727 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.891 HG23 ' H ' ' A' ' 349' ' ' CYS 0.253 7.5 p -147.92 170.16 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 124.354 2.025 . . . . 0.0 108.707 -173.123 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.37 140.6 38.24 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.0 OUTLIER -130.5 167.67 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.682 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -173.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 23.6 ttm -118.4 138.8 52.2 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 171.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 344' ' ' LEU . 92.5 t -81.6 124.74 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.531 -1.356 . . . . 0.0 111.14 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . 0.253 1.8 mp -125.03 -141.41 0.29 Allowed 'General case' 0 N--CA 1.409 -2.501 0 CA-C-O 126.847 3.213 . . . . 0.0 102.453 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ASP . . . . . 0.473 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.35 4.9 t70 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 -152.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.708 HD13 HG23 ' A' ' 342' ' ' ILE . 4.8 tp -109.99 132.46 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.303 -172.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.44 104.05 5.96 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 101.58 -3.489 . . . . 0.0 101.58 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.57 -9.16 59.25 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.186 2.195 . . . . 0.0 114.026 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.13 -37.29 14.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.181 3.792 . . . . 0.0 111.074 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -100.62 -23.3 14.7 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 124.731 1.212 . . . . 0.0 112.365 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.276 1.5 mmp_? 74.45 46.7 0.15 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 129.491 3.116 . . . . 0.0 113.883 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -125.67 111.92 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 111.119 -2.764 . . . . 0.0 105.214 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.708 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -111.65 130.23 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 2 C-N-CA 133.579 4.752 . . . . 0.0 99.597 179.534 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 343' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 2.5 m -115.12 93.72 4.43 Favored 'General case' 0 CA--C 1.471 -2.063 1 C-N-CA 109.217 -4.993 . . . . 0.0 105.48 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.49 HD12 ' CD1' ' A' ' 296' ' ' ILE . 0.1 OUTLIER -100.35 136.29 40.47 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -150.44 124.46 1.74 Allowed Glycine 0 N--CA 1.47 0.948 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.897 -164.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.714 ' HG ' HG21 ' A' ' 328' ' ' VAL . 0.7 OUTLIER -32.93 154.15 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 2 C-N-CA 135.37 5.468 . . . . 0.0 124.72 -168.5 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -101.94 -79.75 0.51 Allowed 'General case' 0 C--N 1.384 2.089 0 C-N-CA 124.188 0.995 . . . . 0.0 109.531 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.31 0.4 OUTLIER -176.44 46.75 0.01 OUTLIER 'General case' 0 C--N 1.372 1.585 0 N-CA-C 118.278 2.696 . . . . 0.0 118.278 176.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.891 ' H ' HG23 ' A' ' 328' ' ' VAL 0.421 13.4 p 68.18 161.74 0.19 Allowed 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.205 4.15 . . . . 0.0 122.205 169.845 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -77.53 168.76 19.46 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 128.646 2.778 . . . . 0.0 113.33 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -101.81 18.29 20.88 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 118.895 -2.378 . . . . 0.0 113.257 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -174.89 52.21 0.11 Allowed Pre-proline 0 N--CA 1.438 -1.032 0 C-N-CA 129.673 3.189 . . . . 0.0 109.12 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo . . . . . 0 C--N 1.377 2.066 0 C-N-CA 125.005 3.803 . . . . 0.0 114.968 -171.125 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.76 -176.19 3.11 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.829 3.019 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.31 126.92 49.14 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.512 1.125 . . . . 0.0 108.791 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.36 36.49 Favored Glycine 0 C--N 1.367 2.296 0 CA-C-O 123.804 1.78 . . . . 0.0 114.645 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 332' ' ' VAL . 4.1 p -96.62 134.22 40.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 131.152 3.781 . . . . 0.0 102.923 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 21.2 pttp -100.13 149.63 23.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.327 1.537 . . . . 0.0 114.687 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.414 HD23 HG21 ' A' ' 296' ' ' ILE . 2.0 mp -120.95 175.28 6.14 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 123.447 1.594 . . . . 0.0 110.445 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 94.8 m -118.04 132.82 56.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.82 179.15 26.83 Favored Glycine 0 CA--C 1.481 -2.093 0 CA-C-O 123.875 1.819 . . . . 0.0 111.337 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -124.45 146.57 48.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 322' ' ' VAL . 5.0 t -92.27 133.66 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.374 -1.453 . . . . 0.0 112.051 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -125.49 -38.88 2.22 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.87 174.69 10.19 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 121.334 1.879 . . . . 0.0 107.281 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.9 mp -119.53 151.08 39.2 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 119.98 -1.7 . . . . 0.0 110.583 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 178.94 4.12 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -30.05 69.0 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 119.066 -2.271 . . . . 0.0 115.711 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -145.72 39.28 1.14 Allowed 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 123.18 1.467 . . . . 0.0 110.504 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.38 -170.97 37.54 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 5.3 m -135.82 157.12 47.62 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.2 125.74 44.85 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.515 HG11 HG11 ' A' ' 330' ' ' VAL . 16.3 t -104.29 133.58 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 125.586 1.554 . . . . 0.0 107.344 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.43 126.47 46.83 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.811 2.096 . . . . 0.0 114.478 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 300' ' ' VAL . 8.6 mm -104.56 56.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.626 173.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 75.22 171.6 0.27 Allowed 'General case' 0 C--N 1.364 1.236 0 C-N-CA 127.477 2.311 . . . . 0.0 111.877 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.96 119.04 12.66 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.75 -2.469 . . . . 0.0 115.593 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 118.82 -32.71 5.06 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 127.193 2.33 . . . . 0.0 114.987 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.629 HG13 HG13 ' A' ' 342' ' ' ILE . 40.3 t -116.9 130.64 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 127.543 2.337 . . . . 0.0 107.739 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.98 157.02 28.06 Favored 'General case' 0 CA--C 1.478 -1.798 0 O-C-N 118.307 -2.746 . . . . 0.0 104.916 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -125.87 174.07 17.7 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.61 122.26 37.69 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 125.932 1.693 . . . . 0.0 106.866 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 345' ' ' GLY . 2.4 p -93.61 118.79 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -96.48 133.24 41.18 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 117.359 -1.736 . . . . 0.0 112.454 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.269 52.4 t . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 284' ' ' VAL 0.399 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 118.566 2.802 . . . . 0.0 118.566 . . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.458 ' H ' HG22 ' A' ' 322' ' ' VAL . 39.7 t30 -109.66 148.96 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.4 p -78.67 120.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.696 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 88.24 25.63 30.64 Favored Glycine 0 C--N 1.361 1.924 0 C-N-CA 124.31 0.957 . . . . 0.0 113.457 -170.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.83 158.0 15.87 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.674 1.99 . . . . 0.0 108.88 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -117.02 136.56 53.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.264 10.7 p -147.49 175.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 130.764 3.626 . . . . 0.0 108.225 -166.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -114.69 141.71 47.45 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.4 m -124.37 166.5 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -171.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 35.2 ttm -121.12 141.09 51.13 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.431 HG22 HD12 ' A' ' 344' ' ' LEU . 39.8 t -81.66 131.86 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.593 -1.317 . . . . 0.0 113.522 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.48 -136.35 0.29 Allowed 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.252 10.5 t70 -63.84 112.05 2.73 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.585 4.291 . . . . 0.0 122.585 -153.651 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.267 2.8 tp -101.13 112.38 33.9 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 CA-C-O 122.7 1.238 . . . . 0.0 108.882 176.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.07 117.15 23.33 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.481 1.112 . . . . 0.0 108.166 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -80.96 -2.79 49.19 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.331 1.853 . . . . 0.0 115.128 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -89.56 -37.64 14.55 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.622 2.769 . . . . 0.0 111.463 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -103.13 -30.8 10.49 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.259 1.424 . . . . 0.0 112.454 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 16.9 mmm180 72.49 52.83 0.17 Allowed 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 129.925 3.29 . . . . 0.0 111.928 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.0 ptp180 -124.58 135.19 52.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 129.16 2.984 . . . . 0.0 107.768 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.629 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -108.88 130.04 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 167.373 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -102.57 94.74 5.81 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 111.781 -3.968 . . . . 0.0 107.246 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 332' ' ' VAL 0.306 2.1 mm? -96.12 136.87 36.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 120.129 -1.607 . . . . 0.0 108.464 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -135.15 127.69 4.47 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 6.9 mp -45.43 155.85 0.13 Allowed 'General case' 0 C--N 1.359 1.016 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -167.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -131.42 -62.74 0.86 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.64 124.31 1.92 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 173.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 7.4 p -47.63 151.88 0.77 Allowed 'General case' 0 C--N 1.361 1.084 1 C-N-CA 139.628 7.171 . . . . 0.0 117.48 169.259 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.13 162.73 27.75 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 127.403 2.281 . . . . 0.0 115.49 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -104.63 24.52 11.62 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.305 1.842 . . . . 0.0 112.548 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -175.64 51.69 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 129.702 3.201 . . . . 0.0 109.204 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.379 2.172 1 C-N-CA 126.388 4.725 . . . . 0.0 116.615 -167.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.68 -48.92 8.02 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.697 3.598 . . . . 0.0 114.116 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 82.39 118.77 0.05 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 128.994 2.917 . . . . 0.0 113.919 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.42 58.1 Favored Glycine 0 C--N 1.375 2.696 0 CA-C-O 124.556 2.198 . . . . 0.0 112.231 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 19.6 p -97.45 126.21 42.57 Favored 'General case' 0 CA--C 1.509 -0.629 1 C-N-CA 133.267 4.627 . . . . 0.0 103.475 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -95.85 144.57 26.09 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.666 1.698 . . . . 0.0 112.859 -178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.77 174.09 7.34 Favored 'General case' 0 CA--C 1.487 -1.446 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.566 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.5 m -110.83 139.85 45.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -153.9 173.28 32.57 Favored Glycine 0 CA--C 1.482 -1.989 0 CA-C-O 123.543 1.635 . . . . 0.0 111.69 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.59 ' HG2' HG22 ' A' ' 327' ' ' VAL . 30.6 mtp-105 -127.54 135.37 50.24 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.53 132.08 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 113.869 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -130.19 -31.04 1.91 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -169.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.271 1.2 t-20 -133.75 176.09 8.87 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-N 121.751 2.069 . . . . 0.0 108.379 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.0 OUTLIER -120.47 156.37 31.62 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.255 -1.528 . . . . 0.0 113.174 176.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 178.57 4.25 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -68.33 -25.49 65.13 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.533 2.333 . . . . 0.0 115.037 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -162.55 54.05 0.21 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.225 2.61 . . . . 0.0 107.039 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.97 -170.48 41.66 Favored Glycine 0 CA--C 1.468 -2.865 1 N-CA-C 100.573 -5.011 . . . . 0.0 100.573 171.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.8 m -139.91 169.82 17.01 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.493 1.117 . . . . 0.0 108.852 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.83 128.71 56.2 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-O 123.128 1.442 . . . . 0.0 109.182 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 330' ' ' VAL . 21.2 t -103.93 138.27 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 C-N-CA 125.862 1.665 . . . . 0.0 107.006 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -99.89 123.84 44.57 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 119.703 -1.873 . . . . 0.0 112.157 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.61 52.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 122.878 1.323 . . . . 0.0 111.616 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 79.07 174.97 0.15 Allowed 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.932 2.493 . . . . 0.0 109.716 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -68.22 119.72 13.23 Favored 'General case' 0 CA--C 1.558 1.285 0 O-C-N 119.871 -1.768 . . . . 0.0 114.181 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.0 32.4 Favored Glycine 0 C--N 1.367 2.262 0 C-N-CA 127.44 2.448 . . . . 0.0 115.196 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.18 143.99 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.125 1.77 . . . . 0.0 109.865 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -153.51 149.81 28.08 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 118.851 -2.405 . . . . 0.0 105.435 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 344' ' ' LEU . . . -131.38 174.36 20.06 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-O 124.824 2.347 . . . . 0.0 112.44 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 51.7 tp -98.38 162.63 13.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.703 2.001 . . . . 0.0 107.484 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 346' ' ' LEU . 2.4 p -128.82 117.15 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 161.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -95.21 134.89 37.45 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 119.09 -1.044 . . . . 0.0 113.792 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.272 1.0 OUTLIER . . . . . 0 C--N 1.38 1.93 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.507 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 123.372 1.558 . . . . 0.0 114.37 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -104.7 151.07 24.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 123.935 1.826 . . . . 0.0 112.527 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 324' ' ' VAL . 1.4 p -69.15 120.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 C-N-CA 127.052 2.141 . . . . 0.0 108.633 174.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 97.03 8.37 56.84 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 125.723 1.63 . . . . 0.0 115.626 -172.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.73 160.5 14.94 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.885 -1.362 . . . . 0.0 109.091 171.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 283' ' ' ARG . 35.0 t -117.82 137.41 51.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -144.01 178.99 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 CA-C-O 126.043 2.83 . . . . 0.0 108.979 -173.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.5 133.55 55.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.2 m -135.48 139.2 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.0 ttp -101.79 143.82 31.24 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 120.63 -1.294 . . . . 0.0 108.181 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.425 HG13 HG22 ' A' ' 342' ' ' ILE . 84.1 t -84.88 131.67 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.9 -133.13 0.3 Allowed 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 100.293 -3.966 . . . . 0.0 100.293 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.436 11.7 m-20 -53.21 112.65 0.91 Allowed 'General case' 0 CA--C 1.503 -0.831 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -154.991 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.59 HD13 HG23 ' A' ' 342' ' ' ILE . 5.8 tp -111.3 122.2 65.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 4.3 t0 -146.55 116.16 7.16 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -106.05 22.8 15.07 Favored 'General case' 0 C--N 1.365 1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 112.707 -172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -110.96 -43.7 3.73 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.526 1.93 . . . . 0.0 107.732 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 336' ' ' ASP 0.305 34.3 mmt180 -68.69 -38.53 80.38 Favored 'General case' 0 C--N 1.349 0.571 1 C-N-CA 132.956 4.503 . . . . 0.0 113.345 171.262 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.338 33.0 mmt180 74.98 51.38 0.08 Allowed 'General case' 0 C--N 1.347 0.487 1 C-N-CA 132.595 4.358 . . . . 0.0 113.481 173.334 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.46 133.73 52.33 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 111.622 -2.535 . . . . 0.0 112.389 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -119.61 127.22 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 1 N-CA-C 96.922 -5.214 . . . . 0.0 96.922 172.088 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.8 103.05 10.27 Favored 'General case' 0 CA--C 1.457 -2.627 1 C-N-CA 110.787 -4.365 . . . . 0.0 106.892 -170.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.471 HD13 ' HA3' ' A' ' 302' ' ' GLY . 2.1 mp -96.5 170.75 9.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 122.921 2.601 . . . . 0.0 112.077 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -156.24 141.69 8.19 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.788 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.412 1.4 pt? -51.13 159.0 0.67 Allowed 'General case' 0 C--N 1.374 1.65 1 N-CA-C 124.761 5.097 . . . . 0.0 124.761 -165.464 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -125.44 -55.86 1.53 Allowed 'General case' 0 C--N 1.38 1.93 0 O-C-N 120.948 -1.095 . . . . 0.0 109.962 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.34 2.1 pt20 -121.02 -105.26 0.38 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 18.7 p 159.71 171.1 0.01 OUTLIER 'General case' 0 C--N 1.349 0.561 1 C-N-CA 131.954 4.101 . . . . 0.0 101.677 -169.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -91.1 161.47 15.09 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.936 1.294 . . . . 0.0 111.989 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -96.79 77.0 2.8 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 118.912 -2.367 . . . . 0.0 109.737 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 40.4 t30 104.67 66.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 130.417 3.487 . . . . 0.0 107.675 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.382 2.31 1 C-N-CA 126.293 4.662 . . . . 0.0 112.313 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.06 122.17 9.86 Favored 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 125.382 4.055 . . . . 0.0 114.204 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.63 114.84 6.59 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 129.077 2.951 . . . . 0.0 113.16 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.92 7.79 40.71 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 123.633 1.685 . . . . 0.0 114.766 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 72.9 p -96.9 144.19 27.06 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 129.044 2.938 . . . . 0.0 103.543 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 92.5 mttt -105.87 155.3 19.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 119.867 -1.771 . . . . 0.0 115.203 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.59 HD21 HG22 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -128.33 173.42 10.18 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.809 2.243 . . . . 0.0 107.802 178.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.5 m -114.34 135.68 53.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.27 170.52 29.55 Favored Glycine 0 CA--C 1.48 -2.118 0 CA-C-O 124.097 1.943 . . . . 0.0 110.045 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -129.61 133.81 47.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 113.576 -1.312 . . . . 0.0 108.041 -171.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 322' ' ' VAL . 11.3 t -76.88 127.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.3 t -109.15 -41.96 4.54 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 112.763 -2.017 . . . . 0.0 113.632 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER -135.28 174.56 10.48 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 119.962 -1.711 . . . . 0.0 110.248 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 147.13 45.8 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.328 -1.483 . . . . 0.0 108.136 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 289' ' ' ASP . 1.0 OUTLIER -112.05 177.69 4.56 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 124.242 1.017 . . . . 0.0 108.885 -176.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 288' ' ' THR . 52.9 m-20 -71.25 -12.26 61.36 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.231 2.612 . . . . 0.0 114.572 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.439 ' CD2' ' HE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -164.34 47.42 0.11 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 123.842 1.782 . . . . 0.0 109.83 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 169.38 -160.28 33.48 Favored Glycine 0 CA--C 1.47 -2.759 0 N-CA-C 106.295 -2.722 . . . . 0.0 106.295 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.58 164.05 32.88 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -102.35 120.38 40.39 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.3 125.27 65.04 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.13 131.79 35.79 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 344' ' ' LEU . 3.9 mt -85.38 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 120.743 -1.223 . . . . 0.0 110.752 168.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.258 57.6 mm-40 84.65 167.31 0.09 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 127.577 2.351 . . . . 0.0 107.514 -167.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.01 118.89 9.13 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 112.81 -20.06 20.46 Favored Glycine 0 C--N 1.371 2.506 0 C-N-CA 126.867 2.175 . . . . 0.0 116.748 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.4 122.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.3 144.86 24.93 Favored 'General case' 0 CA--C 1.483 -1.601 0 O-C-N 119.489 -2.007 . . . . 0.0 111.275 -165.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.463 ' HA3' HD12 ' A' ' 344' ' ' LEU . . . -106.84 175.1 20.54 Favored Glycine 0 CA--C 1.491 -1.454 0 C-N-CA 128.099 2.762 . . . . 0.0 117.186 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 11.5 tp -126.0 120.0 29.15 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 126.776 2.03 . . . . 0.0 106.916 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.758 HG21 ' HG3' ' A' ' 347' ' ' LYS 0.284 8.3 p -92.32 118.46 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HE1' ' CD2' ' A' ' 290' ' ' TYR . 8.1 t60 -80.98 124.09 28.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.162 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.368 1.4 0 N-CA-C 121.227 3.788 . . . . 0.0 121.227 -172.43 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 284' ' ' VAL 0.412 33.1 t . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 124.622 2.153 . . . . 0.0 115.646 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.42 150.39 40.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 128.452 2.701 . . . . 0.0 105.459 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.43 121.37 29.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.912 1.339 . . . . 0.0 108.979 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 86.46 29.35 24.76 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.23 1.395 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -92.34 150.47 20.82 Favored 'General case' 0 C--N 1.364 1.218 0 O-C-N 120.636 -1.508 . . . . 0.0 109.311 172.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.282 0.7 OUTLIER -117.08 130.52 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 120.065 -1.647 . . . . 0.0 107.385 175.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -133.85 179.57 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 1 C-N-CA 133.186 4.594 . . . . 0.0 106.933 -171.768 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 346' ' ' LEU . 40.7 tt0 -112.03 150.14 31.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 100.558 -3.867 . . . . 0.0 100.558 172.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -146.51 144.19 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 42.7 ttm -105.84 141.66 36.88 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 120.125 -1.609 . . . . 0.0 107.45 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.59 HG22 HD21 ' A' ' 280' ' ' LEU . 68.4 t -69.59 128.92 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.05 -136.16 0.28 Allowed 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 171.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' A' ' 343' ' ' SER 0.307 19.3 m-20 -61.15 111.86 1.88 Allowed 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -154.363 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.2 tp -101.94 118.36 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 124.023 1.868 . . . . 0.0 108.886 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -117.62 103.29 9.9 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.84 -11.11 59.78 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.614 1.966 . . . . 0.0 115.42 -168.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.04 -33.55 15.47 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 128.201 2.601 . . . . 0.0 111.183 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -100.8 -29.48 12.23 Favored 'General case' 0 C--N 1.368 1.406 0 C-N-CA 125.052 1.341 . . . . 0.0 113.156 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.297 65.2 mtp85 72.96 51.96 0.14 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 128.858 2.863 . . . . 0.0 112.618 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.62 132.79 53.41 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 110.79 -2.914 . . . . 0.0 106.631 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . 0.258 2.1 mt -114.09 129.7 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 334' ' ' ASP . 4.2 t -102.52 94.23 5.55 Favored 'General case' 0 C--N 1.384 2.096 0 C-N-CA 111.854 -3.938 . . . . 0.0 105.801 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.463 HD12 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -97.23 136.29 37.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 119.495 -2.003 . . . . 0.0 107.637 -169.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.495 ' CA ' HG23 ' A' ' 304' ' ' VAL . . . -152.67 123.42 1.45 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.498 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 330' ' ' VAL 0.59 0.2 OUTLIER -140.46 -93.0 0.16 Allowed 'General case' 0 C--N 1.363 1.186 0 C-N-CA 129.691 3.196 . . . . 0.0 109.137 172.383 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 347' ' ' LYS . . . . . 0.758 ' HG3' HG21 ' A' ' 304' ' ' VAL 0.356 35.6 mtmm 111.84 18.09 0.0 OUTLIER 'General case' 0 C--N 1.378 1.815 0 C-N-CA 126.781 2.033 . . . . 0.0 113.265 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.58 82.27 2.27 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 120.285 -1.509 . . . . 0.0 112.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 27.6 p -31.57 157.3 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 2 C-N-CA 135.519 5.527 . . . . 0.0 121.902 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -75.23 166.85 22.99 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 129.588 3.155 . . . . 0.0 114.551 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.76 88.22 3.98 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.708 1.603 . . . . 0.0 108.071 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 87.24 70.83 0.05 OUTLIER Pre-proline 0 C--N 1.357 0.927 0 C-N-CA 130.14 3.376 . . . . 0.0 108.777 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 C--N 1.37 1.672 1 C-N-CA 126.391 4.728 . . . . 0.0 117.662 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.25 -48.28 10.23 Favored 'Trans proline' 0 CA--C 1.546 1.101 1 C-N-CA 125.506 4.137 . . . . 0.0 113.617 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 81.38 126.81 0.04 OUTLIER 'General case' 0 C--N 1.373 1.615 0 C-N-CA 128.884 2.874 . . . . 0.0 113.187 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.97 11.13 56.89 Favored Glycine 0 C--N 1.381 3.058 0 CA-C-O 124.979 2.433 . . . . 0.0 112.41 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 20.6 p -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.45 -0.442 1 C-N-CA 133.252 4.621 . . . . 0.0 102.887 172.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -105.09 153.95 20.81 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 123.0 1.381 . . . . 0.0 113.509 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . 0.335 0.0 OUTLIER -136.1 173.88 11.23 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-O 123.485 1.612 . . . . 0.0 109.229 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.7 m -106.51 138.65 42.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -143.54 176.89 22.69 Favored Glycine 0 CA--C 1.483 -1.953 0 CA-C-O 123.387 1.549 . . . . 0.0 111.629 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -128.31 132.09 48.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 294' ' ' VAL . 3.1 t -82.69 127.48 39.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.41 1.484 . . . . 0.0 114.147 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -107.94 -53.11 2.67 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.357 1.863 . . . . 0.0 112.853 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.27 174.83 9.97 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 120.695 -1.253 . . . . 0.0 111.071 -170.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 150.75 39.84 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 166.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 177.88 4.48 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.64 -24.18 62.67 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.902 2.081 . . . . 0.0 113.606 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -151.56 45.35 0.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 124.579 2.133 . . . . 0.0 109.046 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.46 -164.91 33.28 Favored Glycine 0 CA--C 1.47 -2.765 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 15.3 p -143.5 151.13 39.91 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 123.783 0.833 . . . . 0.0 109.356 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.59 124.44 44.8 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.769 -0.582 . . . . 0.0 109.645 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 284' ' ' VAL . 3.0 t -109.59 131.69 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.516 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.02 122.18 42.5 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.215 -1.553 . . . . 0.0 113.68 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.17 56.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 111.379 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 77.8 170.0 0.22 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.608 2.363 . . . . 0.0 109.92 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.88 119.46 12.6 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 119.594 -1.941 . . . . 0.0 115.192 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.11 -31.84 5.69 Favored Glycine 0 C--N 1.367 2.294 0 C-N-CA 127.1 2.286 . . . . 0.0 115.069 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.27 128.27 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.89 1.676 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -141.83 158.66 43.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 118.675 -2.515 . . . . 0.0 106.868 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -130.69 173.1 20.27 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 123.849 1.805 . . . . 0.0 113.743 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.52 121.41 37.42 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 126.468 1.907 . . . . 0.0 107.514 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.649 HG13 ' H ' ' A' ' 346' ' ' LEU . 95.8 t -86.39 113.18 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.494 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -72.12 115.78 11.75 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.368 1.376 0 N-CA-C 120.383 3.475 . . . . 0.0 120.383 -174.722 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 123.246 1.498 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -104.72 165.98 10.7 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 126.684 1.993 . . . . 0.0 110.773 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.1 121.23 30.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 C-N-CA 126.866 2.066 . . . . 0.0 107.661 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.53 16.06 53.5 Favored Glycine 0 C--N 1.357 1.725 0 C-N-CA 125.426 1.489 . . . . 0.0 113.957 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -90.51 164.05 14.39 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.042 2.137 . . . . 0.0 111.187 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.44 125.07 72.19 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 51.6 t -134.42 165.49 31.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 C-N-CA 127.11 2.164 . . . . 0.0 106.653 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -114.92 135.58 54.05 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 100.931 -3.729 . . . . 0.0 100.931 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 2.8 m -129.81 163.28 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.362 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -169.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 33.1 ttm -127.9 138.03 52.52 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.07 132.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.01 -134.54 0.28 Allowed 'General case' 0 N--CA 1.408 -2.554 1 N-CA-C 98.951 -4.462 . . . . 0.0 98.951 174.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.98 111.81 6.65 Favored 'General case' 0 C--N 1.313 -1.018 1 N-CA-C 122.028 4.084 . . . . 0.0 122.028 -155.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.365 0.1 OUTLIER -96.83 112.52 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 126.615 1.966 . . . . 0.0 107.336 177.352 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.41 102.36 15.09 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 128.845 2.858 . . . . 0.0 105.092 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.19 -3.12 41.02 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -166.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.88 -43.15 14.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 130.001 3.32 . . . . 0.0 110.902 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -99.52 -38.05 8.93 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.167 2.187 . . . . 0.0 113.348 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.389 47.2 mtm105 75.22 51.73 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 1 C-N-CA 134.857 5.263 . . . . 0.0 114.215 179.802 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.5 OUTLIER -116.23 125.54 52.37 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 126.229 1.812 . . . . 0.0 107.348 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.8 mm -91.62 131.12 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 1 C-N-CA 132.876 4.471 . . . . 0.0 108.964 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.1 t -102.87 92.57 4.64 Favored 'General case' 0 C--N 1.385 2.144 1 C-N-CA 110.602 -4.439 . . . . 0.0 106.048 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.437 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -102.86 136.98 41.68 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 119.415 -2.053 . . . . 0.0 109.305 -174.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -130.81 138.51 10.23 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.649 ' H ' HG13 ' A' ' 304' ' ' VAL 0.492 0.1 OUTLIER -54.19 162.26 1.08 Allowed 'General case' 0 C--N 1.369 1.44 1 N-CA-C 127.146 5.98 . . . . 0.0 127.146 -161.32 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -125.4 -48.63 1.69 Allowed 'General case' 0 C--N 1.382 1.996 0 O-C-N 121.732 -0.605 . . . . 0.0 111.989 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.25 48.3 tp60 -124.51 -86.3 0.63 Allowed 'General case' 0 C--N 1.37 1.473 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.307 20.8 p 111.89 146.32 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 1 C-N-CA 131.965 4.106 . . . . 0.0 106.321 -172.438 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -94.89 130.24 41.58 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.279 -1.513 . . . . 0.0 111.143 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.08 75.45 4.08 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.094 2.158 . . . . 0.0 111.216 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ASN . . . . . 0.455 ' H ' ' HD3' ' A' ' 353' ' ' PRO . 1.1 t30 125.29 66.94 0.0 OUTLIER Pre-proline 0 C--N 1.344 0.366 1 C-N-CA 133.955 4.902 . . . . 0.0 102.748 -175.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 353' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 352' ' ' ASN . 83.9 Cg_endo . . . . . 0 C--N 1.359 1.083 0 C-N-CA 124.194 3.263 . . . . 0.0 113.119 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.25 -40.87 1.45 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 124.23 3.287 . . . . 0.0 112.236 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 332' ' ' VAL 0.263 44.4 mt-10 79.84 111.0 0.07 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.984 2.514 . . . . 0.0 113.001 178.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 8.69 38.12 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 123.894 1.83 . . . . 0.0 113.436 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' THR . . . . . 0.535 ' O ' HG12 ' A' ' 332' ' ' VAL . 68.5 p -98.56 139.21 34.63 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 93.8 mttt -97.98 146.1 25.83 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.059 -2.275 . . . . 0.0 111.577 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.44 143.03 39.5 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.579 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.8 m -82.35 142.65 31.84 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.842 -1.162 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.47 173.57 33.62 Favored Glycine 0 CA--C 1.486 -1.721 0 CA-C-O 123.174 1.43 . . . . 0.0 112.719 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 60.2 mtm-85 -117.8 131.08 56.62 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 125.925 1.69 . . . . 0.0 108.655 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 17.6 t -77.38 133.24 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.281 10.1 t -122.62 -39.85 2.51 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -133.82 165.98 23.71 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 3.8 mp -121.16 153.17 37.88 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 122.131 2.241 . . . . 0.0 116.871 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 178.41 4.29 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -29.33 66.31 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.255 18.1 m-85 -156.8 52.72 0.51 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.96 3.704 . . . . 0.0 103.481 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.11 37.22 Favored Glycine 0 N--CA 1.432 -1.62 1 N-CA-C 100.469 -5.053 . . . . 0.0 100.469 172.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' CYS . . . . . 0.506 ' H ' HG13 ' A' ' 304' ' ' VAL . 31.5 p -165.32 172.09 12.74 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.653 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -103.14 120.2 40.27 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 330' ' ' VAL . 49.1 t -108.88 135.89 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -100.19 121.03 40.8 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.603 -1.936 . . . . 0.0 111.254 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.28 40.1 mm -66.65 -87.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -140.04 166.63 24.13 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 131.402 3.881 . . . . 0.0 101.329 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.16 120.28 7.28 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.4 -15.72 59.79 Favored Glycine 0 C--N 1.367 2.302 0 C-N-CA 127.18 2.324 . . . . 0.0 115.441 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.496 HG13 HG13 ' A' ' 342' ' ' ILE . 92.9 t -116.73 121.41 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.538 1.935 . . . . 0.0 111.246 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.87 151.24 50.66 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -119.8 173.48 15.18 Favored Glycine 0 CA--C 1.493 -1.284 0 CA-C-O 124.954 2.419 . . . . 0.0 115.303 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.8 tp -125.7 121.59 33.89 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.506 HG13 ' H ' ' A' ' 292' ' ' CYS 0.311 1.5 p -87.15 121.1 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-O 122.422 1.106 . . . . 0.0 109.838 171.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -86.51 108.9 18.75 Favored 'General case' 0 N--CA 1.397 -3.118 0 C-N-CA 128.48 2.712 . . . . 0.0 109.087 155.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.379 1.883 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 164.659 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.494 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 122.496 1.141 . . . . 0.0 112.854 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.75 145.56 24.5 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.134 1.445 . . . . 0.0 109.792 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.51 121.0 30.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.02 23.27 55.83 Favored Glycine 0 C--N 1.357 1.703 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.67 31.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 118.749 1.275 . . . . 0.0 108.166 171.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.252 2.0 p -96.29 129.36 46.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 CA-C-O 123.416 1.579 . . . . 0.0 108.554 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -130.48 -179.57 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 1 C-N-CA 132.312 4.245 . . . . 0.0 110.834 -173.396 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -124.27 142.29 51.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 294' ' ' VAL . 2.9 m -146.71 139.37 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 46.5 ttp -96.32 131.38 42.9 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 118.525 -2.61 . . . . 0.0 111.109 -173.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 276' ' ' GLU . 7.9 p -74.11 124.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.51 -130.32 0.25 Allowed 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.338 7.4 t70 -57.8 112.46 1.48 Allowed 'General case' 0 N--CA 1.475 0.811 1 N-CA-C 122.586 4.291 . . . . 0.0 122.586 -158.36 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . 0.266 3.4 tp -107.81 114.41 46.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 339' ' ' ARG . 96.1 m-20 -124.7 119.74 29.83 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.518 1.927 . . . . 0.0 107.849 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -88.14 -5.36 58.47 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 125.461 1.504 . . . . 0.0 114.635 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.64 -35.3 14.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.296 2.238 . . . . 0.0 110.285 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.477 ' HB2' ' CB ' ' A' ' 336' ' ' ASP . 0.0 OUTLIER -89.88 -46.93 8.21 Favored 'General case' 0 CA--C 1.508 -0.647 1 C-N-CA 132.08 4.152 . . . . 0.0 112.379 -177.512 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.322 64.5 mtm-85 75.07 52.53 0.08 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 131.135 3.774 . . . . 0.0 112.532 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 133.14 52.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 111.451 -2.613 . . . . 0.0 107.943 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.496 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -110.73 129.5 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.828 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 170.484 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.92 4.8 Favored 'General case' 0 CA--C 1.474 -1.981 1 C-N-CA 111.082 -4.247 . . . . 0.0 107.715 -164.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 332' ' ' VAL . 2.6 mp -97.96 135.57 39.48 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.748 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.18 122.76 1.63 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.815 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.497 ' H ' HG12 ' A' ' 330' ' ' VAL 0.663 0.7 OUTLIER -144.55 -99.04 0.1 Allowed 'General case' 0 C--N 1.37 1.46 0 C-N-CA 128.979 2.911 . . . . 0.0 113.105 178.512 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.454 48.2 mtmt 85.01 68.3 0.01 OUTLIER 'General case' 0 C--N 1.374 1.651 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -118.11 -10.86 10.24 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 120.632 -1.292 . . . . 0.0 111.547 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 328' ' ' VAL 0.277 37.2 m 78.81 170.34 0.19 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 130.293 3.437 . . . . 0.0 116.19 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -91.39 170.9 9.59 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 127.774 2.43 . . . . 0.0 111.989 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.66 78.74 3.33 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.817 2.047 . . . . 0.0 109.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 14.3 t30 101.2 74.18 0.0 OUTLIER Pre-proline 0 C--N 1.361 1.105 0 C-N-CA 131.203 3.801 . . . . 0.0 108.541 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.363 1.327 1 C-N-CA 125.648 4.232 . . . . 0.0 119.392 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -86.14 96.85 0.55 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.968 3.112 . . . . 0.0 108.107 160.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -68.92 138.7 54.85 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 128.867 2.867 . . . . 0.0 114.813 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.76 14.96 47.88 Favored Glycine 0 C--N 1.387 3.401 0 CA-C-O 124.514 2.174 . . . . 0.0 112.799 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 6.0 p -92.78 146.05 23.94 Favored 'General case' 0 CA--C 1.509 -0.602 1 C-N-CA 133.16 4.584 . . . . 0.0 100.799 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.6 OUTLIER -108.03 153.37 23.21 Favored 'General case' 0 CA--C 1.49 -1.348 0 O-C-N 119.847 -1.783 . . . . 0.0 110.411 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.461 HD23 ' CG1' ' A' ' 332' ' ' VAL . 1.6 mm? -125.64 174.34 8.35 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 112.073 -2.33 . . . . 0.0 107.476 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 88.9 m -118.29 137.98 52.69 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -157.16 170.0 34.32 Favored Glycine 0 CA--C 1.478 -2.259 0 CA-C-O 123.241 1.467 . . . . 0.0 110.384 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 327' ' ' VAL . 44.3 ttm-85 -117.15 135.14 53.99 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 124.787 1.235 . . . . 0.0 108.465 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 322' ' ' VAL . 39.4 t -87.92 132.29 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 120.265 -1.522 . . . . 0.0 113.63 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -128.32 -33.43 2.14 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -171.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -133.74 173.06 11.94 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 122.004 2.184 . . . . 0.0 107.332 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.54 150.83 40.25 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 118.908 -2.37 . . . . 0.0 112.761 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.62 178.14 4.4 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -29.02 68.53 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.346 2.258 . . . . 0.0 115.195 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.262 1.7 p90 -149.84 43.1 0.89 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 124.194 1.949 . . . . 0.0 109.634 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.09 -170.81 40.75 Favored Glycine 0 CA--C 1.468 -2.872 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 165.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 2.8 m -134.71 147.1 50.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.31 126.46 36.4 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.231 -1.543 . . . . 0.0 108.982 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.34 138.28 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 125.939 1.696 . . . . 0.0 106.546 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -100.12 124.05 45.07 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.573 -1.33 . . . . 0.0 108.028 168.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 344' ' ' LEU . 0.8 OUTLIER -64.67 -67.87 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 124.905 2.288 . . . . 0.0 116.1 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.38 161.41 35.06 Favored 'General case' 0 CA--C 1.485 -1.551 2 N-CA-C 98.716 -4.55 . . . . 0.0 98.716 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.81 119.5 10.1 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 104.34 -11.58 51.21 Favored Glycine 0 C--N 1.364 2.107 0 C-N-CA 125.526 1.536 . . . . 0.0 116.379 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.63 144.3 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.62 1.968 . . . . 0.0 106.942 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.01 155.11 48.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.182 -1.574 . . . . 0.0 112.082 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -120.9 174.88 15.93 Favored Glycine 0 C--N 1.36 1.886 0 C-N-CA 130.439 3.876 . . . . 0.0 117.526 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 42.6 tp -127.28 116.08 20.01 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 111.965 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 345' ' ' GLY 0.296 6.4 p -92.25 104.38 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 O-C-N 120.495 -1.378 . . . . 0.0 108.268 175.027 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -70.44 129.05 38.24 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 124.749 1.22 . . . . 0.0 113.011 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.157 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 322' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 284' ' ' VAL . 39.7 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -120.43 155.64 33.07 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.8 121.58 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.531 1.532 . . . . 0.0 109.974 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 87.95 23.56 38.0 Favored Glycine 0 C--N 1.362 1.998 0 C-N-CA 125.999 1.761 . . . . 0.0 114.056 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.96 146.04 48.75 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.922 -1.34 . . . . 0.0 110.753 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 283' ' ' ARG 0.306 2.7 p -92.59 138.72 19.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 125.434 1.494 . . . . 0.0 112.18 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 330' ' ' VAL . 4.9 m -140.94 179.39 2.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 C-N-CA 129.195 2.998 . . . . 0.0 108.828 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -110.89 140.39 45.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 346' ' ' LEU . 3.4 m -144.93 139.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 58.8 ttp -104.71 138.59 40.78 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-N 121.12 1.782 . . . . 0.0 108.337 -173.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.685 HG12 HD12 ' A' ' 344' ' ' LEU . 1.9 m -77.08 128.38 37.94 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 -165.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.64 -131.77 0.27 Allowed 'General case' 0 N--CA 1.421 -1.913 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.386 11.6 m-20 -54.64 113.07 1.16 Allowed 'General case' 0 N--CA 1.478 0.953 1 N-CA-C 124.452 4.982 . . . . 0.0 124.452 -156.748 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.68 129.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -145.07 118.5 9.04 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 170.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -16.0 52.43 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 125.179 1.392 . . . . 0.0 113.845 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.35 -35.45 19.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 130.013 3.325 . . . . 0.0 111.374 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -94.87 -26.74 16.05 Favored 'General case' 0 C--N 1.367 1.359 0 C-N-CA 125.103 1.361 . . . . 0.0 111.389 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.304 47.0 mtm180 73.37 48.1 0.17 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 131.115 3.766 . . . . 0.0 113.761 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 129.16 48.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 110.278 -3.146 . . . . 0.0 108.091 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.92 123.3 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.433 1 N-CA-C 95.976 -5.565 . . . . 0.0 95.976 174.28 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.05 94.51 5.21 Favored 'General case' 0 CA--C 1.468 -2.21 1 C-N-CA 110.975 -4.29 . . . . 0.0 106.503 -166.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.685 HD12 HG12 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -97.98 139.02 34.43 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 121.165 1.802 . . . . 0.0 107.68 -175.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 304' ' ' VAL . . . -145.35 122.41 1.7 Allowed Glycine 0 CA--C 1.471 -2.703 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.815 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.535 ' H ' HG12 ' A' ' 330' ' ' VAL 0.759 0.2 OUTLIER -141.57 -107.07 0.14 Allowed 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 127.499 2.32 . . . . 0.0 112.531 171.019 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.355 13.3 pttp 121.95 29.5 0.0 OUTLIER 'General case' 0 C--N 1.382 2.003 0 C-N-CA 129.954 3.302 . . . . 0.0 115.587 -173.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -86.59 16.84 4.29 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 118.438 -2.664 . . . . 0.0 117.181 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.279 11.9 p 62.51 147.87 0.02 OUTLIER 'General case' 0 C--N 1.366 1.314 0 N-CA-C 120.804 3.631 . . . . 0.0 120.804 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -103.28 169.3 8.63 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 125.645 1.578 . . . . 0.0 110.518 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.3 81.36 3.61 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.039 -2.288 . . . . 0.0 111.742 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 94.49 75.2 0.03 OUTLIER Pre-proline 0 C--N 1.354 0.795 1 C-N-CA 132.812 4.445 . . . . 0.0 106.161 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 C--N 1.366 1.494 1 C-N-CA 125.574 4.183 . . . . 0.0 117.277 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.84 -34.88 1.13 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.519 3.48 . . . . 0.0 112.181 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 73.68 124.72 0.04 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 128.657 2.783 . . . . 0.0 114.23 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.08 11.1 43.79 Favored Glycine 0 C--N 1.372 2.545 0 CA-C-O 124.373 2.096 . . . . 0.0 113.114 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 22.6 p -101.43 136.46 41.23 Favored 'General case' 0 CA--C 1.508 -0.663 1 C-N-CA 131.992 4.117 . . . . 0.0 101.354 171.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -109.37 157.13 19.2 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-O 123.852 1.786 . . . . 0.0 113.039 -176.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -133.93 173.75 11.22 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.126 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.6 m -108.57 144.73 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.59 176.94 30.59 Favored Glycine 0 CA--C 1.486 -1.747 0 CA-C-O 123.822 1.79 . . . . 0.0 111.348 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -130.94 130.43 43.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.867 1.267 . . . . 0.0 108.477 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 294' ' ' VAL . 27.7 t -74.95 131.76 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -114.73 -34.87 5.02 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 112.135 -2.302 . . . . 0.0 112.026 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 293' ' ' PHE . 1.3 t-20 -135.13 155.8 50.08 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.63 136.51 54.94 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 164.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.45 176.84 4.85 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -30.11 71.28 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 118.769 -2.457 . . . . 0.0 116.544 -177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -145.7 40.94 1.2 Allowed 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 125.758 1.623 . . . . 0.0 110.524 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 178.55 -162.19 29.27 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 105.363 -3.095 . . . . 0.0 105.363 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 28.2 p -143.31 165.16 28.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 286' ' ' ASN . 9.7 m-85 -115.28 126.59 54.67 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 284' ' ' VAL . 93.2 t -118.9 132.2 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -167.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.93 127.36 41.88 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.255 -1.528 . . . . 0.0 112.734 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.288 26.7 mm -73.98 -86.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 123.822 1.772 . . . . 0.0 113.941 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.26 171.35 14.57 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 130.037 3.335 . . . . 0.0 103.514 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.09 119.77 10.15 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.44 -17.2 58.08 Favored Glycine 0 C--N 1.37 2.436 0 C-N-CA 127.222 2.344 . . . . 0.0 115.524 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.21 113.31 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.549 1.939 . . . . 0.0 110.527 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -135.5 157.82 45.92 Favored 'General case' 0 CA--C 1.481 -1.71 0 O-C-N 118.307 -2.746 . . . . 0.0 108.215 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -124.6 172.53 16.89 Favored Glycine 0 CA--C 1.482 -1.973 0 CA-C-O 127.1 3.611 . . . . 0.0 114.424 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.59 161.11 16.56 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 110.307 -2.947 . . . . 0.0 103.269 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.54 HG13 ' H ' ' A' ' 346' ' ' LEU . 16.2 t -116.13 130.33 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 O-C-N 124.479 1.112 . . . . 0.0 108.76 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -91.8 114.76 27.38 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 166.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.373 1.595 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 -177.283 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.504 -0.821 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.71 158.08 16.37 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 123.641 1.686 . . . . 0.0 107.576 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.38 120.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 C-N-CA 125.199 1.4 . . . . 0.0 109.565 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.49 18.03 53.44 Favored Glycine 0 C--N 1.364 2.098 0 C-N-CA 124.658 1.123 . . . . 0.0 114.235 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.5 144.03 32.83 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 125.501 1.521 . . . . 0.0 109.659 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.85 139.86 16.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 124.006 1.86 . . . . 0.0 111.345 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 346' ' ' LEU . 0.4 OUTLIER -144.59 174.72 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 130.111 3.364 . . . . 0.0 107.32 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.91 144.07 46.64 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 344' ' ' LEU . 0.1 OUTLIER -146.09 139.82 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -175.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 331' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 52.7 ttp -104.0 136.88 42.83 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 119.916 -1.74 . . . . 0.0 109.299 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . 0.267 0.2 OUTLIER -83.83 135.41 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -169.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.46 -126.86 0.26 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ASP . . . . . 0.53 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.437 12.2 m-20 -59.49 113.55 2.26 Favored 'General case' 0 N--CA 1.483 1.181 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -160.014 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 4.9 tp -112.89 120.82 63.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 -165.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 12.3 t0 -140.44 118.57 11.96 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.23 -1.73 57.62 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 126.576 1.95 . . . . 0.0 113.858 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.2 -40.12 9.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 129.245 3.018 . . . . 0.0 109.73 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 336' ' ' ASP . 8.1 mmt180 -88.22 -32.74 18.41 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 131.275 3.83 . . . . 0.0 112.765 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.329 1.3 mmp_? 75.27 50.9 0.08 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 129.426 3.09 . . . . 0.0 114.89 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -125.25 132.22 52.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 110.848 -2.887 . . . . 0.0 108.945 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.99 126.84 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 1 N-CA-C 94.177 -6.231 . . . . 0.0 94.177 171.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 39.6 m -111.0 102.45 10.93 Favored 'General case' 0 CA--C 1.446 -3.053 1 C-N-CA 111.291 -4.164 . . . . 0.0 107.063 -165.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -95.76 173.58 7.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 125.06 2.362 . . . . 0.0 110.913 -165.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.36 136.32 6.23 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.841 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LEU . . . . . 0.54 ' H ' HG13 ' A' ' 304' ' ' VAL . 1.0 OUTLIER -61.8 149.17 40.85 Favored 'General case' 0 C--N 1.369 1.435 1 N-CA-C 123.584 4.661 . . . . 0.0 123.584 -164.976 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -94.92 -98.33 0.16 Allowed 'General case' 0 C--N 1.39 2.363 0 O-C-N 120.916 -1.115 . . . . 0.0 112.8 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -141.24 -1.18 1.37 Allowed 'General case' 0 C--N 1.373 1.601 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.316 3.6 m 79.81 163.36 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.257 1.823 . . . . 0.0 115.445 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' A' ' 353' ' ' PRO . 0.0 OUTLIER -56.69 -145.24 0.0 OUTLIER 'General case' 0 C--N 1.354 0.766 1 C-N-CA 134.535 5.134 . . . . 0.0 118.88 174.114 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 164.9 89.04 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 129.935 3.294 . . . . 0.0 102.969 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 93.11 74.47 0.03 OUTLIER Pre-proline 0 C--N 1.358 0.963 0 C-N-CA 130.087 3.355 . . . . 0.0 105.795 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' PRO . . . . . 0.415 ' HB3' ' HG3' ' A' ' 350' ' ' LYS . 57.9 Cg_endo . . . . . 0 CA--C 1.564 2.019 0 C-N-CA 124.509 3.473 . . . . 0.0 112.29 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.5 m95 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.8 t -106.82 129.64 60.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 124.96 1.304 . . . . 0.0 107.947 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.3 61.36 4.07 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 126.319 1.848 . . . . 0.0 113.554 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . 0.512 10.6 pt 65.07 -34.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 1 C-N-CA 132.056 4.143 . . . . 0.0 119.491 -179.57 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -164.77 93.97 0.66 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.892 2.477 . . . . 0.0 107.498 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -144.95 142.91 30.24 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.746 -1.221 . . . . 0.0 109.938 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.648 ' HE ' HD11 ' A' ' 335' ' ' ILE . 10.8 mtt180 -115.65 -54.77 2.49 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.626 -175.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -89.12 152.92 48.71 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 130.113 3.365 . . . . 0.0 108.942 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.9 -31.28 84.74 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.367 3.378 . . . . 0.0 115.999 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 93.27 119.21 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.665 3.586 . . . . 0.0 109.316 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.13 54.47 Favored Glycine 0 C--N 1.372 2.575 0 CA-C-O 124.74 2.3 . . . . 0.0 112.581 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.84 134.61 44.75 Favored 'General case' 0 CA--C 1.507 -0.684 1 C-N-CA 133.235 4.614 . . . . 0.0 102.479 172.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 12.5 ptmt -103.1 152.56 21.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 10.9 mt -126.05 174.05 8.74 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 124.406 2.051 . . . . 0.0 107.64 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.94 137.15 53.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 168.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -146.98 175.06 26.56 Favored Glycine 0 CA--C 1.482 -1.995 0 CA-C-O 123.783 1.769 . . . . 0.0 111.04 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -117.99 134.82 54.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.455 HG21 HG13 ' A' ' 322' ' ' VAL . 70.0 t -78.87 133.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.302 1.4 t -121.23 -44.19 2.39 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.337 0.3 OUTLIER -136.29 174.83 10.19 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.69 -1.881 . . . . 0.0 111.068 175.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 1.1 mp -121.08 142.01 50.24 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 290' ' ' TYR 0.332 1.1 t -112.49 179.16 4.06 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.564 1.173 . . . . 0.0 110.815 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.44 -28.88 60.77 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 130.129 3.372 . . . . 0.0 115.409 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.413 ' H ' HG23 ' A' ' 288' ' ' THR 0.251 19.2 p90 -156.92 46.76 0.42 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 123.921 1.819 . . . . 0.0 110.025 175.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 174.76 -163.48 33.88 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 0.7 OUTLIER -135.23 151.44 50.6 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.582 1.553 . . . . 0.0 107.535 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.284 57.2 m-85 -105.65 136.18 45.71 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 284' ' ' VAL . 3.7 t -119.94 134.83 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.942 0 CA-C-N 112.316 -2.22 . . . . 0.0 106.285 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -100.12 128.55 46.18 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.856 -1.153 . . . . 0.0 113.302 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.326 29.5 mm -81.53 -103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 123.046 1.403 . . . . 0.0 113.89 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -107.82 169.67 8.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 129.313 3.045 . . . . 0.0 106.813 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.73 119.5 9.42 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 120.114 -1.616 . . . . 0.0 114.591 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 89.26 -5.98 83.78 Favored Glycine 0 C--N 1.369 2.368 0 C-N-CA 127.065 2.269 . . . . 0.0 115.638 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.67 113.49 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.34 2.256 . . . . 0.0 110.802 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.1 157.62 46.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 118.388 -2.695 . . . . 0.0 106.801 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.539 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -126.47 174.0 18.03 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 124.307 2.06 . . . . 0.0 115.901 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 7.9 tp -124.51 125.0 43.49 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.769 1.627 . . . . 0.0 107.888 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.2 110.85 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 C-N-CA 125.997 1.719 . . . . 0.0 107.74 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -79.04 115.14 18.53 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -36.49 -37.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.599 0 C-N-CA 130.861 3.664 . . . . 0.0 119.111 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.4 t -87.68 -5.19 58.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.397 1.479 . . . . 0.0 114.883 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.62 54.84 0.63 Allowed 'General case' 0 C--N 1.373 1.595 0 C-N-CA 126.395 1.878 . . . . 0.0 114.372 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 42.0 ttm -176.18 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.812 -1.18 . . . . 0.0 109.056 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 28.7 t70 90.81 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.624 0 C-N-CA 128.346 2.658 . . . . 0.0 109.497 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -67.3 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.207 3.403 . . . . 0.0 116.395 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.8 m -149.42 133.29 17.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.496 2.318 . . . . 0.0 105.248 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.26 50.3 m-80 116.05 -57.02 0.0 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 131.434 3.894 . . . . 0.0 106.486 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -95.22 16.69 15.92 Favored 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.432 1.893 . . . . 0.0 111.469 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -92.79 -5.76 50.43 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 127.909 2.484 . . . . 0.0 112.919 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 5.6 mt 72.99 -45.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.324 0 C-N-CA 131.32 3.848 . . . . 0.0 113.164 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 319' ' ' SER . 50.9 m-70 -56.1 137.7 73.54 Favored Pre-proline 0 C--N 1.356 0.864 1 C-N-CA 131.939 4.095 . . . . 0.0 118.625 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.5 38.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.61 1 C-N-CA 127.11 5.207 . . . . 0.0 114.32 166.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 317' ' ' HIS 0.42 3.0 t 87.43 24.84 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 130.185 3.394 . . . . 0.0 114.336 177.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.489 0.0 OUTLIER 72.23 22.84 3.46 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 133.388 4.675 . . . . 0.0 110.23 -170.169 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.428 3.7 t 82.28 64.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.61 1 C-N-CA 132.045 4.138 . . . . 0.0 109.715 177.319 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 284' ' ' VAL . 9.8 t -94.64 100.39 11.03 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -114.0 162.88 15.87 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 128.357 2.663 . . . . 0.0 105.678 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.05 120.47 12.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 126.145 1.778 . . . . 0.0 109.493 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.32 13.74 58.21 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 126.081 1.801 . . . . 0.0 116.532 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.84 149.22 21.42 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 126.04 1.736 . . . . 0.0 111.308 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.5 p -100.03 134.21 40.33 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-O 123.415 1.579 . . . . 0.0 110.502 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -134.75 -178.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 1 C-N-CA 134.3 5.04 . . . . 0.0 110.594 -173.171 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -127.34 147.02 50.26 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 129.014 2.925 . . . . 0.0 103.813 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.404 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 1.6 m -146.46 163.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 57.0 ttp -126.53 136.05 52.08 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.54 132.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -136.65 0.3 Allowed 'General case' 0 N--CA 1.417 -2.097 1 N-CA-C 97.92 -4.845 . . . . 0.0 97.92 172.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.32 2.6 t70 -63.2 112.41 2.66 Favored 'General case' 0 C--N 1.316 -0.88 1 N-CA-C 123.205 4.52 . . . . 0.0 123.205 -156.767 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.648 HD11 ' HE ' ' A' ' 273' ' ' ARG 0.334 0.0 OUTLIER -101.71 136.77 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 126.065 1.746 . . . . 0.0 111.36 -177.406 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -139.83 102.86 4.52 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 167.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLU . . . . . 0.454 ' HG2' HD11 ' A' ' 335' ' ' ILE . 24.8 mt-10 -63.14 -18.3 63.3 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 129.124 2.97 . . . . 0.0 113.805 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.33 -32.71 58.85 Favored 'General case' 0 N--CA 1.433 -1.288 1 C-N-CA 133.042 4.537 . . . . 0.0 112.621 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -108.94 -31.64 7.58 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-O 123.188 1.47 . . . . 0.0 112.477 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.342 68.9 mtp180 74.91 50.46 0.09 Allowed 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 130.932 3.693 . . . . 0.0 113.112 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -124.83 125.53 44.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 111.683 -2.508 . . . . 0.0 104.763 178.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.88 130.01 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.216 1 N-CA-C 98.694 -4.558 . . . . 0.0 98.694 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 5.1 t -102.26 92.47 4.74 Favored 'General case' 0 C--N 1.377 1.804 1 C-N-CA 110.298 -4.561 . . . . 0.0 104.336 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -103.78 136.34 43.65 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 117.244 -1.783 . . . . 0.0 111.306 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.66 123.06 1.65 Allowed Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.357 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.404 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.664 1.5 tt -138.89 -90.07 0.21 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 131.176 3.79 . . . . 0.0 108.589 174.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.342 19.4 tttt 101.35 23.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 167.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.43 -47.67 63.36 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.524 ' HA ' HG13 ' A' ' 328' ' ' VAL 0.473 11.8 p 95.28 164.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.374 1 C-N-CA 133.75 4.82 . . . . 0.0 113.916 -177.857 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -92.83 164.15 13.45 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.855 2.062 . . . . 0.0 111.582 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.5 99.31 11.49 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 119.235 -2.165 . . . . 0.0 107.849 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 61.2 t30 91.45 64.44 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.831 0 C-N-CA 131.027 3.731 . . . . 0.0 105.968 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.69 -16.41 13.08 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.063 2.509 . . . . 0.0 113.728 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -110.72 136.52 49.67 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 128.551 2.74 . . . . 0.0 108.103 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -141.11 176.65 8.65 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.447 1.899 . . . . 0.0 107.008 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -79.25 68.34 5.21 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -64.13 71.8 0.03 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.042 2.937 . . . . 0.0 117.161 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -133.41 143.74 49.09 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.28 115.76 4.77 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.74 0.781 . . . . 0.0 108.911 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 45.5 m 169.51 62.72 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.613 1 N-CA-C 98.935 -4.469 . . . . 0.0 98.935 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 . . . . . 0 C--O 1.26 1.634 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.008 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 86.2 m95 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.78 151.17 31.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 125.705 1.602 . . . . 0.0 108.32 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -107.81 -68.93 0.87 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.337 1.855 . . . . 0.0 108.984 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.3 tt -153.04 145.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 127.262 2.225 . . . . 0.0 106.547 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.255 . . 89.16 -108.25 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 128.96 2.904 . . . . 0.0 111.203 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . 0.312 8.0 ptpt -147.33 -78.64 0.16 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.203 1.477 . . . . 0.0 108.006 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -113.1 -61.22 1.77 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 127.017 2.127 . . . . 0.0 111.759 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 275' ' ' PRO . 94.5 m-85 -113.17 149.32 41.23 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.936 2.095 . . . . 0.0 108.318 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 274' ' ' TYR . 40.4 Cg_exo -67.58 177.06 4.32 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.95 3.767 . . . . 0.0 116.011 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.49 135.6 21.41 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.12 5.11 44.11 Favored Glycine 0 C--N 1.369 2.386 0 CA-C-O 123.856 1.809 . . . . 0.0 112.546 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 70.5 p -95.93 121.87 38.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 130.923 3.689 . . . . 0.0 103.775 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -90.03 146.96 23.96 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.72 1.248 . . . . 0.0 113.362 -176.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 332' ' ' VAL . 2.6 mm? -129.21 174.2 9.8 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-N 112.786 -2.006 . . . . 0.0 106.655 -170.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.29 143.78 51.17 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.64 173.73 38.06 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -119.04 138.36 52.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 322' ' ' VAL . 21.8 t -83.47 132.98 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.158 -1.589 . . . . 0.0 115.153 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.267 2.3 t -136.13 -25.57 1.2 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -133.4 174.37 10.48 Favored 'General case' 0 C--N 1.372 1.551 0 CA-C-N 123.484 2.856 . . . . 0.0 108.053 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.9 OUTLIER -121.01 151.41 39.79 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 167.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 178.18 4.38 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -65.59 -29.35 69.93 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.835 2.054 . . . . 0.0 115.663 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.11 44.44 0.72 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 125.126 2.394 . . . . 0.0 107.915 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 306' ' ' VAL . . . -173.27 -165.21 29.82 Favored Glycine 0 CA--C 1.468 -2.869 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.7 t -143.3 153.83 43.17 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 126.266 1.826 . . . . 0.0 106.694 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.291 65.3 m-85 -114.81 142.22 46.84 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-O 124.885 2.279 . . . . 0.0 111.85 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.56 139.18 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.965 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -100.79 119.28 38.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.601 -1.312 . . . . 0.0 110.391 164.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.277 28.8 mt -60.15 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 124.433 2.063 . . . . 0.0 116.19 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.26 147.34 50.23 Favored 'General case' 0 CA--C 1.495 -1.153 1 N-CA-C 98.963 -4.458 . . . . 0.0 98.963 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -57.41 119.97 7.4 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.17 -10.55 47.49 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.731 1.634 . . . . 0.0 114.649 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.3 t -116.24 143.93 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 C-N-CA 127.966 2.506 . . . . 0.0 105.067 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -152.42 149.75 28.92 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 119.282 -2.136 . . . . 0.0 105.841 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 344' ' ' LEU . . . -130.51 173.87 19.92 Favored Glycine 0 CA--C 1.485 -1.84 0 CA-C-O 124.368 2.093 . . . . 0.0 113.924 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 292' ' ' CYS . 62.2 tp -97.81 163.49 12.78 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 120.378 -1.66 . . . . 0.0 110.157 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.263 11.8 t -116.76 118.89 60.28 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -79.87 113.27 17.91 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.43 ' HB ' ' HA2' ' A' ' 291' ' ' GLY 0.386 7.6 p -27.25 -51.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.786 1 N-CA-C 122.003 4.075 . . . . 0.0 122.003 -166.565 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 25.0 p -91.06 -3.45 57.16 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.23 61.39 4.73 Favored 'General case' 0 C--N 1.366 1.311 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 17.2 ttt -99.79 -62.17 1.27 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.678 1.591 . . . . 0.0 107.363 170.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -168.57 -57.98 0.02 OUTLIER 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -154.1 172.64 17.2 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.9 t -164.08 130.8 3.17 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 57.8 t30 150.6 -80.68 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -110.05 43.92 1.29 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.827 1.251 . . . . 0.0 109.561 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -86.42 -19.83 29.08 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.092 1.757 . . . . 0.0 112.175 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 5.6 mt 71.78 -33.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 130.604 3.562 . . . . 0.0 114.928 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -90.32 113.9 59.11 Favored Pre-proline 0 C--N 1.351 0.632 0 C-N-CA 131.073 3.749 . . . . 0.0 117.478 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -64.17 44.39 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.431 1 C-N-CA 127.795 5.664 . . . . 0.0 113.794 165.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 322' ' ' VAL 0.481 1.2 t 87.67 13.5 0.1 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 125.333 2.492 . . . . 0.0 113.204 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.323 18.0 mttp 77.03 28.39 0.64 Allowed 'General case' 0 C--N 1.365 1.239 1 C-N-CA 132.964 4.506 . . . . 0.0 110.037 -170.025 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.467 1.5 t 74.53 62.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 1 C-N-CA 132.034 4.134 . . . . 0.0 111.513 -179.103 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 319' ' ' SER 0.297 4.1 t -77.44 102.8 4.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.605 0 CA-C-O 125.009 2.338 . . . . 0.0 111.007 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -109.47 168.17 9.59 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.364 3.065 . . . . 0.0 107.66 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.33 121.2 23.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.38 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.43 14.95 56.42 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 125.676 1.608 . . . . 0.0 114.225 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.65 143.71 26.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.998 1.319 . . . . 0.0 110.912 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.83 136.25 31.92 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.773 1.273 . . . . 0.0 108.519 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -139.77 177.89 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 129.664 3.186 . . . . 0.0 107.074 -171.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -123.91 138.32 54.5 Favored 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 98.819 -4.512 . . . . 0.0 98.819 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 7.7 m -143.47 139.97 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 100.667 -3.827 . . . . 0.0 100.667 -167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.7 ttm -102.57 141.64 35.07 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 120.363 -1.46 . . . . 0.0 108.781 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 342' ' ' ILE . 74.9 t -81.5 133.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 119.936 -1.727 . . . . 0.0 115.463 -170.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -135.35 0.29 Allowed 'General case' 0 N--CA 1.426 -1.643 1 N-CA-C 99.618 -4.215 . . . . 0.0 99.618 172.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.402 0.8 OUTLIER -59.69 112.72 1.92 Allowed 'General case' 0 N--CA 1.481 1.122 1 N-CA-C 124.196 4.887 . . . . 0.0 124.196 -158.976 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 0.3 OUTLIER -101.48 112.83 35.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 C-N-CA 125.65 1.58 . . . . 0.0 114.176 -176.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.55 107.48 6.67 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.87 7.32 37.81 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 126.535 1.934 . . . . 0.0 112.302 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . 0.25 24.1 mm-40 -82.71 -41.91 18.71 Favored 'General case' 0 N--CA 1.432 -1.351 1 C-N-CA 134.021 4.928 . . . . 0.0 108.831 170.955 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -101.51 -27.08 13.32 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.655 1.982 . . . . 0.0 111.349 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 63.1 mtm-85 75.32 53.21 0.07 Allowed 'General case' 0 C--N 1.35 0.604 1 C-N-CA 131.968 4.107 . . . . 0.0 112.702 -179.933 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.9 ptt180 -124.53 134.0 53.13 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 111.092 -2.776 . . . . 0.0 109.621 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 332' ' ' VAL . 0.7 OUTLIER -118.83 122.0 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 1 N-CA-C 94.44 -6.133 . . . . 0.0 94.44 172.561 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 94.96 5.76 Favored 'General case' 0 CA--C 1.463 -2.366 1 C-N-CA 110.845 -4.342 . . . . 0.0 104.35 -162.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.415 ' CD1' ' HA3' ' A' ' 302' ' ' GLY . 1.0 OUTLIER -96.34 171.24 8.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 118.925 -2.359 . . . . 0.0 109.547 -164.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -154.81 136.91 5.39 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 116.688 -2.672 . . . . 0.0 112.857 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 328' ' ' VAL . 0.2 OUTLIER -53.06 152.79 3.9 Favored 'General case' 0 C--N 1.35 0.592 1 N-CA-C 125.029 5.196 . . . . 0.0 125.029 -163.618 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -108.32 -102.25 0.37 Allowed 'General case' 0 C--N 1.386 2.159 0 O-C-N 121.208 -0.933 . . . . 0.0 111.909 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -139.33 24.25 2.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 120.196 -1.565 . . . . 0.0 114.85 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.485 0.9 OUTLIER 70.84 173.67 0.31 Allowed 'General case' 0 C--N 1.373 1.625 0 C-N-CA 126.334 1.853 . . . . 0.0 115.31 -179.218 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -80.46 159.67 25.52 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.47 -1.394 . . . . 0.0 111.739 174.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.437 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -85.33 54.59 3.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 110.758 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.294 3.3 p30 123.01 94.32 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.801 1 C-N-CA 136.196 5.798 . . . . 0.0 104.977 -171.834 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 -99.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.404 2.736 . . . . 0.0 110.511 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -88.43 75.42 8.43 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.667 1.987 . . . . 0.0 111.338 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.88 173.41 10.57 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.513 1.125 . . . . 0.0 108.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -128.4 175.36 8.56 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 127.246 2.218 . . . . 0.0 106.054 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 66.41 -167.78 0.21 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 127.043 2.137 . . . . 0.0 115.775 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -130.52 58.37 1.69 Allowed 'General case' 0 C--N 1.359 0.985 0 O-C-N 120.608 -1.308 . . . . 0.0 109.826 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.79 149.81 41.44 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.795 1.238 . . . . 0.0 110.683 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.2 m 178.16 147.9 0.17 Allowed 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 C--O 1.267 2.016 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -179.76 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 120.921 0.391 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.28 152.59 8.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.37 42.43 1.04 Allowed 'General case' 0 C--N 1.363 1.163 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.2 tt -169.12 157.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 124.361 1.064 . . . . 0.0 109.622 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 54.71 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.361 1.084 2 C-N-CA 132.925 4.49 . . . . 0.0 122.741 170.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -48.11 124.22 7.38 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 120.286 3.439 . . . . 0.0 120.286 -168.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.496 ' H ' ' HE ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -107.01 17.43 23.06 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.964 1.706 . . . . 0.0 112.733 -172.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.9 151.81 19.7 Favored Pre-proline 0 N--CA 1.445 -0.706 0 C-N-CA 124.92 1.288 . . . . 0.0 109.75 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -81.83 -37.37 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.394 3.396 . . . . 0.0 111.776 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 84.03 123.5 0.04 OUTLIER 'General case' 0 C--N 1.372 1.584 0 C-N-CA 129.637 3.175 . . . . 0.0 112.733 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.75 10.23 44.06 Favored Glycine 0 C--N 1.375 2.744 0 CA-C-O 124.255 2.031 . . . . 0.0 113.356 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.17 166.36 13.42 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 131.431 3.893 . . . . 0.0 103.31 167.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 29.2 mmmt -112.14 146.98 37.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 120.244 -1.535 . . . . 0.0 111.906 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 280' ' ' LEU . 1.8 mp -120.95 174.13 6.82 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 123.926 1.822 . . . . 0.0 107.094 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 89.1 m -141.09 138.28 33.44 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.381 -1.449 . . . . 0.0 108.228 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.91 179.06 36.62 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-O 124.183 1.991 . . . . 0.0 115.638 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -125.4 135.38 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.12 133.5 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 119.134 3.013 . . . . 0.0 119.134 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.255 12.4 t -115.59 -40.6 3.36 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 112.968 -1.923 . . . . 0.0 115.083 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -135.9 172.63 12.73 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.103 1.774 . . . . 0.0 109.138 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 292' ' ' CYS . 1.3 tt -122.18 142.36 50.5 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.652 1.581 . . . . 0.0 107.86 166.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 173.67 6.26 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 121.006 -1.059 . . . . 0.0 109.284 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -28.87 69.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.62 2.368 . . . . 0.0 115.537 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -153.3 48.46 0.69 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 123.494 1.616 . . . . 0.0 107.744 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 177.66 -161.55 28.83 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 167.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 287' ' ' LEU 0.36 0.8 OUTLIER -145.9 164.58 31.52 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 125.017 1.327 . . . . 0.0 109.523 168.538 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -102.92 122.44 44.57 Favored 'General case' 0 C--N 1.357 0.892 0 O-C-N 121.202 -0.936 . . . . 0.0 108.894 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.4 125.94 67.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.27 123.73 35.81 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.7 mm -91.25 48.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.932 -1.105 . . . . 0.0 111.231 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.268 38.0 mt-10 79.95 173.56 0.14 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.116 2.566 . . . . 0.0 110.481 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.56 119.4 12.29 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.92 -33.91 4.7 Favored Glycine 0 C--N 1.367 2.305 0 C-N-CA 127.65 2.548 . . . . 0.0 114.337 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . 0.298 1.8 p -117.35 123.54 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.0 112.03 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.38 154.65 45.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 119.066 -2.272 . . . . 0.0 107.276 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -116.27 172.15 14.09 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-O 124.083 1.935 . . . . 0.0 112.045 163.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 5.1 tp -126.75 126.48 43.51 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.667 ' CG2' ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -92.14 120.22 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 171.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -94.92 132.5 39.68 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 123.647 0.592 . . . . 0.0 111.801 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 t -47.79 -23.01 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 12.2 t -69.33 -25.65 64.31 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.442 2.697 . . . . 0.0 114.496 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -104.09 66.5 0.83 Allowed 'General case' 0 C--N 1.363 1.178 0 C-N-CA 127.291 2.236 . . . . 0.0 107.796 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 67.3 ttp -141.63 -97.07 0.13 Allowed 'General case' 0 C--N 1.357 0.912 0 O-C-N 121.059 -1.026 . . . . 0.0 110.399 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -175.41 -116.3 0.0 OUTLIER 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -169.03 -178.21 3.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 126.322 1.849 . . . . 0.0 106.977 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.9 t -127.27 135.68 50.93 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 120.235 -1.54 . . . . 0.0 111.277 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.7 44.43 1.83 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 57.1 tttm 91.54 38.01 0.01 OUTLIER 'General case' 0 C--N 1.366 1.308 0 C-N-CA 130.641 3.576 . . . . 0.0 108.442 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -116.75 2.65 12.92 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.276 1.9 mp 67.65 -60.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.684 1 C-N-CA 132.413 4.285 . . . . 0.0 114.625 178.38 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 147.05 105.44 0.0 OUTLIER Pre-proline 0 C--N 1.348 0.518 0 C-N-CA 131.598 3.959 . . . . 0.0 106.419 -172.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -56.5 -26.02 61.45 Favored 'Trans proline' 0 C--N 1.37 1.686 1 C-N-CA 126.241 4.628 . . . . 0.0 116.355 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 20.0 t -83.43 -2.74 56.55 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.404 2.282 . . . . 0.0 114.894 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -120.28 -4.7 9.94 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 121.341 1.882 . . . . 0.0 113.056 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.2 m -93.97 5.49 7.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 C-N-CA 125.678 1.591 . . . . 0.0 112.438 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.69 126.18 53.15 Favored 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 126.455 1.902 . . . . 0.0 109.364 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -106.09 171.09 7.53 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 123.568 1.651 . . . . 0.0 108.863 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.49 120.66 2.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 128.261 2.624 . . . . 0.0 113.703 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.74 14.72 72.29 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 114.193 -1.367 . . . . 0.0 115.588 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.1 133.94 34.56 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 126.791 2.037 . . . . 0.0 106.494 172.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.04 135.59 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.405 ' HA ' ' N ' ' A' ' 349' ' ' CYS . 30.5 m -139.99 175.49 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 124.988 2.327 . . . . 0.0 111.462 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -108.51 150.93 26.76 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -138.55 167.05 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 -177.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 31.9 ttm -115.52 138.81 50.66 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.623 ' HB ' HD12 ' A' ' 344' ' ' LEU . 1.2 p -85.7 131.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.91 -137.33 0.3 Allowed 'General case' 0 N--CA 1.414 -2.231 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.29 28.0 m-20 -65.01 112.45 3.33 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.816 4.376 . . . . 0.0 122.816 -155.084 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' ' 273' ' ' ARG 0.431 0.1 OUTLIER -109.66 124.8 66.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 C-N-CA 125.409 1.484 . . . . 0.0 110.14 -179.202 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.26 112.68 13.57 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -78.97 -4.82 51.88 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 123.729 1.728 . . . . 0.0 112.866 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -86.52 -41.19 14.55 Favored 'General case' 0 N--CA 1.425 -1.689 1 C-N-CA 135.378 5.471 . . . . 0.0 111.269 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -103.11 -28.99 11.62 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 113.572 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.271 16.4 mmm180 75.02 48.88 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 128.118 2.567 . . . . 0.0 113.665 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.56 134.28 52.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 128.278 2.631 . . . . 0.0 106.337 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.3 mm -116.54 129.59 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 1 N-CA-C 95.052 -5.907 . . . . 0.0 95.052 168.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.68 94.36 5.25 Favored 'General case' 0 C--N 1.385 2.123 1 C-N-CA 111.037 -4.265 . . . . 0.0 106.425 -167.048 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' A' ' 332' ' ' VAL . 0.2 OUTLIER -101.14 135.36 42.72 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 116.611 -2.035 . . . . 0.0 108.895 -171.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -124.28 134.68 9.25 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 121.652 -0.655 . . . . 0.0 112.943 -176.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.667 ' H ' ' CG2' ' A' ' 304' ' ' VAL 0.353 0.1 OUTLIER -73.49 163.08 28.53 Favored 'General case' 0 C--N 1.368 1.381 1 N-CA-C 128.779 6.585 . . . . 0.0 128.779 -154.586 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -121.52 -105.77 0.37 Allowed 'General case' 0 C--N 1.384 2.108 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -163.6 152.0 13.59 Favored 'General case' 0 C--N 1.349 0.566 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 173.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 328' ' ' VAL . 13.0 t -86.35 -39.2 16.67 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.781 3.658 . . . . 0.0 108.922 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -129.35 165.14 22.09 Favored 'General case' 0 N--CA 1.449 -0.524 1 CA-C-N 104.258 -5.883 . . . . 0.0 108.759 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.22 46.18 1.01 Allowed 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.008 -1.683 . . . . 0.0 109.675 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.286 1.0 OUTLIER 154.94 69.31 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.629 1 C-N-CA 132.808 4.443 . . . . 0.0 106.56 -176.493 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.35 128.88 18.07 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 124.74 3.627 . . . . 0.0 110.971 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -62.42 127.41 31.19 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.31 2.244 . . . . 0.0 116.854 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.84 -15.18 20.34 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.51 114.83 3.89 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 119.936 -1.727 . . . . 0.0 108.911 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.313 97.0 m-85 77.53 47.62 0.06 Allowed 'General case' 0 C--N 1.362 1.126 0 C-N-CA 129.242 3.017 . . . . 0.0 117.39 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -85.27 95.11 9.09 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 120.639 -1.288 . . . . 0.0 111.088 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -111.18 -98.41 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.401 1.08 . . . . 0.0 109.256 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.6 p -112.0 -81.07 0.59 Allowed 'General case' 0 C--N 1.348 0.534 0 C-N-CA 126.609 1.964 . . . . 0.0 110.705 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 . . . . . 0 C--O 1.261 1.663 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.722 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 14.4 t90 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 75.0 t -99.62 117.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 128.144 2.578 . . . . 0.0 109.138 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.93 -8.67 51.25 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.81 133.85 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 86.16 45.31 0.01 OUTLIER 'General case' 0 C--N 1.355 0.822 0 C-N-CA 128.377 2.671 . . . . 0.0 112.27 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -87.61 131.8 34.3 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 127.0 2.12 . . . . 0.0 110.727 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -116.88 -32.0 5.24 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.993 0.917 . . . . 0.0 111.799 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 79.11 142.29 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 128.041 2.537 . . . . 0.0 116.589 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.29 91.12 1.03 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.224 2.616 . . . . 0.0 107.247 168.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.28 151.58 46.75 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 128.714 2.805 . . . . 0.0 118.117 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.26 8.35 55.14 Favored Glycine 0 C--N 1.384 3.214 0 CA-C-O 124.753 2.307 . . . . 0.0 112.336 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 332' ' ' VAL . 2.9 p -96.46 147.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.75 1 C-N-CA 135.136 5.374 . . . . 0.0 101.929 173.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 7.7 ptmt -112.35 156.07 23.08 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 119.007 -2.308 . . . . 0.0 113.399 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.12 151.61 40.91 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.8 m -109.03 139.24 44.17 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.666 -1.271 . . . . 0.0 109.679 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -140.51 -179.18 17.84 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 123.215 1.453 . . . . 0.0 112.083 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -119.07 137.64 53.42 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.82 125.93 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.3 t -106.68 -36.58 6.68 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 111.758 -2.474 . . . . 0.0 112.772 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.27 0.9 OUTLIER -136.64 170.26 16.36 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.819 1.645 . . . . 0.0 109.299 177.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.72 148.05 45.11 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.7 m -112.02 172.56 6.83 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -68.05 -28.09 67.09 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.174 -2.204 . . . . 0.0 113.298 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.68 44.07 1.37 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.949 1.7 . . . . 0.0 107.757 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -179.05 -168.31 37.94 Favored Glycine 0 CA--C 1.471 -2.71 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 145.86 26.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -101.14 118.69 37.49 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.67 125.04 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.19 119.47 33.06 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.246 -1.534 . . . . 0.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 37.5 mm -60.19 -65.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -138.08 166.52 23.91 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -65.52 118.87 10.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.835 -1.166 . . . . 0.0 114.046 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.02 -16.94 53.61 Favored Glycine 0 C--N 1.368 2.329 0 C-N-CA 127.128 2.299 . . . . 0.0 115.851 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.91 117.83 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.941 1.697 . . . . 0.0 109.94 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.76 160.31 37.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 119.346 -2.097 . . . . 0.0 110.299 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.35 173.54 15.35 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 125.946 1.736 . . . . 0.0 114.181 169.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.2 tp -126.22 115.53 19.88 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 126.442 1.897 . . . . 0.0 107.088 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 347' ' ' LYS 0.256 4.3 p -87.34 112.77 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -79.16 123.46 27.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.165 -176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.63 -23.8 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 122.942 2.61 . . . . 0.0 115.911 176.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.8 p -87.07 11.29 14.15 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 131.48 3.912 . . . . 0.0 114.308 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 50.13 0.04 OUTLIER 'General case' 0 C--N 1.378 1.83 0 C-N-CA 128.415 2.686 . . . . 0.0 114.923 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 32.9 ttm -164.44 -61.8 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -163.2 -83.67 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -132.22 11.09 4.57 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.392 -0.818 . . . . 0.0 113.068 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 313' ' ' ASN 0.41 0.6 OUTLIER 83.46 -150.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.056 3.342 . . . . 0.0 111.854 -177.736 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ASN . . . . . 0.463 ' H ' HG23 ' A' ' 312' ' ' THR . 6.5 t-20 74.45 -60.55 0.52 Allowed 'General case' 0 C--N 1.365 1.264 0 C-N-CA 129.993 3.317 . . . . 0.0 111.626 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -66.08 -14.13 61.21 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 131.515 3.926 . . . . 0.0 112.306 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -73.93 -27.85 61.23 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 127.093 2.157 . . . . 0.0 111.219 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.5 mt 68.56 -33.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 130.48 3.512 . . . . 0.0 117.722 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -78.29 110.73 14.62 Favored Pre-proline 0 C--N 1.352 0.707 1 C-N-CA 131.886 4.074 . . . . 0.0 119.204 -176.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -67.47 54.21 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 126.637 4.891 . . . . 0.0 115.46 168.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 92.78 6.96 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 128.957 2.903 . . . . 0.0 110.481 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.26 5.7 tmtp? 72.32 19.04 4.47 Favored 'General case' 0 C--N 1.371 1.532 1 C-N-CA 132.026 4.13 . . . . 0.0 109.54 -169.588 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.426 0.9 OUTLIER 57.16 57.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.467 1 C-N-CA 133.415 4.686 . . . . 0.0 112.381 -171.089 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.84 145.1 8.73 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 C-N-CA 130.184 3.394 . . . . 0.0 114.189 -172.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -120.16 169.06 10.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.09 121.27 26.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 C-N-CA 126.56 1.944 . . . . 0.0 107.834 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.42 53.79 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -98.89 164.46 12.19 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 130.009 3.324 . . . . 0.0 104.13 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.29 0.2 OUTLIER -121.41 138.17 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.302 -1.499 . . . . 0.0 109.925 -175.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.259 0.9 OUTLIER -139.23 163.47 26.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 CA-C-O 122.879 1.323 . . . . 0.0 108.086 179.001 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.24 155.38 18.06 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.443 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 3.1 m -141.1 163.71 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 51.6 ttp -120.71 141.43 50.44 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 278' ' ' THR . 11.9 p -80.72 131.37 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -168.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.36 -136.66 0.29 Allowed 'General case' 0 N--CA 1.42 -1.968 1 N-CA-C 99.953 -4.092 . . . . 0.0 99.953 176.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ASP . . . . . 0.501 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.254 24.7 m-20 -69.45 112.32 5.9 Favored 'General case' 0 C--N 1.31 -1.152 1 N-CA-C 122.702 4.334 . . . . 0.0 122.702 -154.766 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.335 0.1 OUTLIER -102.87 125.39 57.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 C-N-CA 127.266 2.226 . . . . 0.0 109.28 179.607 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.72 110.62 14.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -74.94 -3.43 32.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.025 2.13 . . . . 0.0 113.539 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -88.17 -35.55 17.32 Favored 'General case' 0 N--CA 1.432 -1.358 1 C-N-CA 132.49 4.316 . . . . 0.0 110.766 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -103.71 -39.93 6.48 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.507 1.523 . . . . 0.0 111.806 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.361 92.5 mtt180 74.48 52.49 0.09 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 132.423 4.289 . . . . 0.0 112.606 -179.272 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -124.87 132.85 53.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 127.802 2.441 . . . . 0.0 104.638 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 131.15 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' SER . . . . . 0.501 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 3.9 m -107.32 92.19 3.97 Favored 'General case' 0 C--N 1.381 1.94 1 C-N-CA 111.061 -4.256 . . . . 0.0 105.105 -166.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 332' ' ' VAL . 1.7 mp -101.6 138.28 38.8 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 119.961 1.255 . . . . 0.0 111.45 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -149.12 123.81 1.7 Allowed Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.443 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.741 4.0 tt -139.58 -86.93 0.22 Allowed 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.493 3.517 . . . . 0.0 112.348 174.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 347' ' ' LYS . . . . . 0.639 ' HB2' HG21 ' A' ' 304' ' ' VAL 0.263 29.7 ttmt 93.78 44.2 0.0 OUTLIER 'General case' 0 C--N 1.371 1.506 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 174.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -79.8 -46.83 16.21 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 118.822 -2.424 . . . . 0.0 113.324 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.259 63.0 m 90.02 160.1 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 130.425 3.49 . . . . 0.0 111.492 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 4.9 mmtp -72.16 166.81 21.59 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.466 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -92.24 4.04 54.11 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.801 2.04 . . . . 0.0 114.469 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -168.64 75.58 0.8 Allowed Pre-proline 0 CA--C 1.541 0.626 1 C-N-CA 131.84 4.056 . . . . 0.0 105.183 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -61.66 -27.36 81.22 Favored 'Trans proline' 0 C--N 1.372 1.769 1 C-N-CA 125.478 4.119 . . . . 0.0 116.045 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -129.53 144.55 51.31 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 129.208 3.003 . . . . 0.0 104.124 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -134.34 125.44 27.62 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -167.47 152.21 6.95 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.23 -31.8 20.1 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 115.132 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -149.95 132.49 15.75 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 136.91 -46.62 0.01 OUTLIER 'General case' 0 C--N 1.362 1.152 0 C-N-CA 128.811 2.844 . . . . 0.0 107.106 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 66.7 m -76.16 -23.03 54.75 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 127.295 2.238 . . . . 0.0 112.219 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 C--O 1.259 1.581 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 175.645 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.6 m95 . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.48 145.4 12.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 C-N-CA 125.53 1.532 . . . . 0.0 108.424 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -141.95 166.67 24.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.217 -2.882 . . . . 0.0 103.217 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . 0.408 7.2 pt 68.8 -2.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 129.597 3.159 . . . . 0.0 119.043 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 75.12 -78.07 0.05 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 129.618 3.167 . . . . 0.0 114.074 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -160.99 134.65 6.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 335' ' ' ILE . 7.1 mmm180 -129.02 -83.28 0.57 Allowed 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . 0.291 4.5 m-85 82.44 154.6 0.12 Allowed Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 170.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.89 114.82 4.01 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.666 2.911 . . . . 0.0 109.727 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.3 125.19 27.25 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.809 1.644 . . . . 0.0 111.822 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.04 2.24 31.73 Favored Glycine 0 C--N 1.363 2.074 0 CA-C-O 122.929 1.294 . . . . 0.0 113.551 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 46.8 p -93.23 142.58 27.15 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 28.5 mmtp -97.65 146.03 25.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.559 1.171 . . . . 0.0 112.933 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.87 175.46 6.54 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 124.319 2.009 . . . . 0.0 110.238 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 48.3 m -116.92 129.87 56.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -132.4 173.44 20.79 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 124.42 2.122 . . . . 0.0 111.877 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -129.51 126.33 38.39 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.448 HG21 ' CG1' ' A' ' 322' ' ' VAL . 5.0 t -87.36 136.63 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 119.575 -1.953 . . . . 0.0 115.988 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.323 4.1 t -145.41 -20.35 0.48 Allowed 'General case' 0 C--N 1.361 1.083 0 N-CA-C 121.253 3.798 . . . . 0.0 121.253 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.347 2.6 t-20 -134.19 175.92 9.06 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 123.734 2.97 . . . . 0.0 110.672 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 142.44 49.85 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 119.134 -2.229 . . . . 0.0 108.512 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 289' ' ' ASP . 2.0 m -112.51 178.38 4.32 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 288' ' ' THR . 0.4 OUTLIER -57.85 -29.62 65.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.86 46.39 0.14 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 123.742 1.735 . . . . 0.0 110.278 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.0 -167.58 36.23 Favored Glycine 0 CA--C 1.48 -2.1 1 N-CA-C 101.17 -4.772 . . . . 0.0 101.17 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.258 0.1 OUTLIER -134.6 161.41 35.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -98.95 128.33 45.09 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.79 -1.819 . . . . 0.0 107.972 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.58 133.19 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.446 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.3 126.42 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 118.61 -2.556 . . . . 0.0 111.879 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 297' ' ' GLU . 7.8 mm -83.64 173.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 119.859 -1.776 . . . . 0.0 111.225 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 296' ' ' ILE . 37.8 mm-40 -78.04 -17.72 56.72 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-O 127.315 3.436 . . . . 0.0 117.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.98 154.11 39.45 Favored 'General case' 0 C--N 1.303 -1.439 2 C-N-CA 143.072 8.549 . . . . 0.0 112.797 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.77 2.77 72.39 Favored Glycine 0 C--N 1.371 2.49 0 O-C-N 119.296 -2.128 . . . . 0.0 115.7 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.08 144.93 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 129.679 3.192 . . . . 0.0 108.605 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -115.17 158.24 22.51 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.984 -1.697 . . . . 0.0 107.925 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -110.25 172.92 15.99 Favored Glycine 0 C--N 1.359 1.841 0 CA-C-O 125.058 2.477 . . . . 0.0 112.973 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.3 tp -118.48 114.62 23.14 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 346' ' ' LEU 0.296 1.5 p -79.43 100.02 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 122.858 1.313 . . . . 0.0 107.54 174.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -87.92 114.7 24.79 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.937 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 27.6 m -28.48 -20.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.1 p -64.83 -28.92 69.89 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 131.167 3.787 . . . . 0.0 114.85 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.87 24.27 0.0 OUTLIER 'General case' 0 C--N 1.371 1.512 0 C-N-CA 131.145 3.778 . . . . 0.0 120.701 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 55.7 ttp -58.37 -59.91 4.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.373 3.469 . . . . 0.0 118.893 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 29.8 t70 97.24 -67.5 0.0 OUTLIER 'General case' 0 C--N 1.363 1.169 0 C-N-CA 128.972 2.909 . . . . 0.0 109.885 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -157.76 173.91 16.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.4 t -105.92 161.56 14.35 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.621 1.568 . . . . 0.0 113.807 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.256 66.2 m-80 106.47 -22.84 0.01 OUTLIER 'General case' 0 C--N 1.365 1.266 1 C-N-CA 132.614 4.366 . . . . 0.0 111.035 -178.68 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -111.86 -1.63 15.47 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.442 1.897 . . . . 0.0 112.242 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -88.6 -70.02 0.67 Allowed 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.277 -1.514 . . . . 0.0 114.892 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.7 mp 67.62 -52.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 C-N-CA 131.131 3.772 . . . . 0.0 115.636 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -167.89 105.8 0.57 Allowed Pre-proline 0 C--N 1.345 0.382 0 C-N-CA 126.71 2.004 . . . . 0.0 111.684 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -60.66 13.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.091 1 C-N-CA 127.473 5.449 . . . . 0.0 119.52 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.1 t -140.08 -1.01 1.6 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.73 0.812 . . . . 0.0 111.481 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -99.56 9.82 42.49 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 120.5 1.5 . . . . 0.0 111.015 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.41 139.47 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 1 N-CA-C 98.764 -4.532 . . . . 0.0 98.764 176.293 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.448 ' CG1' HG21 ' A' ' 284' ' ' VAL 0.269 10.0 t 72.73 106.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.797 0 CA-C-N 121.686 2.039 . . . . 0.0 111.946 -173.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.79 172.3 8.73 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 124.406 2.05 . . . . 0.0 111.09 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.64 120.64 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 112.328 -2.215 . . . . 0.0 109.758 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.61 62.25 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 125.88 1.705 . . . . 0.0 115.827 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -93.4 151.67 19.6 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.766 2.427 . . . . 0.0 110.474 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.58 138.55 26.42 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 126.16 1.784 . . . . 0.0 107.727 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.891 HG23 ' H ' ' A' ' 349' ' ' CYS 0.253 7.5 p -147.92 170.16 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 124.354 2.025 . . . . 0.0 108.707 -173.123 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.37 140.6 38.24 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.0 OUTLIER -130.5 167.67 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.682 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -173.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 23.6 ttm -118.4 138.8 52.2 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 171.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 344' ' ' LEU . 92.5 t -81.6 124.74 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.531 -1.356 . . . . 0.0 111.14 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . 0.253 1.8 mp -125.03 -141.41 0.29 Allowed 'General case' 0 N--CA 1.409 -2.501 0 CA-C-O 126.847 3.213 . . . . 0.0 102.453 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ASP . . . . . 0.473 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.35 4.9 t70 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 -152.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.708 HD13 HG23 ' A' ' 342' ' ' ILE . 4.8 tp -109.99 132.46 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.303 -172.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.44 104.05 5.96 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 101.58 -3.489 . . . . 0.0 101.58 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.57 -9.16 59.25 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.186 2.195 . . . . 0.0 114.026 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.13 -37.29 14.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.181 3.792 . . . . 0.0 111.074 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -100.62 -23.3 14.7 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 124.731 1.212 . . . . 0.0 112.365 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.276 1.5 mmp_? 74.45 46.7 0.15 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 129.491 3.116 . . . . 0.0 113.883 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -125.67 111.92 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 111.119 -2.764 . . . . 0.0 105.214 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.708 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -111.65 130.23 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 2 C-N-CA 133.579 4.752 . . . . 0.0 99.597 179.534 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 343' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 2.5 m -115.12 93.72 4.43 Favored 'General case' 0 CA--C 1.471 -2.063 1 C-N-CA 109.217 -4.993 . . . . 0.0 105.48 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.49 HD12 ' CD1' ' A' ' 296' ' ' ILE . 0.1 OUTLIER -100.35 136.29 40.47 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -150.44 124.46 1.74 Allowed Glycine 0 N--CA 1.47 0.948 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.897 -164.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.714 ' HG ' HG21 ' A' ' 328' ' ' VAL . 0.7 OUTLIER -32.93 154.15 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 2 C-N-CA 135.37 5.468 . . . . 0.0 124.72 -168.5 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -101.94 -79.75 0.51 Allowed 'General case' 0 C--N 1.384 2.089 0 C-N-CA 124.188 0.995 . . . . 0.0 109.531 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.31 0.4 OUTLIER -176.44 46.75 0.01 OUTLIER 'General case' 0 C--N 1.372 1.585 0 N-CA-C 118.278 2.696 . . . . 0.0 118.278 176.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.891 ' H ' HG23 ' A' ' 328' ' ' VAL 0.421 13.4 p 68.18 161.74 0.19 Allowed 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.205 4.15 . . . . 0.0 122.205 169.845 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -77.53 168.76 19.46 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 128.646 2.778 . . . . 0.0 113.33 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -101.81 18.29 20.88 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 118.895 -2.378 . . . . 0.0 113.257 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -174.89 52.21 0.11 Allowed Pre-proline 0 N--CA 1.438 -1.032 0 C-N-CA 129.673 3.189 . . . . 0.0 109.12 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.62 -43.96 6.8 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 125.005 3.803 . . . . 0.0 114.968 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -153.68 -159.81 1.03 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -80.94 62.28 4.87 Favored 'General case' 0 C--N 1.362 1.134 0 C-N-CA 127.896 2.478 . . . . 0.0 111.513 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -80.41 54.65 2.07 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.278 2.231 . . . . 0.0 115.838 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.17 49.34 5.6 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.442 3.097 . . . . 0.0 118.442 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -94.98 87.9 5.09 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 119.967 -1.708 . . . . 0.0 109.898 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . 0.294 36.4 mt-10 83.93 -174.52 0.03 OUTLIER 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.291 3.036 . . . . 0.0 112.829 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 14.4 t -137.2 -4.56 1.89 Allowed 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.661 -1.275 . . . . 0.0 111.823 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.27 2.18 2 C-N-CA 132.936 4.494 . . . . 0.0 99.407 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.5 65.65 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 126.292 1.837 . . . . 0.0 111.106 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -142.85 29.38 1.52 Allowed 'General case' 0 C--N 1.349 0.587 0 C-N-CA 126.399 1.88 . . . . 0.0 106.626 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 21.3 tt -168.35 159.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.255 . . 80.65 -73.51 0.05 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 129.023 2.929 . . . . 0.0 116.708 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.56 ' HG2' ' H ' ' A' ' 273' ' ' ARG . 36.4 ttpt -173.98 -127.71 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.56 ' H ' ' HG2' ' A' ' 272' ' ' LYS 0.274 13.4 mmp_? 94.4 119.08 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.777 1 C-N-CA 134.403 5.081 . . . . 0.0 110.074 -178.572 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -102.91 156.34 35.43 Favored Pre-proline 0 C--N 1.351 0.668 0 C-N-CA 127.994 2.518 . . . . 0.0 109.194 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.76 -176.19 3.11 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.829 3.019 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.31 126.92 49.14 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.512 1.125 . . . . 0.0 108.791 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.36 36.49 Favored Glycine 0 C--N 1.367 2.296 0 CA-C-O 123.804 1.78 . . . . 0.0 114.645 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 332' ' ' VAL . 4.1 p -96.62 134.22 40.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 131.152 3.781 . . . . 0.0 102.923 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 21.2 pttp -100.13 149.63 23.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.327 1.537 . . . . 0.0 114.687 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.414 HD23 HG21 ' A' ' 296' ' ' ILE . 2.0 mp -120.95 175.28 6.14 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 123.447 1.594 . . . . 0.0 110.445 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 94.8 m -118.04 132.82 56.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.82 179.15 26.83 Favored Glycine 0 CA--C 1.481 -2.093 0 CA-C-O 123.875 1.819 . . . . 0.0 111.337 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -124.45 146.57 48.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 322' ' ' VAL . 5.0 t -92.27 133.66 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.374 -1.453 . . . . 0.0 112.051 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -125.49 -38.88 2.22 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.87 174.69 10.19 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 121.334 1.879 . . . . 0.0 107.281 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.9 mp -119.53 151.08 39.2 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 119.98 -1.7 . . . . 0.0 110.583 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 178.94 4.12 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -30.05 69.0 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 119.066 -2.271 . . . . 0.0 115.711 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -145.72 39.28 1.14 Allowed 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 123.18 1.467 . . . . 0.0 110.504 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.38 -170.97 37.54 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 5.3 m -135.82 157.12 47.62 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.2 125.74 44.85 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.515 HG11 HG11 ' A' ' 330' ' ' VAL . 16.3 t -104.29 133.58 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 125.586 1.554 . . . . 0.0 107.344 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.43 126.47 46.83 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.811 2.096 . . . . 0.0 114.478 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 300' ' ' VAL . 8.6 mm -104.56 56.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.626 173.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 75.22 171.6 0.27 Allowed 'General case' 0 C--N 1.364 1.236 0 C-N-CA 127.477 2.311 . . . . 0.0 111.877 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.96 119.04 12.66 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.75 -2.469 . . . . 0.0 115.593 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 118.82 -32.71 5.06 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 127.193 2.33 . . . . 0.0 114.987 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.629 HG13 HG13 ' A' ' 342' ' ' ILE . 40.3 t -116.9 130.64 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 127.543 2.337 . . . . 0.0 107.739 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.98 157.02 28.06 Favored 'General case' 0 CA--C 1.478 -1.798 0 O-C-N 118.307 -2.746 . . . . 0.0 104.916 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -125.87 174.07 17.7 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.61 122.26 37.69 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 125.932 1.693 . . . . 0.0 106.866 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 345' ' ' GLY . 2.4 p -93.61 118.79 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -96.48 133.24 41.18 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 117.359 -1.736 . . . . 0.0 112.454 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.269 52.4 t -51.47 -39.09 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.1 p -88.22 23.12 2.23 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.502 1.521 . . . . 0.0 114.785 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -119.03 77.27 1.17 Allowed 'General case' 0 C--N 1.365 1.277 0 C-N-CA 126.063 1.745 . . . . 0.0 110.213 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 49.5 ttp -148.51 -122.79 0.05 Allowed 'General case' 0 C--N 1.362 1.126 0 O-C-N 119.504 -1.997 . . . . 0.0 108.281 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -158.03 -94.06 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.07 -1.644 . . . . 0.0 109.097 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -121.48 132.82 54.93 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 122.544 1.164 . . . . 0.0 110.48 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 15.0 t -113.66 46.9 1.23 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-O 125.674 2.654 . . . . 0.0 105.449 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -99.11 64.77 1.41 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 128.514 2.726 . . . . 0.0 109.564 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . 0.251 47.5 mmtm 82.93 19.8 0.23 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 128.063 2.545 . . . . 0.0 111.565 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.34 -38.66 7.12 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 128.2 2.6 . . . . 0.0 111.094 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 1.8 mp 67.84 -59.13 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.096 1 C-N-CA 133.957 4.903 . . . . 0.0 112.576 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 77.26 102.47 0.03 OUTLIER Pre-proline 0 C--N 1.349 0.547 0 C-N-CA 130.664 3.586 . . . . 0.0 115.776 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.52 -24.86 78.79 Favored 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 125.636 4.224 . . . . 0.0 112.679 167.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.5 m -54.19 -31.44 52.86 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.015 4.926 . . . . 0.0 115.131 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -97.19 -0.05 47.49 Favored 'General case' 0 C--N 1.365 1.266 0 O-C-N 120.199 -1.563 . . . . 0.0 114.063 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.4 t -111.95 -57.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 125.706 1.602 . . . . 0.0 106.76 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 284' ' ' VAL 0.399 0.7 OUTLIER 55.44 159.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.346 0 C-N-CA 129.182 2.993 . . . . 0.0 118.566 177.228 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.458 ' H ' HG22 ' A' ' 322' ' ' VAL . 39.7 t30 -109.66 148.96 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.4 p -78.67 120.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.696 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 88.24 25.63 30.64 Favored Glycine 0 C--N 1.361 1.924 0 C-N-CA 124.31 0.957 . . . . 0.0 113.457 -170.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.83 158.0 15.87 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.674 1.99 . . . . 0.0 108.88 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -117.02 136.56 53.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.264 10.7 p -147.49 175.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 130.764 3.626 . . . . 0.0 108.225 -166.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -114.69 141.71 47.45 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.4 m -124.37 166.5 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -171.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 35.2 ttm -121.12 141.09 51.13 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.431 HG22 HD12 ' A' ' 344' ' ' LEU . 39.8 t -81.66 131.86 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.593 -1.317 . . . . 0.0 113.522 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.48 -136.35 0.29 Allowed 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.252 10.5 t70 -63.84 112.05 2.73 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.585 4.291 . . . . 0.0 122.585 -153.651 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.267 2.8 tp -101.13 112.38 33.9 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 CA-C-O 122.7 1.238 . . . . 0.0 108.882 176.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.07 117.15 23.33 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.481 1.112 . . . . 0.0 108.166 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -80.96 -2.79 49.19 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.331 1.853 . . . . 0.0 115.128 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -89.56 -37.64 14.55 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.622 2.769 . . . . 0.0 111.463 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -103.13 -30.8 10.49 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.259 1.424 . . . . 0.0 112.454 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 16.9 mmm180 72.49 52.83 0.17 Allowed 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 129.925 3.29 . . . . 0.0 111.928 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.0 ptp180 -124.58 135.19 52.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 129.16 2.984 . . . . 0.0 107.768 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.629 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -108.88 130.04 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 167.373 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -102.57 94.74 5.81 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 111.781 -3.968 . . . . 0.0 107.246 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 332' ' ' VAL 0.306 2.1 mm? -96.12 136.87 36.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 120.129 -1.607 . . . . 0.0 108.464 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -135.15 127.69 4.47 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 6.9 mp -45.43 155.85 0.13 Allowed 'General case' 0 C--N 1.359 1.016 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -167.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -131.42 -62.74 0.86 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.64 124.31 1.92 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 173.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 7.4 p -47.63 151.88 0.77 Allowed 'General case' 0 C--N 1.361 1.084 1 C-N-CA 139.628 7.171 . . . . 0.0 117.48 169.259 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.13 162.73 27.75 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 127.403 2.281 . . . . 0.0 115.49 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -104.63 24.52 11.62 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.305 1.842 . . . . 0.0 112.548 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -175.64 51.69 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 129.702 3.201 . . . . 0.0 109.204 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -58.77 -41.83 59.28 Favored 'Trans proline' 0 C--N 1.379 2.172 1 C-N-CA 126.388 4.725 . . . . 0.0 116.615 -167.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -132.1 -95.64 0.34 Allowed 'General case' 0 C--N 1.361 1.09 0 CA-C-N 120.308 1.413 . . . . 0.0 107.668 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . 0.319 24.4 mp0 59.27 -37.26 0.07 Allowed 'General case' 0 C--N 1.368 1.403 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 173.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.363 12.6 tt0 102.37 -62.39 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.025 2.93 . . . . 0.0 115.66 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -66.28 43.85 0.02 OUTLIER 'General case' 0 C--N 1.358 0.971 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -167.81 -55.7 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.71 1.204 . . . . 0.0 108.575 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -82.82 -83.26 0.13 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.134 2.174 . . . . 0.0 115.987 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 86.5 m 175.39 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.359 0.984 0 N-CA-C 100.879 -3.748 . . . . 0.0 100.879 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.435 0 O-C-N 119.363 -2.085 . . . . 0.0 105.597 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 9.4 t90 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.49 164.57 13.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -101.57 50.42 0.85 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.779 1.632 . . . . 0.0 111.429 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 8.8 tt -168.14 -175.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 102.361 -3.199 . . . . 0.0 102.361 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -139.37 -174.28 3.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.838 1.199 . . . . 0.0 108.253 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -83.8 -41.78 17.18 Favored 'General case' 0 C--N 1.363 1.187 0 CA-C-O 123.752 1.739 . . . . 0.0 110.796 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -156.71 -71.25 0.1 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 131.505 3.922 . . . . 0.0 104.447 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -116.88 152.23 48.34 Favored Pre-proline 0 CA--C 1.517 -0.302 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.68 -48.92 8.02 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.697 3.598 . . . . 0.0 114.116 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 82.39 118.77 0.05 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 128.994 2.917 . . . . 0.0 113.919 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.42 58.1 Favored Glycine 0 C--N 1.375 2.696 0 CA-C-O 124.556 2.198 . . . . 0.0 112.231 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 19.6 p -97.45 126.21 42.57 Favored 'General case' 0 CA--C 1.509 -0.629 1 C-N-CA 133.267 4.627 . . . . 0.0 103.475 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -95.85 144.57 26.09 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.666 1.698 . . . . 0.0 112.859 -178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.77 174.09 7.34 Favored 'General case' 0 CA--C 1.487 -1.446 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.566 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.5 m -110.83 139.85 45.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -153.9 173.28 32.57 Favored Glycine 0 CA--C 1.482 -1.989 0 CA-C-O 123.543 1.635 . . . . 0.0 111.69 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.59 ' HG2' HG22 ' A' ' 327' ' ' VAL . 30.6 mtp-105 -127.54 135.37 50.24 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.53 132.08 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 113.869 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -130.19 -31.04 1.91 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -169.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.271 1.2 t-20 -133.75 176.09 8.87 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-N 121.751 2.069 . . . . 0.0 108.379 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.0 OUTLIER -120.47 156.37 31.62 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.255 -1.528 . . . . 0.0 113.174 176.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 178.57 4.25 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -68.33 -25.49 65.13 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.533 2.333 . . . . 0.0 115.037 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -162.55 54.05 0.21 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.225 2.61 . . . . 0.0 107.039 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.97 -170.48 41.66 Favored Glycine 0 CA--C 1.468 -2.865 1 N-CA-C 100.573 -5.011 . . . . 0.0 100.573 171.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.8 m -139.91 169.82 17.01 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.493 1.117 . . . . 0.0 108.852 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.83 128.71 56.2 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-O 123.128 1.442 . . . . 0.0 109.182 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 330' ' ' VAL . 21.2 t -103.93 138.27 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 C-N-CA 125.862 1.665 . . . . 0.0 107.006 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -99.89 123.84 44.57 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 119.703 -1.873 . . . . 0.0 112.157 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.61 52.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 122.878 1.323 . . . . 0.0 111.616 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 79.07 174.97 0.15 Allowed 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.932 2.493 . . . . 0.0 109.716 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -68.22 119.72 13.23 Favored 'General case' 0 CA--C 1.558 1.285 0 O-C-N 119.871 -1.768 . . . . 0.0 114.181 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.0 32.4 Favored Glycine 0 C--N 1.367 2.262 0 C-N-CA 127.44 2.448 . . . . 0.0 115.196 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.18 143.99 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.125 1.77 . . . . 0.0 109.865 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -153.51 149.81 28.08 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 118.851 -2.405 . . . . 0.0 105.435 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 344' ' ' LEU . . . -131.38 174.36 20.06 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-O 124.824 2.347 . . . . 0.0 112.44 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 51.7 tp -98.38 162.63 13.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.703 2.001 . . . . 0.0 107.484 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 346' ' ' LEU . 2.4 p -128.82 117.15 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 161.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -95.21 134.89 37.45 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 119.09 -1.044 . . . . 0.0 113.792 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.272 1.0 OUTLIER -37.82 -41.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.93 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 86.2 p -92.26 -2.15 56.65 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.233 -1.542 . . . . 0.0 114.042 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -79.03 55.92 1.88 Allowed 'General case' 0 C--N 1.369 1.44 0 O-C-N 119.737 -1.852 . . . . 0.0 114.245 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 9.4 ttm -162.15 -80.41 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -145.5 -100.83 0.1 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -127.01 123.6 37.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.9 m -141.18 161.79 37.03 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.904 1.681 . . . . 0.0 106.649 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.264 29.5 m-80 134.47 -61.51 0.0 OUTLIER 'General case' 0 C--N 1.369 1.437 0 C-N-CA 131.105 3.762 . . . . 0.0 107.215 175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.7 17.66 13.52 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.309 1.844 . . . . 0.0 110.156 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.34 -13.44 37.89 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.313 1.845 . . . . 0.0 111.416 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.299 2.7 mp 61.57 -44.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.225 1 C-N-CA 132.187 4.195 . . . . 0.0 117.214 177.294 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -26.07 115.37 0.23 Allowed Pre-proline 0 C--N 1.363 1.185 1 C-N-CA 132.116 4.166 . . . . 0.0 118.059 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -58.01 -23.81 62.3 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.105 4.537 . . . . 0.0 115.146 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 p -82.18 -20.72 37.28 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.814 2.046 . . . . 0.0 113.996 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -83.98 -30.58 26.1 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 124.897 1.279 . . . . 0.0 112.109 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 t -95.16 -54.0 7.64 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 C-N-CA 125.915 1.686 . . . . 0.0 111.31 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.507 0.4 OUTLIER 85.61 134.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 129.654 3.182 . . . . 0.0 114.37 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -104.7 151.07 24.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 123.935 1.826 . . . . 0.0 112.527 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 324' ' ' VAL . 1.4 p -69.15 120.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 C-N-CA 127.052 2.141 . . . . 0.0 108.633 174.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 97.03 8.37 56.84 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 125.723 1.63 . . . . 0.0 115.626 -172.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.73 160.5 14.94 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.885 -1.362 . . . . 0.0 109.091 171.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 283' ' ' ARG . 35.0 t -117.82 137.41 51.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -144.01 178.99 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 CA-C-O 126.043 2.83 . . . . 0.0 108.979 -173.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.5 133.55 55.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.2 m -135.48 139.2 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.0 ttp -101.79 143.82 31.24 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 120.63 -1.294 . . . . 0.0 108.181 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.425 HG13 HG22 ' A' ' 342' ' ' ILE . 84.1 t -84.88 131.67 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.9 -133.13 0.3 Allowed 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 100.293 -3.966 . . . . 0.0 100.293 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.436 11.7 m-20 -53.21 112.65 0.91 Allowed 'General case' 0 CA--C 1.503 -0.831 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -154.991 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.59 HD13 HG23 ' A' ' 342' ' ' ILE . 5.8 tp -111.3 122.2 65.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 4.3 t0 -146.55 116.16 7.16 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -106.05 22.8 15.07 Favored 'General case' 0 C--N 1.365 1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 112.707 -172.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -110.96 -43.7 3.73 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.526 1.93 . . . . 0.0 107.732 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 336' ' ' ASP 0.305 34.3 mmt180 -68.69 -38.53 80.38 Favored 'General case' 0 C--N 1.349 0.571 1 C-N-CA 132.956 4.503 . . . . 0.0 113.345 171.262 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.338 33.0 mmt180 74.98 51.38 0.08 Allowed 'General case' 0 C--N 1.347 0.487 1 C-N-CA 132.595 4.358 . . . . 0.0 113.481 173.334 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.46 133.73 52.33 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 111.622 -2.535 . . . . 0.0 112.389 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -119.61 127.22 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 1 N-CA-C 96.922 -5.214 . . . . 0.0 96.922 172.088 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.8 103.05 10.27 Favored 'General case' 0 CA--C 1.457 -2.627 1 C-N-CA 110.787 -4.365 . . . . 0.0 106.892 -170.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.471 HD13 ' HA3' ' A' ' 302' ' ' GLY . 2.1 mp -96.5 170.75 9.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 122.921 2.601 . . . . 0.0 112.077 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -156.24 141.69 8.19 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.788 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.412 1.4 pt? -51.13 159.0 0.67 Allowed 'General case' 0 C--N 1.374 1.65 1 N-CA-C 124.761 5.097 . . . . 0.0 124.761 -165.464 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -125.44 -55.86 1.53 Allowed 'General case' 0 C--N 1.38 1.93 0 O-C-N 120.948 -1.095 . . . . 0.0 109.962 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.34 2.1 pt20 -121.02 -105.26 0.38 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 18.7 p 159.71 171.1 0.01 OUTLIER 'General case' 0 C--N 1.349 0.561 1 C-N-CA 131.954 4.101 . . . . 0.0 101.677 -169.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -91.1 161.47 15.09 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.936 1.294 . . . . 0.0 111.989 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -96.79 77.0 2.8 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 118.912 -2.367 . . . . 0.0 109.737 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 40.4 t30 104.67 66.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 130.417 3.487 . . . . 0.0 107.675 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.03 146.98 91.76 Favored 'Trans proline' 0 C--N 1.382 2.31 1 C-N-CA 126.293 4.662 . . . . 0.0 112.313 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . 0.304 4.0 t90 -8.67 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.255 2 N-CA-C 124.832 5.123 . . . . 0.0 124.832 -173.8 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -108.73 -4.49 16.94 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.412 -2.055 . . . . 0.0 112.768 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.303 28.3 mt-30 81.67 87.14 0.04 OUTLIER 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.97 2.508 . . . . 0.0 115.064 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -78.76 -92.56 0.04 OUTLIER 'General case' 0 C--N 1.37 1.485 0 O-C-N 120.653 -1.279 . . . . 0.0 113.242 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 65.18 -41.78 0.31 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 129.117 2.967 . . . . 0.0 118.933 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 97.42 -62.44 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 130.439 3.496 . . . . 0.0 107.396 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 13.1 t 162.0 -35.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 129.14 2.976 . . . . 0.0 106.875 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 C--O 1.266 1.962 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 -176.02 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 84.2 m95 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 51.6 t -103.14 140.08 22.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 125.69 1.596 . . . . 0.0 107.896 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -131.56 15.57 4.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.156 1.383 . . . . 0.0 111.239 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.8 pt -139.49 -153.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 127.1 2.16 . . . . 0.0 106.718 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -137.76 -171.19 2.94 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 7.3 pttm -107.88 1.79 22.97 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . 0.279 7.0 mtp180 72.77 -73.49 0.1 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.697 3.599 . . . . 0.0 116.04 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.86 63.11 Favored Pre-proline 0 N--CA 1.448 -0.571 0 C-N-CA 128.007 2.523 . . . . 0.0 112.995 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.06 122.17 9.86 Favored 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 125.382 4.055 . . . . 0.0 114.204 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.63 114.84 6.59 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 129.077 2.951 . . . . 0.0 113.16 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.92 7.79 40.71 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 123.633 1.685 . . . . 0.0 114.766 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 72.9 p -96.9 144.19 27.06 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 129.044 2.938 . . . . 0.0 103.543 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 92.5 mttt -105.87 155.3 19.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 119.867 -1.771 . . . . 0.0 115.203 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.59 HD21 HG22 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -128.33 173.42 10.18 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.809 2.243 . . . . 0.0 107.802 178.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.5 m -114.34 135.68 53.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.27 170.52 29.55 Favored Glycine 0 CA--C 1.48 -2.118 0 CA-C-O 124.097 1.943 . . . . 0.0 110.045 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -129.61 133.81 47.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 113.576 -1.312 . . . . 0.0 108.041 -171.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 322' ' ' VAL . 11.3 t -76.88 127.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.3 t -109.15 -41.96 4.54 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 112.763 -2.017 . . . . 0.0 113.632 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER -135.28 174.56 10.48 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 119.962 -1.711 . . . . 0.0 110.248 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 147.13 45.8 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.328 -1.483 . . . . 0.0 108.136 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 289' ' ' ASP . 1.0 OUTLIER -112.05 177.69 4.56 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 124.242 1.017 . . . . 0.0 108.885 -176.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 288' ' ' THR . 52.9 m-20 -71.25 -12.26 61.36 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.231 2.612 . . . . 0.0 114.572 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.439 ' CD2' ' HE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -164.34 47.42 0.11 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 123.842 1.782 . . . . 0.0 109.83 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 169.38 -160.28 33.48 Favored Glycine 0 CA--C 1.47 -2.759 0 N-CA-C 106.295 -2.722 . . . . 0.0 106.295 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.58 164.05 32.88 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -102.35 120.38 40.39 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.3 125.27 65.04 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.13 131.79 35.79 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 344' ' ' LEU . 3.9 mt -85.38 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 120.743 -1.223 . . . . 0.0 110.752 168.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.258 57.6 mm-40 84.65 167.31 0.09 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 127.577 2.351 . . . . 0.0 107.514 -167.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.01 118.89 9.13 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 112.81 -20.06 20.46 Favored Glycine 0 C--N 1.371 2.506 0 C-N-CA 126.867 2.175 . . . . 0.0 116.748 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.4 122.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.3 144.86 24.93 Favored 'General case' 0 CA--C 1.483 -1.601 0 O-C-N 119.489 -2.007 . . . . 0.0 111.275 -165.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.463 ' HA3' HD12 ' A' ' 344' ' ' LEU . . . -106.84 175.1 20.54 Favored Glycine 0 CA--C 1.491 -1.454 0 C-N-CA 128.099 2.762 . . . . 0.0 117.186 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 11.5 tp -126.0 120.0 29.15 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 126.776 2.03 . . . . 0.0 106.916 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.758 HG21 ' HG3' ' A' ' 347' ' ' LYS 0.284 8.3 p -92.32 118.46 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HE1' ' CD2' ' A' ' 290' ' ' TYR . 8.1 t60 -80.98 124.09 28.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.162 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -49.43 -10.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.4 0 N-CA-C 121.227 3.788 . . . . 0.0 121.227 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 11.1 t -106.44 -0.85 23.77 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.787 1.635 . . . . 0.0 112.103 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -67.24 55.8 0.05 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 118.61 2.818 . . . . 0.0 118.61 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 46.3 ttm 144.71 -76.16 0.0 OUTLIER 'General case' 0 C--N 1.371 1.505 0 C-N-CA 129.789 3.236 . . . . 0.0 110.788 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.6 t70 83.25 -98.35 0.01 OUTLIER 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.088 2.955 . . . . 0.0 110.437 -172.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . 0.272 4.1 t90 61.65 -158.75 0.33 Allowed 'General case' 0 C--N 1.369 1.425 0 C-N-CA 130.443 3.497 . . . . 0.0 116.366 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 t -145.26 145.95 31.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 100.326 -3.953 . . . . 0.0 100.326 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.255 0.1 OUTLIER 95.41 -11.08 0.1 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 126.562 1.945 . . . . 0.0 110.202 -175.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.57 0.57 8.8 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 128.359 2.664 . . . . 0.0 110.261 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.77 -10.22 58.99 Favored 'General case' 0 C--N 1.37 1.497 0 O-C-N 119.671 -1.893 . . . . 0.0 113.561 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 316' ' ' ILE . 3.4 mp -82.55 -7.92 11.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 1 C-N-CA 132.985 4.514 . . . . 0.0 110.385 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 320' ' ' LYS . 6.8 m-70 -81.44 119.35 75.39 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 129.075 2.95 . . . . 0.0 112.912 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.22 -23.12 75.14 Favored 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.09 4.526 . . . . 0.0 113.11 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.7 m -81.04 9.47 6.56 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 128.527 2.731 . . . . 0.0 113.681 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.435 ' HG2' ' HB2' ' A' ' 317' ' ' HIS . 71.7 mmtt -87.58 -20.48 26.35 Favored 'General case' 0 C--N 1.369 1.452 0 C-N-CA 123.801 0.84 . . . . 0.0 109.474 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 32.6 t -105.43 -48.87 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 127.567 2.347 . . . . 0.0 107.274 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 284' ' ' VAL 0.412 33.1 t 93.56 137.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 129.757 3.223 . . . . 0.0 115.646 173.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.42 150.39 40.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 128.452 2.701 . . . . 0.0 105.459 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.43 121.37 29.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.912 1.339 . . . . 0.0 108.979 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 86.46 29.35 24.76 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.23 1.395 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -92.34 150.47 20.82 Favored 'General case' 0 C--N 1.364 1.218 0 O-C-N 120.636 -1.508 . . . . 0.0 109.311 172.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.282 0.7 OUTLIER -117.08 130.52 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 120.065 -1.647 . . . . 0.0 107.385 175.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -133.85 179.57 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 1 C-N-CA 133.186 4.594 . . . . 0.0 106.933 -171.768 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 346' ' ' LEU . 40.7 tt0 -112.03 150.14 31.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 100.558 -3.867 . . . . 0.0 100.558 172.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -146.51 144.19 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 42.7 ttm -105.84 141.66 36.88 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 120.125 -1.609 . . . . 0.0 107.45 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.59 HG22 HD21 ' A' ' 280' ' ' LEU . 68.4 t -69.59 128.92 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.05 -136.16 0.28 Allowed 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 171.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' A' ' 343' ' ' SER 0.307 19.3 m-20 -61.15 111.86 1.88 Allowed 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -154.363 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.2 tp -101.94 118.36 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 124.023 1.868 . . . . 0.0 108.886 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -117.62 103.29 9.9 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.84 -11.11 59.78 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.614 1.966 . . . . 0.0 115.42 -168.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.04 -33.55 15.47 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 128.201 2.601 . . . . 0.0 111.183 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -100.8 -29.48 12.23 Favored 'General case' 0 C--N 1.368 1.406 0 C-N-CA 125.052 1.341 . . . . 0.0 113.156 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.297 65.2 mtp85 72.96 51.96 0.14 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 128.858 2.863 . . . . 0.0 112.618 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.62 132.79 53.41 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 110.79 -2.914 . . . . 0.0 106.631 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . 0.258 2.1 mt -114.09 129.7 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 334' ' ' ASP . 4.2 t -102.52 94.23 5.55 Favored 'General case' 0 C--N 1.384 2.096 0 C-N-CA 111.854 -3.938 . . . . 0.0 105.801 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.463 HD12 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -97.23 136.29 37.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 119.495 -2.003 . . . . 0.0 107.637 -169.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.495 ' CA ' HG23 ' A' ' 304' ' ' VAL . . . -152.67 123.42 1.45 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.498 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 330' ' ' VAL 0.59 0.2 OUTLIER -140.46 -93.0 0.16 Allowed 'General case' 0 C--N 1.363 1.186 0 C-N-CA 129.691 3.196 . . . . 0.0 109.137 172.383 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 347' ' ' LYS . . . . . 0.758 ' HG3' HG21 ' A' ' 304' ' ' VAL 0.356 35.6 mtmm 111.84 18.09 0.0 OUTLIER 'General case' 0 C--N 1.378 1.815 0 C-N-CA 126.781 2.033 . . . . 0.0 113.265 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.58 82.27 2.27 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 120.285 -1.509 . . . . 0.0 112.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 27.6 p -31.57 157.3 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 2 C-N-CA 135.519 5.527 . . . . 0.0 121.902 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -75.23 166.85 22.99 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 129.588 3.155 . . . . 0.0 114.551 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.76 88.22 3.98 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.708 1.603 . . . . 0.0 108.071 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 87.24 70.83 0.05 OUTLIER Pre-proline 0 C--N 1.357 0.927 0 C-N-CA 130.14 3.376 . . . . 0.0 108.777 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.44 -14.38 25.0 Favored 'Trans proline' 0 C--N 1.37 1.672 1 C-N-CA 126.391 4.728 . . . . 0.0 117.662 -173.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -122.31 28.2 7.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 126.303 1.841 . . . . 0.0 110.045 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.15 59.98 0.77 Allowed 'General case' 0 C--N 1.361 1.075 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.3 72.32 7.14 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.312 3.045 . . . . 0.0 116.057 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.258 16.7 m-85 72.02 99.86 0.07 Allowed 'General case' 0 C--N 1.365 1.241 0 N-CA-C 118.202 2.667 . . . . 0.0 118.202 171.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 102.6 -131.23 0.0 OUTLIER 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.136 2.974 . . . . 0.0 108.054 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -94.13 -52.25 4.47 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.225 -0.922 . . . . 0.0 111.928 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . 0.387 32.2 p 113.48 131.23 0.0 OUTLIER 'General case' 0 C--N 1.358 0.939 1 C-N-CA 132.257 4.223 . . . . 0.0 109.061 -176.696 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 13.1 p80 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 -176.785 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 12.7 t90 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.76 122.68 38.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 127.1 2.16 . . . . 0.0 112.508 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -101.34 2.77 39.97 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 125.426 1.49 . . . . 0.0 113.92 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 3.6 pt -126.63 29.37 2.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 127.302 2.241 . . . . 0.0 107.934 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.87 114.22 4.36 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 128.465 2.706 . . . . 0.0 115.017 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -98.19 149.74 22.23 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 124.536 1.134 . . . . 0.0 113.922 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -151.05 -45.27 0.12 Allowed 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 125.902 1.681 . . . . 0.0 108.467 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 75.42 171.05 0.11 Allowed Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 169.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.25 -48.28 10.23 Favored 'Trans proline' 0 CA--C 1.546 1.101 1 C-N-CA 125.506 4.137 . . . . 0.0 113.617 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 81.38 126.81 0.04 OUTLIER 'General case' 0 C--N 1.373 1.615 0 C-N-CA 128.884 2.874 . . . . 0.0 113.187 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.97 11.13 56.89 Favored Glycine 0 C--N 1.381 3.058 0 CA-C-O 124.979 2.433 . . . . 0.0 112.41 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 20.6 p -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.45 -0.442 1 C-N-CA 133.252 4.621 . . . . 0.0 102.887 172.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -105.09 153.95 20.81 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 123.0 1.381 . . . . 0.0 113.509 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . 0.335 0.0 OUTLIER -136.1 173.88 11.23 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-O 123.485 1.612 . . . . 0.0 109.229 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.7 m -106.51 138.65 42.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -143.54 176.89 22.69 Favored Glycine 0 CA--C 1.483 -1.953 0 CA-C-O 123.387 1.549 . . . . 0.0 111.629 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -128.31 132.09 48.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 294' ' ' VAL . 3.1 t -82.69 127.48 39.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.41 1.484 . . . . 0.0 114.147 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -107.94 -53.11 2.67 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.357 1.863 . . . . 0.0 112.853 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.27 174.83 9.97 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 120.695 -1.253 . . . . 0.0 111.071 -170.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 150.75 39.84 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 166.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 177.88 4.48 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.64 -24.18 62.67 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.902 2.081 . . . . 0.0 113.606 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -151.56 45.35 0.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 124.579 2.133 . . . . 0.0 109.046 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.46 -164.91 33.28 Favored Glycine 0 CA--C 1.47 -2.765 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 15.3 p -143.5 151.13 39.91 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 123.783 0.833 . . . . 0.0 109.356 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.59 124.44 44.8 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.769 -0.582 . . . . 0.0 109.645 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 284' ' ' VAL . 3.0 t -109.59 131.69 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.516 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.02 122.18 42.5 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.215 -1.553 . . . . 0.0 113.68 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.17 56.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 111.379 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 77.8 170.0 0.22 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.608 2.363 . . . . 0.0 109.92 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.88 119.46 12.6 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 119.594 -1.941 . . . . 0.0 115.192 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.11 -31.84 5.69 Favored Glycine 0 C--N 1.367 2.294 0 C-N-CA 127.1 2.286 . . . . 0.0 115.069 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.27 128.27 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.89 1.676 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -141.83 158.66 43.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 118.675 -2.515 . . . . 0.0 106.868 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -130.69 173.1 20.27 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 123.849 1.805 . . . . 0.0 113.743 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.52 121.41 37.42 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 126.468 1.907 . . . . 0.0 107.514 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.649 HG13 ' H ' ' A' ' 346' ' ' LEU . 95.8 t -86.39 113.18 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.494 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -72.12 115.78 11.75 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -30.72 -44.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 120.383 3.475 . . . . 0.0 120.383 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 6.9 m -91.31 -0.58 57.68 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 124.994 1.318 . . . . 0.0 113.939 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -100.91 65.46 1.11 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.82 1.648 . . . . 0.0 109.769 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 11.8 ttt -115.53 -10.35 11.92 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.016 -1.678 . . . . 0.0 112.567 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.6 t70 97.05 -85.33 0.0 OUTLIER 'General case' 0 C--N 1.368 1.375 0 C-N-CA 128.557 2.743 . . . . 0.0 106.948 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -91.28 86.6 6.19 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-O 122.575 1.179 . . . . 0.0 110.164 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 12.1 t -143.73 -166.17 2.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.475 -1.39 . . . . 0.0 108.418 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 78.58 -51.87 0.47 Allowed 'General case' 0 C--N 1.356 0.853 0 C-N-CA 130.242 3.417 . . . . 0.0 110.834 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -9.98 59.66 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.415 2.286 . . . . 0.0 112.987 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -88.34 -17.21 31.09 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 129.747 3.219 . . . . 0.0 111.539 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.6 mp 59.52 -37.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.352 1 C-N-CA 132.837 4.455 . . . . 0.0 117.321 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -130.42 100.82 17.89 Favored Pre-proline 0 N--CA 1.444 -0.738 0 C-N-CA 125.738 1.615 . . . . 0.0 110.724 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.71 -17.51 37.74 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.313 3.342 . . . . 0.0 111.854 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 11.1 p -82.84 3.13 30.88 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 129.592 3.157 . . . . 0.0 115.673 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -6.73 15.72 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.687 -1.258 . . . . 0.0 110.194 170.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 17.3 t -102.73 -48.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 C-N-CA 127.067 2.147 . . . . 0.0 109.275 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.9 t -96.7 116.31 38.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 126.295 1.838 . . . . 0.0 109.749 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -104.72 165.98 10.7 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 126.684 1.993 . . . . 0.0 110.773 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.1 121.23 30.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 C-N-CA 126.866 2.066 . . . . 0.0 107.661 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.53 16.06 53.5 Favored Glycine 0 C--N 1.357 1.725 0 C-N-CA 125.426 1.489 . . . . 0.0 113.957 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -90.51 164.05 14.39 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.042 2.137 . . . . 0.0 111.187 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.44 125.07 72.19 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 51.6 t -134.42 165.49 31.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 C-N-CA 127.11 2.164 . . . . 0.0 106.653 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -114.92 135.58 54.05 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 100.931 -3.729 . . . . 0.0 100.931 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 2.8 m -129.81 163.28 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.362 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -169.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 33.1 ttm -127.9 138.03 52.52 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.07 132.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.01 -134.54 0.28 Allowed 'General case' 0 N--CA 1.408 -2.554 1 N-CA-C 98.951 -4.462 . . . . 0.0 98.951 174.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.98 111.81 6.65 Favored 'General case' 0 C--N 1.313 -1.018 1 N-CA-C 122.028 4.084 . . . . 0.0 122.028 -155.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.365 0.1 OUTLIER -96.83 112.52 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 126.615 1.966 . . . . 0.0 107.336 177.352 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.41 102.36 15.09 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 128.845 2.858 . . . . 0.0 105.092 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.19 -3.12 41.02 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -166.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.88 -43.15 14.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 130.001 3.32 . . . . 0.0 110.902 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -99.52 -38.05 8.93 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.167 2.187 . . . . 0.0 113.348 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.389 47.2 mtm105 75.22 51.73 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 1 C-N-CA 134.857 5.263 . . . . 0.0 114.215 179.802 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.5 OUTLIER -116.23 125.54 52.37 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 126.229 1.812 . . . . 0.0 107.348 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.8 mm -91.62 131.12 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 1 C-N-CA 132.876 4.471 . . . . 0.0 108.964 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.1 t -102.87 92.57 4.64 Favored 'General case' 0 C--N 1.385 2.144 1 C-N-CA 110.602 -4.439 . . . . 0.0 106.048 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.437 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -102.86 136.98 41.68 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 119.415 -2.053 . . . . 0.0 109.305 -174.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -130.81 138.51 10.23 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.649 ' H ' HG13 ' A' ' 304' ' ' VAL 0.492 0.1 OUTLIER -54.19 162.26 1.08 Allowed 'General case' 0 C--N 1.369 1.44 1 N-CA-C 127.146 5.98 . . . . 0.0 127.146 -161.32 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -125.4 -48.63 1.69 Allowed 'General case' 0 C--N 1.382 1.996 0 O-C-N 121.732 -0.605 . . . . 0.0 111.989 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.25 48.3 tp60 -124.51 -86.3 0.63 Allowed 'General case' 0 C--N 1.37 1.473 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.307 20.8 p 111.89 146.32 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 1 C-N-CA 131.965 4.106 . . . . 0.0 106.321 -172.438 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -94.89 130.24 41.58 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.279 -1.513 . . . . 0.0 111.143 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.08 75.45 4.08 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.094 2.158 . . . . 0.0 111.216 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ASN . . . . . 0.455 ' H ' ' HD3' ' A' ' 353' ' ' PRO . 1.1 t30 125.29 66.94 0.0 OUTLIER Pre-proline 0 C--N 1.344 0.366 1 C-N-CA 133.955 4.902 . . . . 0.0 102.748 -175.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 353' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 352' ' ' ASN . 83.9 Cg_endo -74.93 -27.42 10.16 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 124.194 3.263 . . . . 0.0 113.119 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -114.11 -126.83 0.29 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.261 1.824 . . . . 0.0 108.753 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -121.16 138.27 54.29 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.515 2.326 . . . . 0.0 109.367 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -159.53 55.31 0.39 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 122.638 1.209 . . . . 0.0 107.881 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.33 46.38 0.26 Allowed 'General case' 0 C--N 1.365 1.256 0 C-N-CA 127.978 2.511 . . . . 0.0 116.973 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -147.22 75.54 1.38 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.536 1.534 . . . . 0.0 106.871 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -127.87 -124.15 0.23 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.721 1.209 . . . . 0.0 111.098 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.8 t -140.21 35.65 1.9 Allowed 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.973 -1.704 . . . . 0.0 108.89 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 . . . . . 0 C--O 1.261 1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.422 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 270' ' ' ILE . 40.7 t -97.52 161.3 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 130.962 3.705 . . . . 0.0 107.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.41 11.01 32.13 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.204 -2.185 . . . . 0.0 116.088 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 268' ' ' VAL . 20.5 tt -163.19 151.82 3.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 O-C-N 120.556 -1.34 . . . . 0.0 107.404 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.294 . . 85.84 -109.08 0.01 OUTLIER 'General case' 0 C--N 1.355 0.809 0 C-N-CA 128.065 2.546 . . . . 0.0 115.126 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . 0.306 9.6 pttp -149.94 -75.08 0.16 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 124.216 1.96 . . . . 0.0 113.379 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -69.88 0.83 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 127.876 2.47 . . . . 0.0 109.323 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -93.53 152.11 40.66 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.25 -40.87 1.45 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 124.23 3.287 . . . . 0.0 112.236 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 332' ' ' VAL 0.263 44.4 mt-10 79.84 111.0 0.07 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.984 2.514 . . . . 0.0 113.001 178.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 8.69 38.12 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 123.894 1.83 . . . . 0.0 113.436 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' THR . . . . . 0.535 ' O ' HG12 ' A' ' 332' ' ' VAL . 68.5 p -98.56 139.21 34.63 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 93.8 mttt -97.98 146.1 25.83 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.059 -2.275 . . . . 0.0 111.577 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.44 143.03 39.5 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.579 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.8 m -82.35 142.65 31.84 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.842 -1.162 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.47 173.57 33.62 Favored Glycine 0 CA--C 1.486 -1.721 0 CA-C-O 123.174 1.43 . . . . 0.0 112.719 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 60.2 mtm-85 -117.8 131.08 56.62 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 125.925 1.69 . . . . 0.0 108.655 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 17.6 t -77.38 133.24 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.281 10.1 t -122.62 -39.85 2.51 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -133.82 165.98 23.71 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 3.8 mp -121.16 153.17 37.88 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 122.131 2.241 . . . . 0.0 116.871 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 178.41 4.29 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -29.33 66.31 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.255 18.1 m-85 -156.8 52.72 0.51 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.96 3.704 . . . . 0.0 103.481 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.11 37.22 Favored Glycine 0 N--CA 1.432 -1.62 1 N-CA-C 100.469 -5.053 . . . . 0.0 100.469 172.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' CYS . . . . . 0.506 ' H ' HG13 ' A' ' 304' ' ' VAL . 31.5 p -165.32 172.09 12.74 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.653 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -103.14 120.2 40.27 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 330' ' ' VAL . 49.1 t -108.88 135.89 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -100.19 121.03 40.8 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.603 -1.936 . . . . 0.0 111.254 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.28 40.1 mm -66.65 -87.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -140.04 166.63 24.13 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 131.402 3.881 . . . . 0.0 101.329 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.16 120.28 7.28 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.4 -15.72 59.79 Favored Glycine 0 C--N 1.367 2.302 0 C-N-CA 127.18 2.324 . . . . 0.0 115.441 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.496 HG13 HG13 ' A' ' 342' ' ' ILE . 92.9 t -116.73 121.41 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.538 1.935 . . . . 0.0 111.246 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.87 151.24 50.66 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -119.8 173.48 15.18 Favored Glycine 0 CA--C 1.493 -1.284 0 CA-C-O 124.954 2.419 . . . . 0.0 115.303 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.619 HD11 ' HG3' ' A' ' 308' ' ' GLU . 13.8 tp -125.7 121.59 33.89 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.506 HG13 ' H ' ' A' ' 292' ' ' CYS 0.311 1.5 p -87.15 121.1 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-O 122.422 1.106 . . . . 0.0 109.838 171.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.65 ' HA ' ' CB ' ' A' ' 308' ' ' GLU . 54.4 m-70 -86.51 108.9 18.75 Favored 'General case' 0 N--CA 1.397 -3.118 0 C-N-CA 128.48 2.712 . . . . 0.0 109.087 155.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.51 -62.47 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.883 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 164.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 1.2 t -144.45 41.88 1.36 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.65 ' CB ' ' HA ' ' A' ' 305' ' ' HIS . 5.8 tm-20 -62.19 70.16 0.01 OUTLIER 'General case' 0 C--N 1.403 2.908 0 C-N-CA 128.263 2.625 . . . . 0.0 113.148 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 11.9 ttt -122.2 -128.0 0.26 Allowed 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 128.419 2.688 . . . . 0.0 109.7 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.71 22.65 5.43 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 126.623 1.969 . . . . 0.0 110.604 -169.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -98.92 154.67 17.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.6 t -149.3 156.26 41.82 Favored 'General case' 0 C--N 1.367 1.358 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 170.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 156.73 -51.17 0.0 OUTLIER 'General case' 0 C--N 1.357 0.914 0 N-CA-C 102.186 -3.264 . . . . 0.0 102.186 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -111.34 27.29 9.82 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.609 1.564 . . . . 0.0 111.91 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.26 -10.62 52.52 Favored 'General case' 0 C--N 1.378 1.846 0 O-C-N 118.65 -2.531 . . . . 0.0 114.491 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 316' ' ' ILE . 3.6 mp -83.1 -15.5 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 1 C-N-CA 133.022 4.529 . . . . 0.0 111.106 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -84.38 115.97 62.87 Favored Pre-proline 0 C--N 1.368 1.372 0 C-N-CA 125.663 1.585 . . . . 0.0 110.247 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.5 -20.87 51.38 Favored 'Trans proline' 0 C--N 1.373 1.851 1 C-N-CA 126.347 4.698 . . . . 0.0 116.024 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.1 p -80.01 -20.44 45.39 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 128.671 2.789 . . . . 0.0 113.521 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -88.89 -16.67 31.34 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 111.527 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.0 -71.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.617 1.567 . . . . 0.0 109.142 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.494 0.4 OUTLIER 87.73 160.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 128.118 2.567 . . . . 0.0 112.854 -178.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.75 145.56 24.5 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.134 1.445 . . . . 0.0 109.792 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.51 121.0 30.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.02 23.27 55.83 Favored Glycine 0 C--N 1.357 1.703 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.67 31.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 118.749 1.275 . . . . 0.0 108.166 171.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.252 2.0 p -96.29 129.36 46.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 CA-C-O 123.416 1.579 . . . . 0.0 108.554 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -130.48 -179.57 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 1 C-N-CA 132.312 4.245 . . . . 0.0 110.834 -173.396 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -124.27 142.29 51.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 294' ' ' VAL . 2.9 m -146.71 139.37 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 46.5 ttp -96.32 131.38 42.9 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 118.525 -2.61 . . . . 0.0 111.109 -173.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 276' ' ' GLU . 7.9 p -74.11 124.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.51 -130.32 0.25 Allowed 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.338 7.4 t70 -57.8 112.46 1.48 Allowed 'General case' 0 N--CA 1.475 0.811 1 N-CA-C 122.586 4.291 . . . . 0.0 122.586 -158.36 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . 0.266 3.4 tp -107.81 114.41 46.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 339' ' ' ARG . 96.1 m-20 -124.7 119.74 29.83 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.518 1.927 . . . . 0.0 107.849 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -88.14 -5.36 58.47 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 125.461 1.504 . . . . 0.0 114.635 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.64 -35.3 14.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.296 2.238 . . . . 0.0 110.285 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.477 ' HB2' ' CB ' ' A' ' 336' ' ' ASP . 0.0 OUTLIER -89.88 -46.93 8.21 Favored 'General case' 0 CA--C 1.508 -0.647 1 C-N-CA 132.08 4.152 . . . . 0.0 112.379 -177.512 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.322 64.5 mtm-85 75.07 52.53 0.08 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 131.135 3.774 . . . . 0.0 112.532 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 133.14 52.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 111.451 -2.613 . . . . 0.0 107.943 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.496 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -110.73 129.5 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.828 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 170.484 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.92 4.8 Favored 'General case' 0 CA--C 1.474 -1.981 1 C-N-CA 111.082 -4.247 . . . . 0.0 107.715 -164.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 332' ' ' VAL . 2.6 mp -97.96 135.57 39.48 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.748 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.18 122.76 1.63 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.815 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.497 ' H ' HG12 ' A' ' 330' ' ' VAL 0.663 0.7 OUTLIER -144.55 -99.04 0.1 Allowed 'General case' 0 C--N 1.37 1.46 0 C-N-CA 128.979 2.911 . . . . 0.0 113.105 178.512 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.454 48.2 mtmt 85.01 68.3 0.01 OUTLIER 'General case' 0 C--N 1.374 1.651 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -118.11 -10.86 10.24 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 120.632 -1.292 . . . . 0.0 111.547 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 328' ' ' VAL 0.277 37.2 m 78.81 170.34 0.19 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 130.293 3.437 . . . . 0.0 116.19 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -91.39 170.9 9.59 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 127.774 2.43 . . . . 0.0 111.989 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.66 78.74 3.33 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.817 2.047 . . . . 0.0 109.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 14.3 t30 101.2 74.18 0.0 OUTLIER Pre-proline 0 C--N 1.361 1.105 0 C-N-CA 131.203 3.801 . . . . 0.0 108.541 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.24 14.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.363 1.327 1 C-N-CA 125.648 4.232 . . . . 0.0 119.392 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -89.62 -160.57 0.69 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-N 121.858 2.117 . . . . 0.0 115.371 -171.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -138.12 21.66 2.81 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 120.301 -1.499 . . . . 0.0 109.879 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.53 75.32 3.25 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.067 1.747 . . . . 0.0 115.036 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.256 14.2 m-85 64.55 -63.68 0.16 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 130.922 3.689 . . . . 0.0 118.321 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -120.83 105.06 10.35 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -109.72 156.2 20.58 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 125.729 1.612 . . . . 0.0 113.78 -175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 41.83 0.01 OUTLIER 'General case' 0 C--N 1.364 1.226 1 C-N-CA 132.645 4.378 . . . . 0.0 117.897 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 C--O 1.261 1.677 1 C-N-CA 132.291 4.237 . . . . 0.0 108.608 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 47.0 m95 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 26.3 t -106.33 141.58 21.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 C-N-CA 127.004 2.122 . . . . 0.0 105.995 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.2 -21.67 64.86 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ILE . . . . . 0.41 ' HB ' ' H ' ' A' ' 271' ' ' ALA . 0.2 OUTLIER -137.44 -155.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 129.424 3.09 . . . . 0.0 108.363 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.41 ' H ' ' HB ' ' A' ' 270' ' ' ILE . . . 75.14 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.357 0.921 0 C-N-CA 129.753 3.221 . . . . 0.0 114.988 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -178.45 137.03 0.16 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 128.713 2.805 . . . . 0.0 105.586 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.1 21.39 12.35 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 113.043 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -167.41 162.06 10.29 Favored Pre-proline 0 C--N 1.348 0.504 0 O-C-N 119.657 -1.902 . . . . 0.0 112.992 -173.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -86.14 96.85 0.55 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.968 3.112 . . . . 0.0 108.107 160.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -68.92 138.7 54.85 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 128.867 2.867 . . . . 0.0 114.813 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.76 14.96 47.88 Favored Glycine 0 C--N 1.387 3.401 0 CA-C-O 124.514 2.174 . . . . 0.0 112.799 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 6.0 p -92.78 146.05 23.94 Favored 'General case' 0 CA--C 1.509 -0.602 1 C-N-CA 133.16 4.584 . . . . 0.0 100.799 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.6 OUTLIER -108.03 153.37 23.21 Favored 'General case' 0 CA--C 1.49 -1.348 0 O-C-N 119.847 -1.783 . . . . 0.0 110.411 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.461 HD23 ' CG1' ' A' ' 332' ' ' VAL . 1.6 mm? -125.64 174.34 8.35 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 112.073 -2.33 . . . . 0.0 107.476 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 88.9 m -118.29 137.98 52.69 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -157.16 170.0 34.32 Favored Glycine 0 CA--C 1.478 -2.259 0 CA-C-O 123.241 1.467 . . . . 0.0 110.384 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 327' ' ' VAL . 44.3 ttm-85 -117.15 135.14 53.99 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 124.787 1.235 . . . . 0.0 108.465 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 322' ' ' VAL . 39.4 t -87.92 132.29 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 120.265 -1.522 . . . . 0.0 113.63 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -128.32 -33.43 2.14 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -171.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -133.74 173.06 11.94 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 122.004 2.184 . . . . 0.0 107.332 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.54 150.83 40.25 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 118.908 -2.37 . . . . 0.0 112.761 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.62 178.14 4.4 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -29.02 68.53 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.346 2.258 . . . . 0.0 115.195 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.262 1.7 p90 -149.84 43.1 0.89 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 124.194 1.949 . . . . 0.0 109.634 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.09 -170.81 40.75 Favored Glycine 0 CA--C 1.468 -2.872 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 165.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 2.8 m -134.71 147.1 50.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.31 126.46 36.4 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.231 -1.543 . . . . 0.0 108.982 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.34 138.28 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 125.939 1.696 . . . . 0.0 106.546 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -100.12 124.05 45.07 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.573 -1.33 . . . . 0.0 108.028 168.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 344' ' ' LEU . 0.8 OUTLIER -64.67 -67.87 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 124.905 2.288 . . . . 0.0 116.1 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.38 161.41 35.06 Favored 'General case' 0 CA--C 1.485 -1.551 2 N-CA-C 98.716 -4.55 . . . . 0.0 98.716 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.81 119.5 10.1 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 104.34 -11.58 51.21 Favored Glycine 0 C--N 1.364 2.107 0 C-N-CA 125.526 1.536 . . . . 0.0 116.379 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.63 144.3 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.62 1.968 . . . . 0.0 106.942 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.01 155.11 48.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.182 -1.574 . . . . 0.0 112.082 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -120.9 174.88 15.93 Favored Glycine 0 C--N 1.36 1.886 0 C-N-CA 130.439 3.876 . . . . 0.0 117.526 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 42.6 tp -127.28 116.08 20.01 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 111.965 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 345' ' ' GLY 0.296 6.4 p -92.25 104.38 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 O-C-N 120.495 -1.378 . . . . 0.0 108.268 175.027 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -70.44 129.05 38.24 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 124.749 1.22 . . . . 0.0 113.011 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -52.75 -21.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 p -83.1 -13.39 55.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.276 3.03 . . . . 0.0 115.277 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -74.75 42.48 0.17 Allowed 'General case' 0 C--N 1.372 1.553 0 O-C-N 118.994 -2.316 . . . . 0.0 115.751 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 17.2 ttt -84.59 -42.24 15.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.863 3.265 . . . . 0.0 115.533 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 30.4 t70 84.72 -72.1 0.03 OUTLIER 'General case' 0 C--N 1.367 1.335 0 C-N-CA 127.431 2.293 . . . . 0.0 111.268 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -162.91 179.44 7.59 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 128.152 2.581 . . . . 0.0 104.4 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 4.7 t -82.23 59.48 4.51 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 127.599 2.36 . . . . 0.0 111.19 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -93.34 58.36 2.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 128.267 2.627 . . . . 0.0 111.106 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 77.18 32.63 0.46 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 129.294 3.037 . . . . 0.0 110.381 -175.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.37 -52.21 2.8 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.137 1.775 . . . . 0.0 112.619 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.269 2.4 mp 73.56 -50.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 C-N-CA 130.271 3.428 . . . . 0.0 112.701 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.405 ' HB2' ' HG2' ' A' ' 320' ' ' LYS . 1.7 m-70 -143.4 126.13 8.82 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 127.772 2.429 . . . . 0.0 108.083 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -77.48 29.36 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 125.12 3.88 . . . . 0.0 113.459 176.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 10.4 p -124.55 -6.31 7.55 Favored 'General case' 0 N--CA 1.436 -1.134 1 C-N-CA 131.937 4.095 . . . . 0.0 109.421 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 317' ' ' HIS . 31.3 mmtp -90.3 -46.12 8.61 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.262 3.7 m -85.07 14.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.331 0 O-C-N 119.418 -2.051 . . . . 0.0 115.682 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 284' ' ' VAL . 39.7 t -129.75 116.43 38.05 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 C-N-CA 127.246 2.219 . . . . 0.0 107.362 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -120.43 155.64 33.07 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.8 121.58 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.531 1.532 . . . . 0.0 109.974 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 87.95 23.56 38.0 Favored Glycine 0 C--N 1.362 1.998 0 C-N-CA 125.999 1.761 . . . . 0.0 114.056 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.96 146.04 48.75 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.922 -1.34 . . . . 0.0 110.753 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 283' ' ' ARG 0.306 2.7 p -92.59 138.72 19.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 125.434 1.494 . . . . 0.0 112.18 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 330' ' ' VAL . 4.9 m -140.94 179.39 2.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 C-N-CA 129.195 2.998 . . . . 0.0 108.828 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -110.89 140.39 45.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 346' ' ' LEU . 3.4 m -144.93 139.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 58.8 ttp -104.71 138.59 40.78 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-N 121.12 1.782 . . . . 0.0 108.337 -173.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.685 HG12 HD12 ' A' ' 344' ' ' LEU . 1.9 m -77.08 128.38 37.94 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 -165.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.64 -131.77 0.27 Allowed 'General case' 0 N--CA 1.421 -1.913 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.386 11.6 m-20 -54.64 113.07 1.16 Allowed 'General case' 0 N--CA 1.478 0.953 1 N-CA-C 124.452 4.982 . . . . 0.0 124.452 -156.748 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.68 129.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -145.07 118.5 9.04 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 170.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -16.0 52.43 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 125.179 1.392 . . . . 0.0 113.845 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.35 -35.45 19.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 130.013 3.325 . . . . 0.0 111.374 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -94.87 -26.74 16.05 Favored 'General case' 0 C--N 1.367 1.359 0 C-N-CA 125.103 1.361 . . . . 0.0 111.389 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.304 47.0 mtm180 73.37 48.1 0.17 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 131.115 3.766 . . . . 0.0 113.761 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 129.16 48.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 110.278 -3.146 . . . . 0.0 108.091 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.92 123.3 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.433 1 N-CA-C 95.976 -5.565 . . . . 0.0 95.976 174.28 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.05 94.51 5.21 Favored 'General case' 0 CA--C 1.468 -2.21 1 C-N-CA 110.975 -4.29 . . . . 0.0 106.503 -166.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.685 HD12 HG12 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -97.98 139.02 34.43 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 121.165 1.802 . . . . 0.0 107.68 -175.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 304' ' ' VAL . . . -145.35 122.41 1.7 Allowed Glycine 0 CA--C 1.471 -2.703 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.815 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.535 ' H ' HG12 ' A' ' 330' ' ' VAL 0.759 0.2 OUTLIER -141.57 -107.07 0.14 Allowed 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 127.499 2.32 . . . . 0.0 112.531 171.019 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.355 13.3 pttp 121.95 29.5 0.0 OUTLIER 'General case' 0 C--N 1.382 2.003 0 C-N-CA 129.954 3.302 . . . . 0.0 115.587 -173.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -86.59 16.84 4.29 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 118.438 -2.664 . . . . 0.0 117.181 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.279 11.9 p 62.51 147.87 0.02 OUTLIER 'General case' 0 C--N 1.366 1.314 0 N-CA-C 120.804 3.631 . . . . 0.0 120.804 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -103.28 169.3 8.63 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 125.645 1.578 . . . . 0.0 110.518 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.3 81.36 3.61 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.039 -2.288 . . . . 0.0 111.742 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 94.49 75.2 0.03 OUTLIER Pre-proline 0 C--N 1.354 0.795 1 C-N-CA 132.812 4.445 . . . . 0.0 106.161 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.23 -2.29 4.69 Favored 'Trans proline' 0 C--N 1.366 1.494 1 C-N-CA 125.574 4.183 . . . . 0.0 117.277 -172.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -94.38 -15.96 23.88 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.011 2.124 . . . . 0.0 109.554 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . 0.256 9.3 tt0 85.64 90.01 0.03 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.783 3.233 . . . . 0.0 116.783 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -85.27 161.15 19.66 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.248 1.419 . . . . 0.0 108.777 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -64.05 97.97 0.2 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 128.246 2.618 . . . . 0.0 114.6 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 56.32 -109.1 0.47 Allowed 'General case' 0 C--N 1.365 1.272 0 C-N-CA 129.052 2.941 . . . . 0.0 116.534 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -108.81 63.51 0.61 Allowed 'General case' 0 C--N 1.355 0.835 0 C-N-CA 126.659 1.984 . . . . 0.0 109.602 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.1 p -116.11 29.35 8.03 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.558 1.543 . . . . 0.0 109.298 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.43 0 C-N-CA 129.465 3.106 . . . . 0.0 103.86 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.5 m95 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 2.1 t -7.05 103.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.332 1 C-N-CA 134.513 5.125 . . . . 0.0 121.166 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.41 47.96 1.14 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.301 1.44 . . . . 0.0 112.875 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.9 tt -170.41 175.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 74.89 -39.02 0.4 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 128.555 2.742 . . . . 0.0 117.926 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -73.43 138.4 45.18 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.178 2.991 . . . . 0.0 112.904 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -95.72 -13.5 24.14 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -167.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -138.57 163.44 46.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.84 -34.88 1.13 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.519 3.48 . . . . 0.0 112.181 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 73.68 124.72 0.04 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 128.657 2.783 . . . . 0.0 114.23 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.08 11.1 43.79 Favored Glycine 0 C--N 1.372 2.545 0 CA-C-O 124.373 2.096 . . . . 0.0 113.114 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 22.6 p -101.43 136.46 41.23 Favored 'General case' 0 CA--C 1.508 -0.663 1 C-N-CA 131.992 4.117 . . . . 0.0 101.354 171.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -109.37 157.13 19.2 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-O 123.852 1.786 . . . . 0.0 113.039 -176.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -133.93 173.75 11.22 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.126 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.6 m -108.57 144.73 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.59 176.94 30.59 Favored Glycine 0 CA--C 1.486 -1.747 0 CA-C-O 123.822 1.79 . . . . 0.0 111.348 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -130.94 130.43 43.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.867 1.267 . . . . 0.0 108.477 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 294' ' ' VAL . 27.7 t -74.95 131.76 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -114.73 -34.87 5.02 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 112.135 -2.302 . . . . 0.0 112.026 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 293' ' ' PHE . 1.3 t-20 -135.13 155.8 50.08 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.63 136.51 54.94 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 164.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.45 176.84 4.85 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -30.11 71.28 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 118.769 -2.457 . . . . 0.0 116.544 -177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -145.7 40.94 1.2 Allowed 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 125.758 1.623 . . . . 0.0 110.524 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 178.55 -162.19 29.27 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 105.363 -3.095 . . . . 0.0 105.363 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 28.2 p -143.31 165.16 28.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 286' ' ' ASN . 9.7 m-85 -115.28 126.59 54.67 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 284' ' ' VAL . 93.2 t -118.9 132.2 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -167.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.93 127.36 41.88 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.255 -1.528 . . . . 0.0 112.734 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.288 26.7 mm -73.98 -86.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 123.822 1.772 . . . . 0.0 113.941 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.26 171.35 14.57 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 130.037 3.335 . . . . 0.0 103.514 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.09 119.77 10.15 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.44 -17.2 58.08 Favored Glycine 0 C--N 1.37 2.436 0 C-N-CA 127.222 2.344 . . . . 0.0 115.524 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.21 113.31 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.549 1.939 . . . . 0.0 110.527 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -135.5 157.82 45.92 Favored 'General case' 0 CA--C 1.481 -1.71 0 O-C-N 118.307 -2.746 . . . . 0.0 108.215 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -124.6 172.53 16.89 Favored Glycine 0 CA--C 1.482 -1.973 0 CA-C-O 127.1 3.611 . . . . 0.0 114.424 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.59 161.11 16.56 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 110.307 -2.947 . . . . 0.0 103.269 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.54 HG13 ' H ' ' A' ' 346' ' ' LEU . 16.2 t -116.13 130.33 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 O-C-N 124.479 1.112 . . . . 0.0 108.76 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -91.8 114.76 27.38 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 166.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.92 -23.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.595 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.0 m -80.74 -13.23 59.17 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.351 2.661 . . . . 0.0 111.658 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -101.97 68.26 1.12 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 127.06 2.144 . . . . 0.0 106.685 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 25.3 ttt -168.61 -96.95 0.01 OUTLIER 'General case' 0 C--N 1.35 0.617 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -153.58 -114.64 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -144.1 114.67 7.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 12.2 t -164.76 173.62 11.61 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 79.44 -50.74 0.41 Allowed 'General case' 0 C--N 1.364 1.212 0 C-N-CA 128.171 2.588 . . . . 0.0 110.382 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -77.37 2.46 15.87 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 130.692 3.597 . . . . 0.0 112.292 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -104.99 -112.57 0.25 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 127.169 2.188 . . . . 0.0 108.164 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.85 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.036 0 O-C-N 119.546 -1.972 . . . . 0.0 108.808 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -108.23 120.47 46.62 Favored Pre-proline 0 C--N 1.356 0.87 0 O-C-N 119.421 -2.049 . . . . 0.0 112.879 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.17 -28.33 7.42 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 123.98 3.12 . . . . 0.0 110.877 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 8.2 m -61.64 -16.9 52.65 Favored 'General case' 0 C--N 1.368 1.402 1 C-N-CA 133.1 4.56 . . . . 0.0 115.421 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.254 22.4 pttp -91.72 -36.35 13.64 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 125.269 1.428 . . . . 0.0 114.142 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 26.2 m -90.98 -23.61 5.88 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-N 121.265 1.848 . . . . 0.0 112.468 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.32 107.78 17.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.71 158.08 16.37 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 123.641 1.686 . . . . 0.0 107.576 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.38 120.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 C-N-CA 125.199 1.4 . . . . 0.0 109.565 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.49 18.03 53.44 Favored Glycine 0 C--N 1.364 2.098 0 C-N-CA 124.658 1.123 . . . . 0.0 114.235 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.5 144.03 32.83 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 125.501 1.521 . . . . 0.0 109.659 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.85 139.86 16.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 124.006 1.86 . . . . 0.0 111.345 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 346' ' ' LEU . 0.4 OUTLIER -144.59 174.72 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 130.111 3.364 . . . . 0.0 107.32 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.91 144.07 46.64 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 344' ' ' LEU . 0.1 OUTLIER -146.09 139.82 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -175.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 331' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 52.7 ttp -104.0 136.88 42.83 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 119.916 -1.74 . . . . 0.0 109.299 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . 0.267 0.2 OUTLIER -83.83 135.41 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -169.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.46 -126.86 0.26 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ASP . . . . . 0.53 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.437 12.2 m-20 -59.49 113.55 2.26 Favored 'General case' 0 N--CA 1.483 1.181 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -160.014 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 4.9 tp -112.89 120.82 63.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 -165.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 12.3 t0 -140.44 118.57 11.96 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.23 -1.73 57.62 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 126.576 1.95 . . . . 0.0 113.858 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.2 -40.12 9.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 129.245 3.018 . . . . 0.0 109.73 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 336' ' ' ASP . 8.1 mmt180 -88.22 -32.74 18.41 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 131.275 3.83 . . . . 0.0 112.765 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.329 1.3 mmp_? 75.27 50.9 0.08 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 129.426 3.09 . . . . 0.0 114.89 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -125.25 132.22 52.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 110.848 -2.887 . . . . 0.0 108.945 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.99 126.84 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 1 N-CA-C 94.177 -6.231 . . . . 0.0 94.177 171.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 39.6 m -111.0 102.45 10.93 Favored 'General case' 0 CA--C 1.446 -3.053 1 C-N-CA 111.291 -4.164 . . . . 0.0 107.063 -165.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -95.76 173.58 7.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 125.06 2.362 . . . . 0.0 110.913 -165.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.36 136.32 6.23 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.841 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LEU . . . . . 0.54 ' H ' HG13 ' A' ' 304' ' ' VAL . 1.0 OUTLIER -61.8 149.17 40.85 Favored 'General case' 0 C--N 1.369 1.435 1 N-CA-C 123.584 4.661 . . . . 0.0 123.584 -164.976 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -94.92 -98.33 0.16 Allowed 'General case' 0 C--N 1.39 2.363 0 O-C-N 120.916 -1.115 . . . . 0.0 112.8 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -141.24 -1.18 1.37 Allowed 'General case' 0 C--N 1.373 1.601 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.316 3.6 m 79.81 163.36 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.257 1.823 . . . . 0.0 115.445 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' A' ' 353' ' ' PRO . 0.0 OUTLIER -56.69 -145.24 0.0 OUTLIER 'General case' 0 C--N 1.354 0.766 1 C-N-CA 134.535 5.134 . . . . 0.0 118.88 174.114 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 164.9 89.04 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 129.935 3.294 . . . . 0.0 102.969 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 93.11 74.47 0.03 OUTLIER Pre-proline 0 C--N 1.358 0.963 0 C-N-CA 130.087 3.355 . . . . 0.0 105.795 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' PRO . . . . . 0.415 ' HB3' ' HG3' ' A' ' 350' ' ' LYS . 57.9 Cg_endo -68.01 148.04 75.03 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.509 3.473 . . . . 0.0 112.29 -174.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 46.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 130.983 3.713 . . . . 0.0 120.643 -175.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -133.92 -61.3 0.8 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.561 1.544 . . . . 0.0 110.639 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER 88.86 126.08 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.245 2.618 . . . . 0.0 112.626 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -93.95 166.31 12.23 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 125.892 1.677 . . . . 0.0 112.014 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -94.76 66.06 3.11 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.764 1.626 . . . . 0.0 111.786 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -150.88 147.71 27.55 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 73.2 p -106.85 55.15 0.66 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 126.302 1.841 . . . . 0.0 110.738 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.267 2.008 2 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 116.849 -1.548 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.9 -31.28 84.74 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.367 3.378 . . . . 0.0 115.999 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 93.27 119.21 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.665 3.586 . . . . 0.0 109.316 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.13 54.47 Favored Glycine 0 C--N 1.372 2.575 0 CA-C-O 124.74 2.3 . . . . 0.0 112.581 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.84 134.61 44.75 Favored 'General case' 0 CA--C 1.507 -0.684 1 C-N-CA 133.235 4.614 . . . . 0.0 102.479 172.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 12.5 ptmt -103.1 152.56 21.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 10.9 mt -126.05 174.05 8.74 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 124.406 2.051 . . . . 0.0 107.64 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.94 137.15 53.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 168.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -146.98 175.06 26.56 Favored Glycine 0 CA--C 1.482 -1.995 0 CA-C-O 123.783 1.769 . . . . 0.0 111.04 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -117.99 134.82 54.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.455 HG21 HG13 ' A' ' 322' ' ' VAL . 70.0 t -78.87 133.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.302 1.4 t -121.23 -44.19 2.39 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.337 0.3 OUTLIER -136.29 174.83 10.19 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.69 -1.881 . . . . 0.0 111.068 175.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 1.1 mp -121.08 142.01 50.24 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 290' ' ' TYR 0.332 1.1 t -112.49 179.16 4.06 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.564 1.173 . . . . 0.0 110.815 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.44 -28.88 60.77 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 130.129 3.372 . . . . 0.0 115.409 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.413 ' H ' HG23 ' A' ' 288' ' ' THR 0.251 19.2 p90 -156.92 46.76 0.42 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 123.921 1.819 . . . . 0.0 110.025 175.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 174.76 -163.48 33.88 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 0.7 OUTLIER -135.23 151.44 50.6 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.582 1.553 . . . . 0.0 107.535 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.284 57.2 m-85 -105.65 136.18 45.71 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 284' ' ' VAL . 3.7 t -119.94 134.83 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.942 0 CA-C-N 112.316 -2.22 . . . . 0.0 106.285 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -100.12 128.55 46.18 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.856 -1.153 . . . . 0.0 113.302 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.326 29.5 mm -81.53 -103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 123.046 1.403 . . . . 0.0 113.89 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -107.82 169.67 8.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 129.313 3.045 . . . . 0.0 106.813 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.73 119.5 9.42 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 120.114 -1.616 . . . . 0.0 114.591 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 89.26 -5.98 83.78 Favored Glycine 0 C--N 1.369 2.368 0 C-N-CA 127.065 2.269 . . . . 0.0 115.638 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.67 113.49 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.34 2.256 . . . . 0.0 110.802 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.1 157.62 46.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 118.388 -2.695 . . . . 0.0 106.801 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.539 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -126.47 174.0 18.03 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 124.307 2.06 . . . . 0.0 115.901 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 7.9 tp -124.51 125.0 43.49 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.769 1.627 . . . . 0.0 107.888 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.2 110.85 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 C-N-CA 125.997 1.719 . . . . 0.0 107.74 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -79.04 115.14 18.53 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--N 1.373 1.599 0 C-N-CA 130.861 3.664 . . . . 0.0 119.111 -175.376 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 284' ' ' VAL . 9.8 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -114.0 162.88 15.87 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 128.357 2.663 . . . . 0.0 105.678 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.05 120.47 12.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 126.145 1.778 . . . . 0.0 109.493 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.32 13.74 58.21 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 126.081 1.801 . . . . 0.0 116.532 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.84 149.22 21.42 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 126.04 1.736 . . . . 0.0 111.308 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.5 p -100.03 134.21 40.33 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-O 123.415 1.579 . . . . 0.0 110.502 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -134.75 -178.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 1 C-N-CA 134.3 5.04 . . . . 0.0 110.594 -173.171 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -127.34 147.02 50.26 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 129.014 2.925 . . . . 0.0 103.813 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.404 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 1.6 m -146.46 163.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 57.0 ttp -126.53 136.05 52.08 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.54 132.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -136.65 0.3 Allowed 'General case' 0 N--CA 1.417 -2.097 1 N-CA-C 97.92 -4.845 . . . . 0.0 97.92 172.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.32 2.6 t70 -63.2 112.41 2.66 Favored 'General case' 0 C--N 1.316 -0.88 1 N-CA-C 123.205 4.52 . . . . 0.0 123.205 -156.767 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.454 HD11 ' HG2' ' A' ' 337' ' ' GLU 0.334 0.0 OUTLIER -101.71 136.77 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 126.065 1.746 . . . . 0.0 111.36 -177.406 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -139.83 102.86 4.52 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 167.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . 0.454 ' HG2' HD11 ' A' ' 335' ' ' ILE . 24.8 mt-10 -63.14 -18.3 63.3 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 129.124 2.97 . . . . 0.0 113.805 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.33 -32.71 58.85 Favored 'General case' 0 N--CA 1.433 -1.288 1 C-N-CA 133.042 4.537 . . . . 0.0 112.621 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -108.94 -31.64 7.58 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-O 123.188 1.47 . . . . 0.0 112.477 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.342 68.9 mtp180 74.91 50.46 0.09 Allowed 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 130.932 3.693 . . . . 0.0 113.112 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -124.83 125.53 44.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 111.683 -2.508 . . . . 0.0 104.763 178.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.88 130.01 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.216 1 N-CA-C 98.694 -4.558 . . . . 0.0 98.694 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 5.1 t -102.26 92.47 4.74 Favored 'General case' 0 C--N 1.377 1.804 1 C-N-CA 110.298 -4.561 . . . . 0.0 104.336 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -103.78 136.34 43.65 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 117.244 -1.783 . . . . 0.0 111.306 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.66 123.06 1.65 Allowed Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.357 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.404 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.664 1.5 tt -138.89 -90.07 0.21 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 131.176 3.79 . . . . 0.0 108.589 174.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.342 19.4 tttt 101.35 23.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 167.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.43 -47.67 63.36 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.524 ' HA ' HG13 ' A' ' 328' ' ' VAL 0.473 11.8 p 95.28 164.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.374 1 C-N-CA 133.75 4.82 . . . . 0.0 113.916 -177.857 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -92.83 164.15 13.45 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.855 2.062 . . . . 0.0 111.582 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.5 99.31 11.49 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 119.235 -2.165 . . . . 0.0 107.849 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 91.45 64.44 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.831 0 C-N-CA 131.027 3.731 . . . . 0.0 105.968 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo . . . . . 0 C--N 1.368 1.59 0 C-N-CA 123.063 2.509 . . . . 0.0 113.728 -170.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 275' ' ' PRO . 94.5 m-85 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 274' ' ' TYR . 40.4 Cg_exo -67.58 177.06 4.32 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.95 3.767 . . . . 0.0 116.011 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.49 135.6 21.41 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.12 5.11 44.11 Favored Glycine 0 C--N 1.369 2.386 0 CA-C-O 123.856 1.809 . . . . 0.0 112.546 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 70.5 p -95.93 121.87 38.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 130.923 3.689 . . . . 0.0 103.775 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -90.03 146.96 23.96 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.72 1.248 . . . . 0.0 113.362 -176.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 332' ' ' VAL . 2.6 mm? -129.21 174.2 9.8 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-N 112.786 -2.006 . . . . 0.0 106.655 -170.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.29 143.78 51.17 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.64 173.73 38.06 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -119.04 138.36 52.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 322' ' ' VAL . 21.8 t -83.47 132.98 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.158 -1.589 . . . . 0.0 115.153 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.267 2.3 t -136.13 -25.57 1.2 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -133.4 174.37 10.48 Favored 'General case' 0 C--N 1.372 1.551 0 CA-C-N 123.484 2.856 . . . . 0.0 108.053 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.9 OUTLIER -121.01 151.41 39.79 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 167.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 178.18 4.38 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -65.59 -29.35 69.93 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.835 2.054 . . . . 0.0 115.663 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.11 44.44 0.72 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 125.126 2.394 . . . . 0.0 107.915 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 306' ' ' VAL . . . -173.27 -165.21 29.82 Favored Glycine 0 CA--C 1.468 -2.869 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.7 t -143.3 153.83 43.17 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 126.266 1.826 . . . . 0.0 106.694 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.291 65.3 m-85 -114.81 142.22 46.84 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-O 124.885 2.279 . . . . 0.0 111.85 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.56 139.18 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.965 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -100.79 119.28 38.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.601 -1.312 . . . . 0.0 110.391 164.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.277 28.8 mt -60.15 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 124.433 2.063 . . . . 0.0 116.19 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.26 147.34 50.23 Favored 'General case' 0 CA--C 1.495 -1.153 1 N-CA-C 98.963 -4.458 . . . . 0.0 98.963 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -57.41 119.97 7.4 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.17 -10.55 47.49 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.731 1.634 . . . . 0.0 114.649 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.3 t -116.24 143.93 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 C-N-CA 127.966 2.506 . . . . 0.0 105.067 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -152.42 149.75 28.92 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 119.282 -2.136 . . . . 0.0 105.841 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 344' ' ' LEU . . . -130.51 173.87 19.92 Favored Glycine 0 CA--C 1.485 -1.84 0 CA-C-O 124.368 2.093 . . . . 0.0 113.924 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 292' ' ' CYS . 62.2 tp -97.81 163.49 12.78 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 120.378 -1.66 . . . . 0.0 110.157 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.263 11.8 t -116.76 118.89 60.28 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -79.87 113.27 17.91 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.43 ' HB ' ' HA2' ' A' ' 291' ' ' GLY 0.386 7.6 p . . . . . 0 C--N 1.377 1.786 1 N-CA-C 122.003 4.075 . . . . 0.0 122.003 -166.565 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 284' ' ' VAL 0.297 4.1 t . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 125.009 2.338 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -109.47 168.17 9.59 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.364 3.065 . . . . 0.0 107.66 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.33 121.2 23.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.38 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.43 14.95 56.42 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 125.676 1.608 . . . . 0.0 114.225 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.65 143.71 26.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.998 1.319 . . . . 0.0 110.912 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.83 136.25 31.92 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.773 1.273 . . . . 0.0 108.519 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -139.77 177.89 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 129.664 3.186 . . . . 0.0 107.074 -171.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -123.91 138.32 54.5 Favored 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 98.819 -4.512 . . . . 0.0 98.819 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 7.7 m -143.47 139.97 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 100.667 -3.827 . . . . 0.0 100.667 -167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.7 ttm -102.57 141.64 35.07 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 120.363 -1.46 . . . . 0.0 108.781 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 342' ' ' ILE . 74.9 t -81.5 133.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 119.936 -1.727 . . . . 0.0 115.463 -170.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -135.35 0.29 Allowed 'General case' 0 N--CA 1.426 -1.643 1 N-CA-C 99.618 -4.215 . . . . 0.0 99.618 172.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.402 0.8 OUTLIER -59.69 112.72 1.92 Allowed 'General case' 0 N--CA 1.481 1.122 1 N-CA-C 124.196 4.887 . . . . 0.0 124.196 -158.976 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 0.3 OUTLIER -101.48 112.83 35.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 C-N-CA 125.65 1.58 . . . . 0.0 114.176 -176.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.55 107.48 6.67 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.87 7.32 37.81 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 126.535 1.934 . . . . 0.0 112.302 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . 0.25 24.1 mm-40 -82.71 -41.91 18.71 Favored 'General case' 0 N--CA 1.432 -1.351 1 C-N-CA 134.021 4.928 . . . . 0.0 108.831 170.955 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -101.51 -27.08 13.32 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.655 1.982 . . . . 0.0 111.349 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 63.1 mtm-85 75.32 53.21 0.07 Allowed 'General case' 0 C--N 1.35 0.604 1 C-N-CA 131.968 4.107 . . . . 0.0 112.702 -179.933 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.9 ptt180 -124.53 134.0 53.13 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 111.092 -2.776 . . . . 0.0 109.621 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 332' ' ' VAL . 0.7 OUTLIER -118.83 122.0 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 1 N-CA-C 94.44 -6.133 . . . . 0.0 94.44 172.561 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 94.96 5.76 Favored 'General case' 0 CA--C 1.463 -2.366 1 C-N-CA 110.845 -4.342 . . . . 0.0 104.35 -162.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.415 ' CD1' ' HA3' ' A' ' 302' ' ' GLY . 1.0 OUTLIER -96.34 171.24 8.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 118.925 -2.359 . . . . 0.0 109.547 -164.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -154.81 136.91 5.39 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 116.688 -2.672 . . . . 0.0 112.857 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 328' ' ' VAL . 0.2 OUTLIER -53.06 152.79 3.9 Favored 'General case' 0 C--N 1.35 0.592 1 N-CA-C 125.029 5.196 . . . . 0.0 125.029 -163.618 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -108.32 -102.25 0.37 Allowed 'General case' 0 C--N 1.386 2.159 0 O-C-N 121.208 -0.933 . . . . 0.0 111.909 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -139.33 24.25 2.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 120.196 -1.565 . . . . 0.0 114.85 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.485 0.9 OUTLIER 70.84 173.67 0.31 Allowed 'General case' 0 C--N 1.373 1.625 0 C-N-CA 126.334 1.853 . . . . 0.0 115.31 -179.218 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -80.46 159.67 25.52 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.47 -1.394 . . . . 0.0 111.739 174.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.437 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -85.33 54.59 3.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 110.758 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.294 3.3 p30 123.01 94.32 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.801 1 C-N-CA 136.196 5.798 . . . . 0.0 104.977 -171.834 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 CA--C 1.556 1.584 0 C-N-CA 123.404 2.736 . . . . 0.0 110.511 -178.334 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -81.83 -37.37 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.394 3.396 . . . . 0.0 111.776 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 84.03 123.5 0.04 OUTLIER 'General case' 0 C--N 1.372 1.584 0 C-N-CA 129.637 3.175 . . . . 0.0 112.733 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.75 10.23 44.06 Favored Glycine 0 C--N 1.375 2.744 0 CA-C-O 124.255 2.031 . . . . 0.0 113.356 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.17 166.36 13.42 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 131.431 3.893 . . . . 0.0 103.31 167.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 29.2 mmmt -112.14 146.98 37.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 120.244 -1.535 . . . . 0.0 111.906 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 280' ' ' LEU . 1.8 mp -120.95 174.13 6.82 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 123.926 1.822 . . . . 0.0 107.094 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 89.1 m -141.09 138.28 33.44 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.381 -1.449 . . . . 0.0 108.228 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.91 179.06 36.62 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-O 124.183 1.991 . . . . 0.0 115.638 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -125.4 135.38 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.12 133.5 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 119.134 3.013 . . . . 0.0 119.134 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.255 12.4 t -115.59 -40.6 3.36 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 112.968 -1.923 . . . . 0.0 115.083 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -135.9 172.63 12.73 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.103 1.774 . . . . 0.0 109.138 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 292' ' ' CYS . 1.3 tt -122.18 142.36 50.5 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.652 1.581 . . . . 0.0 107.86 166.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 173.67 6.26 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 121.006 -1.059 . . . . 0.0 109.284 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -28.87 69.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.62 2.368 . . . . 0.0 115.537 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -153.3 48.46 0.69 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 123.494 1.616 . . . . 0.0 107.744 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 177.66 -161.55 28.83 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 167.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 287' ' ' LEU 0.36 0.8 OUTLIER -145.9 164.58 31.52 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 125.017 1.327 . . . . 0.0 109.523 168.538 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -102.92 122.44 44.57 Favored 'General case' 0 C--N 1.357 0.892 0 O-C-N 121.202 -0.936 . . . . 0.0 108.894 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.4 125.94 67.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.27 123.73 35.81 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.7 mm -91.25 48.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.932 -1.105 . . . . 0.0 111.231 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.268 38.0 mt-10 79.95 173.56 0.14 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.116 2.566 . . . . 0.0 110.481 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.56 119.4 12.29 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.92 -33.91 4.7 Favored Glycine 0 C--N 1.367 2.305 0 C-N-CA 127.65 2.548 . . . . 0.0 114.337 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . 0.298 1.8 p -117.35 123.54 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.0 112.03 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.38 154.65 45.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 119.066 -2.272 . . . . 0.0 107.276 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -116.27 172.15 14.09 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-O 124.083 1.935 . . . . 0.0 112.045 163.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 5.1 tp -126.75 126.48 43.51 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.667 ' CG2' ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -92.14 120.22 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 171.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -94.92 132.5 39.68 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 123.647 0.592 . . . . 0.0 111.801 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 176.733 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--O 1.234 0.271 0 CA-C-O 122.697 1.236 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -106.09 171.09 7.53 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 123.568 1.651 . . . . 0.0 108.863 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.49 120.66 2.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 128.261 2.624 . . . . 0.0 113.703 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.74 14.72 72.29 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 114.193 -1.367 . . . . 0.0 115.588 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.1 133.94 34.56 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 126.791 2.037 . . . . 0.0 106.494 172.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.04 135.59 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.405 ' HA ' ' N ' ' A' ' 349' ' ' CYS . 30.5 m -139.99 175.49 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 124.988 2.327 . . . . 0.0 111.462 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -108.51 150.93 26.76 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -138.55 167.05 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 -177.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 31.9 ttm -115.52 138.81 50.66 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.623 ' HB ' HD12 ' A' ' 344' ' ' LEU . 1.2 p -85.7 131.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.91 -137.33 0.3 Allowed 'General case' 0 N--CA 1.414 -2.231 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.29 28.0 m-20 -65.01 112.45 3.33 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.816 4.376 . . . . 0.0 122.816 -155.084 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.431 0.1 OUTLIER -109.66 124.8 66.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 C-N-CA 125.409 1.484 . . . . 0.0 110.14 -179.202 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.26 112.68 13.57 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -78.97 -4.82 51.88 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 123.729 1.728 . . . . 0.0 112.866 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -86.52 -41.19 14.55 Favored 'General case' 0 N--CA 1.425 -1.689 1 C-N-CA 135.378 5.471 . . . . 0.0 111.269 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -103.11 -28.99 11.62 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 113.572 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.271 16.4 mmm180 75.02 48.88 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 128.118 2.567 . . . . 0.0 113.665 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.56 134.28 52.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 128.278 2.631 . . . . 0.0 106.337 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.3 mm -116.54 129.59 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 1 N-CA-C 95.052 -5.907 . . . . 0.0 95.052 168.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.68 94.36 5.25 Favored 'General case' 0 C--N 1.385 2.123 1 C-N-CA 111.037 -4.265 . . . . 0.0 106.425 -167.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' A' ' 332' ' ' VAL . 0.2 OUTLIER -101.14 135.36 42.72 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 116.611 -2.035 . . . . 0.0 108.895 -171.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -124.28 134.68 9.25 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 121.652 -0.655 . . . . 0.0 112.943 -176.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.667 ' H ' ' CG2' ' A' ' 304' ' ' VAL 0.353 0.1 OUTLIER -73.49 163.08 28.53 Favored 'General case' 0 C--N 1.368 1.381 1 N-CA-C 128.779 6.585 . . . . 0.0 128.779 -154.586 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -121.52 -105.77 0.37 Allowed 'General case' 0 C--N 1.384 2.108 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -163.6 152.0 13.59 Favored 'General case' 0 C--N 1.349 0.566 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 173.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 328' ' ' VAL . 13.0 t -86.35 -39.2 16.67 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.781 3.658 . . . . 0.0 108.922 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -129.35 165.14 22.09 Favored 'General case' 0 N--CA 1.449 -0.524 1 CA-C-N 104.258 -5.883 . . . . 0.0 108.759 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.22 46.18 1.01 Allowed 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.008 -1.683 . . . . 0.0 109.675 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.286 1.0 OUTLIER 154.94 69.31 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.629 1 C-N-CA 132.808 4.443 . . . . 0.0 106.56 -176.493 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo . . . . . 0 C--N 1.368 1.58 0 C-N-CA 124.74 3.627 . . . . 0.0 110.971 177.482 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.29 91.12 1.03 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.224 2.616 . . . . 0.0 107.247 168.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.28 151.58 46.75 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 128.714 2.805 . . . . 0.0 118.117 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.26 8.35 55.14 Favored Glycine 0 C--N 1.384 3.214 0 CA-C-O 124.753 2.307 . . . . 0.0 112.336 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 332' ' ' VAL . 2.9 p -96.46 147.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.75 1 C-N-CA 135.136 5.374 . . . . 0.0 101.929 173.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 7.7 ptmt -112.35 156.07 23.08 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 119.007 -2.308 . . . . 0.0 113.399 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.12 151.61 40.91 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.8 m -109.03 139.24 44.17 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.666 -1.271 . . . . 0.0 109.679 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -140.51 -179.18 17.84 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 123.215 1.453 . . . . 0.0 112.083 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -119.07 137.64 53.42 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.82 125.93 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.3 t -106.68 -36.58 6.68 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 111.758 -2.474 . . . . 0.0 112.772 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.27 0.9 OUTLIER -136.64 170.26 16.36 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.819 1.645 . . . . 0.0 109.299 177.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.72 148.05 45.11 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.7 m -112.02 172.56 6.83 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -68.05 -28.09 67.09 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.174 -2.204 . . . . 0.0 113.298 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.68 44.07 1.37 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.949 1.7 . . . . 0.0 107.757 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -179.05 -168.31 37.94 Favored Glycine 0 CA--C 1.471 -2.71 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 145.86 26.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -101.14 118.69 37.49 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.67 125.04 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.19 119.47 33.06 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.246 -1.534 . . . . 0.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 37.5 mm -60.19 -65.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -138.08 166.52 23.91 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -65.52 118.87 10.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.835 -1.166 . . . . 0.0 114.046 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.02 -16.94 53.61 Favored Glycine 0 C--N 1.368 2.329 0 C-N-CA 127.128 2.299 . . . . 0.0 115.851 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.91 117.83 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.941 1.697 . . . . 0.0 109.94 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.76 160.31 37.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 119.346 -2.097 . . . . 0.0 110.299 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.35 173.54 15.35 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 125.946 1.736 . . . . 0.0 114.181 169.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.2 tp -126.22 115.53 19.88 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 126.442 1.897 . . . . 0.0 107.088 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 347' ' ' LYS 0.256 4.3 p -87.34 112.77 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -79.16 123.46 27.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.165 -176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.508 2.439 0 CA-C-N 122.942 2.61 . . . . 0.0 115.911 176.106 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.46 0.069 0 CA-C-O 123.805 1.764 . . . . 0.0 114.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -120.16 169.06 10.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.09 121.27 26.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 C-N-CA 126.56 1.944 . . . . 0.0 107.834 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.42 53.79 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -98.89 164.46 12.19 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 130.009 3.324 . . . . 0.0 104.13 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.29 0.2 OUTLIER -121.41 138.17 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.302 -1.499 . . . . 0.0 109.925 -175.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.259 0.9 OUTLIER -139.23 163.47 26.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 CA-C-O 122.879 1.323 . . . . 0.0 108.086 179.001 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.24 155.38 18.06 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.443 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 3.1 m -141.1 163.71 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 51.6 ttp -120.71 141.43 50.44 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 278' ' ' THR . 11.9 p -80.72 131.37 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -168.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.36 -136.66 0.29 Allowed 'General case' 0 N--CA 1.42 -1.968 1 N-CA-C 99.953 -4.092 . . . . 0.0 99.953 176.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . 0.501 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.254 24.7 m-20 -69.45 112.32 5.9 Favored 'General case' 0 C--N 1.31 -1.152 1 N-CA-C 122.702 4.334 . . . . 0.0 122.702 -154.766 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.335 0.1 OUTLIER -102.87 125.39 57.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 C-N-CA 127.266 2.226 . . . . 0.0 109.28 179.607 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.72 110.62 14.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -74.94 -3.43 32.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.025 2.13 . . . . 0.0 113.539 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -88.17 -35.55 17.32 Favored 'General case' 0 N--CA 1.432 -1.358 1 C-N-CA 132.49 4.316 . . . . 0.0 110.766 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -103.71 -39.93 6.48 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.507 1.523 . . . . 0.0 111.806 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.361 92.5 mtt180 74.48 52.49 0.09 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 132.423 4.289 . . . . 0.0 112.606 -179.272 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -124.87 132.85 53.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 127.802 2.441 . . . . 0.0 104.638 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 131.15 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . 0.501 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 3.9 m -107.32 92.19 3.97 Favored 'General case' 0 C--N 1.381 1.94 1 C-N-CA 111.061 -4.256 . . . . 0.0 105.105 -166.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 332' ' ' VAL . 1.7 mp -101.6 138.28 38.8 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 119.961 1.255 . . . . 0.0 111.45 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -149.12 123.81 1.7 Allowed Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.443 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.741 4.0 tt -139.58 -86.93 0.22 Allowed 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.493 3.517 . . . . 0.0 112.348 174.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . 0.639 ' HB2' HG21 ' A' ' 304' ' ' VAL 0.263 29.7 ttmt 93.78 44.2 0.0 OUTLIER 'General case' 0 C--N 1.371 1.506 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 174.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -79.8 -46.83 16.21 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 118.822 -2.424 . . . . 0.0 113.324 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.259 63.0 m 90.02 160.1 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 130.425 3.49 . . . . 0.0 111.492 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 4.9 mmtp -72.16 166.81 21.59 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.466 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -92.24 4.04 54.11 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.801 2.04 . . . . 0.0 114.469 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -168.64 75.58 0.8 Allowed Pre-proline 0 CA--C 1.541 0.626 1 C-N-CA 131.84 4.056 . . . . 0.0 105.183 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo . . . . . 0 C--N 1.372 1.769 1 C-N-CA 125.478 4.119 . . . . 0.0 116.045 -175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . 0.291 4.5 m-85 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.89 114.82 4.01 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.666 2.911 . . . . 0.0 109.727 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.3 125.19 27.25 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.809 1.644 . . . . 0.0 111.822 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.04 2.24 31.73 Favored Glycine 0 C--N 1.363 2.074 0 CA-C-O 122.929 1.294 . . . . 0.0 113.551 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 46.8 p -93.23 142.58 27.15 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 28.5 mmtp -97.65 146.03 25.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.559 1.171 . . . . 0.0 112.933 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.87 175.46 6.54 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 124.319 2.009 . . . . 0.0 110.238 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 48.3 m -116.92 129.87 56.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -132.4 173.44 20.79 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 124.42 2.122 . . . . 0.0 111.877 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -129.51 126.33 38.39 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.448 HG21 ' CG1' ' A' ' 322' ' ' VAL . 5.0 t -87.36 136.63 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 119.575 -1.953 . . . . 0.0 115.988 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.323 4.1 t -145.41 -20.35 0.48 Allowed 'General case' 0 C--N 1.361 1.083 0 N-CA-C 121.253 3.798 . . . . 0.0 121.253 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.347 2.6 t-20 -134.19 175.92 9.06 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 123.734 2.97 . . . . 0.0 110.672 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 142.44 49.85 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 119.134 -2.229 . . . . 0.0 108.512 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 289' ' ' ASP . 2.0 m -112.51 178.38 4.32 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 288' ' ' THR . 0.4 OUTLIER -57.85 -29.62 65.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.86 46.39 0.14 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 123.742 1.735 . . . . 0.0 110.278 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.0 -167.58 36.23 Favored Glycine 0 CA--C 1.48 -2.1 1 N-CA-C 101.17 -4.772 . . . . 0.0 101.17 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.258 0.1 OUTLIER -134.6 161.41 35.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -98.95 128.33 45.09 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.79 -1.819 . . . . 0.0 107.972 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.58 133.19 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.446 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.3 126.42 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 118.61 -2.556 . . . . 0.0 111.879 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 297' ' ' GLU . 7.8 mm -83.64 173.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 119.859 -1.776 . . . . 0.0 111.225 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 296' ' ' ILE . 37.8 mm-40 -78.04 -17.72 56.72 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-O 127.315 3.436 . . . . 0.0 117.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.98 154.11 39.45 Favored 'General case' 0 C--N 1.303 -1.439 2 C-N-CA 143.072 8.549 . . . . 0.0 112.797 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.77 2.77 72.39 Favored Glycine 0 C--N 1.371 2.49 0 O-C-N 119.296 -2.128 . . . . 0.0 115.7 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.08 144.93 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 129.679 3.192 . . . . 0.0 108.605 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -115.17 158.24 22.51 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.984 -1.697 . . . . 0.0 107.925 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -110.25 172.92 15.99 Favored Glycine 0 C--N 1.359 1.841 0 CA-C-O 125.058 2.477 . . . . 0.0 112.973 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.3 tp -118.48 114.62 23.14 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 346' ' ' LEU 0.296 1.5 p -79.43 100.02 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 122.858 1.313 . . . . 0.0 107.54 174.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -87.92 114.7 24.79 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.937 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 177.755 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.448 ' CG1' HG21 ' A' ' 284' ' ' VAL 0.269 10.0 t . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.728 0.775 . . . . 0.0 111.946 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.79 172.3 8.73 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 124.406 2.05 . . . . 0.0 111.09 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.64 120.64 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 112.328 -2.215 . . . . 0.0 109.758 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.61 62.25 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 125.88 1.705 . . . . 0.0 115.827 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -93.4 151.67 19.6 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.766 2.427 . . . . 0.0 110.474 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.58 138.55 26.42 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 126.16 1.784 . . . . 0.0 107.727 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.891 HG23 ' H ' ' A' ' 349' ' ' CYS 0.253 7.5 p -147.92 170.16 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 124.354 2.025 . . . . 0.0 108.707 -173.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.37 140.6 38.24 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.0 OUTLIER -130.5 167.67 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.682 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -173.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 23.6 ttm -118.4 138.8 52.2 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 171.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 344' ' ' LEU . 92.5 t -81.6 124.74 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.531 -1.356 . . . . 0.0 111.14 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . 0.253 1.8 mp -125.03 -141.41 0.29 Allowed 'General case' 0 N--CA 1.409 -2.501 0 CA-C-O 126.847 3.213 . . . . 0.0 102.453 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . 0.473 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.35 4.9 t70 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 -152.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.708 HD13 HG23 ' A' ' 342' ' ' ILE . 4.8 tp -109.99 132.46 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.303 -172.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.44 104.05 5.96 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 101.58 -3.489 . . . . 0.0 101.58 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.57 -9.16 59.25 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.186 2.195 . . . . 0.0 114.026 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.13 -37.29 14.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.181 3.792 . . . . 0.0 111.074 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -100.62 -23.3 14.7 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 124.731 1.212 . . . . 0.0 112.365 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.276 1.5 mmp_? 74.45 46.7 0.15 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 129.491 3.116 . . . . 0.0 113.883 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -125.67 111.92 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 111.119 -2.764 . . . . 0.0 105.214 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.708 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -111.65 130.23 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 2 C-N-CA 133.579 4.752 . . . . 0.0 99.597 179.534 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 2.5 m -115.12 93.72 4.43 Favored 'General case' 0 CA--C 1.471 -2.063 1 C-N-CA 109.217 -4.993 . . . . 0.0 105.48 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.49 HD12 ' CD1' ' A' ' 296' ' ' ILE . 0.1 OUTLIER -100.35 136.29 40.47 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -150.44 124.46 1.74 Allowed Glycine 0 N--CA 1.47 0.948 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.897 -164.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.714 ' HG ' HG21 ' A' ' 328' ' ' VAL . 0.7 OUTLIER -32.93 154.15 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 2 C-N-CA 135.37 5.468 . . . . 0.0 124.72 -168.5 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -101.94 -79.75 0.51 Allowed 'General case' 0 C--N 1.384 2.089 0 C-N-CA 124.188 0.995 . . . . 0.0 109.531 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.31 0.4 OUTLIER -176.44 46.75 0.01 OUTLIER 'General case' 0 C--N 1.372 1.585 0 N-CA-C 118.278 2.696 . . . . 0.0 118.278 176.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.891 ' H ' HG23 ' A' ' 328' ' ' VAL 0.421 13.4 p 68.18 161.74 0.19 Allowed 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.205 4.15 . . . . 0.0 122.205 169.845 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -77.53 168.76 19.46 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 128.646 2.778 . . . . 0.0 113.33 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -101.81 18.29 20.88 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 118.895 -2.378 . . . . 0.0 113.257 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -174.89 52.21 0.11 Allowed Pre-proline 0 N--CA 1.438 -1.032 0 C-N-CA 129.673 3.189 . . . . 0.0 109.12 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo . . . . . 0 C--N 1.377 2.066 0 C-N-CA 125.005 3.803 . . . . 0.0 114.968 -171.125 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.76 -176.19 3.11 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.829 3.019 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.31 126.92 49.14 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.512 1.125 . . . . 0.0 108.791 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.36 36.49 Favored Glycine 0 C--N 1.367 2.296 0 CA-C-O 123.804 1.78 . . . . 0.0 114.645 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 332' ' ' VAL . 4.1 p -96.62 134.22 40.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 131.152 3.781 . . . . 0.0 102.923 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 21.2 pttp -100.13 149.63 23.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.327 1.537 . . . . 0.0 114.687 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.414 HD23 HG21 ' A' ' 296' ' ' ILE . 2.0 mp -120.95 175.28 6.14 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 123.447 1.594 . . . . 0.0 110.445 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 94.8 m -118.04 132.82 56.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.82 179.15 26.83 Favored Glycine 0 CA--C 1.481 -2.093 0 CA-C-O 123.875 1.819 . . . . 0.0 111.337 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -124.45 146.57 48.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 322' ' ' VAL . 5.0 t -92.27 133.66 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.374 -1.453 . . . . 0.0 112.051 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -125.49 -38.88 2.22 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.87 174.69 10.19 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 121.334 1.879 . . . . 0.0 107.281 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.9 mp -119.53 151.08 39.2 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 119.98 -1.7 . . . . 0.0 110.583 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 178.94 4.12 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -30.05 69.0 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 119.066 -2.271 . . . . 0.0 115.711 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -145.72 39.28 1.14 Allowed 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 123.18 1.467 . . . . 0.0 110.504 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.38 -170.97 37.54 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 5.3 m -135.82 157.12 47.62 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.2 125.74 44.85 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.515 HG11 HG11 ' A' ' 330' ' ' VAL . 16.3 t -104.29 133.58 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 125.586 1.554 . . . . 0.0 107.344 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.43 126.47 46.83 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.811 2.096 . . . . 0.0 114.478 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 300' ' ' VAL . 8.6 mm -104.56 56.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.626 173.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 75.22 171.6 0.27 Allowed 'General case' 0 C--N 1.364 1.236 0 C-N-CA 127.477 2.311 . . . . 0.0 111.877 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.96 119.04 12.66 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.75 -2.469 . . . . 0.0 115.593 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 118.82 -32.71 5.06 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 127.193 2.33 . . . . 0.0 114.987 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.629 HG13 HG13 ' A' ' 342' ' ' ILE . 40.3 t -116.9 130.64 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 127.543 2.337 . . . . 0.0 107.739 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.98 157.02 28.06 Favored 'General case' 0 CA--C 1.478 -1.798 0 O-C-N 118.307 -2.746 . . . . 0.0 104.916 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -125.87 174.07 17.7 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.61 122.26 37.69 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 125.932 1.693 . . . . 0.0 106.866 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 345' ' ' GLY . 2.4 p -93.61 118.79 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -96.48 133.24 41.18 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 117.359 -1.736 . . . . 0.0 112.454 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.269 52.4 t . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 284' ' ' VAL 0.399 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 118.566 2.802 . . . . 0.0 118.566 . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.458 ' H ' HG22 ' A' ' 322' ' ' VAL . 39.7 t30 -109.66 148.96 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.4 p -78.67 120.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.696 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 88.24 25.63 30.64 Favored Glycine 0 C--N 1.361 1.924 0 C-N-CA 124.31 0.957 . . . . 0.0 113.457 -170.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.83 158.0 15.87 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.674 1.99 . . . . 0.0 108.88 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -117.02 136.56 53.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.264 10.7 p -147.49 175.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 130.764 3.626 . . . . 0.0 108.225 -166.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -114.69 141.71 47.45 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.4 m -124.37 166.5 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -171.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 35.2 ttm -121.12 141.09 51.13 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.431 HG22 HD12 ' A' ' 344' ' ' LEU . 39.8 t -81.66 131.86 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.593 -1.317 . . . . 0.0 113.522 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.48 -136.35 0.29 Allowed 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.252 10.5 t70 -63.84 112.05 2.73 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.585 4.291 . . . . 0.0 122.585 -153.651 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.267 2.8 tp -101.13 112.38 33.9 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 CA-C-O 122.7 1.238 . . . . 0.0 108.882 176.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.07 117.15 23.33 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.481 1.112 . . . . 0.0 108.166 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -80.96 -2.79 49.19 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.331 1.853 . . . . 0.0 115.128 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -89.56 -37.64 14.55 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.622 2.769 . . . . 0.0 111.463 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -103.13 -30.8 10.49 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.259 1.424 . . . . 0.0 112.454 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 16.9 mmm180 72.49 52.83 0.17 Allowed 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 129.925 3.29 . . . . 0.0 111.928 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.0 ptp180 -124.58 135.19 52.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 129.16 2.984 . . . . 0.0 107.768 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.629 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -108.88 130.04 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 167.373 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -102.57 94.74 5.81 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 111.781 -3.968 . . . . 0.0 107.246 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 332' ' ' VAL 0.306 2.1 mm? -96.12 136.87 36.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 120.129 -1.607 . . . . 0.0 108.464 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -135.15 127.69 4.47 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 6.9 mp -45.43 155.85 0.13 Allowed 'General case' 0 C--N 1.359 1.016 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -167.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -131.42 -62.74 0.86 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.64 124.31 1.92 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 173.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 7.4 p -47.63 151.88 0.77 Allowed 'General case' 0 C--N 1.361 1.084 1 C-N-CA 139.628 7.171 . . . . 0.0 117.48 169.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.13 162.73 27.75 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 127.403 2.281 . . . . 0.0 115.49 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -104.63 24.52 11.62 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.305 1.842 . . . . 0.0 112.548 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -175.64 51.69 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 129.702 3.201 . . . . 0.0 109.204 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo . . . . . 0 C--N 1.379 2.172 1 C-N-CA 126.388 4.725 . . . . 0.0 116.615 -167.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.68 -48.92 8.02 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.697 3.598 . . . . 0.0 114.116 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 82.39 118.77 0.05 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 128.994 2.917 . . . . 0.0 113.919 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.42 58.1 Favored Glycine 0 C--N 1.375 2.696 0 CA-C-O 124.556 2.198 . . . . 0.0 112.231 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 19.6 p -97.45 126.21 42.57 Favored 'General case' 0 CA--C 1.509 -0.629 1 C-N-CA 133.267 4.627 . . . . 0.0 103.475 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -95.85 144.57 26.09 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.666 1.698 . . . . 0.0 112.859 -178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.77 174.09 7.34 Favored 'General case' 0 CA--C 1.487 -1.446 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.566 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.5 m -110.83 139.85 45.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -153.9 173.28 32.57 Favored Glycine 0 CA--C 1.482 -1.989 0 CA-C-O 123.543 1.635 . . . . 0.0 111.69 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.59 ' HG2' HG22 ' A' ' 327' ' ' VAL . 30.6 mtp-105 -127.54 135.37 50.24 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.53 132.08 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 113.869 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -130.19 -31.04 1.91 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -169.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.271 1.2 t-20 -133.75 176.09 8.87 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-N 121.751 2.069 . . . . 0.0 108.379 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.0 OUTLIER -120.47 156.37 31.62 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.255 -1.528 . . . . 0.0 113.174 176.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 178.57 4.25 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -68.33 -25.49 65.13 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.533 2.333 . . . . 0.0 115.037 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -162.55 54.05 0.21 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.225 2.61 . . . . 0.0 107.039 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.97 -170.48 41.66 Favored Glycine 0 CA--C 1.468 -2.865 1 N-CA-C 100.573 -5.011 . . . . 0.0 100.573 171.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.8 m -139.91 169.82 17.01 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.493 1.117 . . . . 0.0 108.852 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.83 128.71 56.2 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-O 123.128 1.442 . . . . 0.0 109.182 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 330' ' ' VAL . 21.2 t -103.93 138.27 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 C-N-CA 125.862 1.665 . . . . 0.0 107.006 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -99.89 123.84 44.57 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 119.703 -1.873 . . . . 0.0 112.157 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.61 52.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 122.878 1.323 . . . . 0.0 111.616 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 79.07 174.97 0.15 Allowed 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.932 2.493 . . . . 0.0 109.716 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -68.22 119.72 13.23 Favored 'General case' 0 CA--C 1.558 1.285 0 O-C-N 119.871 -1.768 . . . . 0.0 114.181 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.0 32.4 Favored Glycine 0 C--N 1.367 2.262 0 C-N-CA 127.44 2.448 . . . . 0.0 115.196 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.18 143.99 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.125 1.77 . . . . 0.0 109.865 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -153.51 149.81 28.08 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 118.851 -2.405 . . . . 0.0 105.435 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 344' ' ' LEU . . . -131.38 174.36 20.06 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-O 124.824 2.347 . . . . 0.0 112.44 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 51.7 tp -98.38 162.63 13.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.703 2.001 . . . . 0.0 107.484 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 346' ' ' LEU . 2.4 p -128.82 117.15 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 161.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -95.21 134.89 37.45 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 119.09 -1.044 . . . . 0.0 113.792 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.272 1.0 OUTLIER . . . . . 0 C--N 1.38 1.93 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.507 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 123.372 1.558 . . . . 0.0 114.37 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -104.7 151.07 24.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 123.935 1.826 . . . . 0.0 112.527 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 324' ' ' VAL . 1.4 p -69.15 120.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 C-N-CA 127.052 2.141 . . . . 0.0 108.633 174.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 97.03 8.37 56.84 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 125.723 1.63 . . . . 0.0 115.626 -172.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.73 160.5 14.94 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.885 -1.362 . . . . 0.0 109.091 171.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 283' ' ' ARG . 35.0 t -117.82 137.41 51.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -144.01 178.99 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 CA-C-O 126.043 2.83 . . . . 0.0 108.979 -173.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.5 133.55 55.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.2 m -135.48 139.2 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.0 ttp -101.79 143.82 31.24 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 120.63 -1.294 . . . . 0.0 108.181 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.425 HG13 HG22 ' A' ' 342' ' ' ILE . 84.1 t -84.88 131.67 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.9 -133.13 0.3 Allowed 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 100.293 -3.966 . . . . 0.0 100.293 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.436 11.7 m-20 -53.21 112.65 0.91 Allowed 'General case' 0 CA--C 1.503 -0.831 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -154.991 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.59 HD13 HG23 ' A' ' 342' ' ' ILE . 5.8 tp -111.3 122.2 65.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 4.3 t0 -146.55 116.16 7.16 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -106.05 22.8 15.07 Favored 'General case' 0 C--N 1.365 1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 112.707 -172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -110.96 -43.7 3.73 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.526 1.93 . . . . 0.0 107.732 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 336' ' ' ASP 0.305 34.3 mmt180 -68.69 -38.53 80.38 Favored 'General case' 0 C--N 1.349 0.571 1 C-N-CA 132.956 4.503 . . . . 0.0 113.345 171.262 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.338 33.0 mmt180 74.98 51.38 0.08 Allowed 'General case' 0 C--N 1.347 0.487 1 C-N-CA 132.595 4.358 . . . . 0.0 113.481 173.334 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.46 133.73 52.33 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 111.622 -2.535 . . . . 0.0 112.389 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -119.61 127.22 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 1 N-CA-C 96.922 -5.214 . . . . 0.0 96.922 172.088 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.8 103.05 10.27 Favored 'General case' 0 CA--C 1.457 -2.627 1 C-N-CA 110.787 -4.365 . . . . 0.0 106.892 -170.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.471 HD13 ' HA3' ' A' ' 302' ' ' GLY . 2.1 mp -96.5 170.75 9.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 122.921 2.601 . . . . 0.0 112.077 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -156.24 141.69 8.19 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.788 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.412 1.4 pt? -51.13 159.0 0.67 Allowed 'General case' 0 C--N 1.374 1.65 1 N-CA-C 124.761 5.097 . . . . 0.0 124.761 -165.464 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -125.44 -55.86 1.53 Allowed 'General case' 0 C--N 1.38 1.93 0 O-C-N 120.948 -1.095 . . . . 0.0 109.962 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.34 2.1 pt20 -121.02 -105.26 0.38 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 18.7 p 159.71 171.1 0.01 OUTLIER 'General case' 0 C--N 1.349 0.561 1 C-N-CA 131.954 4.101 . . . . 0.0 101.677 -169.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -91.1 161.47 15.09 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.936 1.294 . . . . 0.0 111.989 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -96.79 77.0 2.8 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 118.912 -2.367 . . . . 0.0 109.737 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 40.4 t30 104.67 66.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 130.417 3.487 . . . . 0.0 107.675 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 C--N 1.382 2.31 1 C-N-CA 126.293 4.662 . . . . 0.0 112.313 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.995 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.06 122.17 9.86 Favored 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 125.382 4.055 . . . . 0.0 114.204 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.63 114.84 6.59 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 129.077 2.951 . . . . 0.0 113.16 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.92 7.79 40.71 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 123.633 1.685 . . . . 0.0 114.766 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 72.9 p -96.9 144.19 27.06 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 129.044 2.938 . . . . 0.0 103.543 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 92.5 mttt -105.87 155.3 19.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 119.867 -1.771 . . . . 0.0 115.203 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.59 HD21 HG22 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -128.33 173.42 10.18 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.809 2.243 . . . . 0.0 107.802 178.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.5 m -114.34 135.68 53.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.27 170.52 29.55 Favored Glycine 0 CA--C 1.48 -2.118 0 CA-C-O 124.097 1.943 . . . . 0.0 110.045 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -129.61 133.81 47.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 113.576 -1.312 . . . . 0.0 108.041 -171.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 322' ' ' VAL . 11.3 t -76.88 127.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.3 t -109.15 -41.96 4.54 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 112.763 -2.017 . . . . 0.0 113.632 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER -135.28 174.56 10.48 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 119.962 -1.711 . . . . 0.0 110.248 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 147.13 45.8 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.328 -1.483 . . . . 0.0 108.136 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 289' ' ' ASP . 1.0 OUTLIER -112.05 177.69 4.56 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 124.242 1.017 . . . . 0.0 108.885 -176.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 288' ' ' THR . 52.9 m-20 -71.25 -12.26 61.36 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.231 2.612 . . . . 0.0 114.572 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.439 ' CD2' ' HE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -164.34 47.42 0.11 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 123.842 1.782 . . . . 0.0 109.83 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 169.38 -160.28 33.48 Favored Glycine 0 CA--C 1.47 -2.759 0 N-CA-C 106.295 -2.722 . . . . 0.0 106.295 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.58 164.05 32.88 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -102.35 120.38 40.39 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.3 125.27 65.04 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.13 131.79 35.79 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 344' ' ' LEU . 3.9 mt -85.38 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 120.743 -1.223 . . . . 0.0 110.752 168.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.258 57.6 mm-40 84.65 167.31 0.09 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 127.577 2.351 . . . . 0.0 107.514 -167.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.01 118.89 9.13 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 112.81 -20.06 20.46 Favored Glycine 0 C--N 1.371 2.506 0 C-N-CA 126.867 2.175 . . . . 0.0 116.748 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.4 122.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.3 144.86 24.93 Favored 'General case' 0 CA--C 1.483 -1.601 0 O-C-N 119.489 -2.007 . . . . 0.0 111.275 -165.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.463 ' HA3' HD12 ' A' ' 344' ' ' LEU . . . -106.84 175.1 20.54 Favored Glycine 0 CA--C 1.491 -1.454 0 C-N-CA 128.099 2.762 . . . . 0.0 117.186 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 11.5 tp -126.0 120.0 29.15 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 126.776 2.03 . . . . 0.0 106.916 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.758 HG21 ' HG3' ' A' ' 347' ' ' LYS 0.284 8.3 p -92.32 118.46 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HE1' ' CD2' ' A' ' 290' ' ' TYR . 8.1 t60 -80.98 124.09 28.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.162 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.368 1.4 0 N-CA-C 121.227 3.788 . . . . 0.0 121.227 -172.43 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 284' ' ' VAL 0.412 33.1 t . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 124.622 2.153 . . . . 0.0 115.646 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.42 150.39 40.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 128.452 2.701 . . . . 0.0 105.459 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.43 121.37 29.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.912 1.339 . . . . 0.0 108.979 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 86.46 29.35 24.76 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.23 1.395 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -92.34 150.47 20.82 Favored 'General case' 0 C--N 1.364 1.218 0 O-C-N 120.636 -1.508 . . . . 0.0 109.311 172.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.282 0.7 OUTLIER -117.08 130.52 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 120.065 -1.647 . . . . 0.0 107.385 175.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -133.85 179.57 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 1 C-N-CA 133.186 4.594 . . . . 0.0 106.933 -171.768 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 346' ' ' LEU . 40.7 tt0 -112.03 150.14 31.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 100.558 -3.867 . . . . 0.0 100.558 172.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -146.51 144.19 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 42.7 ttm -105.84 141.66 36.88 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 120.125 -1.609 . . . . 0.0 107.45 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.59 HG22 HD21 ' A' ' 280' ' ' LEU . 68.4 t -69.59 128.92 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.05 -136.16 0.28 Allowed 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 171.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' A' ' 343' ' ' SER 0.307 19.3 m-20 -61.15 111.86 1.88 Allowed 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -154.363 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.2 tp -101.94 118.36 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 124.023 1.868 . . . . 0.0 108.886 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -117.62 103.29 9.9 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.84 -11.11 59.78 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.614 1.966 . . . . 0.0 115.42 -168.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.04 -33.55 15.47 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 128.201 2.601 . . . . 0.0 111.183 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -100.8 -29.48 12.23 Favored 'General case' 0 C--N 1.368 1.406 0 C-N-CA 125.052 1.341 . . . . 0.0 113.156 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.297 65.2 mtp85 72.96 51.96 0.14 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 128.858 2.863 . . . . 0.0 112.618 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.62 132.79 53.41 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 110.79 -2.914 . . . . 0.0 106.631 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . 0.258 2.1 mt -114.09 129.7 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 334' ' ' ASP . 4.2 t -102.52 94.23 5.55 Favored 'General case' 0 C--N 1.384 2.096 0 C-N-CA 111.854 -3.938 . . . . 0.0 105.801 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.463 HD12 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -97.23 136.29 37.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 119.495 -2.003 . . . . 0.0 107.637 -169.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.495 ' CA ' HG23 ' A' ' 304' ' ' VAL . . . -152.67 123.42 1.45 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.498 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 330' ' ' VAL 0.59 0.2 OUTLIER -140.46 -93.0 0.16 Allowed 'General case' 0 C--N 1.363 1.186 0 C-N-CA 129.691 3.196 . . . . 0.0 109.137 172.383 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . 0.758 ' HG3' HG21 ' A' ' 304' ' ' VAL 0.356 35.6 mtmm 111.84 18.09 0.0 OUTLIER 'General case' 0 C--N 1.378 1.815 0 C-N-CA 126.781 2.033 . . . . 0.0 113.265 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.58 82.27 2.27 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 120.285 -1.509 . . . . 0.0 112.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 27.6 p -31.57 157.3 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 2 C-N-CA 135.519 5.527 . . . . 0.0 121.902 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -75.23 166.85 22.99 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 129.588 3.155 . . . . 0.0 114.551 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.76 88.22 3.98 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.708 1.603 . . . . 0.0 108.071 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 87.24 70.83 0.05 OUTLIER Pre-proline 0 C--N 1.357 0.927 0 C-N-CA 130.14 3.376 . . . . 0.0 108.777 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo . . . . . 0 C--N 1.37 1.672 1 C-N-CA 126.391 4.728 . . . . 0.0 117.662 -173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.755 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.25 -48.28 10.23 Favored 'Trans proline' 0 CA--C 1.546 1.101 1 C-N-CA 125.506 4.137 . . . . 0.0 113.617 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 81.38 126.81 0.04 OUTLIER 'General case' 0 C--N 1.373 1.615 0 C-N-CA 128.884 2.874 . . . . 0.0 113.187 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.97 11.13 56.89 Favored Glycine 0 C--N 1.381 3.058 0 CA-C-O 124.979 2.433 . . . . 0.0 112.41 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 20.6 p -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.45 -0.442 1 C-N-CA 133.252 4.621 . . . . 0.0 102.887 172.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -105.09 153.95 20.81 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 123.0 1.381 . . . . 0.0 113.509 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . 0.335 0.0 OUTLIER -136.1 173.88 11.23 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-O 123.485 1.612 . . . . 0.0 109.229 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.7 m -106.51 138.65 42.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -143.54 176.89 22.69 Favored Glycine 0 CA--C 1.483 -1.953 0 CA-C-O 123.387 1.549 . . . . 0.0 111.629 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -128.31 132.09 48.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 294' ' ' VAL . 3.1 t -82.69 127.48 39.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.41 1.484 . . . . 0.0 114.147 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -107.94 -53.11 2.67 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.357 1.863 . . . . 0.0 112.853 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.27 174.83 9.97 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 120.695 -1.253 . . . . 0.0 111.071 -170.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 150.75 39.84 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 166.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 177.88 4.48 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.64 -24.18 62.67 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.902 2.081 . . . . 0.0 113.606 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -151.56 45.35 0.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 124.579 2.133 . . . . 0.0 109.046 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.46 -164.91 33.28 Favored Glycine 0 CA--C 1.47 -2.765 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 15.3 p -143.5 151.13 39.91 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 123.783 0.833 . . . . 0.0 109.356 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.59 124.44 44.8 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.769 -0.582 . . . . 0.0 109.645 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 284' ' ' VAL . 3.0 t -109.59 131.69 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.516 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.02 122.18 42.5 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.215 -1.553 . . . . 0.0 113.68 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.17 56.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 111.379 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 77.8 170.0 0.22 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.608 2.363 . . . . 0.0 109.92 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.88 119.46 12.6 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 119.594 -1.941 . . . . 0.0 115.192 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.11 -31.84 5.69 Favored Glycine 0 C--N 1.367 2.294 0 C-N-CA 127.1 2.286 . . . . 0.0 115.069 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.27 128.27 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.89 1.676 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -141.83 158.66 43.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 118.675 -2.515 . . . . 0.0 106.868 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -130.69 173.1 20.27 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 123.849 1.805 . . . . 0.0 113.743 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.52 121.41 37.42 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 126.468 1.907 . . . . 0.0 107.514 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.649 HG13 ' H ' ' A' ' 346' ' ' LEU . 95.8 t -86.39 113.18 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.494 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.12 115.78 11.75 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.368 1.376 0 N-CA-C 120.383 3.475 . . . . 0.0 120.383 -174.722 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 123.246 1.498 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -104.72 165.98 10.7 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 126.684 1.993 . . . . 0.0 110.773 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.1 121.23 30.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 C-N-CA 126.866 2.066 . . . . 0.0 107.661 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.53 16.06 53.5 Favored Glycine 0 C--N 1.357 1.725 0 C-N-CA 125.426 1.489 . . . . 0.0 113.957 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -90.51 164.05 14.39 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.042 2.137 . . . . 0.0 111.187 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.44 125.07 72.19 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 51.6 t -134.42 165.49 31.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 C-N-CA 127.11 2.164 . . . . 0.0 106.653 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -114.92 135.58 54.05 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 100.931 -3.729 . . . . 0.0 100.931 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 2.8 m -129.81 163.28 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.362 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -169.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 33.1 ttm -127.9 138.03 52.52 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.07 132.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.01 -134.54 0.28 Allowed 'General case' 0 N--CA 1.408 -2.554 1 N-CA-C 98.951 -4.462 . . . . 0.0 98.951 174.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.98 111.81 6.65 Favored 'General case' 0 C--N 1.313 -1.018 1 N-CA-C 122.028 4.084 . . . . 0.0 122.028 -155.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.365 0.1 OUTLIER -96.83 112.52 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 126.615 1.966 . . . . 0.0 107.336 177.352 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.41 102.36 15.09 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 128.845 2.858 . . . . 0.0 105.092 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.19 -3.12 41.02 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -166.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.88 -43.15 14.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 130.001 3.32 . . . . 0.0 110.902 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -99.52 -38.05 8.93 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.167 2.187 . . . . 0.0 113.348 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.389 47.2 mtm105 75.22 51.73 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 1 C-N-CA 134.857 5.263 . . . . 0.0 114.215 179.802 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.5 OUTLIER -116.23 125.54 52.37 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 126.229 1.812 . . . . 0.0 107.348 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.8 mm -91.62 131.12 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 1 C-N-CA 132.876 4.471 . . . . 0.0 108.964 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.1 t -102.87 92.57 4.64 Favored 'General case' 0 C--N 1.385 2.144 1 C-N-CA 110.602 -4.439 . . . . 0.0 106.048 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.437 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -102.86 136.98 41.68 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 119.415 -2.053 . . . . 0.0 109.305 -174.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -130.81 138.51 10.23 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.649 ' H ' HG13 ' A' ' 304' ' ' VAL 0.492 0.1 OUTLIER -54.19 162.26 1.08 Allowed 'General case' 0 C--N 1.369 1.44 1 N-CA-C 127.146 5.98 . . . . 0.0 127.146 -161.32 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -125.4 -48.63 1.69 Allowed 'General case' 0 C--N 1.382 1.996 0 O-C-N 121.732 -0.605 . . . . 0.0 111.989 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.25 48.3 tp60 -124.51 -86.3 0.63 Allowed 'General case' 0 C--N 1.37 1.473 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.307 20.8 p 111.89 146.32 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 1 C-N-CA 131.965 4.106 . . . . 0.0 106.321 -172.438 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -94.89 130.24 41.58 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.279 -1.513 . . . . 0.0 111.143 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.08 75.45 4.08 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.094 2.158 . . . . 0.0 111.216 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . 0.455 ' H ' ' HD3' ' A' ' 353' ' ' PRO . 1.1 t30 125.29 66.94 0.0 OUTLIER Pre-proline 0 C--N 1.344 0.366 1 C-N-CA 133.955 4.902 . . . . 0.0 102.748 -175.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 352' ' ' ASN . 83.9 Cg_endo . . . . . 0 C--N 1.359 1.083 0 C-N-CA 124.194 3.263 . . . . 0.0 113.119 -175.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.25 -40.87 1.45 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 124.23 3.287 . . . . 0.0 112.236 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 332' ' ' VAL 0.263 44.4 mt-10 79.84 111.0 0.07 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.984 2.514 . . . . 0.0 113.001 178.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 8.69 38.12 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 123.894 1.83 . . . . 0.0 113.436 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . 0.535 ' O ' HG12 ' A' ' 332' ' ' VAL . 68.5 p -98.56 139.21 34.63 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 93.8 mttt -97.98 146.1 25.83 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.059 -2.275 . . . . 0.0 111.577 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.44 143.03 39.5 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.579 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.8 m -82.35 142.65 31.84 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.842 -1.162 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.47 173.57 33.62 Favored Glycine 0 CA--C 1.486 -1.721 0 CA-C-O 123.174 1.43 . . . . 0.0 112.719 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 60.2 mtm-85 -117.8 131.08 56.62 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 125.925 1.69 . . . . 0.0 108.655 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 17.6 t -77.38 133.24 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.281 10.1 t -122.62 -39.85 2.51 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -133.82 165.98 23.71 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 3.8 mp -121.16 153.17 37.88 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 122.131 2.241 . . . . 0.0 116.871 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 178.41 4.29 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -29.33 66.31 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.255 18.1 m-85 -156.8 52.72 0.51 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.96 3.704 . . . . 0.0 103.481 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.11 37.22 Favored Glycine 0 N--CA 1.432 -1.62 1 N-CA-C 100.469 -5.053 . . . . 0.0 100.469 172.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . 0.506 ' H ' HG13 ' A' ' 304' ' ' VAL . 31.5 p -165.32 172.09 12.74 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.653 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -103.14 120.2 40.27 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 330' ' ' VAL . 49.1 t -108.88 135.89 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -100.19 121.03 40.8 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.603 -1.936 . . . . 0.0 111.254 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.28 40.1 mm -66.65 -87.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -140.04 166.63 24.13 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 131.402 3.881 . . . . 0.0 101.329 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.16 120.28 7.28 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.4 -15.72 59.79 Favored Glycine 0 C--N 1.367 2.302 0 C-N-CA 127.18 2.324 . . . . 0.0 115.441 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.496 HG13 HG13 ' A' ' 342' ' ' ILE . 92.9 t -116.73 121.41 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.538 1.935 . . . . 0.0 111.246 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.87 151.24 50.66 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -119.8 173.48 15.18 Favored Glycine 0 CA--C 1.493 -1.284 0 CA-C-O 124.954 2.419 . . . . 0.0 115.303 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.8 tp -125.7 121.59 33.89 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.506 HG13 ' H ' ' A' ' 292' ' ' CYS 0.311 1.5 p -87.15 121.1 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-O 122.422 1.106 . . . . 0.0 109.838 171.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -86.51 108.9 18.75 Favored 'General case' 0 N--CA 1.397 -3.118 0 C-N-CA 128.48 2.712 . . . . 0.0 109.087 155.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.379 1.883 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 164.659 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.494 0.4 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 122.496 1.141 . . . . 0.0 112.854 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.75 145.56 24.5 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.134 1.445 . . . . 0.0 109.792 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.51 121.0 30.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.02 23.27 55.83 Favored Glycine 0 C--N 1.357 1.703 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.67 31.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 118.749 1.275 . . . . 0.0 108.166 171.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.252 2.0 p -96.29 129.36 46.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 CA-C-O 123.416 1.579 . . . . 0.0 108.554 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -130.48 -179.57 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 1 C-N-CA 132.312 4.245 . . . . 0.0 110.834 -173.396 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -124.27 142.29 51.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 294' ' ' VAL . 2.9 m -146.71 139.37 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 46.5 ttp -96.32 131.38 42.9 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 118.525 -2.61 . . . . 0.0 111.109 -173.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 276' ' ' GLU . 7.9 p -74.11 124.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.51 -130.32 0.25 Allowed 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.338 7.4 t70 -57.8 112.46 1.48 Allowed 'General case' 0 N--CA 1.475 0.811 1 N-CA-C 122.586 4.291 . . . . 0.0 122.586 -158.36 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . 0.266 3.4 tp -107.81 114.41 46.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 339' ' ' ARG . 96.1 m-20 -124.7 119.74 29.83 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.518 1.927 . . . . 0.0 107.849 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -88.14 -5.36 58.47 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 125.461 1.504 . . . . 0.0 114.635 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.64 -35.3 14.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.296 2.238 . . . . 0.0 110.285 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.477 ' HB2' ' CB ' ' A' ' 336' ' ' ASP . 0.0 OUTLIER -89.88 -46.93 8.21 Favored 'General case' 0 CA--C 1.508 -0.647 1 C-N-CA 132.08 4.152 . . . . 0.0 112.379 -177.512 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.322 64.5 mtm-85 75.07 52.53 0.08 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 131.135 3.774 . . . . 0.0 112.532 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 133.14 52.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 111.451 -2.613 . . . . 0.0 107.943 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.496 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -110.73 129.5 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.828 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 170.484 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.92 4.8 Favored 'General case' 0 CA--C 1.474 -1.981 1 C-N-CA 111.082 -4.247 . . . . 0.0 107.715 -164.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 332' ' ' VAL . 2.6 mp -97.96 135.57 39.48 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.748 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.18 122.76 1.63 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.815 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.497 ' H ' HG12 ' A' ' 330' ' ' VAL 0.663 0.7 OUTLIER -144.55 -99.04 0.1 Allowed 'General case' 0 C--N 1.37 1.46 0 C-N-CA 128.979 2.911 . . . . 0.0 113.105 178.512 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.454 48.2 mtmt 85.01 68.3 0.01 OUTLIER 'General case' 0 C--N 1.374 1.651 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -118.11 -10.86 10.24 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 120.632 -1.292 . . . . 0.0 111.547 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 328' ' ' VAL 0.277 37.2 m 78.81 170.34 0.19 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 130.293 3.437 . . . . 0.0 116.19 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -91.39 170.9 9.59 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 127.774 2.43 . . . . 0.0 111.989 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.66 78.74 3.33 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.817 2.047 . . . . 0.0 109.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 14.3 t30 101.2 74.18 0.0 OUTLIER Pre-proline 0 C--N 1.361 1.105 0 C-N-CA 131.203 3.801 . . . . 0.0 108.541 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--N 1.363 1.327 1 C-N-CA 125.648 4.232 . . . . 0.0 119.392 -176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -86.14 96.85 0.55 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.968 3.112 . . . . 0.0 108.107 160.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -68.92 138.7 54.85 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 128.867 2.867 . . . . 0.0 114.813 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.76 14.96 47.88 Favored Glycine 0 C--N 1.387 3.401 0 CA-C-O 124.514 2.174 . . . . 0.0 112.799 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 6.0 p -92.78 146.05 23.94 Favored 'General case' 0 CA--C 1.509 -0.602 1 C-N-CA 133.16 4.584 . . . . 0.0 100.799 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.6 OUTLIER -108.03 153.37 23.21 Favored 'General case' 0 CA--C 1.49 -1.348 0 O-C-N 119.847 -1.783 . . . . 0.0 110.411 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.461 HD23 ' CG1' ' A' ' 332' ' ' VAL . 1.6 mm? -125.64 174.34 8.35 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 112.073 -2.33 . . . . 0.0 107.476 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 88.9 m -118.29 137.98 52.69 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -157.16 170.0 34.32 Favored Glycine 0 CA--C 1.478 -2.259 0 CA-C-O 123.241 1.467 . . . . 0.0 110.384 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 327' ' ' VAL . 44.3 ttm-85 -117.15 135.14 53.99 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 124.787 1.235 . . . . 0.0 108.465 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 322' ' ' VAL . 39.4 t -87.92 132.29 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 120.265 -1.522 . . . . 0.0 113.63 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -128.32 -33.43 2.14 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -171.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -133.74 173.06 11.94 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 122.004 2.184 . . . . 0.0 107.332 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.54 150.83 40.25 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 118.908 -2.37 . . . . 0.0 112.761 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.62 178.14 4.4 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -29.02 68.53 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.346 2.258 . . . . 0.0 115.195 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.262 1.7 p90 -149.84 43.1 0.89 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 124.194 1.949 . . . . 0.0 109.634 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.09 -170.81 40.75 Favored Glycine 0 CA--C 1.468 -2.872 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 165.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 2.8 m -134.71 147.1 50.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.31 126.46 36.4 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.231 -1.543 . . . . 0.0 108.982 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.34 138.28 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 125.939 1.696 . . . . 0.0 106.546 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -100.12 124.05 45.07 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.573 -1.33 . . . . 0.0 108.028 168.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 344' ' ' LEU . 0.8 OUTLIER -64.67 -67.87 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 124.905 2.288 . . . . 0.0 116.1 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.38 161.41 35.06 Favored 'General case' 0 CA--C 1.485 -1.551 2 N-CA-C 98.716 -4.55 . . . . 0.0 98.716 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.81 119.5 10.1 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 104.34 -11.58 51.21 Favored Glycine 0 C--N 1.364 2.107 0 C-N-CA 125.526 1.536 . . . . 0.0 116.379 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.63 144.3 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.62 1.968 . . . . 0.0 106.942 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.01 155.11 48.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.182 -1.574 . . . . 0.0 112.082 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -120.9 174.88 15.93 Favored Glycine 0 C--N 1.36 1.886 0 C-N-CA 130.439 3.876 . . . . 0.0 117.526 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 42.6 tp -127.28 116.08 20.01 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 111.965 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 345' ' ' GLY 0.296 6.4 p -92.25 104.38 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 O-C-N 120.495 -1.378 . . . . 0.0 108.268 175.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -70.44 129.05 38.24 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 124.749 1.22 . . . . 0.0 113.011 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.5 2.035 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.157 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 284' ' ' VAL . 39.7 t . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -120.43 155.64 33.07 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.8 121.58 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.531 1.532 . . . . 0.0 109.974 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 87.95 23.56 38.0 Favored Glycine 0 C--N 1.362 1.998 0 C-N-CA 125.999 1.761 . . . . 0.0 114.056 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.96 146.04 48.75 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.922 -1.34 . . . . 0.0 110.753 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 283' ' ' ARG 0.306 2.7 p -92.59 138.72 19.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 125.434 1.494 . . . . 0.0 112.18 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 330' ' ' VAL . 4.9 m -140.94 179.39 2.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 C-N-CA 129.195 2.998 . . . . 0.0 108.828 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -110.89 140.39 45.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 346' ' ' LEU . 3.4 m -144.93 139.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 58.8 ttp -104.71 138.59 40.78 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-N 121.12 1.782 . . . . 0.0 108.337 -173.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.685 HG12 HD12 ' A' ' 344' ' ' LEU . 1.9 m -77.08 128.38 37.94 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 -165.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.64 -131.77 0.27 Allowed 'General case' 0 N--CA 1.421 -1.913 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.386 11.6 m-20 -54.64 113.07 1.16 Allowed 'General case' 0 N--CA 1.478 0.953 1 N-CA-C 124.452 4.982 . . . . 0.0 124.452 -156.748 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.68 129.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -145.07 118.5 9.04 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 170.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -16.0 52.43 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 125.179 1.392 . . . . 0.0 113.845 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.35 -35.45 19.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 130.013 3.325 . . . . 0.0 111.374 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -94.87 -26.74 16.05 Favored 'General case' 0 C--N 1.367 1.359 0 C-N-CA 125.103 1.361 . . . . 0.0 111.389 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.304 47.0 mtm180 73.37 48.1 0.17 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 131.115 3.766 . . . . 0.0 113.761 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 129.16 48.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 110.278 -3.146 . . . . 0.0 108.091 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.92 123.3 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.433 1 N-CA-C 95.976 -5.565 . . . . 0.0 95.976 174.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.05 94.51 5.21 Favored 'General case' 0 CA--C 1.468 -2.21 1 C-N-CA 110.975 -4.29 . . . . 0.0 106.503 -166.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.685 HD12 HG12 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -97.98 139.02 34.43 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 121.165 1.802 . . . . 0.0 107.68 -175.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 304' ' ' VAL . . . -145.35 122.41 1.7 Allowed Glycine 0 CA--C 1.471 -2.703 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.815 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.535 ' H ' HG12 ' A' ' 330' ' ' VAL 0.759 0.2 OUTLIER -141.57 -107.07 0.14 Allowed 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 127.499 2.32 . . . . 0.0 112.531 171.019 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.355 13.3 pttp 121.95 29.5 0.0 OUTLIER 'General case' 0 C--N 1.382 2.003 0 C-N-CA 129.954 3.302 . . . . 0.0 115.587 -173.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -86.59 16.84 4.29 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 118.438 -2.664 . . . . 0.0 117.181 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.279 11.9 p 62.51 147.87 0.02 OUTLIER 'General case' 0 C--N 1.366 1.314 0 N-CA-C 120.804 3.631 . . . . 0.0 120.804 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -103.28 169.3 8.63 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 125.645 1.578 . . . . 0.0 110.518 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.3 81.36 3.61 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.039 -2.288 . . . . 0.0 111.742 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 94.49 75.2 0.03 OUTLIER Pre-proline 0 C--N 1.354 0.795 1 C-N-CA 132.812 4.445 . . . . 0.0 106.161 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo . . . . . 0 C--N 1.366 1.494 1 C-N-CA 125.574 4.183 . . . . 0.0 117.277 -172.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.84 -34.88 1.13 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.519 3.48 . . . . 0.0 112.181 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 73.68 124.72 0.04 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 128.657 2.783 . . . . 0.0 114.23 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.08 11.1 43.79 Favored Glycine 0 C--N 1.372 2.545 0 CA-C-O 124.373 2.096 . . . . 0.0 113.114 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 22.6 p -101.43 136.46 41.23 Favored 'General case' 0 CA--C 1.508 -0.663 1 C-N-CA 131.992 4.117 . . . . 0.0 101.354 171.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -109.37 157.13 19.2 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-O 123.852 1.786 . . . . 0.0 113.039 -176.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -133.93 173.75 11.22 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.126 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.6 m -108.57 144.73 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.59 176.94 30.59 Favored Glycine 0 CA--C 1.486 -1.747 0 CA-C-O 123.822 1.79 . . . . 0.0 111.348 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -130.94 130.43 43.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.867 1.267 . . . . 0.0 108.477 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 294' ' ' VAL . 27.7 t -74.95 131.76 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -114.73 -34.87 5.02 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 112.135 -2.302 . . . . 0.0 112.026 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 293' ' ' PHE . 1.3 t-20 -135.13 155.8 50.08 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.63 136.51 54.94 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 164.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.45 176.84 4.85 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -30.11 71.28 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 118.769 -2.457 . . . . 0.0 116.544 -177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -145.7 40.94 1.2 Allowed 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 125.758 1.623 . . . . 0.0 110.524 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 178.55 -162.19 29.27 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 105.363 -3.095 . . . . 0.0 105.363 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 28.2 p -143.31 165.16 28.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 286' ' ' ASN . 9.7 m-85 -115.28 126.59 54.67 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 284' ' ' VAL . 93.2 t -118.9 132.2 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -167.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.93 127.36 41.88 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.255 -1.528 . . . . 0.0 112.734 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.288 26.7 mm -73.98 -86.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 123.822 1.772 . . . . 0.0 113.941 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.26 171.35 14.57 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 130.037 3.335 . . . . 0.0 103.514 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.09 119.77 10.15 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.44 -17.2 58.08 Favored Glycine 0 C--N 1.37 2.436 0 C-N-CA 127.222 2.344 . . . . 0.0 115.524 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.21 113.31 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.549 1.939 . . . . 0.0 110.527 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -135.5 157.82 45.92 Favored 'General case' 0 CA--C 1.481 -1.71 0 O-C-N 118.307 -2.746 . . . . 0.0 108.215 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -124.6 172.53 16.89 Favored Glycine 0 CA--C 1.482 -1.973 0 CA-C-O 127.1 3.611 . . . . 0.0 114.424 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.59 161.11 16.56 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 110.307 -2.947 . . . . 0.0 103.269 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.54 HG13 ' H ' ' A' ' 346' ' ' LEU . 16.2 t -116.13 130.33 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 O-C-N 124.479 1.112 . . . . 0.0 108.76 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -91.8 114.76 27.38 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 166.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.373 1.595 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 -177.283 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.504 -0.821 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.71 158.08 16.37 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 123.641 1.686 . . . . 0.0 107.576 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.38 120.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 C-N-CA 125.199 1.4 . . . . 0.0 109.565 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.49 18.03 53.44 Favored Glycine 0 C--N 1.364 2.098 0 C-N-CA 124.658 1.123 . . . . 0.0 114.235 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.5 144.03 32.83 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 125.501 1.521 . . . . 0.0 109.659 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.85 139.86 16.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 124.006 1.86 . . . . 0.0 111.345 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 346' ' ' LEU . 0.4 OUTLIER -144.59 174.72 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 130.111 3.364 . . . . 0.0 107.32 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.91 144.07 46.64 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 344' ' ' LEU . 0.1 OUTLIER -146.09 139.82 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -175.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 52.7 ttp -104.0 136.88 42.83 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 119.916 -1.74 . . . . 0.0 109.299 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . 0.267 0.2 OUTLIER -83.83 135.41 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -169.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.46 -126.86 0.26 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ASP . . . . . 0.53 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.437 12.2 m-20 -59.49 113.55 2.26 Favored 'General case' 0 N--CA 1.483 1.181 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -160.014 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 4.9 tp -112.89 120.82 63.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 -165.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 12.3 t0 -140.44 118.57 11.96 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.23 -1.73 57.62 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 126.576 1.95 . . . . 0.0 113.858 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.2 -40.12 9.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 129.245 3.018 . . . . 0.0 109.73 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 336' ' ' ASP . 8.1 mmt180 -88.22 -32.74 18.41 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 131.275 3.83 . . . . 0.0 112.765 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.329 1.3 mmp_? 75.27 50.9 0.08 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 129.426 3.09 . . . . 0.0 114.89 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -125.25 132.22 52.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 110.848 -2.887 . . . . 0.0 108.945 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.99 126.84 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 1 N-CA-C 94.177 -6.231 . . . . 0.0 94.177 171.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 39.6 m -111.0 102.45 10.93 Favored 'General case' 0 CA--C 1.446 -3.053 1 C-N-CA 111.291 -4.164 . . . . 0.0 107.063 -165.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -95.76 173.58 7.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 125.06 2.362 . . . . 0.0 110.913 -165.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.36 136.32 6.23 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.841 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LEU . . . . . 0.54 ' H ' HG13 ' A' ' 304' ' ' VAL . 1.0 OUTLIER -61.8 149.17 40.85 Favored 'General case' 0 C--N 1.369 1.435 1 N-CA-C 123.584 4.661 . . . . 0.0 123.584 -164.976 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -94.92 -98.33 0.16 Allowed 'General case' 0 C--N 1.39 2.363 0 O-C-N 120.916 -1.115 . . . . 0.0 112.8 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -141.24 -1.18 1.37 Allowed 'General case' 0 C--N 1.373 1.601 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.316 3.6 m 79.81 163.36 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.257 1.823 . . . . 0.0 115.445 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' A' ' 353' ' ' PRO . 0.0 OUTLIER -56.69 -145.24 0.0 OUTLIER 'General case' 0 C--N 1.354 0.766 1 C-N-CA 134.535 5.134 . . . . 0.0 118.88 174.114 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 164.9 89.04 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 129.935 3.294 . . . . 0.0 102.969 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 93.11 74.47 0.03 OUTLIER Pre-proline 0 C--N 1.358 0.963 0 C-N-CA 130.087 3.355 . . . . 0.0 105.795 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' PRO . . . . . 0.415 ' HB3' ' HG3' ' A' ' 350' ' ' LYS . 57.9 Cg_endo . . . . . 0 CA--C 1.564 2.019 0 C-N-CA 124.509 3.473 . . . . 0.0 112.29 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.5 m95 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.8 t -106.82 129.64 60.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 124.96 1.304 . . . . 0.0 107.947 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.3 61.36 4.07 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 126.319 1.848 . . . . 0.0 113.554 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . 0.512 10.6 pt 65.07 -34.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.258 1 C-N-CA 132.056 4.143 . . . . 0.0 119.491 -179.57 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -164.77 93.97 0.66 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 127.892 2.477 . . . . 0.0 107.498 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -144.95 142.91 30.24 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 120.746 -1.221 . . . . 0.0 109.938 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.648 ' HE ' HD11 ' A' ' 335' ' ' ILE . 10.8 mtt180 -115.65 -54.77 2.49 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 126.268 1.827 . . . . 0.0 111.626 -175.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -89.12 152.92 48.71 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 130.113 3.365 . . . . 0.0 108.942 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.9 -31.28 84.74 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 124.367 3.378 . . . . 0.0 115.999 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 93.27 119.21 0.02 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.665 3.586 . . . . 0.0 109.316 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.74 13.13 54.47 Favored Glycine 0 C--N 1.372 2.575 0 CA-C-O 124.74 2.3 . . . . 0.0 112.581 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.84 134.61 44.75 Favored 'General case' 0 CA--C 1.507 -0.684 1 C-N-CA 133.235 4.614 . . . . 0.0 102.479 172.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 12.5 ptmt -103.1 152.56 21.26 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 10.9 mt -126.05 174.05 8.74 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 124.406 2.051 . . . . 0.0 107.64 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.94 137.15 53.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 168.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -146.98 175.06 26.56 Favored Glycine 0 CA--C 1.482 -1.995 0 CA-C-O 123.783 1.769 . . . . 0.0 111.04 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -117.99 134.82 54.6 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -175.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.455 HG21 HG13 ' A' ' 322' ' ' VAL . 70.0 t -78.87 133.82 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.302 1.4 t -121.23 -44.19 2.39 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.337 0.3 OUTLIER -136.29 174.83 10.19 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.69 -1.881 . . . . 0.0 111.068 175.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 1.1 mp -121.08 142.01 50.24 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 290' ' ' TYR 0.332 1.1 t -112.49 179.16 4.06 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-O 122.564 1.173 . . . . 0.0 110.815 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.44 -28.88 60.77 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 130.129 3.372 . . . . 0.0 115.409 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.413 ' H ' HG23 ' A' ' 288' ' ' THR 0.251 19.2 p90 -156.92 46.76 0.42 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 123.921 1.819 . . . . 0.0 110.025 175.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 174.76 -163.48 33.88 Favored Glycine 0 CA--C 1.482 -2.017 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 0.7 OUTLIER -135.23 151.44 50.6 Favored 'General case' 0 CA--C 1.501 -0.938 0 C-N-CA 125.582 1.553 . . . . 0.0 107.535 -179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.284 57.2 m-85 -105.65 136.18 45.71 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 172.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 284' ' ' VAL . 3.7 t -119.94 134.83 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.942 0 CA-C-N 112.316 -2.22 . . . . 0.0 106.285 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -100.12 128.55 46.18 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 120.856 -1.153 . . . . 0.0 113.302 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.326 29.5 mm -81.53 -103.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-O 123.046 1.403 . . . . 0.0 113.89 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -107.82 169.67 8.46 Favored 'General case' 0 CA--C 1.504 -0.808 0 C-N-CA 129.313 3.045 . . . . 0.0 106.813 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.73 119.5 9.42 Favored 'General case' 0 CA--C 1.555 1.147 0 O-C-N 120.114 -1.616 . . . . 0.0 114.591 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 89.26 -5.98 83.78 Favored Glycine 0 C--N 1.369 2.368 0 C-N-CA 127.065 2.269 . . . . 0.0 115.638 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.67 113.49 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.34 2.256 . . . . 0.0 110.802 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -136.1 157.62 46.38 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 118.388 -2.695 . . . . 0.0 106.801 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.539 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -126.47 174.0 18.03 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 124.307 2.06 . . . . 0.0 115.901 175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 7.9 tp -124.51 125.0 43.49 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 125.769 1.627 . . . . 0.0 107.888 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.2 110.85 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 C-N-CA 125.997 1.719 . . . . 0.0 107.74 173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -79.04 115.14 18.53 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -36.49 -37.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.599 0 C-N-CA 130.861 3.664 . . . . 0.0 119.111 -175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.4 t -87.68 -5.19 58.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.397 1.479 . . . . 0.0 114.883 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -74.62 54.84 0.63 Allowed 'General case' 0 C--N 1.373 1.595 0 C-N-CA 126.395 1.878 . . . . 0.0 114.372 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 42.0 ttm -176.18 -51.61 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 120.812 -1.18 . . . . 0.0 109.056 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 28.7 t70 90.81 -56.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.624 0 C-N-CA 128.346 2.658 . . . . 0.0 109.497 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -67.3 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 130.207 3.403 . . . . 0.0 116.395 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.8 m -149.42 133.29 17.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 127.496 2.318 . . . . 0.0 105.248 173.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.26 50.3 m-80 116.05 -57.02 0.0 OUTLIER 'General case' 0 C--N 1.365 1.241 0 C-N-CA 131.434 3.894 . . . . 0.0 106.486 -176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -95.22 16.69 15.92 Favored 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.432 1.893 . . . . 0.0 111.469 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -92.79 -5.76 50.43 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 127.909 2.484 . . . . 0.0 112.919 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 5.6 mt 72.99 -45.98 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.324 0 C-N-CA 131.32 3.848 . . . . 0.0 113.164 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.438 ' C ' ' H ' ' A' ' 319' ' ' SER . 50.9 m-70 -56.1 137.7 73.54 Favored Pre-proline 0 C--N 1.356 0.864 1 C-N-CA 131.939 4.095 . . . . 0.0 118.625 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -62.5 38.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.61 1 C-N-CA 127.11 5.207 . . . . 0.0 114.32 166.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 317' ' ' HIS 0.42 3.0 t 87.43 24.84 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 130.185 3.394 . . . . 0.0 114.336 177.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.489 0.0 OUTLIER 72.23 22.84 3.46 Favored 'General case' 0 C--N 1.369 1.426 1 C-N-CA 133.388 4.675 . . . . 0.0 110.23 -170.169 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.428 3.7 t 82.28 64.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.61 1 C-N-CA 132.045 4.138 . . . . 0.0 109.715 177.319 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 284' ' ' VAL . 9.8 t -94.64 100.39 11.03 Favored 'Isoleucine or valine' 0 C--N 1.371 1.507 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -114.0 162.88 15.87 Favored 'General case' 0 CA--C 1.489 -1.395 0 C-N-CA 128.357 2.663 . . . . 0.0 105.678 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.05 120.47 12.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.575 0 C-N-CA 126.145 1.778 . . . . 0.0 109.493 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.32 13.74 58.21 Favored Glycine 0 C--N 1.353 1.506 0 C-N-CA 126.081 1.801 . . . . 0.0 116.532 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.84 149.22 21.42 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 126.04 1.736 . . . . 0.0 111.308 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.5 p -100.03 134.21 40.33 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 CA-C-O 123.415 1.579 . . . . 0.0 110.502 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -134.75 -178.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.366 1.295 1 C-N-CA 134.3 5.04 . . . . 0.0 110.594 -173.171 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -127.34 147.02 50.26 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 129.014 2.925 . . . . 0.0 103.813 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.404 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 1.6 m -146.46 163.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.29 0 N-CA-C 104.338 -2.468 . . . . 0.0 104.338 -176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 57.0 ttp -126.53 136.05 52.08 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.54 132.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.0 -136.65 0.3 Allowed 'General case' 0 N--CA 1.417 -2.097 1 N-CA-C 97.92 -4.845 . . . . 0.0 97.92 172.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.32 2.6 t70 -63.2 112.41 2.66 Favored 'General case' 0 C--N 1.316 -0.88 1 N-CA-C 123.205 4.52 . . . . 0.0 123.205 -156.767 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.648 HD11 ' HE ' ' A' ' 273' ' ' ARG 0.334 0.0 OUTLIER -101.71 136.77 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 126.065 1.746 . . . . 0.0 111.36 -177.406 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -139.83 102.86 4.52 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 167.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . 0.454 ' HG2' HD11 ' A' ' 335' ' ' ILE . 24.8 mt-10 -63.14 -18.3 63.3 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 129.124 2.97 . . . . 0.0 113.805 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.33 -32.71 58.85 Favored 'General case' 0 N--CA 1.433 -1.288 1 C-N-CA 133.042 4.537 . . . . 0.0 112.621 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -108.94 -31.64 7.58 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-O 123.188 1.47 . . . . 0.0 112.477 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.342 68.9 mtp180 74.91 50.46 0.09 Allowed 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 130.932 3.693 . . . . 0.0 113.112 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -124.83 125.53 44.15 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 111.683 -2.508 . . . . 0.0 104.763 178.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 3.5 mm -119.88 130.01 74.71 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.216 1 N-CA-C 98.694 -4.558 . . . . 0.0 98.694 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 5.1 t -102.26 92.47 4.74 Favored 'General case' 0 C--N 1.377 1.804 1 C-N-CA 110.298 -4.561 . . . . 0.0 104.336 -171.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.539 HD22 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -103.78 136.34 43.65 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 117.244 -1.783 . . . . 0.0 111.306 -172.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.66 123.06 1.65 Allowed Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.357 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.404 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.664 1.5 tt -138.89 -90.07 0.21 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 131.176 3.79 . . . . 0.0 108.589 174.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.342 19.4 tttt 101.35 23.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.661 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 167.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.43 -47.67 63.36 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.524 ' HA ' HG13 ' A' ' 328' ' ' VAL 0.473 11.8 p 95.28 164.88 0.02 OUTLIER 'General case' 0 C--N 1.345 0.374 1 C-N-CA 133.75 4.82 . . . . 0.0 113.916 -177.857 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -92.83 164.15 13.45 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.855 2.062 . . . . 0.0 111.582 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.5 99.31 11.49 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 119.235 -2.165 . . . . 0.0 107.849 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 91.45 64.44 0.03 OUTLIER Pre-proline 0 C--N 1.355 0.831 0 C-N-CA 131.027 3.731 . . . . 0.0 105.968 -170.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.69 -16.41 13.08 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.063 2.509 . . . . 0.0 113.728 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -110.72 136.52 49.67 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 128.551 2.74 . . . . 0.0 108.103 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -141.11 176.65 8.65 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.447 1.899 . . . . 0.0 107.008 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -79.25 68.34 5.21 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -64.13 71.8 0.03 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.042 2.937 . . . . 0.0 117.161 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -133.41 143.74 49.09 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -152.28 115.76 4.77 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 121.74 0.781 . . . . 0.0 108.911 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 45.5 m 169.51 62.72 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.613 1 N-CA-C 98.935 -4.469 . . . . 0.0 98.935 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 . . . . . 0 C--O 1.26 1.634 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.008 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 86.2 m95 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.78 151.17 31.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 125.705 1.602 . . . . 0.0 108.32 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -107.81 -68.93 0.87 Allowed 'General case' 0 C--N 1.354 0.78 0 C-N-CA 126.337 1.855 . . . . 0.0 108.984 176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.3 tt -153.04 145.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 127.262 2.225 . . . . 0.0 106.547 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.255 . . 89.16 -108.25 0.01 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 128.96 2.904 . . . . 0.0 111.203 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . 0.312 8.0 ptpt -147.33 -78.64 0.16 Allowed 'General case' 0 CA--C 1.493 -1.219 0 CA-C-O 123.203 1.477 . . . . 0.0 108.006 175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -113.1 -61.22 1.77 Allowed 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 127.017 2.127 . . . . 0.0 111.759 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 275' ' ' PRO . 94.5 m-85 -113.17 149.32 41.23 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 126.936 2.095 . . . . 0.0 108.318 178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 274' ' ' TYR . 40.4 Cg_exo -67.58 177.06 4.32 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.95 3.767 . . . . 0.0 116.011 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -147.49 135.6 21.41 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.12 5.11 44.11 Favored Glycine 0 C--N 1.369 2.386 0 CA-C-O 123.856 1.809 . . . . 0.0 112.546 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 70.5 p -95.93 121.87 38.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 130.923 3.689 . . . . 0.0 103.775 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -90.03 146.96 23.96 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 122.72 1.248 . . . . 0.0 113.362 -176.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.402 HD23 HG23 ' A' ' 332' ' ' VAL . 2.6 mm? -129.21 174.2 9.8 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-N 112.786 -2.006 . . . . 0.0 106.655 -170.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.29 143.78 51.17 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 173.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -161.64 173.73 38.06 Favored Glycine 0 CA--C 1.473 -2.561 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 -119.04 138.36 52.9 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 322' ' ' VAL . 21.8 t -83.47 132.98 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.158 -1.589 . . . . 0.0 115.153 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.267 2.3 t -136.13 -25.57 1.2 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 119.425 3.12 . . . . 0.0 119.425 -174.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -133.4 174.37 10.48 Favored 'General case' 0 C--N 1.372 1.551 0 CA-C-N 123.484 2.856 . . . . 0.0 108.053 178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.9 OUTLIER -121.01 151.41 39.79 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 167.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 178.18 4.38 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -65.59 -29.35 69.93 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.835 2.054 . . . . 0.0 115.663 178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -152.11 44.44 0.72 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 125.126 2.394 . . . . 0.0 107.915 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . 0.43 ' HA2' ' HB ' ' A' ' 306' ' ' VAL . . . -173.27 -165.21 29.82 Favored Glycine 0 CA--C 1.468 -2.869 0 N-CA-C 107.706 -2.157 . . . . 0.0 107.706 174.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.7 t -143.3 153.83 43.17 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 126.266 1.826 . . . . 0.0 106.694 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . 0.291 65.3 m-85 -114.81 142.22 46.84 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-O 124.885 2.279 . . . . 0.0 111.85 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.56 139.18 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.3 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.965 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -100.79 119.28 38.4 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.601 -1.312 . . . . 0.0 110.391 164.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.277 28.8 mt -60.15 -83.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-O 124.433 2.063 . . . . 0.0 116.19 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.26 147.34 50.23 Favored 'General case' 0 CA--C 1.495 -1.153 1 N-CA-C 98.963 -4.458 . . . . 0.0 98.963 175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -57.41 119.97 7.4 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 105.17 -10.55 47.49 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.731 1.634 . . . . 0.0 114.649 -175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 18.3 t -116.24 143.93 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 C-N-CA 127.966 2.506 . . . . 0.0 105.067 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -152.42 149.75 28.92 Favored 'General case' 0 CA--C 1.492 -1.28 0 O-C-N 119.282 -2.136 . . . . 0.0 105.841 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 344' ' ' LEU . . . -130.51 173.87 19.92 Favored Glycine 0 CA--C 1.485 -1.84 0 CA-C-O 124.368 2.093 . . . . 0.0 113.924 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 292' ' ' CYS . 62.2 tp -97.81 163.49 12.78 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 120.378 -1.66 . . . . 0.0 110.157 173.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . 0.263 11.8 t -116.76 118.89 60.28 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.262 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 162.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -79.87 113.27 17.91 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 172.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.43 ' HB ' ' HA2' ' A' ' 291' ' ' GLY 0.386 7.6 p -27.25 -51.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.786 1 N-CA-C 122.003 4.075 . . . . 0.0 122.003 -166.565 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 25.0 p -91.06 -3.45 57.16 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -81.23 61.39 4.73 Favored 'General case' 0 C--N 1.366 1.311 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 17.2 ttt -99.79 -62.17 1.27 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.678 1.591 . . . . 0.0 107.363 170.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -168.57 -57.98 0.02 OUTLIER 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -154.1 172.64 17.2 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.9 t -164.08 130.8 3.17 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 57.8 t30 150.6 -80.68 0.0 OUTLIER 'General case' 0 C--N 1.357 0.932 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -110.05 43.92 1.29 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.827 1.251 . . . . 0.0 109.561 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -86.42 -19.83 29.08 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.092 1.757 . . . . 0.0 112.175 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 5.6 mt 71.78 -33.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.177 0 C-N-CA 130.604 3.562 . . . . 0.0 114.928 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -90.32 113.9 59.11 Favored Pre-proline 0 C--N 1.351 0.632 0 C-N-CA 131.073 3.749 . . . . 0.0 117.478 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -64.17 44.39 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.431 1 C-N-CA 127.795 5.664 . . . . 0.0 113.794 165.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . 0.482 ' HB3' ' HB ' ' A' ' 322' ' ' VAL 0.481 1.2 t 87.67 13.5 0.1 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 125.333 2.492 . . . . 0.0 113.204 -178.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.323 18.0 mttp 77.03 28.39 0.64 Allowed 'General case' 0 C--N 1.365 1.239 1 C-N-CA 132.964 4.506 . . . . 0.0 110.037 -170.025 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.467 1.5 t 74.53 62.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.88 1 C-N-CA 132.034 4.134 . . . . 0.0 111.513 -179.103 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 319' ' ' SER 0.297 4.1 t -77.44 102.8 4.12 Favored 'Isoleucine or valine' 0 C--N 1.373 1.605 0 CA-C-O 125.009 2.338 . . . . 0.0 111.007 -178.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -109.47 168.17 9.59 Favored 'General case' 0 CA--C 1.485 -1.531 0 C-N-CA 129.364 3.065 . . . . 0.0 107.66 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.1 p -73.33 121.2 23.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.399 0 CA-C-N 113.333 -1.758 . . . . 0.0 109.38 174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.43 14.95 56.42 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 125.676 1.608 . . . . 0.0 114.225 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.65 143.71 26.06 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.998 1.319 . . . . 0.0 110.912 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.83 136.25 31.92 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 CA-C-O 122.773 1.273 . . . . 0.0 108.519 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 346' ' ' LEU . 0.0 OUTLIER -139.77 177.89 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 C-N-CA 129.664 3.186 . . . . 0.0 107.074 -171.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -123.91 138.32 54.5 Favored 'General case' 0 CA--C 1.489 -1.4 1 N-CA-C 98.819 -4.512 . . . . 0.0 98.819 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 7.7 m -143.47 139.97 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 100.667 -3.827 . . . . 0.0 100.667 -167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.7 ttm -102.57 141.64 35.07 Favored 'General case' 0 CA--C 1.49 -1.334 0 O-C-N 120.363 -1.46 . . . . 0.0 108.781 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 342' ' ' ILE . 74.9 t -81.5 133.14 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 119.936 -1.727 . . . . 0.0 115.463 -170.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.98 -135.35 0.29 Allowed 'General case' 0 N--CA 1.426 -1.643 1 N-CA-C 99.618 -4.215 . . . . 0.0 99.618 172.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.402 0.8 OUTLIER -59.69 112.72 1.92 Allowed 'General case' 0 N--CA 1.481 1.122 1 N-CA-C 124.196 4.887 . . . . 0.0 124.196 -158.976 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 0.3 OUTLIER -101.48 112.83 35.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 C-N-CA 125.65 1.58 . . . . 0.0 114.176 -176.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.55 107.48 6.67 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 177.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -89.87 7.32 37.81 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 126.535 1.934 . . . . 0.0 112.302 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . 0.25 24.1 mm-40 -82.71 -41.91 18.71 Favored 'General case' 0 N--CA 1.432 -1.351 1 C-N-CA 134.021 4.928 . . . . 0.0 108.831 170.955 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -101.51 -27.08 13.32 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.655 1.982 . . . . 0.0 111.349 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 63.1 mtm-85 75.32 53.21 0.07 Allowed 'General case' 0 C--N 1.35 0.604 1 C-N-CA 131.968 4.107 . . . . 0.0 112.702 -179.933 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.9 ptt180 -124.53 134.0 53.13 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 111.092 -2.776 . . . . 0.0 109.621 -177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.463 HG22 HG13 ' A' ' 332' ' ' VAL . 0.7 OUTLIER -118.83 122.0 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 1 N-CA-C 94.44 -6.133 . . . . 0.0 94.44 172.561 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.5 94.96 5.76 Favored 'General case' 0 CA--C 1.463 -2.366 1 C-N-CA 110.845 -4.342 . . . . 0.0 104.35 -162.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.415 ' CD1' ' HA3' ' A' ' 302' ' ' GLY . 1.0 OUTLIER -96.34 171.24 8.7 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 118.925 -2.359 . . . . 0.0 109.547 -164.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -154.81 136.91 5.39 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 116.688 -2.672 . . . . 0.0 112.857 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 328' ' ' VAL . 0.2 OUTLIER -53.06 152.79 3.9 Favored 'General case' 0 C--N 1.35 0.592 1 N-CA-C 125.029 5.196 . . . . 0.0 125.029 -163.618 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -108.32 -102.25 0.37 Allowed 'General case' 0 C--N 1.386 2.159 0 O-C-N 121.208 -0.933 . . . . 0.0 111.909 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -139.33 24.25 2.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 120.196 -1.565 . . . . 0.0 114.85 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.485 0.9 OUTLIER 70.84 173.67 0.31 Allowed 'General case' 0 C--N 1.373 1.625 0 C-N-CA 126.334 1.853 . . . . 0.0 115.31 -179.218 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 0.0 OUTLIER -80.46 159.67 25.52 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.47 -1.394 . . . . 0.0 111.739 174.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.437 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -85.33 54.59 3.16 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 110.758 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.294 3.3 p30 123.01 94.32 0.0 OUTLIER Pre-proline 0 C--N 1.354 0.801 1 C-N-CA 136.196 5.798 . . . . 0.0 104.977 -171.834 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 -99.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.584 0 C-N-CA 123.404 2.736 . . . . 0.0 110.511 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -88.43 75.42 8.43 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.667 1.987 . . . . 0.0 111.338 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.88 173.41 10.57 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.513 1.125 . . . . 0.0 108.549 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -128.4 175.36 8.56 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 127.246 2.218 . . . . 0.0 106.054 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 66.41 -167.78 0.21 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 127.043 2.137 . . . . 0.0 115.775 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -130.52 58.37 1.69 Allowed 'General case' 0 C--N 1.359 0.985 0 O-C-N 120.608 -1.308 . . . . 0.0 109.826 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.79 149.81 41.44 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.795 1.238 . . . . 0.0 110.683 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.2 m 178.16 147.9 0.17 Allowed 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 1.8 p80 . . . . . 0 C--O 1.267 2.016 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -179.76 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 120.921 0.391 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.28 152.59 8.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -87.37 42.43 1.04 Allowed 'General case' 0 C--N 1.363 1.163 0 N-CA-C 116.382 1.993 . . . . 0.0 116.382 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 17.2 tt -169.12 157.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 124.361 1.064 . . . . 0.0 109.622 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 54.71 -43.12 0.02 OUTLIER 'General case' 0 C--N 1.361 1.084 2 C-N-CA 132.925 4.49 . . . . 0.0 122.741 170.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -48.11 124.22 7.38 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 120.286 3.439 . . . . 0.0 120.286 -168.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.496 ' H ' ' HE ' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -107.01 17.43 23.06 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.964 1.706 . . . . 0.0 112.733 -172.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -157.9 151.81 19.7 Favored Pre-proline 0 N--CA 1.445 -0.706 0 C-N-CA 124.92 1.288 . . . . 0.0 109.75 -169.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -81.83 -37.37 0.26 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.394 3.396 . . . . 0.0 111.776 169.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 84.03 123.5 0.04 OUTLIER 'General case' 0 C--N 1.372 1.584 0 C-N-CA 129.637 3.175 . . . . 0.0 112.733 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.75 10.23 44.06 Favored Glycine 0 C--N 1.375 2.744 0 CA-C-O 124.255 2.031 . . . . 0.0 113.356 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.17 166.36 13.42 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 131.431 3.893 . . . . 0.0 103.31 167.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 29.2 mmmt -112.14 146.98 37.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 O-C-N 120.244 -1.535 . . . . 0.0 111.906 -174.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 280' ' ' LEU . 1.8 mp -120.95 174.13 6.82 Favored 'General case' 0 CA--C 1.488 -1.442 0 CA-C-O 123.926 1.822 . . . . 0.0 107.094 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 89.1 m -141.09 138.28 33.44 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 120.381 -1.449 . . . . 0.0 108.228 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -160.91 179.06 36.62 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-O 124.183 1.991 . . . . 0.0 115.638 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -125.4 135.38 52.33 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 14.6 t -72.12 133.5 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 119.134 3.013 . . . . 0.0 119.134 -175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.255 12.4 t -115.59 -40.6 3.36 Favored 'General case' 0 C--N 1.354 0.783 0 CA-C-N 112.968 -1.923 . . . . 0.0 115.083 -178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -135.9 172.63 12.73 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 121.103 1.774 . . . . 0.0 109.138 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.416 ' HA ' ' HB2' ' A' ' 292' ' ' CYS . 1.3 tt -122.18 142.36 50.5 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 125.652 1.581 . . . . 0.0 107.86 166.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 173.67 6.26 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 121.006 -1.059 . . . . 0.0 109.284 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.62 -28.87 69.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.62 2.368 . . . . 0.0 115.537 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -153.3 48.46 0.69 Allowed 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 123.494 1.616 . . . . 0.0 107.744 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 177.66 -161.55 28.83 Favored Glycine 0 CA--C 1.486 -1.742 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 167.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 287' ' ' LEU 0.36 0.8 OUTLIER -145.9 164.58 31.52 Favored 'General case' 0 CA--C 1.508 -0.669 0 C-N-CA 125.017 1.327 . . . . 0.0 109.523 168.538 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -102.92 122.44 44.57 Favored 'General case' 0 C--N 1.357 0.892 0 O-C-N 121.202 -0.936 . . . . 0.0 108.894 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.4 125.94 67.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.288 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.27 123.73 35.81 Favored 'General case' 0 C--N 1.347 0.467 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 9.7 mm -91.25 48.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.932 -1.105 . . . . 0.0 111.231 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.268 38.0 mt-10 79.95 173.56 0.14 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.116 2.566 . . . . 0.0 110.481 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.56 119.4 12.29 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.92 -33.91 4.7 Favored Glycine 0 C--N 1.367 2.305 0 C-N-CA 127.65 2.548 . . . . 0.0 114.337 177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . 0.298 1.8 p -117.35 123.54 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 126.228 1.811 . . . . 0.0 112.03 -178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.38 154.65 45.77 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 119.066 -2.272 . . . . 0.0 107.276 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -116.27 172.15 14.09 Favored Glycine 0 CA--C 1.477 -2.322 0 CA-C-O 124.083 1.935 . . . . 0.0 112.045 163.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 5.1 tp -126.75 126.48 43.51 Favored 'General case' 0 CA--C 1.469 -2.145 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 171.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.667 ' CG2' ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -92.14 120.22 40.95 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.654 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 171.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -94.92 132.5 39.68 Favored 'General case' 0 C--N 1.345 0.395 0 O-C-N 123.647 0.592 . . . . 0.0 111.801 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 t -47.79 -23.01 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 12.2 t -69.33 -25.65 64.31 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.442 2.697 . . . . 0.0 114.496 171.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -104.09 66.5 0.83 Allowed 'General case' 0 C--N 1.363 1.178 0 C-N-CA 127.291 2.236 . . . . 0.0 107.796 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 67.3 ttp -141.63 -97.07 0.13 Allowed 'General case' 0 C--N 1.357 0.912 0 O-C-N 121.059 -1.026 . . . . 0.0 110.399 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -175.41 -116.3 0.0 OUTLIER 'General case' 0 C--N 1.356 0.87 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 -175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -169.03 -178.21 3.2 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 126.322 1.849 . . . . 0.0 106.977 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.9 t -127.27 135.68 50.93 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 120.235 -1.54 . . . . 0.0 111.277 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.7 44.43 1.83 Allowed 'General case' 0 C--N 1.348 0.512 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 57.1 tttm 91.54 38.01 0.01 OUTLIER 'General case' 0 C--N 1.366 1.308 0 C-N-CA 130.641 3.576 . . . . 0.0 108.442 -173.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -116.75 2.65 12.92 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 125.654 1.581 . . . . 0.0 110.351 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.276 1.9 mp 67.65 -60.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.684 1 C-N-CA 132.413 4.285 . . . . 0.0 114.625 178.38 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 147.05 105.44 0.0 OUTLIER Pre-proline 0 C--N 1.348 0.518 0 C-N-CA 131.598 3.959 . . . . 0.0 106.419 -172.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -56.5 -26.02 61.45 Favored 'Trans proline' 0 C--N 1.37 1.686 1 C-N-CA 126.241 4.628 . . . . 0.0 116.355 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 20.0 t -83.43 -2.74 56.55 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 127.404 2.282 . . . . 0.0 114.894 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -120.28 -4.7 9.94 Favored 'General case' 0 C--N 1.369 1.435 0 CA-C-N 121.341 1.882 . . . . 0.0 113.056 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 27.2 m -93.97 5.49 7.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 C-N-CA 125.678 1.591 . . . . 0.0 112.438 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 59.8 t -99.69 126.18 53.15 Favored 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 126.455 1.902 . . . . 0.0 109.364 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -106.09 171.09 7.53 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 123.568 1.651 . . . . 0.0 108.863 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 15.0 p -54.49 120.66 2.35 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 C-N-CA 128.261 2.624 . . . . 0.0 113.703 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.74 14.72 72.29 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 114.193 -1.367 . . . . 0.0 115.588 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.1 133.94 34.56 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 126.791 2.037 . . . . 0.0 106.494 172.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 7.3 p -96.04 135.59 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.776 0 C-N-CA 124.622 1.169 . . . . 0.0 110.302 -173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.405 ' HA ' ' N ' ' A' ' 349' ' ' CYS . 30.5 m -139.99 175.49 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 CA-C-O 124.988 2.327 . . . . 0.0 111.462 176.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -108.51 150.93 26.76 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 0.5 OUTLIER -138.55 167.05 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.43 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 -177.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.439 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 31.9 ttm -115.52 138.81 50.66 Favored 'General case' 0 CA--C 1.482 -1.658 0 N-CA-C 102.945 -2.983 . . . . 0.0 102.945 177.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.623 ' HB ' HD12 ' A' ' 344' ' ' LEU . 1.2 p -85.7 131.76 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -171.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -122.91 -137.33 0.3 Allowed 'General case' 0 N--CA 1.414 -2.231 1 N-CA-C 99.226 -4.361 . . . . 0.0 99.226 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.29 28.0 m-20 -65.01 112.45 3.33 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.816 4.376 . . . . 0.0 122.816 -155.084 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' ' 273' ' ' ARG 0.431 0.1 OUTLIER -109.66 124.8 66.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 C-N-CA 125.409 1.484 . . . . 0.0 110.14 -179.202 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.26 112.68 13.57 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -78.97 -4.82 51.88 Favored 'General case' 0 C--N 1.365 1.265 0 CA-C-O 123.729 1.728 . . . . 0.0 112.866 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -86.52 -41.19 14.55 Favored 'General case' 0 N--CA 1.425 -1.689 1 C-N-CA 135.378 5.471 . . . . 0.0 111.269 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -103.11 -28.99 11.62 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 113.572 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.271 16.4 mmm180 75.02 48.88 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 C-N-CA 128.118 2.567 . . . . 0.0 113.665 175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.56 134.28 52.02 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 128.278 2.631 . . . . 0.0 106.337 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.3 mm -116.54 129.59 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.418 1 N-CA-C 95.052 -5.907 . . . . 0.0 95.052 168.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.68 94.36 5.25 Favored 'General case' 0 C--N 1.385 2.123 1 C-N-CA 111.037 -4.265 . . . . 0.0 106.425 -167.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.623 HD12 ' HB ' ' A' ' 332' ' ' VAL . 0.2 OUTLIER -101.14 135.36 42.72 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 116.611 -2.035 . . . . 0.0 108.895 -171.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -124.28 134.68 9.25 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 121.652 -0.655 . . . . 0.0 112.943 -176.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.667 ' H ' ' CG2' ' A' ' 304' ' ' VAL 0.353 0.1 OUTLIER -73.49 163.08 28.53 Favored 'General case' 0 C--N 1.368 1.381 1 N-CA-C 128.779 6.585 . . . . 0.0 128.779 -154.586 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -121.52 -105.77 0.37 Allowed 'General case' 0 C--N 1.384 2.108 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -163.6 152.0 13.59 Favored 'General case' 0 C--N 1.349 0.566 1 N-CA-C 97.765 -4.902 . . . . 0.0 97.765 173.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.405 ' N ' ' HA ' ' A' ' 328' ' ' VAL . 13.0 t -86.35 -39.2 16.67 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.781 3.658 . . . . 0.0 108.922 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -129.35 165.14 22.09 Favored 'General case' 0 N--CA 1.449 -0.524 1 CA-C-N 104.258 -5.883 . . . . 0.0 108.759 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.22 46.18 1.01 Allowed 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.008 -1.683 . . . . 0.0 109.675 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . 0.286 1.0 OUTLIER 154.94 69.31 0.0 OUTLIER Pre-proline 0 C--N 1.35 0.629 1 C-N-CA 132.808 4.443 . . . . 0.0 106.56 -176.493 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.35 128.88 18.07 Favored 'Trans proline' 0 C--N 1.368 1.58 0 C-N-CA 124.74 3.627 . . . . 0.0 110.971 177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -62.42 127.41 31.19 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.31 2.244 . . . . 0.0 116.854 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -97.84 -15.18 20.34 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.51 114.83 3.89 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 119.936 -1.727 . . . . 0.0 108.911 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.313 97.0 m-85 77.53 47.62 0.06 Allowed 'General case' 0 C--N 1.362 1.126 0 C-N-CA 129.242 3.017 . . . . 0.0 117.39 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -85.27 95.11 9.09 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 120.639 -1.288 . . . . 0.0 111.088 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -111.18 -98.41 0.41 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.401 1.08 . . . . 0.0 109.256 -178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.6 p -112.0 -81.07 0.59 Allowed 'General case' 0 C--N 1.348 0.534 0 C-N-CA 126.609 1.964 . . . . 0.0 110.705 -176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 . . . . . 0 C--O 1.261 1.663 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 179.722 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 14.4 t90 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 75.0 t -99.62 117.7 45.17 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 C-N-CA 128.144 2.578 . . . . 0.0 109.138 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -89.93 -8.67 51.25 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.4 tt -146.81 133.85 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 86.16 45.31 0.01 OUTLIER 'General case' 0 C--N 1.355 0.822 0 C-N-CA 128.377 2.671 . . . . 0.0 112.27 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -87.61 131.8 34.3 Favored 'General case' 0 C--N 1.349 0.575 0 C-N-CA 127.0 2.12 . . . . 0.0 110.727 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 34.3 mmt-85 -116.88 -32.0 5.24 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.993 0.917 . . . . 0.0 111.799 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 79.11 142.29 0.08 OUTLIER Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 128.041 2.537 . . . . 0.0 116.589 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.29 91.12 1.03 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 123.224 2.616 . . . . 0.0 107.247 168.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -66.28 151.58 46.75 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 128.714 2.805 . . . . 0.0 118.117 -171.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.26 8.35 55.14 Favored Glycine 0 C--N 1.384 3.214 0 CA-C-O 124.753 2.307 . . . . 0.0 112.336 -176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 332' ' ' VAL . 2.9 p -96.46 147.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.75 1 C-N-CA 135.136 5.374 . . . . 0.0 101.929 173.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 7.7 ptmt -112.35 156.07 23.08 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 119.007 -2.308 . . . . 0.0 113.399 -173.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.2 mp -143.12 151.61 40.91 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 11.8 m -109.03 139.24 44.17 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.666 -1.271 . . . . 0.0 109.679 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -140.51 -179.18 17.84 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 123.215 1.453 . . . . 0.0 112.083 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -119.07 137.64 53.42 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 48.4 t -73.82 125.93 33.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 N-CA-C 116.366 1.987 . . . . 0.0 116.366 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.3 t -106.68 -36.58 6.68 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 111.758 -2.474 . . . . 0.0 112.772 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.27 0.9 OUTLIER -136.64 170.26 16.36 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.819 1.645 . . . . 0.0 109.299 177.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.1 tp -121.72 148.05 45.11 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 166.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.7 m -112.02 172.56 6.83 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -68.05 -28.09 67.09 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 119.174 -2.204 . . . . 0.0 113.298 177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.68 44.07 1.37 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 125.949 1.7 . . . . 0.0 107.757 176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -179.05 -168.31 37.94 Favored Glycine 0 CA--C 1.471 -2.71 0 N-CA-C 108.191 -1.963 . . . . 0.0 108.191 169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.76 145.86 26.87 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -101.14 118.69 37.49 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.67 125.04 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -94.19 119.47 33.06 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.246 -1.534 . . . . 0.0 110.554 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 37.5 mm -60.19 -65.25 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 116.78 2.141 . . . . 0.0 116.78 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -138.08 166.52 23.91 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 101.538 -3.504 . . . . 0.0 101.538 175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -65.52 118.87 10.09 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.835 -1.166 . . . . 0.0 114.046 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 103.02 -16.94 53.61 Favored Glycine 0 C--N 1.368 2.329 0 C-N-CA 127.128 2.299 . . . . 0.0 115.851 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 5.4 p -116.91 117.83 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.941 1.697 . . . . 0.0 109.94 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.76 160.31 37.2 Favored 'General case' 0 CA--C 1.487 -1.447 0 O-C-N 119.346 -2.097 . . . . 0.0 110.299 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -120.35 173.54 15.35 Favored Glycine 0 C--N 1.354 1.552 0 C-N-CA 125.946 1.736 . . . . 0.0 114.181 169.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 13.2 tp -126.22 115.53 19.88 Favored 'General case' 0 CA--C 1.484 -1.594 0 C-N-CA 126.442 1.897 . . . . 0.0 107.088 174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 347' ' ' LYS 0.256 4.3 p -87.34 112.77 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -79.16 123.46 27.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.165 -176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t -54.63 -23.8 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-N 122.942 2.61 . . . . 0.0 115.911 176.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 42.8 p -87.07 11.29 14.15 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 131.48 3.912 . . . . 0.0 114.308 173.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.02 50.13 0.04 OUTLIER 'General case' 0 C--N 1.378 1.83 0 C-N-CA 128.415 2.686 . . . . 0.0 114.923 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 32.9 ttm -164.44 -61.8 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 104.15 -2.537 . . . . 0.0 104.15 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -163.2 -83.67 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -132.22 11.09 4.57 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.392 -0.818 . . . . 0.0 113.068 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 313' ' ' ASN 0.41 0.6 OUTLIER 83.46 -150.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 130.056 3.342 . . . . 0.0 111.854 -177.736 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . 0.463 ' H ' HG23 ' A' ' 312' ' ' THR . 6.5 t-20 74.45 -60.55 0.52 Allowed 'General case' 0 C--N 1.365 1.264 0 C-N-CA 129.993 3.317 . . . . 0.0 111.626 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -66.08 -14.13 61.21 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 131.515 3.926 . . . . 0.0 112.306 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -73.93 -27.85 61.23 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 127.093 2.157 . . . . 0.0 111.219 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.5 mt 68.56 -33.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.362 0 C-N-CA 130.48 3.512 . . . . 0.0 117.722 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -78.29 110.73 14.62 Favored Pre-proline 0 C--N 1.352 0.707 1 C-N-CA 131.886 4.074 . . . . 0.0 119.204 -176.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -67.47 54.21 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 126.637 4.891 . . . . 0.0 115.46 168.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 92.78 6.96 0.04 OUTLIER 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 128.957 2.903 . . . . 0.0 110.481 177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.26 5.7 tmtp? 72.32 19.04 4.47 Favored 'General case' 0 C--N 1.371 1.532 1 C-N-CA 132.026 4.13 . . . . 0.0 109.54 -169.588 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.426 0.9 OUTLIER 57.16 57.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.37 1.467 1 C-N-CA 133.415 4.686 . . . . 0.0 112.381 -171.089 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 12.3 t -83.84 145.1 8.73 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 C-N-CA 130.184 3.394 . . . . 0.0 114.189 -172.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -120.16 169.06 10.58 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 6.7 p -75.09 121.27 26.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 C-N-CA 126.56 1.944 . . . . 0.0 107.834 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.1 18.42 53.79 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 116.492 1.357 . . . . 0.0 116.492 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -98.89 164.46 12.19 Favored 'General case' 0 C--N 1.35 0.611 0 C-N-CA 130.009 3.324 . . . . 0.0 104.13 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.29 0.2 OUTLIER -121.41 138.17 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 O-C-N 120.302 -1.499 . . . . 0.0 109.925 -175.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.259 0.9 OUTLIER -139.23 163.47 26.28 Favored 'Isoleucine or valine' 0 C--N 1.368 1.388 0 CA-C-O 122.879 1.323 . . . . 0.0 108.086 179.001 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -101.24 155.38 18.06 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.443 ' HA ' ' N ' ' A' ' 346' ' ' LEU . 3.1 m -141.1 163.71 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 51.6 ttp -120.71 141.43 50.44 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 278' ' ' THR . 11.9 p -80.72 131.37 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -168.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.36 -136.66 0.29 Allowed 'General case' 0 N--CA 1.42 -1.968 1 N-CA-C 99.953 -4.092 . . . . 0.0 99.953 176.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . 0.501 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.254 24.7 m-20 -69.45 112.32 5.9 Favored 'General case' 0 C--N 1.31 -1.152 1 N-CA-C 122.702 4.334 . . . . 0.0 122.702 -154.766 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.335 0.1 OUTLIER -102.87 125.39 57.25 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 C-N-CA 127.266 2.226 . . . . 0.0 109.28 179.607 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -124.72 110.62 14.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -74.94 -3.43 32.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.025 2.13 . . . . 0.0 113.539 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -88.17 -35.55 17.32 Favored 'General case' 0 N--CA 1.432 -1.358 1 C-N-CA 132.49 4.316 . . . . 0.0 110.766 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -103.71 -39.93 6.48 Favored 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.507 1.523 . . . . 0.0 111.806 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.361 92.5 mtt180 74.48 52.49 0.09 Allowed 'General case' 0 CA--C 1.508 -0.664 1 C-N-CA 132.423 4.289 . . . . 0.0 112.606 -179.272 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -124.87 132.85 53.26 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 127.802 2.441 . . . . 0.0 104.638 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 131.15 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . 0.501 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 3.9 m -107.32 92.19 3.97 Favored 'General case' 0 C--N 1.381 1.94 1 C-N-CA 111.061 -4.256 . . . . 0.0 105.105 -166.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 332' ' ' VAL . 1.7 mp -101.6 138.28 38.8 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-N 119.961 1.255 . . . . 0.0 111.45 -175.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -149.12 123.81 1.7 Allowed Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.309 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.443 ' N ' ' HA ' ' A' ' 330' ' ' VAL 0.741 4.0 tt -139.58 -86.93 0.22 Allowed 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.493 3.517 . . . . 0.0 112.348 174.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . 0.639 ' HB2' HG21 ' A' ' 304' ' ' VAL 0.263 29.7 ttmt 93.78 44.2 0.0 OUTLIER 'General case' 0 C--N 1.371 1.506 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 174.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -79.8 -46.83 16.21 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 118.822 -2.424 . . . . 0.0 113.324 175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.259 63.0 m 90.02 160.1 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 130.425 3.49 . . . . 0.0 111.492 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.466 ' HD3' ' H ' ' A' ' 351' ' ' ALA . 4.9 mmtp -72.16 166.81 21.59 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 173.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.466 ' H ' ' HD3' ' A' ' 350' ' ' LYS . . . -92.24 4.04 54.11 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.801 2.04 . . . . 0.0 114.469 -178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -168.64 75.58 0.8 Allowed Pre-proline 0 CA--C 1.541 0.626 1 C-N-CA 131.84 4.056 . . . . 0.0 105.183 176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -61.66 -27.36 81.22 Favored 'Trans proline' 0 C--N 1.372 1.769 1 C-N-CA 125.478 4.119 . . . . 0.0 116.045 -175.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -129.53 144.55 51.31 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 129.208 3.003 . . . . 0.0 104.124 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -134.34 125.44 27.62 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -167.47 152.21 6.95 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -87.23 -31.8 20.1 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 115.132 -174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -149.95 132.49 15.75 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 136.91 -46.62 0.01 OUTLIER 'General case' 0 C--N 1.362 1.152 0 C-N-CA 128.811 2.844 . . . . 0.0 107.106 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 66.7 m -76.16 -23.03 54.75 Favored 'General case' 0 C--N 1.36 1.025 0 C-N-CA 127.295 2.238 . . . . 0.0 112.219 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 C--O 1.259 1.581 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 175.645 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.6 m95 . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.48 145.4 12.11 Favored 'Isoleucine or valine' 0 C--N 1.361 1.095 0 C-N-CA 125.53 1.532 . . . . 0.0 108.424 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -141.95 166.67 24.08 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 103.217 -2.882 . . . . 0.0 103.217 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . 0.408 7.2 pt 68.8 -2.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 129.597 3.159 . . . . 0.0 119.043 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 75.12 -78.07 0.05 OUTLIER 'General case' 0 C--N 1.349 0.548 0 C-N-CA 129.618 3.167 . . . . 0.0 114.074 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -160.99 134.65 6.74 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 172.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' A' ' 335' ' ' ILE . 7.1 mmm180 -129.02 -83.28 0.57 Allowed 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 171.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . 0.291 4.5 m-85 82.44 154.6 0.12 Allowed Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 170.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.89 114.82 4.01 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.666 2.911 . . . . 0.0 109.727 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -73.3 125.19 27.25 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.809 1.644 . . . . 0.0 111.822 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.04 2.24 31.73 Favored Glycine 0 C--N 1.363 2.074 0 CA-C-O 122.929 1.294 . . . . 0.0 113.551 -170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 46.8 p -93.23 142.58 27.15 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 28.5 mmtp -97.65 146.03 25.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 122.559 1.171 . . . . 0.0 112.933 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 mp -122.87 175.46 6.54 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 124.319 2.009 . . . . 0.0 110.238 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 48.3 m -116.92 129.87 56.34 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -132.4 173.44 20.79 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 124.42 2.122 . . . . 0.0 111.877 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -129.51 126.33 38.39 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.448 HG21 ' CG1' ' A' ' 322' ' ' VAL . 5.0 t -87.36 136.63 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 119.575 -1.953 . . . . 0.0 115.988 -173.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.323 4.1 t -145.41 -20.35 0.48 Allowed 'General case' 0 C--N 1.361 1.083 0 N-CA-C 121.253 3.798 . . . . 0.0 121.253 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.347 2.6 t-20 -134.19 175.92 9.06 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 123.734 2.97 . . . . 0.0 110.672 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.12 142.44 49.85 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 119.134 -2.229 . . . . 0.0 108.512 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 289' ' ' ASP . 2.0 m -112.51 178.38 4.32 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 288' ' ' THR . 0.4 OUTLIER -57.85 -29.62 65.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 179.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -162.86 46.39 0.14 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 123.742 1.735 . . . . 0.0 110.278 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.0 -167.58 36.23 Favored Glycine 0 CA--C 1.48 -2.1 1 N-CA-C 101.17 -4.772 . . . . 0.0 101.17 174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . 0.258 0.1 OUTLIER -134.6 161.41 35.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -98.95 128.33 45.09 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.79 -1.819 . . . . 0.0 107.972 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.58 133.19 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 CA-C-N 114.245 -1.343 . . . . 0.0 107.446 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.3 126.42 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 118.61 -2.556 . . . . 0.0 111.879 177.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 297' ' ' GLU . 7.8 mm -83.64 173.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 O-C-N 119.859 -1.776 . . . . 0.0 111.225 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . 0.498 ' H ' HG22 ' A' ' 296' ' ' ILE . 37.8 mm-40 -78.04 -17.72 56.72 Favored 'General case' 0 C--N 1.37 1.474 0 CA-C-O 127.315 3.436 . . . . 0.0 117.126 -178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.98 154.11 39.45 Favored 'General case' 0 C--N 1.303 -1.439 2 C-N-CA 143.072 8.549 . . . . 0.0 112.797 171.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -79.77 2.77 72.39 Favored Glycine 0 C--N 1.371 2.49 0 O-C-N 119.296 -2.128 . . . . 0.0 115.7 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.08 144.93 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 129.679 3.192 . . . . 0.0 108.605 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -115.17 158.24 22.51 Favored 'General case' 0 CA--C 1.489 -1.384 0 O-C-N 119.984 -1.697 . . . . 0.0 107.925 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -110.25 172.92 15.99 Favored Glycine 0 C--N 1.359 1.841 0 CA-C-O 125.058 2.477 . . . . 0.0 112.973 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.3 tp -118.48 114.62 23.14 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 346' ' ' LEU 0.296 1.5 p -79.43 100.02 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 122.858 1.313 . . . . 0.0 107.54 174.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -87.92 114.7 24.79 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.937 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 27.6 m -28.48 -20.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 121.276 3.806 . . . . 0.0 121.276 177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 89.1 p -64.83 -28.92 69.89 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 131.167 3.787 . . . . 0.0 114.85 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.87 24.27 0.0 OUTLIER 'General case' 0 C--N 1.371 1.512 0 C-N-CA 131.145 3.778 . . . . 0.0 120.701 179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 55.7 ttp -58.37 -59.91 4.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.373 3.469 . . . . 0.0 118.893 -173.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 29.8 t70 97.24 -67.5 0.0 OUTLIER 'General case' 0 C--N 1.363 1.169 0 C-N-CA 128.972 2.909 . . . . 0.0 109.885 -174.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -157.76 173.91 16.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.4 t -105.92 161.56 14.35 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.621 1.568 . . . . 0.0 113.807 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.256 66.2 m-80 106.47 -22.84 0.01 OUTLIER 'General case' 0 C--N 1.365 1.266 1 C-N-CA 132.614 4.366 . . . . 0.0 111.035 -178.68 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -111.86 -1.63 15.47 Favored 'General case' 0 C--N 1.354 0.787 0 C-N-CA 126.442 1.897 . . . . 0.0 112.242 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -88.6 -70.02 0.67 Allowed 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.277 -1.514 . . . . 0.0 114.892 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.7 mp 67.62 -52.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 C-N-CA 131.131 3.772 . . . . 0.0 115.636 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -167.89 105.8 0.57 Allowed Pre-proline 0 C--N 1.345 0.382 0 C-N-CA 126.71 2.004 . . . . 0.0 111.684 -175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -60.66 13.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.091 1 C-N-CA 127.473 5.449 . . . . 0.0 119.52 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 7.1 t -140.08 -1.01 1.6 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.73 0.812 . . . . 0.0 111.481 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -99.56 9.82 42.49 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 120.5 1.5 . . . . 0.0 111.015 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.41 139.47 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 1 N-CA-C 98.764 -4.532 . . . . 0.0 98.764 176.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.448 ' CG1' HG21 ' A' ' 284' ' ' VAL 0.269 10.0 t 72.73 106.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.377 1.797 0 CA-C-N 121.686 2.039 . . . . 0.0 111.946 -173.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.79 172.3 8.73 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-O 124.406 2.05 . . . . 0.0 111.09 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.5 p -70.64 120.64 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 112.328 -2.215 . . . . 0.0 109.758 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.15 10.61 62.25 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 125.88 1.705 . . . . 0.0 115.827 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -93.4 151.67 19.6 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 127.766 2.427 . . . . 0.0 110.474 176.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.58 138.55 26.42 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 126.16 1.784 . . . . 0.0 107.727 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.891 HG23 ' H ' ' A' ' 349' ' ' CYS 0.253 7.5 p -147.92 170.16 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 124.354 2.025 . . . . 0.0 108.707 -173.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -105.37 140.6 38.24 Favored 'General case' 0 CA--C 1.483 -1.633 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.0 OUTLIER -130.5 167.67 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.682 0 N-CA-C 104.379 -2.452 . . . . 0.0 104.379 -173.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 23.6 ttm -118.4 138.8 52.2 Favored 'General case' 0 CA--C 1.485 -1.542 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 171.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.424 HG13 HD22 ' A' ' 344' ' ' LEU . 92.5 t -81.6 124.74 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.531 -1.356 . . . . 0.0 111.14 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . 0.253 1.8 mp -125.03 -141.41 0.29 Allowed 'General case' 0 N--CA 1.409 -2.501 0 CA-C-O 126.847 3.213 . . . . 0.0 102.453 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . 0.473 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.35 4.9 t70 -65.3 112.12 3.33 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 121.682 3.956 . . . . 0.0 121.682 -152.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.708 HD13 HG23 ' A' ' 342' ' ' ILE . 4.8 tp -109.99 132.46 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 112.765 -2.016 . . . . 0.0 112.303 -172.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -134.44 104.05 5.96 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 101.58 -3.489 . . . . 0.0 101.58 173.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -78.57 -9.16 59.25 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.186 2.195 . . . . 0.0 114.026 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.13 -37.29 14.31 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.181 3.792 . . . . 0.0 111.074 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -100.62 -23.3 14.7 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 124.731 1.212 . . . . 0.0 112.365 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.276 1.5 mmp_? 74.45 46.7 0.15 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 129.491 3.116 . . . . 0.0 113.883 173.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.1 OUTLIER -125.67 111.92 15.51 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 111.119 -2.764 . . . . 0.0 105.214 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.708 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -111.65 130.23 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 2 C-N-CA 133.579 4.752 . . . . 0.0 99.597 179.534 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . 0.473 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 2.5 m -115.12 93.72 4.43 Favored 'General case' 0 CA--C 1.471 -2.063 1 C-N-CA 109.217 -4.993 . . . . 0.0 105.48 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.49 HD12 ' CD1' ' A' ' 296' ' ' ILE . 0.1 OUTLIER -100.35 136.29 40.47 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 103.579 -2.748 . . . . 0.0 103.579 -179.183 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -150.44 124.46 1.74 Allowed Glycine 0 N--CA 1.47 0.948 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.897 -164.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.714 ' HG ' HG21 ' A' ' 328' ' ' VAL . 0.7 OUTLIER -32.93 154.15 0.0 OUTLIER 'General case' 0 C--N 1.363 1.154 2 C-N-CA 135.37 5.468 . . . . 0.0 124.72 -168.5 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -101.94 -79.75 0.51 Allowed 'General case' 0 C--N 1.384 2.089 0 C-N-CA 124.188 0.995 . . . . 0.0 109.531 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.31 0.4 OUTLIER -176.44 46.75 0.01 OUTLIER 'General case' 0 C--N 1.372 1.585 0 N-CA-C 118.278 2.696 . . . . 0.0 118.278 176.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.891 ' H ' HG23 ' A' ' 328' ' ' VAL 0.421 13.4 p 68.18 161.74 0.19 Allowed 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.205 4.15 . . . . 0.0 122.205 169.845 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -77.53 168.76 19.46 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 128.646 2.778 . . . . 0.0 113.33 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -101.81 18.29 20.88 Favored 'General case' 0 C--N 1.367 1.336 0 O-C-N 118.895 -2.378 . . . . 0.0 113.257 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -174.89 52.21 0.11 Allowed Pre-proline 0 N--CA 1.438 -1.032 0 C-N-CA 129.673 3.189 . . . . 0.0 109.12 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -66.62 -43.96 6.8 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 125.005 3.803 . . . . 0.0 114.968 -171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -153.68 -159.81 1.03 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -80.94 62.28 4.87 Favored 'General case' 0 C--N 1.362 1.134 0 C-N-CA 127.896 2.478 . . . . 0.0 111.513 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -80.41 54.65 2.07 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.278 2.231 . . . . 0.0 115.838 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 61.17 49.34 5.6 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.442 3.097 . . . . 0.0 118.442 174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -94.98 87.9 5.09 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 119.967 -1.708 . . . . 0.0 109.898 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . 0.294 36.4 mt-10 83.93 -174.52 0.03 OUTLIER 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.291 3.036 . . . . 0.0 112.829 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 14.4 t -137.2 -4.56 1.89 Allowed 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.661 -1.275 . . . . 0.0 111.823 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.27 2.18 2 C-N-CA 132.936 4.494 . . . . 0.0 99.407 -177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 45.4 t -86.5 65.65 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 126.292 1.837 . . . . 0.0 111.106 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -142.85 29.38 1.52 Allowed 'General case' 0 C--N 1.349 0.587 0 C-N-CA 126.399 1.88 . . . . 0.0 106.626 178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 21.3 tt -168.35 159.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.255 . . 80.65 -73.51 0.05 Allowed 'General case' 0 C--N 1.358 0.97 0 C-N-CA 129.023 2.929 . . . . 0.0 116.708 174.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.56 ' HG2' ' H ' ' A' ' 273' ' ' ARG . 36.4 ttpt -173.98 -127.71 0.01 OUTLIER 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.56 ' H ' ' HG2' ' A' ' 272' ' ' LYS 0.274 13.4 mmp_? 94.4 119.08 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.777 1 C-N-CA 134.403 5.081 . . . . 0.0 110.074 -178.572 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 15.5 m-30 -102.91 156.34 35.43 Favored Pre-proline 0 C--N 1.351 0.668 0 C-N-CA 127.994 2.518 . . . . 0.0 109.194 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.76 -176.19 3.11 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 123.829 3.019 . . . . 0.0 112.969 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.31 126.92 49.14 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 124.512 1.125 . . . . 0.0 108.791 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.82 4.36 36.49 Favored Glycine 0 C--N 1.367 2.296 0 CA-C-O 123.804 1.78 . . . . 0.0 114.645 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 332' ' ' VAL . 4.1 p -96.62 134.22 40.13 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 131.152 3.781 . . . . 0.0 102.923 171.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 21.2 pttp -100.13 149.63 23.32 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-O 123.327 1.537 . . . . 0.0 114.687 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.414 HD23 HG21 ' A' ' 296' ' ' ILE . 2.0 mp -120.95 175.28 6.14 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-O 123.447 1.594 . . . . 0.0 110.445 -174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 94.8 m -118.04 132.82 56.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.82 179.15 26.83 Favored Glycine 0 CA--C 1.481 -2.093 0 CA-C-O 123.875 1.819 . . . . 0.0 111.337 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 57.3 mtp85 -124.45 146.57 48.85 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 177.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 322' ' ' VAL . 5.0 t -92.27 133.66 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 120.374 -1.453 . . . . 0.0 112.051 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -125.49 -38.88 2.22 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 -171.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -133.87 174.69 10.19 Favored 'General case' 0 C--N 1.371 1.536 0 CA-C-N 121.334 1.879 . . . . 0.0 107.281 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.9 mp -119.53 151.08 39.2 Favored 'General case' 0 CA--C 1.503 -0.84 0 O-C-N 119.98 -1.7 . . . . 0.0 110.583 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.75 178.94 4.12 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.24 -30.05 69.0 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 119.066 -2.271 . . . . 0.0 115.711 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -145.72 39.28 1.14 Allowed 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 123.18 1.467 . . . . 0.0 110.504 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -173.38 -170.97 37.54 Favored Glycine 0 CA--C 1.473 -2.554 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 5.3 m -135.82 157.12 47.62 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -99.2 125.74 44.85 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.515 HG11 HG11 ' A' ' 330' ' ' VAL . 16.3 t -104.29 133.58 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 125.586 1.554 . . . . 0.0 107.344 -175.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -100.43 126.47 46.83 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 121.811 2.096 . . . . 0.0 114.478 172.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.626 ' HB ' HG12 ' A' ' 300' ' ' VAL . 8.6 mm -104.56 56.44 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.255 -0.903 . . . . 0.0 111.626 173.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 75.22 171.6 0.27 Allowed 'General case' 0 C--N 1.364 1.236 0 C-N-CA 127.477 2.311 . . . . 0.0 111.877 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.96 119.04 12.66 Favored 'General case' 0 CA--C 1.563 1.476 0 O-C-N 118.75 -2.469 . . . . 0.0 115.593 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 118.82 -32.71 5.06 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 127.193 2.33 . . . . 0.0 114.987 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.629 HG13 HG13 ' A' ' 342' ' ' ILE . 40.3 t -116.9 130.64 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 127.543 2.337 . . . . 0.0 107.739 -178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -159.98 157.02 28.06 Favored 'General case' 0 CA--C 1.478 -1.798 0 O-C-N 118.307 -2.746 . . . . 0.0 104.916 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -125.87 174.07 17.7 Favored Glycine 0 CA--C 1.489 -1.553 0 N-CA-C 118.056 1.982 . . . . 0.0 118.056 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.61 122.26 37.69 Favored 'General case' 0 CA--C 1.492 -1.259 0 C-N-CA 125.932 1.693 . . . . 0.0 106.866 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 345' ' ' GLY . 2.4 p -93.61 118.79 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -96.48 133.24 41.18 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 117.359 -1.736 . . . . 0.0 112.454 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.269 52.4 t -51.47 -39.09 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 116.704 2.112 . . . . 0.0 116.704 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 13.1 p -88.22 23.12 2.23 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 125.502 1.521 . . . . 0.0 114.785 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -119.03 77.27 1.17 Allowed 'General case' 0 C--N 1.365 1.277 0 C-N-CA 126.063 1.745 . . . . 0.0 110.213 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 49.5 ttp -148.51 -122.79 0.05 Allowed 'General case' 0 C--N 1.362 1.126 0 O-C-N 119.504 -1.997 . . . . 0.0 108.281 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -158.03 -94.06 0.03 OUTLIER 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.07 -1.644 . . . . 0.0 109.097 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -121.48 132.82 54.93 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 122.544 1.164 . . . . 0.0 110.48 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 15.0 t -113.66 46.9 1.23 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-O 125.674 2.654 . . . . 0.0 105.449 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -99.11 64.77 1.41 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 128.514 2.726 . . . . 0.0 109.564 -174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . 0.251 47.5 mmtm 82.93 19.8 0.23 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 128.063 2.545 . . . . 0.0 111.565 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -103.34 -38.66 7.12 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 128.2 2.6 . . . . 0.0 111.094 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 1.8 mp 67.84 -59.13 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.096 1 C-N-CA 133.957 4.903 . . . . 0.0 112.576 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 77.26 102.47 0.03 OUTLIER Pre-proline 0 C--N 1.349 0.547 0 C-N-CA 130.664 3.586 . . . . 0.0 115.776 -177.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -61.52 -24.86 78.79 Favored 'Trans proline' 0 C--N 1.374 1.914 1 C-N-CA 125.636 4.224 . . . . 0.0 112.679 167.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 1.5 m -54.19 -31.44 52.86 Favored 'General case' 0 C--N 1.366 1.314 1 C-N-CA 134.015 4.926 . . . . 0.0 115.131 173.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 41.7 pttt -97.19 -0.05 47.49 Favored 'General case' 0 C--N 1.365 1.266 0 O-C-N 120.199 -1.563 . . . . 0.0 114.063 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 70.4 t -111.95 -57.09 4.09 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 125.706 1.602 . . . . 0.0 106.76 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.555 HG21 HG21 ' A' ' 284' ' ' VAL 0.399 0.7 OUTLIER 55.44 159.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.346 0 C-N-CA 129.182 2.993 . . . . 0.0 118.566 177.228 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.458 ' H ' HG22 ' A' ' 322' ' ' VAL . 39.7 t30 -109.66 148.96 30.43 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 172.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 5.4 p -78.67 120.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 CA-C-N 114.579 -1.191 . . . . 0.0 108.696 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 88.24 25.63 30.64 Favored Glycine 0 C--N 1.361 1.924 0 C-N-CA 124.31 0.957 . . . . 0.0 113.457 -170.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -93.83 158.0 15.87 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.674 1.99 . . . . 0.0 108.88 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -117.02 136.56 53.77 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 349' ' ' CYS 0.264 10.7 p -147.49 175.64 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.936 0 C-N-CA 130.764 3.626 . . . . 0.0 108.225 -166.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -114.69 141.71 47.45 Favored 'General case' 0 CA--C 1.486 -1.497 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.4 m -124.37 166.5 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -171.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 35.2 ttm -121.12 141.09 51.13 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.431 HG22 HD12 ' A' ' 344' ' ' LEU . 39.8 t -81.66 131.86 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 120.593 -1.317 . . . . 0.0 113.522 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.48 -136.35 0.29 Allowed 'General case' 0 N--CA 1.417 -2.117 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.252 10.5 t70 -63.84 112.05 2.73 Favored 'General case' 0 C--N 1.309 -1.161 1 N-CA-C 122.585 4.291 . . . . 0.0 122.585 -153.651 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.267 2.8 tp -101.13 112.38 33.9 Favored 'Isoleucine or valine' 0 C--N 1.364 1.204 0 CA-C-O 122.7 1.238 . . . . 0.0 108.882 176.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.07 117.15 23.33 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.481 1.112 . . . . 0.0 108.166 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -80.96 -2.79 49.19 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.331 1.853 . . . . 0.0 115.128 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -89.56 -37.64 14.55 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 128.622 2.769 . . . . 0.0 111.463 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -103.13 -30.8 10.49 Favored 'General case' 0 C--N 1.362 1.118 0 C-N-CA 125.259 1.424 . . . . 0.0 112.454 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.294 16.9 mmm180 72.49 52.83 0.17 Allowed 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 129.925 3.29 . . . . 0.0 111.928 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 2.0 ptp180 -124.58 135.19 52.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 129.16 2.984 . . . . 0.0 107.768 -176.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.629 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -108.88 130.04 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.467 1 N-CA-C 98.091 -4.781 . . . . 0.0 98.091 167.373 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 2.7 t -102.57 94.74 5.81 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 111.781 -3.968 . . . . 0.0 107.246 -169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.431 HD12 HG22 ' A' ' 332' ' ' VAL 0.306 2.1 mm? -96.12 136.87 36.0 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 120.129 -1.607 . . . . 0.0 108.464 -172.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -135.15 127.69 4.47 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.167 -1.973 . . . . 0.0 108.167 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 330' ' ' VAL . 6.9 mp -45.43 155.85 0.13 Allowed 'General case' 0 C--N 1.359 1.016 1 N-CA-C 122.043 4.09 . . . . 0.0 122.043 -167.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -131.42 -62.74 0.86 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.64 124.31 1.92 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.055 2.242 . . . . 0.0 117.055 173.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 7.4 p -47.63 151.88 0.77 Allowed 'General case' 0 C--N 1.361 1.084 1 C-N-CA 139.628 7.171 . . . . 0.0 117.48 169.259 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -70.13 162.73 27.75 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 127.403 2.281 . . . . 0.0 115.49 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -104.63 24.52 11.62 Favored 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.305 1.842 . . . . 0.0 112.548 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -175.64 51.69 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 129.702 3.201 . . . . 0.0 109.204 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -58.77 -41.83 59.28 Favored 'Trans proline' 0 C--N 1.379 2.172 1 C-N-CA 126.388 4.725 . . . . 0.0 116.615 -167.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -132.1 -95.64 0.34 Allowed 'General case' 0 C--N 1.361 1.09 0 CA-C-N 120.308 1.413 . . . . 0.0 107.668 174.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . 0.319 24.4 mp0 59.27 -37.26 0.07 Allowed 'General case' 0 C--N 1.368 1.403 0 N-CA-C 119.856 3.28 . . . . 0.0 119.856 173.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.363 12.6 tt0 102.37 -62.39 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.025 2.93 . . . . 0.0 115.66 176.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -66.28 43.85 0.02 OUTLIER 'General case' 0 C--N 1.358 0.971 0 N-CA-C 118.701 2.852 . . . . 0.0 118.701 -171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -167.81 -55.7 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.71 1.204 . . . . 0.0 108.575 -178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -82.82 -83.26 0.13 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.134 2.174 . . . . 0.0 115.987 -175.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 86.5 m 175.39 -119.74 0.0 OUTLIER 'General case' 0 C--N 1.359 0.984 0 N-CA-C 100.879 -3.748 . . . . 0.0 100.879 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.435 0 O-C-N 119.363 -2.085 . . . . 0.0 105.597 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 9.4 t90 . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.49 164.57 13.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -101.57 50.42 0.85 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.779 1.632 . . . . 0.0 111.429 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 8.8 tt -168.14 -175.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 102.361 -3.199 . . . . 0.0 102.361 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -139.37 -174.28 3.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.838 1.199 . . . . 0.0 108.253 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -83.8 -41.78 17.18 Favored 'General case' 0 C--N 1.363 1.187 0 CA-C-O 123.752 1.739 . . . . 0.0 110.796 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -156.71 -71.25 0.1 Allowed 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 131.505 3.922 . . . . 0.0 104.447 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -116.88 152.23 48.34 Favored Pre-proline 0 CA--C 1.517 -0.302 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 171.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.68 -48.92 8.02 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.697 3.598 . . . . 0.0 114.116 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 82.39 118.77 0.05 OUTLIER 'General case' 0 C--N 1.365 1.28 0 C-N-CA 128.994 2.917 . . . . 0.0 113.919 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 96.87 6.42 58.1 Favored Glycine 0 C--N 1.375 2.696 0 CA-C-O 124.556 2.198 . . . . 0.0 112.231 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 19.6 p -97.45 126.21 42.57 Favored 'General case' 0 CA--C 1.509 -0.629 1 C-N-CA 133.267 4.627 . . . . 0.0 103.475 174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -95.85 144.57 26.09 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 123.666 1.698 . . . . 0.0 112.859 -178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.77 174.09 7.34 Favored 'General case' 0 CA--C 1.487 -1.446 0 CA-C-N 113.431 -1.713 . . . . 0.0 106.566 -171.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 30.5 m -110.83 139.85 45.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -153.9 173.28 32.57 Favored Glycine 0 CA--C 1.482 -1.989 0 CA-C-O 123.543 1.635 . . . . 0.0 111.69 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.59 ' HG2' HG22 ' A' ' 327' ' ' VAL . 30.6 mtp-105 -127.54 135.37 50.24 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.53 132.08 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 C-N-CA 124.717 1.207 . . . . 0.0 113.869 -170.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -130.19 -31.04 1.91 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 118.355 2.724 . . . . 0.0 118.355 -169.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.271 1.2 t-20 -133.75 176.09 8.87 Favored 'General case' 0 C--N 1.367 1.358 0 CA-C-N 121.751 2.069 . . . . 0.0 108.379 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 292' ' ' CYS . 0.0 OUTLIER -120.47 156.37 31.62 Favored 'General case' 0 CA--C 1.504 -0.803 0 O-C-N 120.255 -1.528 . . . . 0.0 113.174 176.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.54 178.57 4.25 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -68.33 -25.49 65.13 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 127.533 2.333 . . . . 0.0 115.037 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -162.55 54.05 0.21 Allowed 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 128.225 2.61 . . . . 0.0 107.039 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.97 -170.48 41.66 Favored Glycine 0 CA--C 1.468 -2.865 1 N-CA-C 100.573 -5.011 . . . . 0.0 100.573 171.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 287' ' ' LEU . 1.8 m -139.91 169.82 17.01 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.493 1.117 . . . . 0.0 108.852 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -111.83 128.71 56.2 Favored 'General case' 0 C--N 1.367 1.33 0 CA-C-O 123.128 1.442 . . . . 0.0 109.182 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.429 HG21 HG11 ' A' ' 330' ' ' VAL . 21.2 t -103.93 138.27 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.239 0 C-N-CA 125.862 1.665 . . . . 0.0 107.006 -174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -99.89 123.84 44.57 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 119.703 -1.873 . . . . 0.0 112.157 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.61 52.61 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 122.878 1.323 . . . . 0.0 111.616 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 79.07 174.97 0.15 Allowed 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.932 2.493 . . . . 0.0 109.716 -173.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -68.22 119.72 13.23 Favored 'General case' 0 CA--C 1.558 1.285 0 O-C-N 119.871 -1.768 . . . . 0.0 114.181 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.05 -21.0 32.4 Favored Glycine 0 C--N 1.367 2.262 0 C-N-CA 127.44 2.448 . . . . 0.0 115.196 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 t -117.18 143.99 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 126.125 1.77 . . . . 0.0 109.865 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -153.51 149.81 28.08 Favored 'General case' 0 N--CA 1.439 -0.992 0 O-C-N 118.851 -2.405 . . . . 0.0 105.435 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.471 ' HA3' HD13 ' A' ' 344' ' ' LEU . . . -131.38 174.36 20.06 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-O 124.824 2.347 . . . . 0.0 112.44 176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 51.7 tp -98.38 162.63 13.07 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.703 2.001 . . . . 0.0 107.484 169.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.59 HG23 ' H ' ' A' ' 346' ' ' LEU . 2.4 p -128.82 117.15 43.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.027 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 161.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -95.21 134.89 37.45 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 119.09 -1.044 . . . . 0.0 113.792 -175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . 0.272 1.0 OUTLIER -37.82 -41.82 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.38 1.93 0 N-CA-C 120.007 3.336 . . . . 0.0 120.007 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 86.2 p -92.26 -2.15 56.65 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.233 -1.542 . . . . 0.0 114.042 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -79.03 55.92 1.88 Allowed 'General case' 0 C--N 1.369 1.44 0 O-C-N 119.737 -1.852 . . . . 0.0 114.245 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 9.4 ttm -162.15 -80.41 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -145.5 -100.83 0.1 Allowed 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -127.01 123.6 37.43 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.9 m -141.18 161.79 37.03 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.904 1.681 . . . . 0.0 106.649 -177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.264 29.5 m-80 134.47 -61.51 0.0 OUTLIER 'General case' 0 C--N 1.369 1.437 0 C-N-CA 131.105 3.762 . . . . 0.0 107.215 175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -118.7 17.66 13.52 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.309 1.844 . . . . 0.0 110.156 178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.34 -13.44 37.89 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.313 1.845 . . . . 0.0 111.416 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.299 2.7 mp 61.57 -44.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.225 1 C-N-CA 132.187 4.195 . . . . 0.0 117.214 177.294 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -26.07 115.37 0.23 Allowed Pre-proline 0 C--N 1.363 1.185 1 C-N-CA 132.116 4.166 . . . . 0.0 118.059 -177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -58.01 -23.81 62.3 Favored 'Trans proline' 0 C--N 1.367 1.547 1 C-N-CA 126.105 4.537 . . . . 0.0 115.146 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 22.5 p -82.18 -20.72 37.28 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 126.814 2.046 . . . . 0.0 113.996 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -83.98 -30.58 26.1 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 124.897 1.279 . . . . 0.0 112.109 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.2 t -95.16 -54.0 7.64 Favored 'Isoleucine or valine' 0 C--N 1.362 1.125 0 C-N-CA 125.915 1.686 . . . . 0.0 111.31 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.507 0.4 OUTLIER 85.61 134.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.126 0 C-N-CA 129.654 3.182 . . . . 0.0 114.37 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -104.7 151.07 24.16 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 123.935 1.826 . . . . 0.0 112.527 -171.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.413 HG12 ' H ' ' A' ' 324' ' ' VAL . 1.4 p -69.15 120.83 17.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.037 0 C-N-CA 127.052 2.141 . . . . 0.0 108.633 174.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 97.03 8.37 56.84 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 125.723 1.63 . . . . 0.0 115.626 -172.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.73 160.5 14.94 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 120.885 -1.362 . . . . 0.0 109.091 171.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 283' ' ' ARG . 35.0 t -117.82 137.41 51.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.596 0 N-CA-C 104.274 -2.491 . . . . 0.0 104.274 174.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -144.01 178.99 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 CA-C-O 126.043 2.83 . . . . 0.0 108.979 -173.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -115.5 133.55 55.92 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.469 -3.9 . . . . 0.0 100.469 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 1.2 m -135.48 139.2 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.954 0 N-CA-C 102.769 -3.049 . . . . 0.0 102.769 -173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.636 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 44.0 ttp -101.79 143.82 31.24 Favored 'General case' 0 CA--C 1.477 -1.847 0 O-C-N 120.63 -1.294 . . . . 0.0 108.181 -173.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.425 HG13 HG22 ' A' ' 342' ' ' ILE . 84.1 t -84.88 131.67 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 -171.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.9 -133.13 0.3 Allowed 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 100.293 -3.966 . . . . 0.0 100.293 172.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.436 11.7 m-20 -53.21 112.65 0.91 Allowed 'General case' 0 CA--C 1.503 -0.831 1 N-CA-C 123.423 4.601 . . . . 0.0 123.423 -154.991 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.59 HD13 HG23 ' A' ' 342' ' ' ILE . 5.8 tp -111.3 122.2 65.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -171.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 4.3 t0 -146.55 116.16 7.16 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -106.05 22.8 15.07 Favored 'General case' 0 C--N 1.365 1.277 0 C-N-CA 125.66 1.584 . . . . 0.0 112.707 -172.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -110.96 -43.7 3.73 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.526 1.93 . . . . 0.0 107.732 167.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 336' ' ' ASP 0.305 34.3 mmt180 -68.69 -38.53 80.38 Favored 'General case' 0 C--N 1.349 0.571 1 C-N-CA 132.956 4.503 . . . . 0.0 113.345 171.262 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.338 33.0 mmt180 74.98 51.38 0.08 Allowed 'General case' 0 C--N 1.347 0.487 1 C-N-CA 132.595 4.358 . . . . 0.0 113.481 173.334 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.2 OUTLIER -125.46 133.73 52.33 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-N 111.622 -2.535 . . . . 0.0 112.389 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.59 HG23 HD13 ' A' ' 335' ' ' ILE . 0.0 OUTLIER -119.61 127.22 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.499 1 N-CA-C 96.922 -5.214 . . . . 0.0 96.922 172.088 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.8 103.05 10.27 Favored 'General case' 0 CA--C 1.457 -2.627 1 C-N-CA 110.787 -4.365 . . . . 0.0 106.892 -170.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.471 HD13 ' HA3' ' A' ' 302' ' ' GLY . 2.1 mp -96.5 170.75 9.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 122.921 2.601 . . . . 0.0 112.077 -170.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -156.24 141.69 8.19 Favored Glycine 0 N--CA 1.488 2.143 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.788 167.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.653 ' HA ' ' HA ' ' A' ' 330' ' ' VAL 0.412 1.4 pt? -51.13 159.0 0.67 Allowed 'General case' 0 C--N 1.374 1.65 1 N-CA-C 124.761 5.097 . . . . 0.0 124.761 -165.464 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -125.44 -55.86 1.53 Allowed 'General case' 0 C--N 1.38 1.93 0 O-C-N 120.948 -1.095 . . . . 0.0 109.962 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.34 2.1 pt20 -121.02 -105.26 0.38 Allowed 'General case' 0 C--N 1.364 1.23 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 18.7 p 159.71 171.1 0.01 OUTLIER 'General case' 0 C--N 1.349 0.561 1 C-N-CA 131.954 4.101 . . . . 0.0 101.677 -169.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -91.1 161.47 15.09 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.936 1.294 . . . . 0.0 111.989 176.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -96.79 77.0 2.8 Favored 'General case' 0 C--N 1.353 0.757 0 O-C-N 118.912 -2.367 . . . . 0.0 109.737 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 40.4 t30 104.67 66.73 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 130.417 3.487 . . . . 0.0 107.675 -174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.03 146.98 91.76 Favored 'Trans proline' 0 C--N 1.382 2.31 1 C-N-CA 126.293 4.662 . . . . 0.0 112.313 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . 0.304 4.0 t90 -8.67 -31.06 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.255 2 N-CA-C 124.832 5.123 . . . . 0.0 124.832 -173.8 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -108.73 -4.49 16.94 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.412 -2.055 . . . . 0.0 112.768 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.303 28.3 mt-30 81.67 87.14 0.04 OUTLIER 'General case' 0 C--N 1.355 0.846 0 C-N-CA 127.97 2.508 . . . . 0.0 115.064 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -78.76 -92.56 0.04 OUTLIER 'General case' 0 C--N 1.37 1.485 0 O-C-N 120.653 -1.279 . . . . 0.0 113.242 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 65.18 -41.78 0.31 Allowed 'General case' 0 C--N 1.367 1.361 0 C-N-CA 129.117 2.967 . . . . 0.0 118.933 177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 97.42 -62.44 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 130.439 3.496 . . . . 0.0 107.396 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 13.1 t 162.0 -35.56 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 129.14 2.976 . . . . 0.0 106.875 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 C--O 1.266 1.962 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 -176.02 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 84.2 m95 . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 51.6 t -103.14 140.08 22.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 125.69 1.596 . . . . 0.0 107.896 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -131.56 15.57 4.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.156 1.383 . . . . 0.0 111.239 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 13.8 pt -139.49 -153.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.913 0 C-N-CA 127.1 2.16 . . . . 0.0 106.718 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -137.76 -171.19 2.94 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 7.3 pttm -107.88 1.79 22.97 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . 0.279 7.0 mtp180 72.77 -73.49 0.1 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.697 3.599 . . . . 0.0 116.04 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.86 63.11 Favored Pre-proline 0 N--CA 1.448 -0.571 0 C-N-CA 128.007 2.523 . . . . 0.0 112.995 -174.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.06 122.17 9.86 Favored 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 125.382 4.055 . . . . 0.0 114.204 178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.63 114.84 6.59 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 129.077 2.951 . . . . 0.0 113.16 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.92 7.79 40.71 Favored Glycine 0 C--N 1.367 2.272 0 CA-C-O 123.633 1.685 . . . . 0.0 114.766 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 72.9 p -96.9 144.19 27.06 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 129.044 2.938 . . . . 0.0 103.543 168.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 92.5 mttt -105.87 155.3 19.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 119.867 -1.771 . . . . 0.0 115.203 -173.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.59 HD21 HG22 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -128.33 173.42 10.18 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.809 2.243 . . . . 0.0 107.802 178.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 61.5 m -114.34 135.68 53.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -149.27 170.52 29.55 Favored Glycine 0 CA--C 1.48 -2.118 0 CA-C-O 124.097 1.943 . . . . 0.0 110.045 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 76.8 mtt180 -129.61 133.81 47.36 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 113.576 -1.312 . . . . 0.0 108.041 -171.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 322' ' ' VAL . 11.3 t -76.88 127.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.3 t -109.15 -41.96 4.54 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 112.763 -2.017 . . . . 0.0 113.632 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER -135.28 174.56 10.48 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 119.962 -1.711 . . . . 0.0 110.248 174.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 147.13 45.8 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.328 -1.483 . . . . 0.0 108.136 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 289' ' ' ASP . 1.0 OUTLIER -112.05 177.69 4.56 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 124.242 1.017 . . . . 0.0 108.885 -176.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . 0.471 ' H ' HG22 ' A' ' 288' ' ' THR . 52.9 m-20 -71.25 -12.26 61.36 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.231 2.612 . . . . 0.0 114.572 176.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.439 ' CD2' ' HE1' ' A' ' 305' ' ' HIS . 0.0 OUTLIER -164.34 47.42 0.11 Allowed 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 123.842 1.782 . . . . 0.0 109.83 176.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 169.38 -160.28 33.48 Favored Glycine 0 CA--C 1.47 -2.759 0 N-CA-C 106.295 -2.722 . . . . 0.0 106.295 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 17.6 p -145.58 164.05 32.88 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -102.35 120.38 40.39 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.3 125.27 65.04 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.569 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -90.13 131.79 35.79 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 115.246 1.572 . . . . 0.0 115.246 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 344' ' ' LEU . 3.9 mt -85.38 48.19 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.511 2.575 0 O-C-N 120.743 -1.223 . . . . 0.0 110.752 168.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . 0.258 57.6 mm-40 84.65 167.31 0.09 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 127.577 2.351 . . . . 0.0 107.514 -167.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -64.01 118.89 9.13 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 117.181 2.289 . . . . 0.0 117.181 -174.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 112.81 -20.06 20.46 Favored Glycine 0 C--N 1.371 2.506 0 C-N-CA 126.867 2.175 . . . . 0.0 116.748 173.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.5 p -117.4 122.53 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.3 144.86 24.93 Favored 'General case' 0 CA--C 1.483 -1.601 0 O-C-N 119.489 -2.007 . . . . 0.0 111.275 -165.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.463 ' HA3' HD12 ' A' ' 344' ' ' LEU . . . -106.84 175.1 20.54 Favored Glycine 0 CA--C 1.491 -1.454 0 C-N-CA 128.099 2.762 . . . . 0.0 117.186 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 11.5 tp -126.0 120.0 29.15 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 126.776 2.03 . . . . 0.0 106.916 172.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.758 HG21 ' HG3' ' A' ' 347' ' ' LYS 0.284 8.3 p -92.32 118.46 37.89 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.439 ' HE1' ' CD2' ' A' ' 290' ' ' TYR . 8.1 t60 -80.98 124.09 28.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.162 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -49.43 -10.4 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.4 0 N-CA-C 121.227 3.788 . . . . 0.0 121.227 -172.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 11.1 t -106.44 -0.85 23.77 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.787 1.635 . . . . 0.0 112.103 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -67.24 55.8 0.05 Allowed 'General case' 0 C--N 1.373 1.594 0 N-CA-C 118.61 2.818 . . . . 0.0 118.61 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 46.3 ttm 144.71 -76.16 0.0 OUTLIER 'General case' 0 C--N 1.371 1.505 0 C-N-CA 129.789 3.236 . . . . 0.0 110.788 173.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.6 t70 83.25 -98.35 0.01 OUTLIER 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.088 2.955 . . . . 0.0 110.437 -172.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . 0.272 4.1 t90 61.65 -158.75 0.33 Allowed 'General case' 0 C--N 1.369 1.425 0 C-N-CA 130.443 3.497 . . . . 0.0 116.366 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 t -145.26 145.95 31.48 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 100.326 -3.953 . . . . 0.0 100.326 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . 0.255 0.1 OUTLIER 95.41 -11.08 0.1 Allowed 'General case' 0 C--N 1.357 0.92 0 C-N-CA 126.562 1.945 . . . . 0.0 110.202 -175.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.57 0.57 8.8 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 128.359 2.664 . . . . 0.0 110.261 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.77 -10.22 58.99 Favored 'General case' 0 C--N 1.37 1.497 0 O-C-N 119.671 -1.893 . . . . 0.0 113.561 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.465 ' N ' HD12 ' A' ' 316' ' ' ILE . 3.4 mp -82.55 -7.92 11.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 1 C-N-CA 132.985 4.514 . . . . 0.0 110.385 -177.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.435 ' HB2' ' HG2' ' A' ' 320' ' ' LYS . 6.8 m-70 -81.44 119.35 75.39 Favored Pre-proline 0 N--CA 1.442 -0.83 0 C-N-CA 129.075 2.95 . . . . 0.0 112.912 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.22 -23.12 75.14 Favored 'Trans proline' 0 C--N 1.368 1.564 1 C-N-CA 126.09 4.526 . . . . 0.0 113.11 174.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 16.7 m -81.04 9.47 6.56 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 128.527 2.731 . . . . 0.0 113.681 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.435 ' HG2' ' HB2' ' A' ' 317' ' ' HIS . 71.7 mmtt -87.58 -20.48 26.35 Favored 'General case' 0 C--N 1.369 1.452 0 C-N-CA 123.801 0.84 . . . . 0.0 109.474 164.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 32.6 t -105.43 -48.87 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 C-N-CA 127.567 2.347 . . . . 0.0 107.274 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 284' ' ' VAL 0.412 33.1 t 93.56 137.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 129.757 3.223 . . . . 0.0 115.646 173.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.42 150.39 40.87 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 128.452 2.701 . . . . 0.0 105.459 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.43 121.37 29.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 CA-C-O 122.912 1.339 . . . . 0.0 108.979 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 86.46 29.35 24.76 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.23 1.395 . . . . 0.0 115.317 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -92.34 150.47 20.82 Favored 'General case' 0 C--N 1.364 1.218 0 O-C-N 120.636 -1.508 . . . . 0.0 109.311 172.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.282 0.7 OUTLIER -117.08 130.52 71.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 120.065 -1.647 . . . . 0.0 107.385 175.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.705 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 0.0 OUTLIER -133.85 179.57 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 1 C-N-CA 133.186 4.594 . . . . 0.0 106.933 -171.768 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 346' ' ' LEU . 40.7 tt0 -112.03 150.14 31.04 Favored 'General case' 0 CA--C 1.489 -1.393 0 N-CA-C 100.558 -3.867 . . . . 0.0 100.558 172.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 346' ' ' LEU . 0.3 OUTLIER -146.51 144.19 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 42.7 ttm -105.84 141.66 36.88 Favored 'General case' 0 CA--C 1.503 -0.853 0 O-C-N 120.125 -1.609 . . . . 0.0 107.45 -178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.59 HG22 HD21 ' A' ' 280' ' ' LEU . 68.4 t -69.59 128.92 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -124.05 -136.16 0.28 Allowed 'General case' 0 N--CA 1.422 -1.858 1 N-CA-C 99.045 -4.428 . . . . 0.0 99.045 171.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' A' ' 343' ' ' SER 0.307 19.3 m-20 -61.15 111.86 1.88 Allowed 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 123.201 4.519 . . . . 0.0 123.201 -154.363 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 4.2 tp -101.94 118.36 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-O 124.023 1.868 . . . . 0.0 108.886 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -117.62 103.29 9.9 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -76.84 -11.11 59.78 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.614 1.966 . . . . 0.0 115.42 -168.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -91.04 -33.55 15.47 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 128.201 2.601 . . . . 0.0 111.183 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -100.8 -29.48 12.23 Favored 'General case' 0 C--N 1.368 1.406 0 C-N-CA 125.052 1.341 . . . . 0.0 113.156 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.297 65.2 mtp85 72.96 51.96 0.14 Allowed 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 128.858 2.863 . . . . 0.0 112.618 172.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.62 132.79 53.41 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 110.79 -2.914 . . . . 0.0 106.631 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . 0.258 2.1 mt -114.09 129.7 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.559 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 334' ' ' ASP . 4.2 t -102.52 94.23 5.55 Favored 'General case' 0 C--N 1.384 2.096 0 C-N-CA 111.854 -3.938 . . . . 0.0 105.801 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.463 HD12 ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -97.23 136.29 37.95 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 119.495 -2.003 . . . . 0.0 107.637 -169.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.495 ' CA ' HG23 ' A' ' 304' ' ' VAL . . . -152.67 123.42 1.45 Allowed Glycine 0 CA--C 1.499 -0.908 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.498 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.48 ' H ' HG12 ' A' ' 330' ' ' VAL 0.59 0.2 OUTLIER -140.46 -93.0 0.16 Allowed 'General case' 0 C--N 1.363 1.186 0 C-N-CA 129.691 3.196 . . . . 0.0 109.137 172.383 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . 0.758 ' HG3' HG21 ' A' ' 304' ' ' VAL 0.356 35.6 mtmm 111.84 18.09 0.0 OUTLIER 'General case' 0 C--N 1.378 1.815 0 C-N-CA 126.781 2.033 . . . . 0.0 113.265 -178.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.58 82.27 2.27 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 120.285 -1.509 . . . . 0.0 112.116 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 328' ' ' VAL . 27.6 p -31.57 157.3 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 2 C-N-CA 135.519 5.527 . . . . 0.0 121.902 175.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -75.23 166.85 22.99 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 129.588 3.155 . . . . 0.0 114.551 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -98.76 88.22 3.98 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.708 1.603 . . . . 0.0 108.071 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 87.24 70.83 0.05 OUTLIER Pre-proline 0 C--N 1.357 0.927 0 C-N-CA 130.14 3.376 . . . . 0.0 108.777 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.44 -14.38 25.0 Favored 'Trans proline' 0 C--N 1.37 1.672 1 C-N-CA 126.391 4.728 . . . . 0.0 117.662 -173.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 42.4 t-105 -122.31 28.2 7.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 126.303 1.841 . . . . 0.0 110.045 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.15 59.98 0.77 Allowed 'General case' 0 C--N 1.361 1.075 0 N-CA-C 117.29 2.33 . . . . 0.0 117.29 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.3 72.32 7.14 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.312 3.045 . . . . 0.0 116.057 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.258 16.7 m-85 72.02 99.86 0.07 Allowed 'General case' 0 C--N 1.365 1.241 0 N-CA-C 118.202 2.667 . . . . 0.0 118.202 171.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 102.6 -131.23 0.0 OUTLIER 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.136 2.974 . . . . 0.0 108.054 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -94.13 -52.25 4.47 Favored 'General case' 0 C--N 1.36 1.023 0 O-C-N 121.225 -0.922 . . . . 0.0 111.928 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . 0.387 32.2 p 113.48 131.23 0.0 OUTLIER 'General case' 0 C--N 1.358 0.939 1 C-N-CA 132.257 4.223 . . . . 0.0 109.061 -176.696 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 13.1 p80 . . . . . 0 C--O 1.256 1.428 0 N-CA-C 103.067 -2.938 . . . . 0.0 103.067 -176.785 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 12.7 t90 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 42.9 t -85.76 122.68 38.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 127.1 2.16 . . . . 0.0 112.508 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -101.34 2.77 39.97 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 125.426 1.49 . . . . 0.0 113.92 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 3.6 pt -126.63 29.37 2.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 C-N-CA 127.302 2.241 . . . . 0.0 107.934 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -64.87 114.22 4.36 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 128.465 2.706 . . . . 0.0 115.017 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -98.19 149.74 22.23 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 124.536 1.134 . . . . 0.0 113.922 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -151.05 -45.27 0.12 Allowed 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 125.902 1.681 . . . . 0.0 108.467 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 75.42 171.05 0.11 Allowed Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 169.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.25 -48.28 10.23 Favored 'Trans proline' 0 CA--C 1.546 1.101 1 C-N-CA 125.506 4.137 . . . . 0.0 113.617 168.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 81.38 126.81 0.04 OUTLIER 'General case' 0 C--N 1.373 1.615 0 C-N-CA 128.884 2.874 . . . . 0.0 113.187 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.97 11.13 56.89 Favored Glycine 0 C--N 1.381 3.058 0 CA-C-O 124.979 2.433 . . . . 0.0 112.41 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 20.6 p -96.83 138.12 34.87 Favored 'General case' 0 N--CA 1.45 -0.442 1 C-N-CA 133.252 4.621 . . . . 0.0 102.887 172.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -105.09 153.95 20.81 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 123.0 1.381 . . . . 0.0 113.509 -175.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . 0.335 0.0 OUTLIER -136.1 173.88 11.23 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-O 123.485 1.612 . . . . 0.0 109.229 179.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.7 m -106.51 138.65 42.29 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -143.54 176.89 22.69 Favored Glycine 0 CA--C 1.483 -1.953 0 CA-C-O 123.387 1.549 . . . . 0.0 111.629 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 28.5 mtt180 -128.31 132.09 48.65 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 294' ' ' VAL . 3.1 t -82.69 127.48 39.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 C-N-CA 125.41 1.484 . . . . 0.0 114.147 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -107.94 -53.11 2.67 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.357 1.863 . . . . 0.0 112.853 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -133.27 174.83 9.97 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 120.695 -1.253 . . . . 0.0 111.071 -170.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.69 150.75 39.84 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 166.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 177.88 4.48 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -70.64 -24.18 62.67 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 126.902 2.081 . . . . 0.0 113.606 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -151.56 45.35 0.78 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 124.579 2.133 . . . . 0.0 109.046 175.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 179.46 -164.91 33.28 Favored Glycine 0 CA--C 1.47 -2.765 0 N-CA-C 106.644 -2.582 . . . . 0.0 106.644 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 15.3 p -143.5 151.13 39.91 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 123.783 0.833 . . . . 0.0 109.356 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -99.59 124.44 44.8 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.769 -0.582 . . . . 0.0 109.645 -175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 284' ' ' VAL . 3.0 t -109.59 131.69 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.516 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -100.02 122.18 42.5 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.215 -1.553 . . . . 0.0 113.68 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . . 14.9 mm -89.17 56.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.118 -0.989 . . . . 0.0 111.379 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 77.8 170.0 0.22 Allowed 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.608 2.363 . . . . 0.0 109.92 -173.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.88 119.46 12.6 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 119.594 -1.941 . . . . 0.0 115.192 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 117.11 -31.84 5.69 Favored Glycine 0 C--N 1.367 2.294 0 C-N-CA 127.1 2.286 . . . . 0.0 115.069 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 97.7 t -117.27 128.27 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.89 1.676 . . . . 0.0 109.48 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -141.83 158.66 43.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 118.675 -2.515 . . . . 0.0 106.868 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.437 ' HA3' ' CD2' ' A' ' 344' ' ' LEU . . . -130.69 173.1 20.27 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-O 123.849 1.805 . . . . 0.0 113.743 171.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 10.8 tp -121.52 121.41 37.42 Favored 'General case' 0 CA--C 1.476 -1.87 0 C-N-CA 126.468 1.907 . . . . 0.0 107.514 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.649 HG13 ' H ' ' A' ' 346' ' ' LEU . 95.8 t -86.39 113.18 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.494 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -72.12 115.78 11.75 Favored 'General case' 0 C--N 1.354 0.774 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -30.72 -44.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.368 1.376 0 N-CA-C 120.383 3.475 . . . . 0.0 120.383 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 6.9 m -91.31 -0.58 57.68 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 124.994 1.318 . . . . 0.0 113.939 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -100.91 65.46 1.11 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.82 1.648 . . . . 0.0 109.769 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 11.8 ttt -115.53 -10.35 11.92 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 120.016 -1.678 . . . . 0.0 112.567 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 9.6 t70 97.05 -85.33 0.0 OUTLIER 'General case' 0 C--N 1.368 1.375 0 C-N-CA 128.557 2.743 . . . . 0.0 106.948 -174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -91.28 86.6 6.19 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-O 122.575 1.179 . . . . 0.0 110.164 175.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 12.1 t -143.73 -166.17 2.28 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.475 -1.39 . . . . 0.0 108.418 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 78.58 -51.87 0.47 Allowed 'General case' 0 C--N 1.356 0.853 0 C-N-CA 130.242 3.417 . . . . 0.0 110.834 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 -9.98 59.66 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.415 2.286 . . . . 0.0 112.987 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -88.34 -17.21 31.09 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 129.747 3.219 . . . . 0.0 111.539 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.6 mp 59.52 -37.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.352 1 C-N-CA 132.837 4.455 . . . . 0.0 117.321 176.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -130.42 100.82 17.89 Favored Pre-proline 0 N--CA 1.444 -0.738 0 C-N-CA 125.738 1.615 . . . . 0.0 110.724 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -69.71 -17.51 37.74 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.313 3.342 . . . . 0.0 111.854 171.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 11.1 p -82.84 3.13 30.88 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 129.592 3.157 . . . . 0.0 115.673 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -6.73 15.72 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.687 -1.258 . . . . 0.0 110.194 170.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 17.3 t -102.73 -48.95 10.69 Favored 'Isoleucine or valine' 0 C--N 1.362 1.133 0 C-N-CA 127.067 2.147 . . . . 0.0 109.275 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 20.9 t -96.7 116.31 38.48 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 126.295 1.838 . . . . 0.0 109.749 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -104.72 165.98 10.7 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 126.684 1.993 . . . . 0.0 110.773 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.1 121.23 30.47 Favored 'Isoleucine or valine' 0 C--N 1.348 0.516 0 C-N-CA 126.866 2.066 . . . . 0.0 107.661 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 91.53 16.06 53.5 Favored Glycine 0 C--N 1.357 1.725 0 C-N-CA 125.426 1.489 . . . . 0.0 113.957 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -90.51 164.05 14.39 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 127.042 2.137 . . . . 0.0 111.187 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.44 125.07 72.19 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 349' ' ' CYS . 51.6 t -134.42 165.49 31.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.99 0 C-N-CA 127.11 2.164 . . . . 0.0 106.653 -174.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -114.92 135.58 54.05 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 100.931 -3.729 . . . . 0.0 100.931 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 346' ' ' LEU . 2.8 m -129.81 163.28 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.362 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 -169.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 33.1 ttm -127.9 138.03 52.52 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 39.4 t -78.07 132.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -167.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.01 -134.54 0.28 Allowed 'General case' 0 N--CA 1.408 -2.554 1 N-CA-C 98.951 -4.462 . . . . 0.0 98.951 174.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -70.98 111.81 6.65 Favored 'General case' 0 C--N 1.313 -1.018 1 N-CA-C 122.028 4.084 . . . . 0.0 122.028 -155.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 341' ' ' ARG 0.365 0.1 OUTLIER -96.83 112.52 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 126.615 1.966 . . . . 0.0 107.336 177.352 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.41 102.36 15.09 Favored 'General case' 0 CA--C 1.487 -1.474 0 C-N-CA 128.845 2.858 . . . . 0.0 105.092 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -78.19 -3.12 41.02 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -166.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -84.88 -43.15 14.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 130.001 3.32 . . . . 0.0 110.902 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -99.52 -38.05 8.93 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.167 2.187 . . . . 0.0 113.348 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.389 47.2 mtm105 75.22 51.73 0.07 Allowed 'General case' 0 CA--C 1.501 -0.928 1 C-N-CA 134.857 5.263 . . . . 0.0 114.215 179.802 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.5 OUTLIER -116.23 125.54 52.37 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 126.229 1.812 . . . . 0.0 107.348 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.8 mm -91.62 131.12 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 1 C-N-CA 132.876 4.471 . . . . 0.0 108.964 -174.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 1.1 t -102.87 92.57 4.64 Favored 'General case' 0 C--N 1.385 2.144 1 C-N-CA 110.602 -4.439 . . . . 0.0 106.048 -173.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.437 ' CD2' ' HA3' ' A' ' 302' ' ' GLY . 0.0 OUTLIER -102.86 136.98 41.68 Favored 'General case' 0 CA--C 1.494 -1.188 0 O-C-N 119.415 -2.053 . . . . 0.0 109.305 -174.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 304' ' ' VAL . . . -130.81 138.51 10.23 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.649 ' H ' HG13 ' A' ' 304' ' ' VAL 0.492 0.1 OUTLIER -54.19 162.26 1.08 Allowed 'General case' 0 C--N 1.369 1.44 1 N-CA-C 127.146 5.98 . . . . 0.0 127.146 -161.32 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -125.4 -48.63 1.69 Allowed 'General case' 0 C--N 1.382 1.996 0 O-C-N 121.732 -0.605 . . . . 0.0 111.989 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . 0.25 48.3 tp60 -124.51 -86.3 0.63 Allowed 'General case' 0 C--N 1.37 1.473 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 328' ' ' VAL 0.307 20.8 p 111.89 146.32 0.0 OUTLIER 'General case' 0 C--N 1.354 0.772 1 C-N-CA 131.965 4.106 . . . . 0.0 106.321 -172.438 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -94.89 130.24 41.58 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 120.279 -1.513 . . . . 0.0 111.143 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -94.08 75.45 4.08 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.094 2.158 . . . . 0.0 111.216 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . 0.455 ' H ' ' HD3' ' A' ' 353' ' ' PRO . 1.1 t30 125.29 66.94 0.0 OUTLIER Pre-proline 0 C--N 1.344 0.366 1 C-N-CA 133.955 4.902 . . . . 0.0 102.748 -175.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . 0.455 ' HD3' ' H ' ' A' ' 352' ' ' ASN . 83.9 Cg_endo -74.93 -27.42 10.16 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 124.194 3.263 . . . . 0.0 113.119 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -114.11 -126.83 0.29 Allowed 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.261 1.824 . . . . 0.0 108.753 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -121.16 138.27 54.29 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 127.515 2.326 . . . . 0.0 109.367 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -159.53 55.31 0.39 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 122.638 1.209 . . . . 0.0 107.881 176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -74.33 46.38 0.26 Allowed 'General case' 0 C--N 1.365 1.256 0 C-N-CA 127.978 2.511 . . . . 0.0 116.973 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -147.22 75.54 1.38 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 125.536 1.534 . . . . 0.0 106.871 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -127.87 -124.15 0.23 Allowed 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.721 1.209 . . . . 0.0 111.098 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.8 t -140.21 35.65 1.9 Allowed 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.973 -1.704 . . . . 0.0 108.89 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 . . . . . 0 C--O 1.261 1.703 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.422 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 270' ' ' ILE . 40.7 t -97.52 161.3 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 130.962 3.705 . . . . 0.0 107.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -94.41 11.01 32.13 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 119.204 -2.185 . . . . 0.0 116.088 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.444 ' H ' HG12 ' A' ' 268' ' ' VAL . 20.5 tt -163.19 151.82 3.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.374 0 O-C-N 120.556 -1.34 . . . . 0.0 107.404 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . 0.294 . . 85.84 -109.08 0.01 OUTLIER 'General case' 0 C--N 1.355 0.809 0 C-N-CA 128.065 2.546 . . . . 0.0 115.126 173.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . 0.306 9.6 pttp -149.94 -75.08 0.16 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 124.216 1.96 . . . . 0.0 113.379 -176.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -69.88 0.83 Allowed 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 127.876 2.47 . . . . 0.0 109.323 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -93.53 152.11 40.66 Favored Pre-proline 0 CA--C 1.544 0.712 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.25 -40.87 1.45 Allowed 'Trans proline' 0 C--N 1.363 1.33 0 C-N-CA 124.23 3.287 . . . . 0.0 112.236 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.592 ' HA ' HG13 ' A' ' 332' ' ' VAL 0.263 44.4 mt-10 79.84 111.0 0.07 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.984 2.514 . . . . 0.0 113.001 178.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 8.69 38.12 Favored Glycine 0 C--N 1.367 2.289 0 CA-C-O 123.894 1.83 . . . . 0.0 113.436 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . 0.535 ' O ' HG12 ' A' ' 332' ' ' VAL . 68.5 p -98.56 139.21 34.63 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 102.187 -3.264 . . . . 0.0 102.187 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 93.8 mttt -97.98 146.1 25.83 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.059 -2.275 . . . . 0.0 111.577 -174.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.5 mp -138.44 143.03 39.5 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 118.491 -1.284 . . . . 0.0 109.579 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 28.8 m -82.35 142.65 31.84 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 120.842 -1.162 . . . . 0.0 111.32 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -155.47 173.57 33.62 Favored Glycine 0 CA--C 1.486 -1.721 0 CA-C-O 123.174 1.43 . . . . 0.0 112.719 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 60.2 mtm-85 -117.8 131.08 56.62 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 125.925 1.69 . . . . 0.0 108.655 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . . . . . . . . . 17.6 t -77.38 133.24 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.281 10.1 t -122.62 -39.85 2.51 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -133.82 165.98 23.71 Favored 'General case' 0 C--N 1.38 1.931 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 3.8 mp -121.16 153.17 37.88 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 122.131 2.241 . . . . 0.0 116.871 -177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.44 178.41 4.29 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.06 -29.33 66.31 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.255 18.1 m-85 -156.8 52.72 0.51 Allowed 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 130.96 3.704 . . . . 0.0 103.481 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.11 37.22 Favored Glycine 0 N--CA 1.432 -1.62 1 N-CA-C 100.469 -5.053 . . . . 0.0 100.469 172.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . 0.506 ' H ' HG13 ' A' ' 304' ' ' VAL . 31.5 p -165.32 172.09 12.74 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 123.915 0.886 . . . . 0.0 108.653 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -103.14 120.2 40.27 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.561 HG21 HG11 ' A' ' 330' ' ' VAL . 49.1 t -108.88 135.89 46.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -173.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -100.19 121.03 40.8 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.603 -1.936 . . . . 0.0 111.254 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.28 40.1 mm -66.65 -87.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 117.713 2.486 . . . . 0.0 117.713 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -140.04 166.63 24.13 Favored 'General case' 0 CA--C 1.488 -1.432 0 C-N-CA 131.402 3.881 . . . . 0.0 101.329 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -56.16 120.28 7.28 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.4 -15.72 59.79 Favored Glycine 0 C--N 1.367 2.302 0 C-N-CA 127.18 2.324 . . . . 0.0 115.441 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.496 HG13 HG13 ' A' ' 342' ' ' ILE . 92.9 t -116.73 121.41 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.538 1.935 . . . . 0.0 111.246 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.87 151.24 50.66 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 174.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -119.8 173.48 15.18 Favored Glycine 0 CA--C 1.493 -1.284 0 CA-C-O 124.954 2.419 . . . . 0.0 115.303 172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.619 HD11 ' HG3' ' A' ' 308' ' ' GLU . 13.8 tp -125.7 121.59 33.89 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 173.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.506 HG13 ' H ' ' A' ' 292' ' ' CYS 0.311 1.5 p -87.15 121.1 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.34 0 CA-C-O 122.422 1.106 . . . . 0.0 109.838 171.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.65 ' HA ' ' CB ' ' A' ' 308' ' ' GLU . 54.4 m-70 -86.51 108.9 18.75 Favored 'General case' 0 N--CA 1.397 -3.118 0 C-N-CA 128.48 2.712 . . . . 0.0 109.087 155.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.5 t -94.51 -62.47 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.379 1.883 0 N-CA-C 101.206 -3.627 . . . . 0.0 101.206 164.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 1.2 t -144.45 41.88 1.36 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.086 -2.931 . . . . 0.0 103.086 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.65 ' CB ' ' HA ' ' A' ' 305' ' ' HIS . 5.8 tm-20 -62.19 70.16 0.01 OUTLIER 'General case' 0 C--N 1.403 2.908 0 C-N-CA 128.263 2.625 . . . . 0.0 113.148 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 11.9 ttt -122.2 -128.0 0.26 Allowed 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 128.419 2.688 . . . . 0.0 109.7 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -129.71 22.65 5.43 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 126.623 1.969 . . . . 0.0 110.604 -169.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -98.92 154.67 17.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 10.6 t -149.3 156.26 41.82 Favored 'General case' 0 C--N 1.367 1.358 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 170.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 156.73 -51.17 0.0 OUTLIER 'General case' 0 C--N 1.357 0.914 0 N-CA-C 102.186 -3.264 . . . . 0.0 102.186 -173.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -111.34 27.29 9.82 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.609 1.564 . . . . 0.0 111.91 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -67.26 -10.62 52.52 Favored 'General case' 0 C--N 1.378 1.846 0 O-C-N 118.65 -2.531 . . . . 0.0 114.491 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 316' ' ' ILE . 3.6 mp -83.1 -15.5 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 1 C-N-CA 133.022 4.529 . . . . 0.0 111.106 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -84.38 115.97 62.87 Favored Pre-proline 0 C--N 1.368 1.372 0 C-N-CA 125.663 1.585 . . . . 0.0 110.247 176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.5 -20.87 51.38 Favored 'Trans proline' 0 C--N 1.373 1.851 1 C-N-CA 126.347 4.698 . . . . 0.0 116.024 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 12.1 p -80.01 -20.44 45.39 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 128.671 2.789 . . . . 0.0 113.521 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -88.89 -16.67 31.34 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 126.008 1.723 . . . . 0.0 111.527 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.0 -71.35 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.617 1.567 . . . . 0.0 109.142 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . 0.494 0.4 OUTLIER 87.73 160.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 128.118 2.567 . . . . 0.0 112.854 -178.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.75 145.56 24.5 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-O 123.134 1.445 . . . . 0.0 109.792 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 84.9 t -78.51 121.0 30.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 83.02 23.27 55.83 Favored Glycine 0 C--N 1.357 1.703 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -169.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.27 138.67 31.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 118.749 1.275 . . . . 0.0 108.166 171.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . 0.252 2.0 p -96.29 129.36 46.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 CA-C-O 123.416 1.579 . . . . 0.0 108.554 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 349' ' ' CYS . 0.1 OUTLIER -130.48 -179.57 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 1 C-N-CA 132.312 4.245 . . . . 0.0 110.834 -173.396 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -124.27 142.29 51.38 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.561 HG11 HG21 ' A' ' 294' ' ' VAL . 2.9 m -146.71 139.37 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.561 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 46.5 ttp -96.32 131.38 42.9 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 118.525 -2.61 . . . . 0.0 111.109 -173.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 276' ' ' GLU . 7.9 p -74.11 124.57 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -166.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.51 -130.32 0.25 Allowed 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 101.559 -3.497 . . . . 0.0 101.559 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.338 7.4 t70 -57.8 112.46 1.48 Allowed 'General case' 0 N--CA 1.475 0.811 1 N-CA-C 122.586 4.291 . . . . 0.0 122.586 -158.36 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . 0.266 3.4 tp -107.81 114.41 46.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 C-N-CA 125.76 1.624 . . . . 0.0 112.533 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.477 ' CB ' ' HB2' ' A' ' 339' ' ' ARG . 96.1 m-20 -124.7 119.74 29.83 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.518 1.927 . . . . 0.0 107.849 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -88.14 -5.36 58.47 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 125.461 1.504 . . . . 0.0 114.635 -176.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -91.64 -35.3 14.29 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 127.296 2.238 . . . . 0.0 110.285 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.477 ' HB2' ' CB ' ' A' ' 336' ' ' ASP . 0.0 OUTLIER -89.88 -46.93 8.21 Favored 'General case' 0 CA--C 1.508 -0.647 1 C-N-CA 132.08 4.152 . . . . 0.0 112.379 -177.512 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.322 64.5 mtm-85 75.07 52.53 0.08 Allowed 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 131.135 3.774 . . . . 0.0 112.532 177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.59 133.14 52.38 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 111.451 -2.613 . . . . 0.0 107.943 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.496 HG13 HG13 ' A' ' 300' ' ' VAL . 0.0 OUTLIER -110.73 129.5 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.828 1 N-CA-C 98.106 -4.776 . . . . 0.0 98.106 170.484 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.84 92.92 4.8 Favored 'General case' 0 CA--C 1.474 -1.981 1 C-N-CA 111.082 -4.247 . . . . 0.0 107.715 -164.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.442 ' HG ' HG23 ' A' ' 332' ' ' VAL . 2.6 mp -97.96 135.57 39.48 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.748 -172.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -147.18 122.76 1.63 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 120.166 -1.016 . . . . 0.0 112.815 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.497 ' H ' HG12 ' A' ' 330' ' ' VAL 0.663 0.7 OUTLIER -144.55 -99.04 0.1 Allowed 'General case' 0 C--N 1.37 1.46 0 C-N-CA 128.979 2.911 . . . . 0.0 113.105 178.512 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.454 48.2 mtmt 85.01 68.3 0.01 OUTLIER 'General case' 0 C--N 1.374 1.651 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 -177.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -118.11 -10.86 10.24 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 120.632 -1.292 . . . . 0.0 111.547 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . 0.482 ' H ' HG12 ' A' ' 328' ' ' VAL 0.277 37.2 m 78.81 170.34 0.19 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 130.293 3.437 . . . . 0.0 116.19 176.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -91.39 170.9 9.59 Favored 'General case' 0 C--N 1.363 1.181 0 C-N-CA 127.774 2.43 . . . . 0.0 111.989 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.66 78.74 3.33 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.817 2.047 . . . . 0.0 109.492 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 14.3 t30 101.2 74.18 0.0 OUTLIER Pre-proline 0 C--N 1.361 1.105 0 C-N-CA 131.203 3.801 . . . . 0.0 108.541 -171.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.24 14.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.363 1.327 1 C-N-CA 125.648 4.232 . . . . 0.0 119.392 -176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -89.62 -160.57 0.69 Allowed 'General case' 0 C--N 1.358 0.955 0 CA-C-N 121.858 2.117 . . . . 0.0 115.371 -171.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -138.12 21.66 2.81 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 120.301 -1.499 . . . . 0.0 109.879 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.53 75.32 3.25 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 126.067 1.747 . . . . 0.0 115.036 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . 0.256 14.2 m-85 64.55 -63.68 0.16 Allowed 'General case' 0 C--N 1.356 0.85 0 C-N-CA 130.922 3.689 . . . . 0.0 118.321 174.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -120.83 105.06 10.35 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -109.72 156.2 20.58 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 125.729 1.612 . . . . 0.0 113.78 -175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 41.83 0.01 OUTLIER 'General case' 0 C--N 1.364 1.226 1 C-N-CA 132.645 4.378 . . . . 0.0 117.897 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 C--O 1.261 1.677 1 C-N-CA 132.291 4.237 . . . . 0.0 108.608 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 47.0 m95 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 26.3 t -106.33 141.58 21.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 C-N-CA 127.004 2.122 . . . . 0.0 105.995 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -68.2 -21.67 64.86 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . 0.41 ' HB ' ' H ' ' A' ' 271' ' ' ALA . 0.2 OUTLIER -137.44 -155.83 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 129.424 3.09 . . . . 0.0 108.363 176.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.41 ' H ' ' HB ' ' A' ' 270' ' ' ILE . . . 75.14 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.357 0.921 0 C-N-CA 129.753 3.221 . . . . 0.0 114.988 174.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -178.45 137.03 0.16 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 128.713 2.805 . . . . 0.0 105.586 175.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.1 21.39 12.35 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.766 1.626 . . . . 0.0 113.043 -173.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -167.41 162.06 10.29 Favored Pre-proline 0 C--N 1.348 0.504 0 O-C-N 119.657 -1.902 . . . . 0.0 112.992 -173.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -86.14 96.85 0.55 Allowed 'Trans proline' 0 CA--C 1.553 1.445 0 C-N-CA 123.968 3.112 . . . . 0.0 108.107 160.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -68.92 138.7 54.85 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 128.867 2.867 . . . . 0.0 114.813 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 94.76 14.96 47.88 Favored Glycine 0 C--N 1.387 3.401 0 CA-C-O 124.514 2.174 . . . . 0.0 112.799 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 6.0 p -92.78 146.05 23.94 Favored 'General case' 0 CA--C 1.509 -0.602 1 C-N-CA 133.16 4.584 . . . . 0.0 100.799 170.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.6 OUTLIER -108.03 153.37 23.21 Favored 'General case' 0 CA--C 1.49 -1.348 0 O-C-N 119.847 -1.783 . . . . 0.0 110.411 -179.15 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.461 HD23 ' CG1' ' A' ' 332' ' ' VAL . 1.6 mm? -125.64 174.34 8.35 Favored 'General case' 0 CA--C 1.482 -1.648 0 CA-C-N 112.073 -2.33 . . . . 0.0 107.476 -174.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 88.9 m -118.29 137.98 52.69 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 103.451 -2.796 . . . . 0.0 103.451 171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -157.16 170.0 34.32 Favored Glycine 0 CA--C 1.478 -2.259 0 CA-C-O 123.241 1.467 . . . . 0.0 110.384 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 327' ' ' VAL . 44.3 ttm-85 -117.15 135.14 53.99 Favored 'General case' 0 CA--C 1.487 -1.472 0 C-N-CA 124.787 1.235 . . . . 0.0 108.465 -173.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 322' ' ' VAL . 39.4 t -87.92 132.29 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 120.265 -1.522 . . . . 0.0 113.63 -172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -128.32 -33.43 2.14 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -171.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -133.74 173.06 11.94 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 122.004 2.184 . . . . 0.0 107.332 177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.3 mp -120.54 150.83 40.25 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 118.908 -2.37 . . . . 0.0 112.761 175.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.62 178.14 4.4 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -29.02 68.53 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.346 2.258 . . . . 0.0 115.195 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . 0.262 1.7 p90 -149.84 43.1 0.89 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 124.194 1.949 . . . . 0.0 109.634 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . -178.09 -170.81 40.75 Favored Glycine 0 CA--C 1.468 -2.872 0 N-CA-C 107.393 -2.283 . . . . 0.0 107.393 165.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 2.8 m -134.71 147.1 50.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -91.31 126.46 36.4 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.231 -1.543 . . . . 0.0 108.982 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.34 138.28 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 125.939 1.696 . . . . 0.0 106.546 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -100.12 124.05 45.07 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.573 -1.33 . . . . 0.0 108.028 168.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . 0.621 HG12 HD21 ' A' ' 344' ' ' LEU . 0.8 OUTLIER -64.67 -67.87 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 124.905 2.288 . . . . 0.0 116.1 -179.171 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -134.38 161.41 35.06 Favored 'General case' 0 CA--C 1.485 -1.551 2 N-CA-C 98.716 -4.55 . . . . 0.0 98.716 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.81 119.5 10.1 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 104.34 -11.58 51.21 Favored Glycine 0 C--N 1.364 2.107 0 C-N-CA 125.526 1.536 . . . . 0.0 116.379 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 2.8 p -117.63 144.3 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.62 1.968 . . . . 0.0 106.942 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.01 155.11 48.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 O-C-N 120.182 -1.574 . . . . 0.0 112.082 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . 0.648 ' HA3' HD22 ' A' ' 344' ' ' LEU . . . -120.9 174.88 15.93 Favored Glycine 0 C--N 1.36 1.886 0 C-N-CA 130.439 3.876 . . . . 0.0 117.526 169.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 42.6 tp -127.28 116.08 20.01 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.231 2.212 . . . . 0.0 111.965 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.434 ' HA ' ' CA ' ' A' ' 345' ' ' GLY 0.296 6.4 p -92.25 104.38 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.022 0 O-C-N 120.495 -1.378 . . . . 0.0 108.268 175.027 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -70.44 129.05 38.24 Favored 'General case' 0 C--N 1.367 1.347 0 C-N-CA 124.749 1.22 . . . . 0.0 113.011 -177.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -52.75 -21.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 5.1 p -83.1 -13.39 55.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.276 3.03 . . . . 0.0 115.277 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -74.75 42.48 0.17 Allowed 'General case' 0 C--N 1.372 1.553 0 O-C-N 118.994 -2.316 . . . . 0.0 115.751 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 17.2 ttt -84.59 -42.24 15.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.863 3.265 . . . . 0.0 115.533 -177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 30.4 t70 84.72 -72.1 0.03 OUTLIER 'General case' 0 C--N 1.367 1.335 0 C-N-CA 127.431 2.293 . . . . 0.0 111.268 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -162.91 179.44 7.59 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 128.152 2.581 . . . . 0.0 104.4 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 4.7 t -82.23 59.48 4.51 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 127.599 2.36 . . . . 0.0 111.19 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -93.34 58.36 2.81 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 128.267 2.627 . . . . 0.0 111.106 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 19.9 tptm 77.18 32.63 0.46 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 129.294 3.037 . . . . 0.0 110.381 -175.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.37 -52.21 2.8 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.137 1.775 . . . . 0.0 112.619 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . 0.269 2.4 mp 73.56 -50.37 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 C-N-CA 130.271 3.428 . . . . 0.0 112.701 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.405 ' HB2' ' HG2' ' A' ' 320' ' ' LYS . 1.7 m-70 -143.4 126.13 8.82 Favored Pre-proline 0 C--N 1.351 0.638 0 C-N-CA 127.772 2.429 . . . . 0.0 108.083 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -77.48 29.36 0.43 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 125.12 3.88 . . . . 0.0 113.459 176.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 10.4 p -124.55 -6.31 7.55 Favored 'General case' 0 N--CA 1.436 -1.134 1 C-N-CA 131.937 4.095 . . . . 0.0 109.421 174.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 317' ' ' HIS . 31.3 mmtp -90.3 -46.12 8.61 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 176.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . 0.262 3.7 m -85.07 14.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.367 1.331 0 O-C-N 119.418 -2.051 . . . . 0.0 115.682 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 284' ' ' VAL . 39.7 t -129.75 116.43 38.05 Favored 'Isoleucine or valine' 0 C--N 1.366 1.289 0 C-N-CA 127.246 2.219 . . . . 0.0 107.362 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -120.43 155.64 33.07 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 103.632 -2.729 . . . . 0.0 103.632 174.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 9.2 p -78.8 121.58 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.531 1.532 . . . . 0.0 109.974 177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 87.95 23.56 38.0 Favored Glycine 0 C--N 1.362 1.998 0 C-N-CA 125.999 1.761 . . . . 0.0 114.056 -174.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.96 146.04 48.75 Favored 'General case' 0 C--N 1.351 0.66 0 O-C-N 120.922 -1.34 . . . . 0.0 110.753 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 283' ' ' ARG 0.306 2.7 p -92.59 138.72 19.38 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 125.434 1.494 . . . . 0.0 112.18 -178.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.41 HG23 HG13 ' A' ' 330' ' ' VAL . 4.9 m -140.94 179.39 2.38 Favored 'Isoleucine or valine' 0 C--N 1.362 1.151 0 C-N-CA 129.195 2.998 . . . . 0.0 108.828 -176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -110.89 140.39 45.39 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 174.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 346' ' ' LEU . 3.4 m -144.93 139.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.13 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 -168.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.569 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 58.8 ttp -104.71 138.59 40.78 Favored 'General case' 0 CA--C 1.484 -1.588 0 CA-C-N 121.12 1.782 . . . . 0.0 108.337 -173.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.685 HG12 HD12 ' A' ' 344' ' ' LEU . 1.9 m -77.08 128.38 37.94 Favored 'Isoleucine or valine' 0 C--N 1.363 1.156 0 N-CA-C 118.485 2.772 . . . . 0.0 118.485 -165.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -123.64 -131.77 0.27 Allowed 'General case' 0 N--CA 1.421 -1.913 1 N-CA-C 99.731 -4.174 . . . . 0.0 99.731 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . . . . . . . . 0.386 11.6 m-20 -54.64 113.07 1.16 Allowed 'General case' 0 N--CA 1.478 0.953 1 N-CA-C 124.452 4.982 . . . . 0.0 124.452 -156.748 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.68 129.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -145.07 118.5 9.04 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 170.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.77 -16.0 52.43 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 125.179 1.392 . . . . 0.0 113.845 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -86.35 -35.45 19.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 130.013 3.325 . . . . 0.0 111.374 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -94.87 -26.74 16.05 Favored 'General case' 0 C--N 1.367 1.359 0 C-N-CA 125.103 1.361 . . . . 0.0 111.389 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.304 47.0 mtm180 73.37 48.1 0.17 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 131.115 3.766 . . . . 0.0 113.761 173.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.82 129.16 48.85 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 110.278 -3.146 . . . . 0.0 108.091 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.92 123.3 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.433 1 N-CA-C 95.976 -5.565 . . . . 0.0 95.976 174.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.05 94.51 5.21 Favored 'General case' 0 CA--C 1.468 -2.21 1 C-N-CA 110.975 -4.29 . . . . 0.0 106.503 -166.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.685 HD12 HG12 ' A' ' 332' ' ' VAL . 0.0 OUTLIER -97.98 139.02 34.43 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 121.165 1.802 . . . . 0.0 107.68 -175.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 304' ' ' VAL . . . -145.35 122.41 1.7 Allowed Glycine 0 CA--C 1.471 -2.703 0 CA-C-N 114.211 -1.359 . . . . 0.0 109.815 177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.535 ' H ' HG12 ' A' ' 330' ' ' VAL 0.759 0.2 OUTLIER -141.57 -107.07 0.14 Allowed 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 127.499 2.32 . . . . 0.0 112.531 171.019 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . 0.355 13.3 pttp 121.95 29.5 0.0 OUTLIER 'General case' 0 C--N 1.382 2.003 0 C-N-CA 129.954 3.302 . . . . 0.0 115.587 -173.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -86.59 16.84 4.29 Favored 'General case' 0 C--N 1.369 1.441 0 O-C-N 118.438 -2.664 . . . . 0.0 117.181 -175.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.279 11.9 p 62.51 147.87 0.02 OUTLIER 'General case' 0 C--N 1.366 1.314 0 N-CA-C 120.804 3.631 . . . . 0.0 120.804 173.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -103.28 169.3 8.63 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 125.645 1.578 . . . . 0.0 110.518 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -95.3 81.36 3.61 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 119.039 -2.288 . . . . 0.0 111.742 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 94.49 75.2 0.03 OUTLIER Pre-proline 0 C--N 1.354 0.795 1 C-N-CA 132.812 4.445 . . . . 0.0 106.161 -175.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.23 -2.29 4.69 Favored 'Trans proline' 0 C--N 1.366 1.494 1 C-N-CA 125.574 4.183 . . . . 0.0 117.277 -172.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -94.38 -15.96 23.88 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 127.011 2.124 . . . . 0.0 109.554 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . 0.256 9.3 tt0 85.64 90.01 0.03 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.783 3.233 . . . . 0.0 116.783 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -85.27 161.15 19.66 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 125.248 1.419 . . . . 0.0 108.777 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -64.05 97.97 0.2 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 128.246 2.618 . . . . 0.0 114.6 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . 56.32 -109.1 0.47 Allowed 'General case' 0 C--N 1.365 1.272 0 C-N-CA 129.052 2.941 . . . . 0.0 116.534 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -108.81 63.51 0.61 Allowed 'General case' 0 C--N 1.355 0.835 0 C-N-CA 126.659 1.984 . . . . 0.0 109.602 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.1 p -116.11 29.35 8.03 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.558 1.543 . . . . 0.0 109.298 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.43 0 C-N-CA 129.465 3.106 . . . . 0.0 103.86 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' TRP . . . . . . . . . . . . . 81.5 m95 . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 2.1 t -7.05 103.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.332 1 C-N-CA 134.513 5.125 . . . . 0.0 121.166 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.41 47.96 1.14 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.301 1.44 . . . . 0.0 112.875 176.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ILE . . . . . . . . . . . . . 16.9 tt -170.41 175.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . 74.89 -39.02 0.4 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 128.555 2.742 . . . . 0.0 117.926 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -73.43 138.4 45.18 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.178 2.991 . . . . 0.0 112.904 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -95.72 -13.5 24.14 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -167.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -138.57 163.44 46.89 Favored Pre-proline 0 N--CA 1.449 -0.49 0 N-CA-C 103.563 -2.754 . . . . 0.0 103.563 178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -78.84 -34.88 1.13 Allowed 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.519 3.48 . . . . 0.0 112.181 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 73.68 124.72 0.04 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 128.657 2.783 . . . . 0.0 114.23 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 100.08 11.1 43.79 Favored Glycine 0 C--N 1.372 2.545 0 CA-C-O 124.373 2.096 . . . . 0.0 113.114 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' THR . . . . . . . . . . . . . 22.6 p -101.43 136.46 41.23 Favored 'General case' 0 CA--C 1.508 -0.663 1 C-N-CA 131.992 4.117 . . . . 0.0 101.354 171.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 331' ' ' MET . 0.0 OUTLIER -109.37 157.13 19.2 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-O 123.852 1.786 . . . . 0.0 113.039 -176.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -133.93 173.75 11.22 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 112.48 -2.145 . . . . 0.0 107.126 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 38.6 m -108.57 144.73 35.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -152.59 176.94 30.59 Favored Glycine 0 CA--C 1.486 -1.747 0 CA-C-O 123.822 1.79 . . . . 0.0 111.348 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -130.94 130.43 43.44 Favored 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 124.867 1.267 . . . . 0.0 108.477 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 294' ' ' VAL . 27.7 t -74.95 131.76 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 116.196 1.924 . . . . 0.0 116.196 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -114.73 -34.87 5.02 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 112.135 -2.302 . . . . 0.0 112.026 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 293' ' ' PHE . 1.3 t-20 -135.13 155.8 50.08 Favored 'General case' 0 C--N 1.373 1.62 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.63 136.51 54.94 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 101.977 -3.342 . . . . 0.0 101.977 164.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.45 176.84 4.85 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -170.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -30.11 71.28 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 118.769 -2.457 . . . . 0.0 116.544 -177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -145.7 40.94 1.2 Allowed 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 125.758 1.623 . . . . 0.0 110.524 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLY . . . . . . . . . . . . . . . 178.55 -162.19 29.27 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 105.363 -3.095 . . . . 0.0 105.363 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' CYS . . . . . . . . . . . . . 28.2 p -143.31 165.16 28.25 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 173.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 286' ' ' ASN . 9.7 m-85 -115.28 126.59 54.67 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 284' ' ' VAL . 93.2 t -118.9 132.2 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.606 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -167.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -95.93 127.36 41.88 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.255 -1.528 . . . . 0.0 112.734 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ILE . . . . . . . . . . . . 0.288 26.7 mm -73.98 -86.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 123.822 1.772 . . . . 0.0 113.941 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.26 171.35 14.57 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 130.037 3.335 . . . . 0.0 103.514 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.09 119.77 10.15 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 99.44 -17.2 58.08 Favored Glycine 0 C--N 1.37 2.436 0 C-N-CA 127.222 2.344 . . . . 0.0 115.524 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.21 113.31 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.549 1.939 . . . . 0.0 110.527 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -135.5 157.82 45.92 Favored 'General case' 0 CA--C 1.481 -1.71 0 O-C-N 118.307 -2.746 . . . . 0.0 108.215 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . -124.6 172.53 16.89 Favored Glycine 0 CA--C 1.482 -1.973 0 CA-C-O 127.1 3.611 . . . . 0.0 114.424 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . . . . . . . . . 6.6 tp -111.59 161.11 16.56 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 110.307 -2.947 . . . . 0.0 103.269 168.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.54 HG13 ' H ' ' A' ' 346' ' ' LEU . 16.2 t -116.13 130.33 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 O-C-N 124.479 1.112 . . . . 0.0 108.76 163.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -91.8 114.76 27.38 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 166.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 3.3 p -48.92 -23.75 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.373 1.595 0 N-CA-C 120.217 3.414 . . . . 0.0 120.217 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' SER . . . . . . . . . . . . . 4.0 m -80.74 -13.23 59.17 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 128.351 2.661 . . . . 0.0 111.658 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -101.97 68.26 1.12 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 127.06 2.144 . . . . 0.0 106.685 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' MET . . . . . . . . . . . . . 25.3 ttt -168.61 -96.95 0.01 OUTLIER 'General case' 0 C--N 1.35 0.617 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 -174.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -153.58 -114.64 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -144.1 114.67 7.63 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 12.2 t -164.76 173.62 11.61 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 79.44 -50.74 0.41 Allowed 'General case' 0 C--N 1.364 1.212 0 C-N-CA 128.171 2.588 . . . . 0.0 110.382 -176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -77.37 2.46 15.87 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 130.692 3.597 . . . . 0.0 112.292 171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -104.99 -112.57 0.25 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 127.169 2.188 . . . . 0.0 108.164 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.85 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.036 0 O-C-N 119.546 -1.972 . . . . 0.0 108.808 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 60.4 m170 -108.23 120.47 46.62 Favored Pre-proline 0 C--N 1.356 0.87 0 O-C-N 119.421 -2.049 . . . . 0.0 112.879 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.17 -28.33 7.42 Favored 'Trans proline' 0 C--N 1.36 1.148 0 C-N-CA 123.98 3.12 . . . . 0.0 110.877 174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 8.2 m -61.64 -16.9 52.65 Favored 'General case' 0 C--N 1.368 1.402 1 C-N-CA 133.1 4.56 . . . . 0.0 115.421 176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . 0.254 22.4 pttp -91.72 -36.35 13.64 Favored 'General case' 0 C--N 1.373 1.602 0 C-N-CA 125.269 1.428 . . . . 0.0 114.142 174.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' VAL . . . . . . . . . . . . . 26.2 m -90.98 -23.61 5.88 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 CA-C-N 121.265 1.848 . . . . 0.0 112.468 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.32 107.78 17.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.827 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -101.71 158.08 16.37 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-O 123.641 1.686 . . . . 0.0 107.576 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 2.2 p -76.38 120.75 27.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 C-N-CA 125.199 1.4 . . . . 0.0 109.565 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLY . . . . . . . . . . . . . . . 89.49 18.03 53.44 Favored Glycine 0 C--N 1.364 2.098 0 C-N-CA 124.658 1.123 . . . . 0.0 114.235 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.5 144.03 32.83 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 125.501 1.521 . . . . 0.0 109.659 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.85 139.86 16.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 CA-C-O 124.006 1.86 . . . . 0.0 111.345 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 346' ' ' LEU . 0.4 OUTLIER -144.59 174.72 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 130.111 3.364 . . . . 0.0 107.32 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -118.91 144.07 46.64 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 103.898 -2.63 . . . . 0.0 103.898 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 344' ' ' LEU . 0.1 OUTLIER -146.09 139.82 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.446 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 -175.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' MET . . . . . 0.585 ' HA ' ' HA ' ' A' ' 279' ' ' LYS . 52.7 ttp -104.0 136.88 42.83 Favored 'General case' 0 CA--C 1.503 -0.842 0 O-C-N 119.916 -1.74 . . . . 0.0 109.299 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . 0.267 0.2 OUTLIER -83.83 135.41 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 -169.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.46 -126.86 0.26 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 102.884 -3.006 . . . . 0.0 102.884 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ASP . . . . . 0.53 ' N ' ' HB2' ' A' ' 343' ' ' SER 0.437 12.2 m-20 -59.49 113.55 2.26 Favored 'General case' 0 N--CA 1.483 1.181 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -160.014 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 341' ' ' ARG . 4.9 tp -112.89 120.82 63.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 118.612 2.819 . . . . 0.0 118.612 -165.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 339' ' ' ARG . 12.3 t0 -140.44 118.57 11.96 Favored 'General case' 0 C--N 1.363 1.155 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.23 -1.73 57.62 Favored 'General case' 0 C--N 1.367 1.344 0 C-N-CA 126.576 1.95 . . . . 0.0 113.858 -176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.2 -40.12 9.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 129.245 3.018 . . . . 0.0 109.73 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.527 ' HB2' ' HB3' ' A' ' 336' ' ' ASP . 8.1 mmt180 -88.22 -32.74 18.41 Favored 'General case' 0 CA--C 1.497 -1.073 0 C-N-CA 131.275 3.83 . . . . 0.0 112.765 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ARG . . . . . . . . . . . . 0.329 1.3 mmp_? 75.27 50.9 0.08 Allowed 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 129.426 3.09 . . . . 0.0 114.89 169.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 335' ' ' ILE . 0.0 OUTLIER -125.25 132.22 52.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 110.848 -2.887 . . . . 0.0 108.945 177.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . . . . . . . . . 1.5 mm -119.99 126.84 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 1 N-CA-C 94.177 -6.231 . . . . 0.0 94.177 171.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 334' ' ' ASP . 39.6 m -111.0 102.45 10.93 Favored 'General case' 0 CA--C 1.446 -3.053 1 C-N-CA 111.291 -4.164 . . . . 0.0 107.063 -165.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -95.76 173.58 7.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 125.06 2.362 . . . . 0.0 110.913 -165.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -146.36 136.32 6.23 Favored Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.841 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LEU . . . . . 0.54 ' H ' HG13 ' A' ' 304' ' ' VAL . 1.0 OUTLIER -61.8 149.17 40.85 Favored 'General case' 0 C--N 1.369 1.435 1 N-CA-C 123.584 4.661 . . . . 0.0 123.584 -164.976 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -94.92 -98.33 0.16 Allowed 'General case' 0 C--N 1.39 2.363 0 O-C-N 120.916 -1.115 . . . . 0.0 112.8 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -141.24 -1.18 1.37 Allowed 'General case' 0 C--N 1.373 1.601 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' CYS . . . . . . . . . . . . 0.316 3.6 m 79.81 163.36 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.257 1.823 . . . . 0.0 115.445 -173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HG3' ' HB3' ' A' ' 353' ' ' PRO . 0.0 OUTLIER -56.69 -145.24 0.0 OUTLIER 'General case' 0 C--N 1.354 0.766 1 C-N-CA 134.535 5.134 . . . . 0.0 118.88 174.114 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 164.9 89.04 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 C-N-CA 129.935 3.294 . . . . 0.0 102.969 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 93.11 74.47 0.03 OUTLIER Pre-proline 0 C--N 1.358 0.963 0 C-N-CA 130.087 3.355 . . . . 0.0 105.795 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' PRO . . . . . 0.415 ' HB3' ' HG3' ' A' ' 350' ' ' LYS . 57.9 Cg_endo -68.01 148.04 75.03 Favored 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 124.509 3.473 . . . . 0.0 112.29 -174.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -52.56 46.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 130.983 3.713 . . . . 0.0 120.643 -175.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -133.92 -61.3 0.8 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.561 1.544 . . . . 0.0 110.639 -178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLN . . . . . . . . . . . . 0.267 0.7 OUTLIER 88.86 126.08 0.03 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.245 2.618 . . . . 0.0 112.626 -176.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -93.95 166.31 12.23 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 125.892 1.677 . . . . 0.0 112.014 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ALA . . . . . . . . . . . . . . . -94.76 66.06 3.11 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.764 1.626 . . . . 0.0 111.786 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -150.88 147.71 27.55 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 73.2 p -106.85 55.15 0.66 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 126.302 1.841 . . . . 0.0 110.738 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.267 2.008 2 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 178.882 . . . . . . . . 2 2 . 1 stop_ save_